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I	  wonder	  how,	  I	  wonder	  why	  
Yesterday	  you	  told	  me	  'bout	  the	  blue	  blue	  sky	  
And	  all	  that	  I	  can	  see	  is	  just	  a	  yellow	  lemon-­‐tree	  
	  
Fool’s	  Garden	  1995,	  Lemon	  Tree	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Enzymes	  are	  proteins,	  things	  of	  beauty	  and	  joy	  forever.	  




















Abstract:	   This	   chapter	   gives	   an	   overview	   of	   oxidative	  
enzymes	  in	  general	  and	  the	  classification	  and	  characteristics	  
of	   the	   flavoprotein	   monooxygenases	   in	   particular.	   The	  
typical	   cofactors	   for	   flavoprotein	   monooxygenases,	   FAD	  
and	   NAD(P)H,	   are	   described	   in	   detail.	   This	   chapter	   also	  
provides	   information	  on	  the	  goal	  of	  the	  described	  research	  
and	  the	  specific	  organism	  Rhodococcus	  jostii	  RHA1	  which	  has	  
been	  used	  as	  source	  of	  the	  enzymes	  described	  in	  this	  thesis.	  
	   	  
GENERAL	  INTRODUCTION	  
 3 
1.1. Oxidative	  enzymes	  	  
Enzymes	   are	   well	   known	   and	   thoroughly	   studied	   biocatalysts	   that	   allow	   green	   and	  
alternative	   solutions	   for	   the	   chemical	   industry.	   They	  are	   categorized	   in	   six	  main	   classes,	  
depending	  on	  their	  chemical	  reactivity.	  Enzymes	  studied	  in	  this	  thesis	  belong	  to	  the	  class	  
of	   oxidoreductases	   or	   redox	   enzymes	   (EC	   1.x.x.x)	   (Dixon	  &	  Webb	   1979).	   Such	   enzymes	  
catalyze	   the	   transfer	   of	   electrons	   in	   biochemical	   reactions.	   Being	   more	   precise,	   the	  
enzymes	   described	   here	   belong	   to	   the	   subclass	   of	   monooxygenases	   (EC	   1.13.x.x	   and	  	  	  	  	  	  	  	  
EC	   1.14.x.x).	   These	   enzymes	   perform	   oxygenation	   reactions	   using	   a	   suitable	   electron	  
donor	  and	  molecular	  oxygen	  (O2)	  as	  oxygen	  donor.	  Hereby,	  monooxygenases	   insert	  only	  
one	  single	  oxygen	  atom	  into	  the	  organic	  substrate	  under	  the	  elimination	  of	  water.	  
To	   perform	   the	   spin-­‐forbidden	   reaction	   between	   molecular	   oxygen	   and	   an	   organic	  
compound,	   the	   ground-­‐state	   dioxygen	   in	   its	   triplet	   state	   needs	   to	   be	   activated	   first	   by	  
receiving	   electrons.	   Therefore,	   most	   oxidative	   enzymes	   require	   cofactors	   like	   flavins,	  
hemes	  or	  transition	  metal-­‐ions	  for	  the	  catalytic	  activity	  (Cirino	  &	  Arnold	  2002).	  The	  affinity	  
of	  the	  cofactor	  towards	  the	  enzyme	  differs	  between:	  
• coenzymes	  that	  act	  like	  a	  substrate	  and	  interact	  with	  different	  enzymes,	  
or	  
• a	   tightly	   (and	   sometimes	   even	   covalently)	   bound	   prosthetic	   group,	  
which	  is	  part	  of	  the	  enzyme	  structure	  itself	  (Torres	  Pazmiño	  et	  al.	  2010).	  
Regarding	   their	   chemical	   composition,	   cofactors	   can	   be	   divided	   in	   two	   main	   classes:	  
inorganic	   (i.e.	   metal	   ions	   and	   iron-­‐sulfur	   clusters)	   (Andreini	   et	   al.	   2008),	   and	   organic	  
cofactors	   (i.e.	   flavin	   and	   heme)	   (Fischer	   et	   al.	   2010).	   In	   processes	   involving	   electron	  
transfers	  mainly	  organic	  cofactors	  are	  used	  as	  80%	  of	  all	  oxidoreductases	  employ	  such	  a	  
cofactor	  (Kopacz	  et	  al.	  2012).	  
1.2. The	  yellow	  cofactor:	  flavin	  	  
In	   1932	   the	   first	   evidence	   for	   the	   oxidative	   power	   of	   a	   yellow	   compound	  was	   found	   in	  
brewers’	  bottom	  yeast	  by	  Warburg	  &	  Christian	  (1932)	  when	  they	  observed	  the	  biological	  
oxidation	   of	   glucose-­‐6-­‐phosphate.	   In	   1935	   Theorell	   was	   able	   to	   purify	   the	   oxidative	  
CHAPTER	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compound,	   yielding	   a	   colorless	   apo	   protein	   and	   a	   yellow	   dye.	   Both	   components	   were	  
shown	   to	   be	   necessary	   for	   the	   observed	   activity.	   This,	   for	   the	   first	   time	   indicated	   the	  
essential	  role	  of	  proteins	  and	  their	  cofactors	  for	  biocatalysis.	  After	  a	  “new”	  yellow	  protein	  
was	  found	  in	  yeast	  1938	  by	  Haas,	  the	  “old”	  one	  got	  its	  final	  name	  which	  is	  still	  valid	  today:	  
old	   yellow	  enzyme	   (OYE)	   (Williams	  &	  Bruce	  2002).	   Soon	  after	   its	   initial	   discovery	   it	  was	  
realized	  that	  the	  yellow	  dye	  in	  OYE	  was	  similar	  to	  vitamin	  B2
	  
(riboflavin).	  This	  showed	  that	  
vitamins	  have	  biochemical	  roles	  in	  enzymes.	  Theorell	  could	  show	  that	  the	  yellow	  cofactor	  
in	   OYE	   was	   a	   phosphorylated	   form	   of	   riboflavin:	   riboflavin	   5’-­‐phosphate	   or	   flavin	  
mononucleotide	   (FMN).	  He	  could	  also	  show	  that	  FMN	  could	  be	  bound	  again	  by	   the	  apo	  
protein	  after	  purification,	  restoring	  the	  activity	  of	  the	  inactive	  apo	  protein	  (Theorell	  1935,	  
Ghisla	  &	   Edmondson	   2009).	   For	   the	   discovery	   of	   the	   interaction	   between	   enzymes	   and	  
their	  cofactors	  he	  was	  awarded	  the	  Nobel	  Price	   in	  Medicine	  in	  1955.	   In	  the	  “new	  yellow	  
enzyme”,	   flavin	   adenine	   dinucleotide	   (FAD)	  was	   found	   to	   be	   the	   flavin	   cofactor	   and	   its	  
chemical	  synthesis	  was	  honored	  with	  the	  Noble	  Prize	  in	  Chemistry	  to	  Sir	  Todd	  in	  1957.	  
Together,	  FAD	  and	  FMN	  represent	  the	  two	  most	  common	  flavin	  cofactors	  containing	  
the	   7,8-­‐dimethyl-­‐10-­‐alkylisoalloxazine	   ring	   system	   (Warburg	   &	   Christian	   1933).	   Their	  
biosynthetic	   precursor	   is	   riboflavin	   (vitamin	   B2)	   (Kopacz	   et	   al.	   2012)	   and	   FAD/FMN	  
represent	  its	  biologically	  active	  form	  (Figure	  1-­‐1).	  In	  contrast	  to	  the	  aqueous	  solubility	  of	  
their	  precursor	   riboflavin	   (<	  10-­‐4	  mol	  L-­‐1),	   the	  solubility	  of	  FMN	  and	  FAD	   is	  high	   (approx.	  
0.1	   mol	   L-­‐1)	   due	   to	   the	   negatively	   charged	   phosphorylated	   side	   chain	   (Ghisla	   &	  
Edmondson	  2009).	  
The	   isoalloxazine	   ring	   system	   is	   a	   formal	   fusion	  of	   xylene	   (dimethylbenzene,	  A-­‐ring),	  
pyrazine	   (phenylenediamine,	  B-­‐ring)	  and	  pyrimidine	   (C-­‐ring)	   (Ghisla	  &	  Edmondson	  2009)	  
and	   is	   responsible	   for	   the	   amphipathic	   character.	   Mainly	   the	   xylene	   ring	   has	   been	  
observed	   to	   be	   involved	   in	   substitution	   and	   addition	   reactions	   that	   result	   in	   naturally	  
occurring	   flavin	   cofactor	   derivatives.	   Being	   the	   redox-­‐active	   center	   of	   flavin	   cofactors,	  
electrons	  are	  delivered	  to	  and	  removed	  from	  the	  three	  ring	  system,	  mainly	  via	  the	  central	  
N5	  or	   bridgehead	   C4α	  atoms	   (Walsh	   &	  Wencewicz	   2013).	   In	   this	   way,	   reversible	   one-­‐	   or	  
two-­‐electron	  transfer	  reactions,	  as	  well	  as	  dioxygen	  activation	  are	  possible	  (Massey	  1994).	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These	   functionalities,	   together	   with	   the	   fact	   that	   these	   reactions	   are	   kinetically	   and	  
thermodynamically	   favorable,	   makes	   the	   flavin	   cofactor	   a	   powerful	   biological	   redox	  
catalyst	  (Ghisla	  &	  Edmondson	  2009,	  Walsh	  &	  Wencewicz	  2013).	  	  
	  
Figure	  1-­‐1:	  Structural	  formulas	  of	  riboflavin	  (B2)	  and	  the	  flavin	  cofactors	  FMN	  and	  FAD.The	  electrophilic	  double	  
imine	  moiety	  N5-­‐C4α-­‐C1α-­‐N1	  is	  highlighted	  in	  grey.	  
The	   central	   pyrazine	   is	   surrounded	   by	   a	   xylene	   and	   a	   pyrimidine.	   The	   pyrophosphate	  
moiety	  and	  the	  adenine	  ring	  are	  used	  for	  binding	  and	  positioning	  of	  the	  flavin	  within	  the	  
enzyme	  (Fruk	  et	  al.	  2009,	  Kopacz	  et	  al.	  2012).	  Also	  the	  hydrophilic	  pyrimidine	  ring	  allows	  
interactions	  with	   the	   protein	   environment	   via	   hydrogen-­‐bonding,	   acting	   as	   both,	   donor	  
and	  acceptor.	  Such	  modulations	  of	  the	  pyrimidine	  ring	  can	  also	  influence	  the	  properties	  of	  
the	   pyrazine	   ring.	   The	   hydrophobic	   xylene	   ring	   on	   the	   other	   side	   allows	   stacking	   with	  
aromatic	  amino	  acid	  side	  chains	  in	  proteins	  (Ghisla	  &	  Edmondson	  2009).	  
While	   the	  pyrimidine	   ring	   is	   relatively	  electron	  deficient,	   the	  xylene	   is	  more	  electron	  
rich.	   The	  pyrazine	   ring	   is	   bridging	   these	   two	   systems	  and	   therefore	   its	  N5	   and	  C4α	   show	  
electrophilic	  properties,	  allowing	  photoaddition	  as	  well	  as	  nucleophilic	  addition	  reactions.	  
Modifications	   in	   the	   pyrimidine	   or	   the	   benzene	   moiety	   can	   strongly	   affect	   the	   redox	  
potential	  of	  the	  flavin	  and	  several	  natural	  occurring	  variants	  are	  known	  (e.g.	  8-­‐desmethyl	  
O-­‐	  or	  N-­‐substituted	  flavin;	  6-­‐	  substituted	  flavin)	  (Ghisla	  &	  Edmondson	  2009).	  	  
CHAPTER	  1	  
 6 
It	   is	   noteworthy	   that	   both	   names	   ‘FMN’	   and	   ‘FAD’	   are	   incorrect.	   FMN	   is	   not	   a	  
mononucleotide,	  nor	  is	  FAD	  a	  dinucleotide	  since	  the	  bond	  between	  the	  ribose	  moiety	  and	  
the	  isoalloxazine	  ring	  is	  not	  glycosidic.	  Nevertheless,	  both	  names	  are	  generally	  accepted	  in	  
the	  scientific	  community	  and	  also	  by	  the	  IUPAC.	  	  
1.2.1. Yellow	  by	  sight	  
A	  prominent	  feature	  of	  the	  flavin	  cofactor	  is	  its	  bright	  yellow	  color	  that	  is	  also	  responsible	  
for	   its	   name:	   flavus	   (latin	   =	   yellow).	   The	   yellow	   color	   results	   from	   the	   lowest	   transition	  
state	  of	  the	  isoalloxazine	  chromophore	  around	  450	  nm.	  In	  total	  four	  prominent	  electronic	  
transitions	  can	  be	  detected	  in	  the	  visible/ultraviolet	  (UV)	  spectral	  region	  (Figure	  1-­‐2).	  	  
The	   reduction	   of	   the	   flavin	   by	   one	   electron	   generates	   the	   flavin	   radical,	   the	  
semiquinone	   form.	   In	   its	   neutral	   form	   it	   displays	   a	   blue	   color	   due	   to	   the	   absorption	  
maxima	  at	  615	  nm	  and	  580	  nm,	  while	   in	  anionic	   form	  the	  color	  shifts	   to	   red	   (Massey	  &	  
Palmer	  1966).	  Adding	  another	  electron	  yields	  the	  ‘leuco’	  or	  fully	  reduced	  flavin,	  which	  is	  
colorless.	  
	  
Figure	   1-­‐2:	   Absorption	   spectra	   of	   the	   flavin	  molecule	   in	   different	   redox	   states	   and	   ionic	   forms.	   The	   radical	  
forms	   (semiquinones)	   can	   only	   be	   stabilized	   when	   bound	   to	   a	   protein.	   Spectra	   taken	   from	   Ghisla	   &	  
Edmondson	  2009	  and	  modified.	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As	   result	   of	   the	   yellow	   color	   of	   oxidized	   flavin,	   flavoproteins	   are	   typically	   yellow	  when	  
isolated.	  This	  feature	  gives	  clear	   indications	  about	  the	  status	  of	  the	  expressed	  protein:	  a	  
properly	  folded	  and	  flavin	  equipped	  holo	  flavoenzyme	  can	  be	  easily	  detected	  by	  sight.	  The	  
flavin	   is	   not	   only	   absorbing	   light	   at	   specific	   wavelengths,	   it	   also	   displays	   typical	  
fluorescence	   emissions.	   Therefore	   changes	   in	   redox	   and	   protonation	   states	   can	   also	   be	  
observed	   in	   fluorescence	   emission	   spectra.	   Oxidized	   flavin	   emits	   light	   at	   520-­‐540	   nm,	  
while	   semiquinones	   (anionic	   or	   neutral)	   and	   the	   fully	   reduced	   flavins	   are	   colorless	   in	  
aqueous	   solutions	   and	   poorly	   fluorescent.	   Differences	   in	   flavin	   fluorescence	   quenching	  
are	  also	  used	  to	  distinguish	  between	  FMN	  and	  FAD	  which	  is	  caused	  by	  an	  intramolecular	  
interaction	  between	  the	  isoalloxazine	  ring	  and	  the	  adenine	  ring	  moieties	  in	  FAD.	  	  
Both,	   the	   absorption	   spectra	   and	   the	   fluorescence	   emission	   of	   the	   different	   redox	  
states	  and	  protonation	  levels	  of	  the	  flavin	  are	  strongly	  dependent	  on	  the	  environment	  the	  
flavin	   is	   situated	   in.	   This	   allows	   probing	   the	   microenvironment	   around	   the	   flavin	   like	  
ligands,	  protein,	  lipid	  membrane	  or	  solvent.	  	  
	  
The	  obvious	  yellow	  color	  of	  a	  flavoprotein	  and	  the	  fact	  that	  the	  spectral	  properties	  
of	  the	  flavin	  change	  with	  its	  redox	  state	  brought	  us	  to	  the	  idea	  to	  develop	  a	  method	  
to	  determine	  the	  concentration	  of	  active	  enzyme	  in	  cell	  extracts:	  only	  enzymes	  with	  
a	   properly	   incorporated	   flavin	   will	   be	   active	   and	   therefore	   can	   selectively	   be	  
reduced	  by	  a	  suitable	  substrate.	  As	  proper	  flavin	  incorporation	  requires	  a	  properly	  
folded	   enzyme	   environment,	   we	   can	   quantify	   the	   produced	   flavoprotein	  




In	  flavoprotein	  monooxygenases	  the	  catalytic	  cycle	  (Figure	  1-­‐3)	  can	  be	  divided	  in	  two	  half	  
reactions.	   In	   the	   reductive	  half	   reaction	   (Figure	   1-­‐3,	   5	  à	   1)	   the	  oxidized	   flavin	  becomes	  
reduced	   by	   the	   oxidation	   of	   a	   cosubstrate	   (NAD(P)H).	   In	   the	   oxidative	   half	   reaction	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oxygenation	  of	  the	  substrate	  takes	  places	  and	  the	  oxidized	  flavin	  cofactor	  is	  formed	  again.	  
In	   this	  way	   the	   flavin	  has	  no	   impact	  on	   the	   reaction	   stoichiometry	  what	  makes	   it	   a	   real	  
catalyst	  (Walsh	  1980).	  
	  
Figure	  1-­‐3:	  Catalytic	  cycle	  of	  flavin-­‐dependent	  monooxygenases	  (van	  Berkel	  et	  al	  2006).	  
At	   the	   beginning	   of	   the	   flavin-­‐cycle	   the	   flavin	   gets	   reduced	   (5	  à	   1)	   by	   NAD(P)H	   via	   a	  
hydride	  transfer	  to	  N5	  due	  to	  the	  electrophilic	  double	   imine	  moiety	  (i.e.	  N5-­‐C4α-­‐C1α-­‐N1	  in	  
the	  oxidized	  flavin).	  Subsequently,	  the	  reduced	  and	  therefore	  electron	  rich	  flavin	  performs	  
a	  one-­‐electron	  transfer	  to	  molecular	  oxygen,	  creating	  a	  reactive	  intermediate	  (consisting	  
of	   a	   superoxide	   and	   a	   flavin	   radical).	   A	   spin-­‐inversion	   then	   allows	   the	   formation	   of	   a	  
covalent	  bond	  between	  the	  oxygen	  and	   the	  C4α	  of	   the	   isoalloxazine	   ring	  system	  yielding	  
the	   C4α-­‐peroxyflavin	   (1	   à	   2)	   (Ghisla	   &	   Massey	   1989).	   This	   intermediate	   stays	   in	  
equilibrium	  with	   its	  protonated	  equivalent,	   the	  C4α-­‐hydroperoxyflavin	   (3)	   (Walsh	  &	  Chen	  
1988,	  Sheng	  et	  al.	  2001).	  Even	  though	  both	  forms	  are	  stabilized	  within	  the	  enzyme,	  they	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either	   directly	   in	   the	   absence	  of	   a	   substrate	   under	   the	   formation	  of	   hydrogen	  peroxide	  
(H2O2)	   as	   a	   net	   oxidase	   reaction	   (uncoupling,	   2	  à	   5).	   Alternatively,	   an	   oxygenation	  will	  
occur.	  The	  oxygenation	  of	  a	  substrate	  (2/3	  à	  4)	  results	  in	  formation	  of	  a	  C4α–hydroxyflavin	  
(4).	  Such	  hydroxyflavin	  decays	  by	  release	  of	  a	  water	  molecule	  (4	  à	  5)	  (Massey	  1994).	  	  
For	   the	   oxygenation	   reaction,	   both	   a	   nucleophilic	   or	   an	   electrophilic	   attack	   are	  
possible,	  depending	  on	  the	  protonation	  state	  of	  the	  C4α-­‐flavin	  intermediate.	  Which	  of	  the	  
two	   peroxy-­‐forms	   of	   the	   flavin	   (peroxyflavin	   (2)	   or	   hydroperoxyflavin	   (3))	   is	   involved	   in	  
catalysis	   strongly	   depends	   on	   the	   enzyme	   and/or	   substrate.	   A	   nucleophilic	   attack	   is	  
required	   for	   Baeyer-­‐Villiger	   reactions	   and	   epoxidation	   reactions	   (2	   à	   4),	   while	   an	  
electrophilic	   attack	   is	   proposed	   for	   sulfoxidations	   and	   hydroxylations	   (3	  à	   4)	   (Walsh	   &	  
Chen	  1988,	  Chen	  et	  al.	  1999,	  Colonna	  et	  al.	  2003).	  
1.3. Priming	  the	  flavin	  cofactor:	  NAD(P)H	  as	  reducing	  coenzyme	  
To	  be	  able	  to	  perform	  oxygenating	  reactions,	  the	  flavin	  cofactor	  needs	  to	  be	  charged	  with	  
electrons.	  Monooxygenases	   that	   are	   able	   to	   obtain	   these	   electrons	   from	   the	   substrate	  
itself	   are	   called	   internal	   monooxygenases	   (EC	   1.13.12)	   and	   are	   extremely	   rare.	   The	  
majority	   of	  monooxygenases	   belong	   to	   the	   external	   family	   (EC	   1.14.13)	   and	   depend	   on	  
external	   electron	  donors	   like	   reduced	   coenzymes	   (van	  Berkel	  et	  al.	   2006).	   The	  enzymes	  
discussed	   in	   this	   thesis	   are	   all	   external	   monooxygenases	   and,	   as	   seen	   in	   Figure	   1-­‐3,	  
specifically	  employ	  nicotinamide	  coenzymes.	  
Nature	  has	  developed	  two	  quite	  similar	   forms	  of	  nicotinamide	  cofactors	   (Figure	  1-­‐4),	  
differing	   only	   in	   one	   phosphate	   group	   at	   the	   ribose	   2´-­‐position:	   NADH	   (nicotinamide	  
adenine	  dinucleotide)	  and	  NADPH	  (nicotinamide	  adenine	  dinucleotide	  phosphate).	  	  
In	   1906	   the	   biochemists	   Harden	   and	   Young	   first	   discovered	   a	   substance	   (later	  
identified	   as	   NADH)	   in	   “yeast-­‐juice”,	   which	   by	   itself	   did	   not	   show	   catalytic	   activity	   on	  
alcoholic	   fermentation	  but	  was	  able	   to	  accelerate	   this	   reaction	   (Harden	  &	  Young	  1906).	  	  
Later,	  Warburg	  was	   able	   to	   unravel	   its	   function	   in	   hydride	   transfer.	   He	   also	   discovered	  
NADPH,	   which	   in	   old	   literature	   is	   referred	   to	   as	   triphosphopyridinucleotide	   (TPN)	   or	  




Figure	  1-­‐4:	  Structural	  formulas	  of	  NADH	  (R	  =	  OH)	  and	  NADPH	  (R	  =	  PO42-­‐).	  
Both	  cofactors	  transport	  hydride	  (H-­‐)	  ions	  in	  their	  reduced	  forms	  NADH	  and	  NADPH.	  This	  
hydride	   ion	   is	   conserved	   in	  an	  energetically	   rich	  bond	  on	   the	  nicotinamide	   ring	  and	  can	  
therefore	  easily	  be	  transferred	  to	  acceptor	  molecules.	  The	  reduced	  nicotinamide	  moiety	  
represents	   a	   quinoid	   system	   that	   absorbs	   light	   with	   a	   wavelength	   of	   340	   nm,	   a	  
characteristic	  that	  the	  oxidized	  form	  does	  not	  show.	  The	  disappearance	  of	  the	  absorption	  
peak	   at	   340	   nm	   due	   to	   the	   consumption	   of	   NAD(P)H	   by	   an	   enzyme	   is	   an	   easy	   way	   to	  
spectrophotometrically	   follow	   the	   enzyme	   activity	   as	   the	   decline	   of	   NAD(P)H	  
concentration	   is	   proportional	   to	   the	   concentration	   of	   converted	   substrate	   –	   under	   the	  
assumption	  that	  no	  uncoupling	  occurs.	  	  
In	   contrast	   to	   the	   flavin	   cofactor	  discussed	  earlier,	  which	   is	  often	   tightly	   (sometimes	  
even	   covalently)	   bound	   by	   a	   protein	   (Valton	   et	   al.	   2008),	   the	   nicotinamide	   coenzymes	  
typically	  dissociate	  after	  each	  catalytic	  cycle	  (Walsh	  1979).	  They	  are	  found	  unbound	  and	  in	  
soluble	  form	  within	  the	  cells	  acting	  as	  electron	  transport	  molecules,	  as	  no	  harmful	  radical	  
is	  formed	  during	  reduction/oxidation	  of	  these	  compounds.	  
The	   extra	   phosphate	   group	   of	   NADPH	   has	   no	   influence	   on	   the	   electron	   transfer	  
capability	  of	  this	  molecule.	  Yet,	  it	  has	  an	  effect	  on	  the	  affinity	  towards	  different	  enzymes.	  
NADPH	   is	   typically	   used	   as	   reducing	   agent	   in	   biosynthetic	   processes,	   while	   NAD+	   is	  
responsible	  for	  oxidations	  in	  the	  cellular	  metabolism.	  Even	  though	  the	  function	  of	  the	  two	  




























This	   system	  allows	   the	   cell	   to	   carefully	   regulate	   its	   energy-­‐	   and	   synthesis	   flow	   and	   also	  
spatial	  separation	  thereof	  (Alberts	  2008).	  The	  redox	  state	  of	  a	  cell	  is	  a	  clear	  indicator	  not	  
only	  for	  its	  metabolic	  situation	  but	  also	  of	  the	  health	  of	  the	  cell	  (Schafer	  &	  Buettner	  2001).	  
While	   the	   extra	   phosphate	   group	  of	  NADPH	  does	   not	   affect	   the	   redox	   properties,	   it	  
clearly	  has	  an	  effect	  on	  the	  price	  of	  the	  two	  different	  nicotinamide	  coenzymes.	  The	  reason	  
for	   this	   is	   the	   fact	   that	   these	   cofactors	  have	   to	  be	   isolated	   from	  biomaterial.	   In	   case	  of	  
eukaryotic	  tissue,	  e.g.	  rat	  liver,	  approximately	  1	  μmol	  per	  gram	  of	  wet	  weight	  NAD+/NADH	  
can	  be	  isolated,	  outnumbering	  the	  NADP+/NADPH	  concentration	  by	  a	  factor	  of	  ten	  (Reiss	  
et	  al.	  1984).	  This	  correlates	  well	  with	  the	  commercial	  price	  of	  the	  two	  coenzymes:	  while	  
NADH	  is	  already	  expensive,	  also	  here	  NADPH	  surpasses	  it	  by	  one	  order	  of	  magnitude.	  This	  
makes	   industrial	   processes	  with	   enzymes	   that	   consume	  NADH	   and	   especially	  NADPH	   in	  
stoichiometric	   amounts	   extremely	   expensive	   and	   therefore	   often	   not	   competitive	   with	  
chemical	  methods.	  
Different	  solutions	  have	  been	  discussed	  in	  the	  past	  decades	  addressing	  the	  question	  of	  
regeneration	   of	   these	   valuable	   coenzymes	   in	   biotechnological	   processes.	   The	   most	  
comfortable	   solution	   clearly	   is	   the	   use	   of	   whole	   cells,	   using	   the	   cellular	   machinery	  
together	  with	   the	   recombinantly	  expressed	  enzyme	  of	   interest	   (Stewart	  1997).	  But	   cells	  
and	   cell	   components	   are	   not	   always	   compatible	   with	   the	   target	   reaction	   or	   process	  
conditions.	   Then	   the	   use	   of	   an	   isolated	   enzyme	   is	   the	  method	   of	   choice.	   However,	   an	  
efficient	   external	   regeneration	   system	   is	   needed	   to	   provide	   the	   enzyme	   with	   its	  
regenerated	  coenzyme.	  Several	  photo-­‐	  and	  electrochemical	  approaches	  have	  been	  tested	  
so	   far	   to	   replace	   a	   second	   coenzyme	   regenerating	   enzyme	   system,	   but	   often	  with	   only	  
poor	  efficiency	  (van	  der	  Donk	  &	  Zhao	  2003,	  Hollmann	  et	  al.	  2006,	  Hollmann	  et	  al.	  2007).	  
Using	   a	   second	   isolated	   enzyme	   for	   cofactor	   regeneration	   seems	   to	   be	   the	   most	  
suitable	  method	  so	  far	  –	  as	   long	  as	  the	  sacrificial	  substrate	   is	  cheap	  and	  no	   interference	  
with	   the	   desired	   enzymatic	   reaction	   (activity	   and	   selectivity)	   takes	   place.	   Especially	  
dehydrogenases	   are	   widely	   used	   for	   this.	   A	   relatively	   recent	   promising	   example	   is	  
phosphite	  dehydrogenase	  (PTDH)	  from	  Pseudomonas	  stutzeri	  WM88	  (Costas	  et	  al.	  2001)	  
which	  merely	  uses	  phosphite	  for	  regeneration	  of	  NADPH	  or	  NADH.	  
CHAPTER	  1	  
 12 
In	  our	  group	  we	  experimented	  with	   fusing	  PTDH	  with	  a	  number	  of	  Baeyer-­‐Villiger	  
monooxygenases	  using	  an	  in-­‐house	  developed	  expression	  vector	  (Torres	  Pazmiño	  et	  
al.	   2008).	   In	  an	  attempt	   to	  optimize	   this	   expression	   system,	  we	  have	  now	  used	  a	  
thermostable	   variant	   of	   the	   PTDH	   (Johannes	   et	   al.	   2005,	   Johannes	   et	   al.	   2006,	  
Woodyer	  et	  al.	  2006)	  and	  tested	  the	  influence	  of	  the	  linker	  length	  and	  composition	  
on	   the	  properties	  of	   the	   fusion	  enzymes.	   The	   results	  of	   this	  work	   can	  be	   found	   in	  
chapter	  2.	  
In	   chapter	   4	   &	   5	   we	   describe	   a	   new	   subclass	   of	   class	   B	   flavoprotein	  
monooxygenases	  (Type	  II	  FMOs),	  that	  –	  in	  contrast	  to	  other	  class	  B	  flavoproteins	  -­‐	  
shows	  no	  preference	  for	  either	  NADH	  or	  NADPH.	  This	  is	  especially	  interesting	  when	  
considering	  the	  applicability	  of	  these	  newly	  discovered	  enzymes	  for	  Baeyer-­‐Villiger	  
oxidations.	  
	  
1.4. Flavoprotein	  monooxygenases	  
Biochemical	   studies	  have	  not	  only	  shown	  that	   flavoprotein	  monooxygenases	  are	  able	   to	  
perform	  a	  wide	   range	  of	   different	   oxygenation	   reactions,	   they	   are	   also	   able	   to	  perform	  
such	   reactions	   with	   highly	   chemo-­‐,	   regio-­‐	   and/or	   enantioselectivity.	   A	   classification	   for	  
external	  flavin-­‐dependent	  monooxygenases	  was	  introduced	  by	  van	  Berkel	  et	  al.	  in	  2006	  as	  
they	   form	   a	   major	   and	   ubiquitous	   group	   of	   monooxygenases,	   performing	   oxygenation	  
reactions	   that	   include	   hydroxylations,	   epoxidations,	   oxidations	   of	   heteroatoms,	  
halogenations	   and	   Baeyer-­‐Villiger	   oxidations.	   However,	   the	   protein	   environment	   and	  
shape	  of	   the	  active	   site	  of	  each	  monooxygenase	   is	   responsible	   for	   its	   specific	   selectivity	  
and	   reaction	   type.	   This	  microenvironment	   on	   one	   hand	   selects	   the	   potential	   substrates	  
and	  their	  positioning	  within	  the	  enzyme,	  on	  the	  other	  hand	   it	  modulates	   the	  electro-­‐	  or	  
nucleophilic	   character	   of	   the	   peroxyflavin	   (van	   Berkel	   et	   al.	   2006).	   Flavoprotein	  
monooxygenases	   can	   be	   divided	   in	   six	   subclasses	   based	   on	   similarity	   in	   amino	   acid	  
sequence	  and	  structural	  homology	  (Figure	  1-­‐5).	  Of	  course,	  all	  members	  of	  the	  flavoprotein	  
monooxygenases	  employ	  a	  flavin,	  usually	  FAD.	  Only	  class	  C	  monooxygenases	  utilizes	  FMN.	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Also	   all	   of	   them	   employ	   the	   nicotinamide	   coenzymes	  NADH	   and/or	   NADPH	   as	   electron	  
donor.	  So	  far,	  class	  B	  monooxygenases	  were	  described	  using	  exclusively	  NADPH.	  However,	  
by	  our	  recent	  discovery	  of	  NADH-­‐accepting	  class	  B	  monooxygenases	  (Chapter	  4	  &	  5),	  this	  
has	  to	  be	  reconsidered.	  	  
All	   flavoprotein	   monooxygenases	   require	   at	   least	   two	   functionalities:	   a	   mono-­‐
oxygenase	  moiety	  for	  the	  oxygenation	  reaction	  and	  a	  reductase	  moiety	  for	  the	  supply	  of	  
electrons	  for	  reduction	  of	  the	  flavin.	  Here	  two	  major	  differences	  can	  be	  found	  within	  the	  6	  
classes	   (Figure	   1-­‐5).	   In	   the	   classes	   C-­‐F,	   both	   components	   are	   encoded	   in	   at	   least	   two	  
different	   genes	   and	   expressed	   as	   separate	   enzymes,	   whereas	   class	   A	   and	   B	  
monooxygenases	  have	  fused	  both	  functionalities	  in	  one	  gene/protomer.	  The	  class	  C	  two-­‐
component	  monooxygenases	  are	  represented	  by	  Type	  II	  Baeyer-­‐Villiger	  monooxygenases	  
(Taylor	  &	  Trudgill	  1986,	  van	  der	  Werf	  2000),	  hydroxylases,	  and	  luciferases	  (light	  emission	  
by	  oxidation	  of	   long	  aliphatic	  aldehydes)	   (Baldwin	  &	  Ziegler	  1992,	  Viviani	  2002).	  Class	  D	  
monooxygenases	  typically	  perform	  oxygenations	  of	  aromatic	  rings	  (Prieto	  &	  Garcia	  1994)	  
or	   non-­‐activated	   long	   chain	   alkanes	   (Li	   et	   al.	   2008),	   while	   class	   E	   monooxygenases	  
perform	   epoxidations	   (Panke	   et	   al.	   1998),	   and	   class	   F	   monooxygenases	   are	   able	   to	  
catalyze	   halogenations	   (Keller	   et	   al.	   2000).	   In	   these	   two-­‐component	   systems	   the	   flavin	  
acts	  as	  a	  coenzyme,	  which	  is	  reduced	  by	  an	  auxiliary	  reductase	  component.	  The	  reduced	  
flavin	   coenzyme	   displays	   a	   high	   affinity	   for	   the	   oxygenase	   component,	   forming	   an	  
oxygenation	  catalyst.	  	  
In	   contrast	   to	   the	   above-­‐mentioned	   flavoprotein	   monooxygenases,	   the	   single	  
component	   flavoprotein	  monooxygenases	   (class	  A	  and	  B)	  normally	  have	  a	   tightly	  bound	  
flavin	   cofactor,	   acting	   as	   prosthetic	   group.	   Both	   classes	   have	   at	   least	   one	   dinucleotide	  
binding	   domain	   which	   can	   easily	   be	   identified	   by	   the	   Rossman	   fold	   sequence	   motif	  
GxGxxG.	  Such	  a	  domain	  is	  able	  to	  bind	  the	  ADP	  moiety	  of	  FAD	  or	  NAD(P)H	  (Wierenga	  et	  al.	  
1986).	   Regardless	   how	   important	   tight	   binding	   of	   the	   flavin	   cofactor	   for	   these	   enzymes	  
might	  be,	  no	  flavoprotein	  monooxygenase	  has	  yet	  been	  found	  having	  the	  flavin	  covalently	  
tethered	  to	  the	  protein	  which	  is	  in	  contrast	  to	  flavoprotein	  oxidases	  (de	  Jong	  et	  al.	  1992,	  




Figure	  1-­‐5:	  Updated	  classification	  of	  external	  flavoprotein	  monooxygenases	  (van	  Berkel	  2006).	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Class	  A	  monooxygenases	  have	  been	  found	  to	  catalyze	  epoxidation	  and	  hydroxylation	  
reactions	  on	  aromatic	  rings.	  They	  usually	  show	  a	  narrow	  substrate	  specificity,	  acting	  on	  a	  
selected	  number	  of	  aromatic	  compounds	  with	  an	  activating	  hydroxyl-­‐	  or	  amino	  group	  (van	  
Berkel	  et	  al.	  2006).	  Even	  though	  class	  A	  enzymes	  are	  using	  both	  FAD	  and	  NAD(P)H,	  they	  
only	  have	  one	  dinucleotide	  binding	  domain	  and	  therefore	  cannot	  bind	  both	  cofactors	  at	  
the	  same	  time.	  This	  is	  in	  line	  with	  the	  reaction	  mechanism,	  as	  the	  FAD	  is	  bound	  tightly	  and	  
the	  NAD(P)+	  is	  released	  directly	  after	  reduction	  of	  the	  FAD.	  
In	  contrast	  to	  class	  A	  enzymes,	  class	  B	  monooxygenases	  have	  two	  dinucleotide	  binding	  
domains,	   each	   involved	   in	   binding	   one	   of	   the	   cofactors	   FAD	   and	   NAD(P)H.	   Different	   to	  
class	  A	  monooxygenases,	  they	  keep	  the	  NADP+	  bound	  during	  the	  whole	  catalytic	  cycle	  as	  it	  
stabilizes	  the	  peroxyflavin	  enzyme	  intermediate.	  The	  coenzyme	  is	  released,	  together	  with	  
the	   elimination	  of	  water	   from	  hydroxyflavin,	   at	   the	   end	  of	   the	   cycle	   (Figure	   1-­‐3,	   4	  à	  5)	  
(van	  den	  Heuvel	  et	  al.	  2005,	  Torres	  Pazmiño	  et	  al.	  2008).	  
	  
The	   research	   described	   in	   this	   thesis	   focused	   on	   the	   discovery	   and	   biocatalytic	  
exploration	  of	  novel	  class	  B	  flavoprotein	  monooxygenases	  (chapter	  3)	  with	  special	  
emphasis	   on	   Type	   I	   BVMOs.	   During	   the	   project,	   a	   new	   subgroup	   of	   class	   B	  
flavoprotein	  monooxygenases	  has	  been	  discovered:	  Type	  II	  FMOs	  (chapter	  4	  &	  5).	  	  
	  
1.4.1. Class	  B	  flavoprotein	  monooxygenases	  
As	   the	   members	   of	   class	   B	   flavoprotein	   monooxygenases	   are	   able	   to	   oxidize	   not	   only	  
carbon	   atoms	   (Baeyer-­‐Villiger	   oxidations	   and	   epoxidations)	   but	   also	   heteroatoms,	   they	  
are	   also	   called	   the	   class	   of	   “multifunctional	   flavin-­‐containing	  monooxygenases”.	   Class	   B	  
flavoprotein	  monooxygenases	  can	  be	  divided	  into	  different	  subfamilies	  based	  on	  specific	  
sequence	  motifs.	  So	  far	  three	  subfamilies	  were	  known	  and	  it	  was	  found	  that	  all	  members	  
are	   strictly	   NADPH	   dependent:	   Type	  I	  Baeyer-­‐Villiger	   monooxygenases	   (BVMOs),	   flavin-­‐
containing	   monooxygenases	   (FMOs)	   and	   N-­‐hydroxylating	   monooxygenases	   (NMOs)	  
(Fraaije	  et	  al.	  2002).	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We	  could	  proof	   the	  existence	  of	  at	   least	  one	  additional	  subclass.	  Members	  of	   this	  
subclass	   share	   high	   sequence	   homology	   with	   members	   of	   the	   above-­‐mentioned	  
subclasses,	  mainly	   the	  FMOs.	  Yet,	   their	  coenzyme	  dependence	  sets	   them	  apart	  as	  
they	   accept	   both	   NADH	   and	   NADPH,	   with	   similar	   affinity.	  While	   referring	   to	   the	  
“old”	   subclass	  of	   FMOs	  as	   Type	   I	   FMOs	  we	  named	   the	  newly	  discovered	   subclass	  
Type	  II	  FMOs	  (chapter	  4).	  	  
	  
Additionally	   to	   the	   two	  Rossman	   fold	  motifs,	   BVMOs	   and	   Type	   I	   FMOs	  display	   a	   typical	  
fingerprint	  motif	  that	  makes	  them	  easy	  to	  be	  recognized	  in	  databases.	  In	  contrast,	  at	  the	  
same	   position	   the	   N-­‐hydroxylating	   monooxygenases	   (NMOs)	   only	   share	   a	   conserved	  
histidine.	  So	  far	  only	  a	  few	  NMOs	  from	  bacteria	  and	  fungi	  have	  been	  reported.	  They	  are	  
often	   involved	   in	   the	  biosynthesis	   of	   siderophores	   and	   they	   typically	   convert	   long-­‐chain	  
primary	  amines	  by	  N-­‐hydroxylation	  (Stehr	  et	  al.	  1998).	  	  
The	  fingerprint	  motifs	  of	  BVMOs	  and	  FMOs	  are	  quite	  similar	  to	  each	  other:	  BVMOs	  are	  
characterized	   by	   the	   (FxGxxxHxxxWP/D)	   and	   FMOs	   by	   the	   (FxGxxxHxxxYK/R)	   sequence	  
motif	  (Fraaije	  et	  al.	  2002)	  and	  both	  are	  found	  between	  the	  two	  Rossman	  folds.	  We	  could	  
show	   that	   the	  motif	   in	   the	   case	   of	   BVMOs	   allows	  more	   variation	   than	   thought	   before.	  
Furthermore,	   the	  motif	   is	   located	   in	   a	   loop	   region	  of	  BVMO/FMO	  structures	   that	   is	   not	  
directly	   involved	   in	   catalysis.	  This	  hints	   to	  a	   rather	  poor	   sequence	  motif	   conservation	   in	  
distant	  homologs.	  
	  
By	  using	  the	  newly	  identified	  BVMOs,	  we	  determined	  an	  additional	  BVMO-­‐typifying	  
sequence	   motif	   involving	   also	   active	   side	   residues.	   This	   motif	   is	   only	   present	   in	  
BVMOs	  and	  clearly	  distinguishes	  them	  from	  FMOs:	  [A/G]GxWxxxx[F/Y]P[G/M]xxxD	  
(chapter	  3)	  (Riebel	  et	  al.	  2012).	  	  
	  
BVMOs	  primarily	  catalyse	  the	  Baeyer-­‐Villiger	  oxidation	  of	  ketones	  or	  aldehydes	  to	  esters	  
or	   lactones	   respectively.	   They	   are	   also	   able	   to	   oxygenate	   heteroatom-­‐containing	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compounds	   (N,	  S,	  B	  or	  Se	  containing	  compounds).	  Usually	  FMOs	  only	  catalyse	   the	   latter	  
activity.	  
	  
With	   the	   discovery	   of	   Type	   II	   FMOs	   we	   added	   a	   new	   subclass	   to	   the	   class	   B	  
flavoprotein	  monooxygenases	   (chapter	   4).	   Type	   II	   FMOs	   show	  a	   slightly	  modified	  
FMO	   sequence	   motif	   while	   exhibiting	   different	   catalytic	   properties:	   they	   accept	  
both	  NADH	  and	  NADPH	  with	  similar	  affinities	  and	  they	  are	  able	  to	  perform	  Baeyer-­‐
Villiger	  oxidations.	  
	  
1.4.2. Type	  I	  Baeyer-­‐Villiger	  monooxygenases	  (BVMOs)	  
Since	  its	  discovery	  more	  than	  100	  years	  ago	  the	  Baeyer-­‐Villiger	  reaction	  is	  one	  of	  the	  key	  
reactions	   in	   organic	   chemistry	   (Baeyer	   &	   Villiger	   1899).	   The	   reaction	   entails	   the	  
conversion	  of	  carbonylic	  compounds	  into	  the	  corresponding	  esters	  or	  lactones	  by	  the	  use	  
of	   peracids.	   The	   reaction	   proceeds	   via	   formation	   of	   a	   tetrahedral	   intermediate,	   the	   so-­‐
called	  Criegee	  intermediate,	  followed	  by	  a	  concerted	  migration	  of	  one	  adjacent	  carbon	  to	  
the	  oxygen	  under	  the	  elimination	  of	  carboxylic	  acid	  (Figure	  1-­‐6).	  	  
	  
	  
Figure	  1-­‐6:	  Baeyer-­‐Villiger	  oxidation.	  
Its	  key	   features	  are	  the	  predictable	  regiochemistry	  as	  well	  as	   its	  stereospecificity,	  as	   the	  
migrating	  group	  retains	  its	  configuration.	  This	  makes	  the	  Baeyer-­‐Villiger	  reaction	  a	  useful	  
tool	  for	  asymmetric	  synthesis	  with	  a	  relative	  migration	  aptitude:	  tertiary	  alkyl	  >	  cyclohexyl	  
>	   secondary	   alkyl	   >	   benzyl	   >	   phenyl	   >	   primary	   alkyl	   >	   cyclopentyl,	   cyclopropyl	   >	  methyl	  


































Already	   in	  1948	  Turfitt	  discovered	  bioactivity	  performing	   this	   reaction	   (Turfitt	  1948).	  
Yet,	   20	   years	   passed	   before	   the	   first	   BVMO	   was	   isolated	   and	   characterized	   (CHMO)	  	  
(Forney	  &	  Markovetz	  1969).	  Malito	  et	  al.	  solved	  the	  first	  crystal	  structure	  for	  a	  member	  of	  
this	  class	  just	  recently	  (PAMO),	  as	  shown	  in	  Figure	  1-­‐7	  (Malito	  et	  al.	  2004).	  	  
Even	   though	   a	   chiral	   variant	   of	   the	   Baeyer-­‐Villiger	   reaction	   is	   the	   most	   prominent	  
reaction	  catalyzed	  by	  BVMOs	  (for	  general	  reviews	  on	  Baeyer–Villiger	  reactions,	  see:	  Renz	  
&	   Meunier	   1999,	   Brink	   et	   al.	   2004,	   Torres	   Pazmiño	   et	   al.	   2010;	   for	   reviews	   on	  
stereoselective	  Baeyer–Villiger	  oxidations	  see:	  Strukul	  1998,	  Blom	  2000,	  Mihovilovic	  et	  al.	  
2004,	   Balke	   et	   al.	   2012),	   oxygenations	   of	   heteroatoms	   like	   sulfur,	   nitrogen,	   boron,	  
phosphate	  and	  others,	  as	  well	  as	  epoxidation	  reactions	  have	  also	  been	  reported	  (Latham	  
&	  Walsh	  1986,	  Latham	  et	  al.	  1986,	  Ottolina	  et	  al.	  1999,	  Colonna	  et	  al.	  2002,	  Gonzalo	  et	  al.	  
2005).	   As	   these	   reactions	   are	   difficult	   to	   perform	   selectively	   with	   chemical	   catalysts,	  
BVMOs	  are	  clearly	  powerful	  tools	  for	  synthetic	  chemistry.	  
Various	  studies	  have	  been	  performed	  with	  the	  aim	  to	  identify	  the	  responsible	  residues	  
for	  the	  different	  substrate	  specificities	  of	  BVMOs.	  As	  most	  of	  the	  known	  BVMOs	  are	  rather	  
unstable,	  the	  best	  model	  enzyme	  so	  far	  turned	  out	  to	  be	  the	  thermostable	  phenylacetone	  
monooxygenase	   (PAMO)	   from	   Thermobifida	   fusca	   (Fraaije	   et	   al.	   2005).	   It	   shows	   a	  
remarkable	  stability	  (t1/2	  =	  24	  h	  at	  52	  °C)	  and	  for	  a	  long	  time	  it	  was	  the	  only	  BVMO	  with	  a	  
known	   crystal	   structure,	  making	   valuable	   structural	   data	   available	   (Figure	   1-­‐7)	   .	   Several	  
engineered	   PAMO	   mutants	   with	   altered	   substrate	   specificities	   have	   been	   created	   and	  
allow	   a	   deeper	   insight	   into	   important	   residues	   for	   selectivity	   and	   substrate	   recognition	  
(Dudek	  et	   al.	   2011).	   But	   even	   by	   using	   this	   knowledge	   it	   is	   still	   impossible	   to	   rationally	  
redesign	  a	  biocatalyst	  with	  predefined	  features.	  Nevertheless,	  the	  interest	  in	  effective	  and	  
selective	  oxidative	  biocatalysts	  is	  high	  in	  academia	  and	  industry.	  Therefore,	  it	  is	  tempting	  
to	  exploit	  the	  available	  typical	  sequence	  motifs	  for	  genome-­‐mining	  approaches	  aimed	  at	  




Figure	  1-­‐7:	  Crystal	  structure	  of	  phenylacetone	  monooxygenase	  (PAMO)	  from	  Thermobifida	  fusca	  (pdb:	  1W4X).	  
The	  FAD	  cofactor	  is	  shown	  as	  orange	  sticks	  with	  its	  binding	  site	  in	  yellow.	  
We	  were	   able	   to	   identify,	   clone,	   recombinantly	   express	   and	   characterize	   22	   new	  
Type	  I	  BVMOs	  using	  the	  genome	  sequence	  of	  Rhodococcus	  jostii	  RHA1	  (chapter	  3).	  
We	  were	  also	  able	  to	  identify	  a	  new	  class	  B	  flavoprotein	  monooxygenase	  subclass,	  




1.5. Rhodococcus	  jostii	  RHA1	  
Rhodococcus	   is	   a	  widely	   occuring	   genus	  of	   the	  Actinomycetales,	   an	  order	   of	   non-­‐motile	  
Gram-­‐positive	   bacteria.	   With	   only	   a	   few	   exceptions,	   Rhodococcus	   species	   are	  
nonpathogenic	   aerobic	   soil	   bacteria.	   Rhodococcus	   jostii	   RHA1	   was	   first	   isolated	   from	  
contaminated	   soil	   in	   1995	   by	   virtue	   of	   its	   ability	   to	   degrade	   polychlorinated	   biphenyls	  
(Seto	  et	  al.	  1995).	  Its	  genome	  was	  sequenced	  in	  2006	  and	  with	  9.7	  Mb	  this	  organism	  has	  
one	   of	   the	   largest	   bacterial	   genomes	   sequenced	   to	   date	   (McLeod	   et	   al.	   2006).	   The	  
genomic	  arrangement	   is	  divided	   into	  one	   linear	   chromosome	  and	   three	   linear	  plasmids.	  
The	   organism	   itself	   displays	   a	   high	   catabolic	   diversity	   that	   makes	   it	   interesting	   for	  
environmental	   and	   biotechnological	   purposes.	   Other	   interests	   lay	   in	   engineering	   this	  
organism	   towards	   an	   alternative	   expression	   and	   production	   host	   (van	   der	   Geize	   &	  
Dijkhuizen	  2004).	  
1.6. Aim	  of	  this	  thesis	  
This	  thesis	  was	  performed	  within	  the	  BIOMOX	  cluster	  of	  the	  “Integrated	  Biosynthesis	  and	  
Organic	   Synthesis	   (IBOS)”	   programme	   of	   the	   Netherlands	   Organization	   for	   Scientific	  
Research	   (NWO).	   The	   aim	   of	   this	   project	   was	   the	   development	   of	   new	   biocatalytic	  
platforms	   performing	   enantio-­‐	   and/or	   regioselective	   oxidation	   reactions.	   The	   targeted	  
reactions	  of	  the	  project	  were	  hydroxylations,	  Baeyer-­‐Villiger	  oxidations,	  epoxidations	  and	  
sulfoxidations.	   Rhodococcus	   jostii	   RHA1	   was	   chosen	   as	   source	   for	   new	   biocatalysts.	   In	  
total	  four	  academic	  groups	  were	  actively	  involved	  in	  this	  research	  project.	  The	  focus	  in	  the	  
Fraaije	   research	   group	   was	   on	   the	   discovery	   of	   novel	   flavoprotein	   monooxygenases	  
catalyzing	  Baeyer-­‐Villiger	  oxidations	  and	  sulfoxidations.	  
As	  interesting	  as	  flavoprotein	  monooxygenases	  may	  be,	  there	  are	  still	  some	  drawbacks	  
in	  their	  applicability.	  One	  is	  the	  fact	  that	  they	  are	  cofactor	  dependent	  and	  for	  the	  use	  in	  an	  
industrial	   process	   an	   NAD(P)H	   regeneration	   system	   is	   required.	   In	   chapter	   2	   we	   have	  
addressed	  this	  problem	  by	  creating	  and	  optimizing	  a	  fused	  coenzyme	  regeneration	  system	  
(pCRE2),	  resulting	  in	  the	  effective	  production	  of	  self-­‐sufficient	  monooxygenases.	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For	  the	  work	  described	  in	  this	  thesis	  we	  decided	  to	  explore	  the	  “oxidative	  treasure”	  in	  
the	   genome	  of	  Rhodococcus	   jostii	   RHA1	   (McLeod	  et	   al.	   2006).	   Even	   though	   BVMOs	   are	  
widespread	   in	   bacteria	   and	   fungi,	   the	   average	   distribution	   is	   only	   around	   one	   or	   two	  
BVMO-­‐encoding	  genes	  per	  microbial	  genome	  (de	  Gonzalo	  et	  al.	  2010).	  FMOs	  and	  NMOs	  
are	   even	   more	   rare	   in	   microbes.	   An	   unusually	   high	   number	   and	   variety	   of	   oxidative	  
enzymes	   could	   be	   identified	   in	   the	   predicted	   proteome	   of	   R.	   jostii.	   We	   were	   able	   to	  
identify,	  express	  and	  characterize	  not	  only	  22	  new	  BVMOs	  (chapter	  3),	  but	  also	  seven	  new	  
FMOs	  and	  one	  putative	  NMO	  (chapter	  4)	  from	  this	  bacterium.	  
The	   newly	   discovered	   BVMOs	   (chapter	   3)	   were	   characterized	   using	   39	   different	  
potential	  substrates	   in	  a	  newly	  developed	  activity-­‐screening	  assay.	  For	  this	  approach,	  an	  
advanced	  method	  to	  determine	  the	  concentration	  of	  NADPH-­‐dependent	  enzymes	   in	  cell	  
extracts	  was	  developed.	  Additionally,	  with	  this	  large	  set	  of	  enzymes	  we	  postulated	  a	  new	  
BVMO-­‐identifying	   fingerprint	  motif,	  which	  can	   facilitate	   the	   future	   identification	  of	   such	  
enzymes	  in	  genome	  databases.	  
The	  flavoprotein	  monooxygenases	  described	  in	  chapter	  4	   formed	  a	  separate	  clade	  of	  
sequence-­‐related	  proteins	  being	  distinct	  from	  the	  known	  FMOs,	  NMOs,	  and	  BVMOs.	  They	  
also	  showed	  distinct	  enzyme	  characteristics,	  as	  they	  accept	  both	  NADH	  and	  NADPH	  with	  
similar	   affinities.	   This	   clearly	   separates	   them	   from	   the	   other	   class	   B	   monooxygenase	  
subclasses	   and	   we	   therefore	   proposed	   a	   new	   subclass	   of	   class	   B	   flavoproteins:	   Type	   II	  
FMOs.	  
Surprisingly,	   three	   of	   the	   newly	   identified	   Type	   II	   FMOs	   were	   also	   able	   to	   catalyze	  
Baeyer-­‐Villiger	   oxidation	   reactions.	   These	   three	   enzymes	   also	   share	   a	   high	   sequence	  
identity	  with	  each	  other,	   including	  an	  N-­‐terminal	  extension	  of	  about	  160	  residues.	  These	  
three	   enzymes	   have	   been	   intensely	   characterized	   in	   chapter	   5.	   Stopped-­‐flow	   kinetic	  
analysis	  proofed	  that	  the	  reaction	  mechanism	  indeed	  follows	  real	  BVMO	  characteristics.	  A	  
careful	  inspection	  of	  the	  active	  site	  residues	  between	  Type	  I	  BVMOs,	  Type	  I	  FMOs	  and	  the	  
three	  special	  members	  of	  the	  Type	   II	  FMOs	  revealed	  that	  two	  conserved	  residues	   in	  the	  
newly	  identified	  class	  II	  FMOs	  represent	  a	  completely	  new	  active	  site	  architecture	  around	  
the	   flavin.	   With	   mutagenesis	   studies	   we	   addressed	   potentially	   important	   active	   site	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residues.	  We	   could	   show	   that	   replacing	   the	   targeted	   residues	   has	   a	   huge	   effect	   on	   the	  
ability	  to	  efficiently	  bind	  the	  flavin	  cofactor.	  
The	  chapters	   2	   –	   5	   describe	   the	   results	  of	   a	  project	   aimed	  at	   the	  discovery	  of	  new	  
oxidative	   biocatalysts.	   The	   work	   has	   resulted	   in	   the	   recombinant	   production	   and	  
biocatalytic	   characterization	   of	   >30	   new	   flavoprotein	  monooxygenases.	  With	   this	   set,	   a	  
wide	   range	   of	   reactions	   can	   be	   performed.	   Chapter	   6	   provides	   an	   overview	   of	   the	  
obtained	  results.	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Any	  sufficiently	  advanced	  technology	  is	  indistinguishable	  from	  magic.	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Abstract:	   To	   facilitate	   the	   purification	   and	   application	   of	  
NADPH-­‐dependent	   BVMOs	   we	   have	   developed	   an	  
expression	   system	   for	   the	   production	   of	   bifunctional	  
biocatalysts:	   BVMOs	   fused	   to	   phosphite	   dehydrogenase	  
(PTDH).	   By	   fusing	   BVMOs	   to	   PTDH	   we	   have	   created	   self-­‐
sufficient	   enzymes	   that	   only	   require	   phosphite	   for	  
regenerating	   a	   catalytic	   amount	  of	  NADPH.	   In	   this	   chapter	  
efforts	  to	  optimize	  the	  expression	  system	  are	  discussed.	  
	   	  
A	  NEW	  GENERATION	  OF	  SELF-­‐SUFFICIENT	  BVMOS	  
 27 
2.1. Introduction	  
Over	   the	   last	   decades	   industrial	   interest	   in	   oxidative	   biocatalysis	   has	   increased	  
significantly.	   One	   of	   the	   most	   prominent	   enzyme	   families	   that	   catalyze	   a	   variety	   of	  
different	  oxidations	  are	  Baeyer-­‐Villiger	  monooxygenases	  (BVMOs).	  These	  biocatalysts	  are	  
part	   of	   an	   exclusive	   family	   of	   flavin-­‐containing	   enzymes	   that	   catalyze	   the	  
biotransformation	   of	   aldehydes	   and	   (a)cyclic	   ketones	   to	   their	   corresponding	   esters	   and	  
lactones	   (Kamerbeek	  et	  al.	  2003,	  van	  Berkel	  et	  al.	  2006,	  Torres	  Pazmiño	  &	  Fraaije	  2007,	  
Alphand	  et	  al.	  2009,	  Kayser	  2009).	  Additionally,	   these	  enzymes	  are	  also	  known	   for	   their	  
capability	   to	   oxidize	   heteroatoms	   (sulphur,	   nitrogen,	   boron)	   and	   perform	   epoxidation	  
reactions	  (Latham	  &	  Walsh	  1986,	  Latham	  et	  al.	  1986,	  Ottolina	  et	  al.	  1999,	  Colonna	  et	  al.	  
2002,	   Gonzalo	   et	   al.	   2005,	   Rial	   et	   al.	   2008).	   Type	   I	   BVMOs	   utilize	   flavin	   adenine	  
dinucleotide	   (FAD)	   as	   cofactor	   and	   NADPH	   as	   electron	   donor	   in	   order	   to	   activate	  
molecular	   oxygen	   (O2)	   and	   generate	   a	   reactive	   C4a-­‐peroxyflavin	   intermediate.	   This	  
enzyme	   intermediate	   acts	   similar	   to	   an	   organic	   peracid	   and	   reacts	   with	   the	   organic	  
substrate	  resulting	  in	  formation	  of	  the	  oxygenated	  product	  (Ryerson	  et	  al.	  1982,	  Sheng	  et	  
al.	   2001,	   Torres	   Pazmiño	   et	   al.	   2008).	   BVMOs	   have	   been	   shown	   to	   carry	   out	   these	  
oxidative	  reactions	  in	  a	  highly	  regio-­‐,	  stereo-­‐	  and	  enantioselective	  manner,	  indicating	  that	  
these	   enzymes	   are	   interesting	   candidates	   for	   various	   biocatalytic	   applications	   (Walsh	  &	  
Chen	  1988,	  Roberts	  &	  Wan	  1998,	  Mihovilovic	  et	  al.	  2002,	  Mihovilovic	  2006).	  An	  obstacle	  
of	  using	  BVMOs	   in	  a	   cost	  efficient	  way	   is	   the	   requirement	  of	   stoichiometric	  amounts	  of	  
expensive	   NADPH	   coenzyme.	   Several	   coenzyme	   regeneration	   methods	   have	   been	  
explored	  in	  the	  recent	  years	  (van	  der	  Donk	  &	  Zhao	  2003,	  Wichmann	  &	  Vasic-­‐Racki	  2005,	  
Hollmann	   et	   al.	   2006).	   The	   most	   efficient	   approach	   is	   based	   on	   the	   regeneration	   of	  
NADPH	   by	   using	   a	   two-­‐enzyme	   system	   (either	   as	   isolated	   enzyme	   or	   in	   whole	   cells)	  
(Stewart	  1997,	  Zambianchi	  et	  al.	  2002,	  Schulz	  et	  al.	  2005,	  Lee	  et	  al.	  2007).	  
Typically,	  NAD(P)+-­‐dependent	  dehydrogenases	  are	  applied	  to	  regenerate	  the	  reduced	  
coenzyme	   at	   the	   expense	   of	   a	   cheaper	   sacrificial	   substrate	   (Peretz	   et	   al.	   1997,	   Tishkov	  	  	  	  	  	  
et	  al.	  1999,	   Tishkov	  &	  Popov	  2006).	   Phosphite	  dehydrogenase	   (PTDH,	  EC	  1.20.1.1)	   is	   an	  
excellent	   example	   of	   such	   NAD(P)H	   regenerating	   enzymes.	   This	   enzyme	   catalyzes	   the	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thermodynamically	   driven	   and	   therefore	   almost	   irreversible	   oxidation	   of	   (cheap)	  
phosphite	   to	   phosphate	   by	   simultaneous	   reduction	   of	   (expensive)	   NAD(P)+	   (Vrtis	   et	   al.	  
2002,	   van	  der	  Donk	  &	  Zhao	  2003).	   In	  our	   research	  group	  we	  have	   recently	   investigated	  
the	  utility	  of	  PTDH	  in	  combination	  with	  BVMOs	  and	  could	  show,	  that	  in	  this	  combination	  
none	   of	   the	   two	   individual	   reactions	   is	   disturbed	   by	   any	   side-­‐reactions	   or	   interferences	  
with	   either	   substrates	   or	   products.	   By	   covalently	   fusing	   the	   PTDH	   to	   the	  N-­‐terminus	   of	  
various	   BVMOs,	   so-­‐called	   CRE/BVMOs	   were	   created	   (CRE;	   coenzyme	   regenerating	  
enzyme)	  (Torres	  Pazmiño	  et	  al.	  2008).	  By	  fusing	  the	  BVMOs	  to	  PTDH	  the	  expression	  levels	  
of	  the	  targeted	  BVMO	  increased	  and	  the	  overall	  solubility	  was	  improved	  when	  compared	  
with	   expression	   of	   the	   non-­‐fused	   BVMOs.	   This	   indicates	   that	   the	   PTDH-­‐gene	   is	   also	  
functioning	  as	  a	  very	  effective	  expression	  tag.	  	  
To	   summarize,	   the	   advantages	   of	   these	   bi-­‐functional	   biocatalysts	   are	   that	   with	   (i)	  
minimum	  effort	  in	  terms	  of	  enzyme	  production	  and	  isolation	  and	  (ii)	  maximum	  simplicity	  
with	   respect	   to	   coenzyme	   regeneration,	   challenging	   enzymatic	   oxidations	   can	   be	  
performed.	  	  
The	   first	  generation	  of	   these	  self-­‐sufficient	  CRE/BVMOs	  were	  successfully	  applied	   for	  
the	   bioconversions	   of	   a	   wide	   variety	   of	   substrates	   by	   using	   whole	   cells,	   cleared	   cell	  
extracts	  (CCEs)	  and	  purified	  enzyme.	  Interestingly,	  biooxidations	  using	  cleared	  cellextracts	  
could	  be	  performed	  without	  addition	  of	  NADPH/NADP+.	  This	  can	  be	  explained	  by	  the	  fact	  
that	  sufficient	  amounts	  of	  coenzyme	  are	  released	   for	  catalysis	  when	  the	  Escherichia	  coli	  
cells	  are	  ruptured.	  	  
However,	   the	   activity	   of	   the	   first	   reported	   self-­‐sufficient	   BVMOs	   decreased	  
significantly	   over	   time	   due	   to	   instability	   of	   the	   PTDH	   fusion	   partner.	   By	   a	   successful	  
combination	  of	   site-­‐directed	  and	   random	  mutagenesis	   approaches,	   Zhao	  and	   coworkers	  
have	  been	  able	  to	  improve	  the	  thermostability	  of	  PTDH,	  as	  well	  as	  its	  resistance	  towards	  
organic	  solvents.	  In	  comparison	  to	  the	  wild-­‐type,	  this	  PTDH	  mutant	  (18x	  PTDH)	  contained	  
18	   mutations	   and	   showed	   a	   7000-­‐fold	   longer	   life	   time	   at	   45	   °C	   (Johannes	   et	   al.	   2005,	  
Johannes	  et	  al.	  2006,	  Woodyer	  et	  al.	  2006).	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Figure	  2-­‐1:	  plasmid	  map	  of	  the	  expression	  vector	  pCRE2/BVMO.	  
	  
In	   this	   chapter	   we	   present	   fusion	   engineering	   and	   biocatalytic	   studies	   of	   a	   new	  
generation	   of	   self-­‐sufficient	   BVMOs	   (Figure	   2-­‐1).	   Except	   for	   replacing	   the	   original	  
PTDH	   by	   a	   more	   robust	   variant,	   we	   also	   investigated	   the	   influence	   of	   the	   linker	  
length	   and	   composition	   between	   both	   fusion	   partners.	   In	   comparison	   to	   the	  
previous	   generation,	   these	   second	   generation	   self-­‐sufficient	   CRE2/BVMOs	   posses	  	  
(i)	   a	   thermostable	   variant	   of	   PTDH	   as	   fusion	   partner	   for	   effective	   coenzyme	  
regeneration,	  (ii)	  a	  codon-­‐optimized	  PTDH	  mutant	  gene	  for	  excellent	  expression	  in	  
E.	   coli	   (Villalobos	   et	   al.	   2006),	   and	   (iii)	   a	   histidine	   purification	   tag	   at	   the	   free	  	  	  	  	  	  	  	  	  	  	  	  
N-­‐terminus	  of	   the	  PTDH	  partner.	   In	   this	  way,	   the	  dehydrogenase	   fusion	  partner	   is	  
not	  only	  exploited	   for	   its	  ability	   to	  efficiently	   regenerate	  nicotinamide	  coenzymes,	  
but	  also	  as	  expression	  and	  purification	  tag	  (Thapa	  et	  al.	  2008).	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2.3. Results	  and	  Discussion	  
2.3.1. Expression	   of	   CRE2/BVMOs	   and	   characterization	   of	   kinetic	  
parameters	  and	  thermostability	  
For	  this	  study,	  six	  representative	  BVMOs	  were	  selected	  and	  fused	  to	  the	  C-­‐terminus	  of	  the	  
thermostable	  PTDH	  variant;	  cyclopentanone	  monooxygenase	  from	  Comamonas	  sp.	  strain	  
NCIMB	  9872	  (CPMO,	  EC	  1.14.13.16)(Griffin	  &	  Trudgill	  1976,	   Iwaki	  et	  al.	  2002,	  van	  Beilen	  	  
et	  al.	  2003),	  cyclohexanone	  monooxygenase	  from	  Acinetobacter	  sp.	  NCIMB	  9871	  (CHMO,	  	  	  
EC	   1.14.13.22)	   (Donoghue	   et	   al.	   1976),	   4-­‐hydroxyacetophenone	   monooxygenase	   from	  
Pseudomonas	   fluorescens	   ACB	   (HAPMO,	   EC	   1.14.13.81)	   (Kamerbeek	   et	   al.	   2001),	  
ethionamide	   monooxygenase	   from	   Mycobacterium	   tuberculosis	   H37Rv	   (EtaA,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
EC	   1.14.13.92)	   (Fraaije	   2003),	   phenylacetone	   monooxygenase	   from	   Thermobifida	   fusca	  
(PAMO;	  EC	  1.14.13.92)	  and	  the	  M446G	  PAMO	  mutant	  (Fraaije	  et	  al.	  2005,	  Torres	  Pazmiño	  
et	  al.	  2007).	  Expression	  levels	  of	  all	  six	  CRE2/BVMOs	  in	  E.	  coli	  TOP10	  were	  excellent	  and	  
subsequent	  purification	  was	  performed	  in	  a	  one	  step	  process	  by	  using	  a	  Ni-­‐NTA	  column.	  
Even	  CRE2−CPMO	  was	  obtained	   in	  good	  purity	  while	  previous	  attempts	   to	  purify	  CPMO	  
from	   a	   recombinant	   host	   failed,	   tentatively	   due	   to	   stability	   reasons	   (Iwaki	   et	   al.	   2002,	  	  	  	  	  
van	  Beilen	  et	  al.	  2003).	  	  
The	   activities	   and	   kinetic	   parameters	   of	   the	   isolated	   CRE2/BVMOs	  were	   determined	  
using	  the	  primary	  substrates	  of	  each	  enzyme.	  In	  general,	  the	  catalytic	  activities	  (kcat)	  and	  
Michaelis-­‐Menten	   constants	   (KM)	   of	   the	   BVMOs	   fused	   to	   the	   thermostable	   PTDH	   were	  
found	   to	   be	   very	   similar	   to	   those	   of	   the	   non-­‐fused	   enzymes	   (Table	   2-­‐1).	   The	   catalytic	  
efficiency	   (kcat/KM)	   of	   the	   PTDH	   subunit	   for	   NADP
+	   was	   found	   to	   vary	   between	   93	   and	  	  
1300	  mM-­‐1	  s-­‐1,	  depending	  on	   its	   fusion	  partner.	  The	  variance	   in	  these	  values	  may	  reflect	  
the	  level	  of	  flavin	  cofactor	  incorporation	  in	  each	  fused	  enzyme	  and	  are	  at	  the	  same	  order	  
of	   magnitude	   compared	   to	   the	   non-­‐fused	   PTDH	   variant	   (kcat/KM	   =	   2.5×10
2	   mM-­‐1	  s-­‐1)	  
(Johannes	  et	  al.	  2006)	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Table	  2-­‐1:	  Kinetic	  parameters	  of	  2nd	  generation	  self-­‐sufficient	  BVMOs	  (CRE2/BVMOs).	  
	  
In	   order	   to	   determine	   the	   stability	   of	   these	   new	   CRE2/BVMOs,	   activity	   measurements	  
were	  carried	  out	  at	  elevated	  temperatures.	  Incubation	  of	  CRE2−CHMO	  at	  37°C	  resulted	  in	  
a	  decrease	  in	  BVMO	  activity	  over	  time	  (t½,	  37	  °C	  =	  95	  minutes),	  whereas	  no	  loss	  in	  activity	  
was	  observed	  for	  the	  PTDH	  subunit	  during	  24	  hours.	  This	  clearly	  indicates	  that	  the	  activity	  
and	  stability	  of	  the	  dehydrogenase	  is	  not	  affected	  by	  the	  thermal	  inactivation	  of	  its	  fusion	  
partner.	  Incubation	  of	  CRE2−PAMO	  at	  50	  °C	  showed	  that	  the	  PTDH	  subunit	  is	  also	  suitable	  
for	  coenzyme	  regeneration	  at	  elevated	  temperatures,	  showing	  a	  half-­‐life	  time	  (t½,	  50°C)	  of	  
39	   hours.	   Additionally,	   we	   determined	   that	   the	   PTDH	   subunit	   tolerates	   methanol	   as	  
organic	   cosolvent.	   The	   initial	   specific	   activity	   of	   the	   dehydrogenase	   subunit	   of	  
CRE2−PAMO	  was	   found	   to	   be	   hardly	   affected	  when	   using	   up	   to	   40	  %	  methanol.	   In	   the	  
presence	   of	   30	   %	   methanol	   at	   30	   °C,	   a	   slow	   decrease	   in	   dehydrogenase	   activity	   was	  
observed	  (t½	  =	  2	  hours).	  	  
2.3.2. Linker	  studies	  
Even	  though	  it	  has	  been	  shown	  that	  fusing	  a	  BVMO	  to	  PTDH	  typically	  has	  almost	  no	  large	  
influence	  on	   the	  performance	  of	   the	  BVMO	  activity,	   still	   some	  small	   effects	  on	  catalytic	  
performance	  have	  been	  observed	  (Torres	  Pazmiño	  et	  al.	  2008).	  In	  the	  case	  of	  CRE2-­‐PAMO	  
and	  CRE2-­‐PAMOM446G	   the	  kinetic	  parameters	   for	   the	  BVMO	  are	   rather	  unaffected,	  while	  
PTDH%subunit
CRE20BVMO kcat%(s
01) KM,%ketone%(μM) KM,%NADPH%(μM) kcat/KM,NADP+%(mM
01%s01%)
CRE2−PAMO 2,6 60 3,5 3,6%×%102
CRE2−CHMO 13 5,5 4 9,3%×%101
CRE2−CPMO 1,8 <%1,0 <%1,0 1,8%×%102
CRE2−HAPMO 12 7,8 8,3 6,1%×%102
CRE2−EtaA 1,0×1001 1,3×103 >%1,2×102 6,9%×%102










the	  PTDH	  appears	  to	  suffer	  from	  the	  fusion	  (Table	  2-­‐2).	  While	  the	  kcat	  values	  increase	  for	  
the	   fused	   PTDH,	   the	   KM	   values	   increase	   significantly,	   resulting	   in	   similar	   catalytic	  
efficiencies	  (kcat/KM).	  	  
Table	   2-­‐2:	   Kinetic	   parameters	   of	   2nd	   generation	   self-­‐sufficient	   CRE2/PAMO	   in	   comparison	   to	   non-­‐fused	  
enzymes.	  
Kinetic	   parameters	   of	   purified	   CRE2-­‐BVMOs	   and	   non-­‐fused	   BVMOs	   at	   25°C.	   BVMO	  activity	   for	   PAMO	  were	  
measured	  using	  phenylacetone	  as	  substrate	  while	  PAMOM446G	  activity	  was	  measured	  using	  benzaldehyde.	  The	  
parameters	  of	  the	  non-­‐fused	  BVMOs	  were	  taken	  from	  literature	  (Torres	  Pazmiño	  et	  al.	  2007	  &	  2008).	  
A	  possible	  explanation	  for	   these	  observations	  might	  be	   incomplete	  FAD	   incorporation	   in	  
the	   fusion-­‐versions,	   due	   to	   the	   overall	   protein	   folding.	   As	   the	   protein	   concentration	  
determination	   is	   done	   via	   analysis	   of	   the	   incorporated	   FAD	   in	   the	   BVMO	   partner,	   the	  
concentration	   of	   active	   PTDH	   might	   be	   underestimated.	   Additionally,	   wild	   type	   PTDH	  
naturally	   forms	   dimers	   and	   experiments	   with	   the	   previous	   fusion	   system	   (not	  
thermostable	   PTDH)	   gave	   indications	   that	   fusion	   did	   not	   prevent	   dimerization.	   As	   an	  
attempt	   to	   improve	   the	   FAD	   binding,	   we	   aimed	   to	   optimize	   the	   linker	   length	   and	  
constellation	  to	  allow	  a	  better	  folding	  and	  cofactor	  binding.	  
Length	   and	   composition	   of	   peptide	   linkers	   are	   known	   to	   affect	   protein	   stability	   and	  
domain-­‐domain	   interactions	   of	   fusion	   enzymes	   (Argos	   1990,	   Robinson	   &	   Sauer	   1998,	  
Evers	  et	  al.	  2006).	  All	  CRE2/BVMOs	  described	  above	  contain	  a	  peptide	  linker	  consisting	  of	  
six	  amino	  acids,	  i.e.	  Ser-­‐Arg-­‐Ser-­‐Ala-­‐Ala-­‐Gly.	  In	  order	  to	  determine	  whether	  the	  linker	  has	  
an	   effect	   on	   the	   stability	   or	   performance	   of	   the	   individual	   enzymes	   in	   the	   fused	  
bifunctional	   enzyme,	   we	   constructed	   three	   additional	   variants	   of	   CRE2−PAMO	   with	  
different	   linkers,	   based	   on	   linker	   properties	   of	   natural	   fusion	   proteins	   and	   biochemical	  
studies	  on	  fusion	  proteins.	  	  
In	  nature	  fusion	  enzymes	  are	  common.	  Based	  on	  the	  study	  of	  Argos	  in	  1990	  a	  natural	  
linker	   normally	   fulfills	   several	   criteria:	   (i)	   it	   is	   composed	   of	   small,	   non-­‐bulky	   and	   polar	  
kcat,%BVMO KM,%ketone KM,%NADPH% kcat,%PTDH KM,%phosphite KM,%NADP+
(s:1) (μM) (μM) (s:1) (μM) (μM)
CRE2–%PAMO%/%PAMO 2,6%/%3,1 60%/%80 3,5%/%0,7 6,2%/1,4 255%/%36 17%/%5,5
CRE2–PAMOM446G%/%PAMOM446G 1,8%/%2,9 2500%/%1600 <%2 10,5%/1,4 340%/%36 8,6%/%5,5
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amino	   acids	   (aa)	  with	   a	  maximum	  of	   two	   charges,	   (ii)	   it	   spans	   a	  minimum	  of	   5	   aa	   to	   a	  
maximum	  of	  20	  aa	  and	  is	  organized	  in	  an	  extended	  coil	  structure	  with	  mainly	  glycincs,	  and	  
(iii)	  it	  may	  include	  turns	  by	  the	  insertion	  of	  prolines	  and	  asparagines.	  Table	  2-­‐3	  shows	  a	  list	  
of	  preferred	  and	  avoided	  aa	  in	  natural	  linkers.	  
Table	  2-­‐3:	  favored	  and	  unfavored	  amino	  acids	  in	  natural	  linkers	  (Argos,	  1990).	  
	  
We	   set	   out	   to	   test	   several	   linker	   variants	   (Table	   2-­‐4).	   Variant	   1	   represents	   a	   linker-­‐
sequence	   that	   is	   often	   used	   in	   artificial	   fusion	   enzymes	   (Robinson	  &	   Sauer	   1998,	   Evers	  	  	  	  	  
et	  al.	  2006),	  consisting	  of	  glycines	  and	  serines.	  This	  linker	  results	  in	  a	  random	  coil	  structure	  
(“glycine-­‐rich”).	  Variant	  2	  consists	  of	  all	  preferred	  amino	  acids	  that	  can	  be	  found	  in	  natural	  
fusion	   enzymes	   (“random”).	   As	   a	   last	   variant	   (3)	   we	   reduced	   the	   linker	   length	   to	   a	  
minimum	  of	  1	  amino	  acid,	  tryptophane,	  representing	  an	  amino	  acid	  that	  nature	  tends	  to	  
avoid	  (“short”).	  
Table	  2-­‐4:	  length	  and	  peptide	  sequences	  of	  the	  different	  linker	  versions.	  
	  
When	  expressing	  the	  different	  linker	  variants	  of	  CRE2−PAMO,	  no	  difference	  in	  expression	  
levels	  could	  be	  detected.	  All	  fusion	  proteins	  show	  the	  same	  massive	  overexpression	  when	  
compared	  with	  the	  original	  CRE2-­‐PAMO.	  The	  thermostability	  of	  the	  variants	  was	  tested	  in	  
two	  different	  ways:	  using	  the	  ThermoFAD	  method	  (Forneris	  et	  al.	  2009)	  and	  by	  monitoring	  












temperature	  (TM)	  via	  the	  Thermo	  FAD	  method	  no	  significant	  difference	  could	  be	  detected	  
(Figure	   2-­‐2).	   All	   CRE2-­‐PAMOs	   (variants	   and	   original	   construct)	   showed	   a	   melting	  
temperature	  of	  58.5°C.	  	  
	  
Figure	   2-­‐2:	   Thermo	   FAD	  measurements	   for	   the	   determination	   of	   the	  melting	   temperature	  with	   (a)	   original	  
linker,	  (b)	  glycine-­‐rich	  linker,	  (c)	  random	  linker,	  (d)	  short	  linker.	  
Also,	  when	  monitoring	  the	  remaining	  activity	  of	  both	  subunits	  of	  the	  CRE2−PAMO	  variants	  
in	   time,	   all	   four	   variants	   were	   found	   to	   have	   similar	   thermostabilities	   (Figure	   2-­‐3).	   The	  
glycine-­‐rich	   linker	   was	   found	   to	   result	   in	   the	  most	   robust	   fusion	   protein.	   These	   results	  
indicate	   that	   the	   termini	   of	   both	  enzymes	  are	   sufficient	   flexible	   and	   solvent-­‐exposed	   to	  
yield	   an	   effective	   and	   thermostable	   fusion	   enzyme,	   regardless	   of	   the	   nature	   of	   the	  
peptide	  linker	  between	  these	  two	  subunits.	  
Figure	  2-­‐3:	  Residual	  activity	  of	  the	  PAMO	  (A)	  and	  PTDH	  (B)	  subunit	  of	  CRE2−PAMO	  containing	  different	  linker	  
variants	  at	  55	  °C,	  followed	  in	  time	  and	  fitted	  with	  an	  exponential	  decay	  (y	  =	  a*e	  –x/b).	  The	  following	  lifetimes	  
(t½,	  55	  °C)	  were	  determined	  for	  these	  variants:	  A	  (PAMO)	  original	  linker,	  208	  min;	  glycine-­‐rich	  linker,	  400	  min;	  
random	  linker,	  264	  min;	  short	  linker,	  333	  min.	  B	  (PTDH)	  original	  linker,	  142	  min;	  glycine-­‐rich	  linker,	  212	  min;	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While	  no	  drastic	  effects	  on	  stability	  were	  observed,	  a	   larger	  effect	  on	  FAD	  incorporation	  
was	  found.	  While	  the	  original	  PTDH-­‐PAMO	  is	  occupied	  for	  67%	  by	  FAD,	  in	  all	  other	  linker	  
variants	   this	   percentage	  was	   <	   50%	   (Table	   2-­‐5).	   This	   indicates	   that	   the	   original	   linker	   is	  
beneficial	  for	  FAD	  incorporation	  in	  PAMO.	  
Table	  2-­‐5:	  FAD	  incorporation	  in	  the	  CRE2-­‐PAMO	  linker	  variants.	  
	  
Based	   on	   the	   results	   above	   we	   conclude	   that	   the	   type	   of	   linker	   does	   not	   have	   a	   huge	  
effect	  on	  the	  stability	  behaviour	  of	  the	  fused	  enzyme.	  The	  original	  linker	  outperforms	  the	  
alternative	   linkers	  with	   respect	   to	   cofactor	   binding,	   even	   though	   it	   contains	   one	   amino	  
acid	  that	  would	  have	  been	  avoided	  in	  terms	  of	  natural	  selection.	  Therefore	  we	  decided	  to	  
continue	  also	  future	  research	  with	  the	  original	  version	  of	  the	  vector	  pCRE2.	  	  
2.3.3. Biocatalysis	  
Previously,	   we	   demonstrated	   that	   bifunctional	   CRE/BVMOs	   can	   be	   also	   applied	   for	  
bioconversions	  using	  whole	  cells	  and	  cleared	  cell	  extracts.	  Cleared	  cell	  extract	  containing	  
CRE−CHMO	   was	   used	   to	   catalyze	   the	   oxidation	   of	   4-­‐methylcyclohexanone	   (1)	   to	   the	  
corresponding	   lactone	   2	   in	   the	   presence	   of	   phosphite.	   The	   biotransformation	   stopped	  
after	  a	  reaction	  time	  of	  6	  hours,	  while	  less	  than	  40	  %	  conversion	  was	  achieved	  (>10	  mM	  
substrate	   concentration)	   (Torres	   Pazmiño	   et	   al.	   2008).	   Performing	   the	   same	  
transformation	   with	   the	   newly	   created	   thermostable	   CRE2−CHMO,	   resulted	   in	   a	   more	  









Figure	   2-­‐4:	   Baeyer-­‐Villiger	   oxidation	   of	   4-­‐methylcyclohexanone	   1	   by	   CCE	   of	   E.	   coli	   TOP10	   expressing	  
CRE2−CHMO	  in	  the	  presence	  of	  100	  mM	  phosphite	  at	  24	  °C,	  while	  no	  coenzyme	  was	  added.	  
In	   contrast	   to	   the	   first	   generation	   self-­‐sufficient	   BVMOs,	   the	   thermostable	   variant	  
CRE2−CHMO	  showed	  no	  inactivation	  within	  the	  presented	  time	  frame.	  This	  resulted	  in	  the	  
full	   conversion	  of	  5	  and	  10	  mM	  of	  ketone	  1	  within	  24	  hours,	  yielding	  >	  80	  %	  product	  2.	  
Despite	  possible	  substrate	  inhibition,	  13	  %	  of	  conversion	  was	  achieved	  by	  using	  30	  mM	  of	  
ketone	   1,	   while	   hardly	   any	   conversion	   was	   observed	   when	   CHMO	   was	   fused	   to	   the	  
relatively	  thermolabile	  PTDH	  (Torres	  Pazmiño	  et	  al.	  2008).	  These	  results	  confirm	  that	  the	  
instability	  of	  PTDH	  in	  the	  first	  reported	  self-­‐sufficient	  CRE/BVMOs	  was	  the	  limiting	  factor	  
for	  efficient	  bioconversions.	  
	  Additionally,	   we	   investigated	   the	   biocatalytic	   activities	   of	   other	   CRE2/BVMOs	   in	  
cleared	  cell	  extract	  using	  bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	  3	  as	  a	  model	  substrate.	  At	  24	  °C,	  	  	  
5	  mM	  of	  bicyclic	  ketone	  3	  was	  efficiently	  oxidized	  to	  the	  corresponding	  lactones	  4	  and	  5	  
(Figure	  2-­‐5)	  by	  both	  CRE2−CHMO	   (100%)	  and	  CRE2−CPMO	   (85%).	  Only	  24	  %	  of	  product	  
formation	   was	   observed	   with	   CRE2−PAMO	   after	   24	   hours.	   At	   higher	   substrate	  
concentrations	   (20	   mM),	   CRE2−CHMO	   fully	   converted	   the	   bicyclic	   ketone	   3	   within	  	  	  	  	  	  	  	  	  	  	  	  	  
24	   hours.	   On	   the	   other	   hand,	   hardly	   any	   conversion	   was	   observed	   with	   CRE2−CPMO,	  
indicating	  that	  the	  CPMO	  subunit	  suffers	  from	  substrate	  inhibition.	  The	  oxidation	  rate	  of	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ketone	   3	   by	   CRE2−PAMO	   was	   found	   to	   increase	   proportional	   to	   the	   substrate	  
concentration,	   as	   similar	   conversion	   percentages	  were	   obtained	   using	   5	   and	   20	  mM	  of	  
substrate.	  This	   latter	  observation	  is	   in	  agreement	  with	  the	  low	  affinity	  of	  PAMO	  towards	  
this	  bicyclic	  compound	  (KM	  =	  15	  mM)	  (Fraaije	  et	  al.	  2005).	  
	  
Figure	  2-­‐5:	  Baeyer-­‐Villiger	  oxidation	  of	  bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	  3.	  
Moreover,	   we	   studied	   the	   biooxidation	   of	   bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	   at	   elevated	  
temperatures.	   In	  order	  to	  stabilize	  the	  BVMO	  subunit	  to	  some	  extent,	  we	  supplemented	  
the	  reaction	  mixture	  with	  10	  μM	  FAD.	  Despite	  the	  moderate	  thermostability	  of	  the	  CHMO	  
subunit	   (t½,	   37	   °C	   =	   95	   minutes),	   CRE2−CHMO	   was	   still	   able	   to	   fully	   convert	   5	   mM	   of	  
bicyclic	   ketone	   within	   3	   hours	   at	   37	  °C.	   However,	   at	   higher	   temperature	   (50	   °C)	   the	  
bifunctional	   enzyme	   was	   inactivated	   within	   20	   minutes	   resulting	   in	   a	   rather	   poor	  
conversion	   (21%).	   CRE2−PAMO	   showed	   a	   higher	   catalytic	   activity	   at	   elevated	  
temperatures	   compared	   to	   the	   reaction	   performed	   at	   24	   °C.	   Even	   at	   50	   °C	   the	   fusion	  
enzyme	  was	   still	   active,	   indicating	   that	   regeneration	   of	   NADPH	   is	   possible	   under	   these	  
conditions.	  Unfortunately,	  hardly	  any	  conversion	  was	  observed	  using	  CRE2−CPMO	  at	  37	  °C	  
and	  50	  °C.	  This	   is	   in	  agreement	  with	  the	   literature	  which	   indicates	  that	  CPMO	  is	  a	   labile	  
biocatalyst	  (Iwaki	  et	  al.	  2002,	  van	  Beilen	  et	  al.	  2003).	  
	  
In	   this	   chapter	   we	   report	   on	   the	   design,	   production	   and	   evaluation	   of	   a	   new	  
generation	   of	   self-­‐sufficient	   Baeyer-­‐Villiger	   monooxygenases:	   CRE2/BVMOs.	   In	  
comparison	  to	  the	  previous	  generation,	  these	  newly	  designed	  bifunctional	  enzymes	  
contain	   a	   multiple	   mutant	   of	   PTDH	   which	   has	   been	   shown	   to	   display	   a	   high	  
thermostability	   (Johannes	  et	  al.	   2006).	   In	  addition,	   the	  gene	  of	   this	  PTDH	  mutant	  
was	  codon-­‐optimized	  for	  expression	  in	  E.	  coli.	  Furthermore,	  CRE2/BVMOs	  contain	  a	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polyhistidine	   affinity-­‐tag	   at	   their	   N-­‐terminus	   that	   facilitates	   purification	   of	   all	  
bifunctional	   biocatalysts.	   The	   purified	   self-­‐sufficient	   BVMOs	   displayed	   similar	  
kinetic	   parameters	   as	   the	   non-­‐fused	   enzymes,	   suggesting	   that	   the	   properties	   of	  
these	   enzymes	   are	   hardly	   affected	   upon	   fusion.	   As	   expected,	   their	   PTDH	   subunit	  
showed	   higher	   (thermo)stability	   than	   the	   dehydrogenase	   subunit	   of	   the	   first	  
reported	  self-­‐sufficient	  BVMOs.	  Furthermore,	  these	  new	  bifunctional	  enzymes	  could	  
be	  applied	  as	  cleared	  cellextracts	  for	  conversion	  of	  several	  ketones	  without	  loss	  of	  
activity.	   Even	   at	   elevated	   temperatures,	   sufficient	   regeneration	   of	   NADPH	   took	  
place	   for	   the	  enzyme-­‐catalyzed	  Baeyer-­‐Villiger	  oxidation	   to	  occur.	  Based	  on	   these	  
results	  we	  can	  conclude	  that	  with	  the	  thermostable	  variant	  of	  PTDH	  as	  fusion-­‐CRE	  
partner,	   stable	   and	   effective	   self-­‐sufficient	   BVMOs	   can	   be	   created	   that	   have	   the	  
potential	  to	  be	  applied	  in	  biocatalytic	  processes.	  
2.4. Experimental	  Section	  
General	  Methods	  
Unless	  otherwise	  noted,	  all	  chemicals	  and	  enzymes	  were	  obtained	  from	  ACROS	  Organics,	  
Sigma-­‐Aldrich,	   Jülich	   Fine	   Chemicals,	   Riedel-­‐de	   Haën	   Fine	   Chemicals,	   Roche	   Applied	  
Sciences,	   New	   England	   Biolabs	   and	   Finnzymes	   and	   used	   without	   further	   purification.	  
Oligonucleotide	  primers	  were	  obtained	   from	  Sigma	  Genosys.	  DNA	  sequencing	  was	  done	  
at	   GATC	   (Konstanz).	   Synthesis	   of	   the	   18x	   ptxD	   gene	   was	   performed	   by	   DNA	   2.0.	   The	  
synthetic	   gene	   encoding	   the	   18-­‐fold	   mutant	   of	   phosphite	   dehydrogenase	   from	  
Pseudomonas	  stutzeri	  WM88	  was	  designed	  using	  Gene	  Designer	   (Villalobos	  et	  al.	  2006).	  
The	  nucleotide	  sequence	  of	  this	  mutant	  was	  optimized	  using	  this	  software	  tool	  for	  optimal	  
codon	  usage	  in	  E.	  coli.	  In	  addition,	  a	  6x	  histidine	  tag	  was	  added	  upstream	  of	  the	  synthetic	  
gene	   to	   facilitate	   enzyme	   purification.	   Furthermore,	   recognition	   sites	   for	   the	   restriction	  
enzymes	  NcoI,	  NdeI	   and	   XhoI	   were	   introduced	   to	   facilitate	   cloning,	   whereas	   PvuII	   and	  
HindIII	  restriction	  sites	  were	  avoided.	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Cloning	  Strategy	  
For	  the	  creation	  of	  pCRE2−PAMO,	  a	  modified	  pBAD	  vector	  was	  used	  in	  which	  the	  NdeI	  site	  
was	   replaced	   by	   the	   original	   NcoI	   site.	   Subsequent	   cloning	   of	   the	   gene	   encoding	   the	  	  	  	  	  	  
18x	   mutant	   of	   phosphite	   dehydrogenase	   with	   N-­‐terminal	   histidine-­‐tag	   (from	  	  	  	  	  	  	  	  	  	  	  	  
pJ36/18x	   PTDH)	   and	   the	  pamO	   gene	   using	  NcoI/XhoI,	   respectively	  PvuII/HindIII,	   yielded	  
expression	   vector	   pCRE2−PAMO.	   Expression	   vectors	   pCRE2−CHMO,	   pCRE2−CPMO,	  
pCRE2−HAPMO	  and	  pCRE2−EtaA	  were	  created	  by	  subcloning	  respectively	  the	  chnB,	  cpnB,	  
hapE	   and	   etaA	   genes	   (Donoghue	   et	   al.	   1976,	   Griffin	   &	   Trudgill	   1976,	   Kamerbeek	   et	   al.	  
2001,	   Iwaki	   et	   al.	   2002,	   Fraaije	   2003,	   van	   Beilen	   et	   al.	   2003).	   Expression	   vector	  
pCRE2−PAMOM446G	  was	   created	  using	   the	  QuikChange®	  Site-­‐Directed	  Mutagenesis	  Kit	   of	  
Stratagene	   with	   pCRE2−PAMO	   as	   template	   and	   following	   the	   recommendations	   of	   the	  
manufacturer.	  	  
Cloning	  Strategy	  CRE2−PAMO	  linker	  variants	  
For	  the	  creation	  of	  pCRE2−PAMO	  linker	  variants	  1	  and	  2,	  the	  original	  linker	  was	  removed	  
using	  XhoI	  and	  PvuII	  restriction	  sites.	  The	  linearized	  vector	  was	  subsequently	  treated	  with	  
Antarctica	   Phosphatase	   (New	   England	   Biolabs)	   according	   to	   the	   manufacturer’s	  
guidelines.	   The	   linker	   fragments	   were	   created	   using	   5’-­‐phosphorylated	   complementary	  
primers	   (Table	   2-­‐6).	   These	   primers	   were	   dimerized	   in	   a	   thermocycler	   by	   incubating	  	  	  	  	  	  	  	  	  	  
100	  μM	  of	  each	  primer	  in	  10	  mM	  Tris/HCl	  (pH	  8,5)	  at	  72	  °C	  for	  2	  min,	  followed	  by	  a	  slow	  
cooling	  down	  to	  23	  °C	  in	  45	  minutes.	  The	  resulting	  double-­‐stranded	  DNA	  was	  then	  ligated	  
to	  the	  linearized	  vector	  using	  T4	  DNA	  ligase	  (New	  England	  Biolabs).	  	  










pCRE2−PAMO	   linker	   variant	   3	  was	   created	   by	   removing	   the	   PTDH	   sequence	   using	  NdeI	  
and	   PvuII	   restriction	   sites.	   The	   PTDH	   gene	   was	   then	   newly	   amplified	   with	   primers	  
including	  a	  NdeI	  restriction	  site	  in	  the	  forward	  primer.	  The	  PCR	  product	  was	  digested	  with	  
NdeI	   (New	   England	   Biolabs)	   according	   to	   the	   manufacturer’s	   guidelines	   to	   create	   the	  
corresponding	  overlapping	  region	  at	  the	  5’end,	  while	  the	  3’end	  stayed	  blunt.	  Ligation	  of	  
the	  linearized	  vector	  and	  the	  PCR	  product	  was	  then	  followed	  by	  a	  QuikChange	  reaction	  to	  
remove	  one	  nucleotide	  (Table	  2-­‐7).	  	  
Table	  2-­‐7:	  Primer	  sequences	  for	  linker	  variant	  3	  and	  quikchange	  primers	  sequences.	  
	  
Overexpression	  and	  fusion	  enzyme	  purification	  
All	   self-­‐sufficient	   BVMOs,	   as	   well	   as	   the	   linker	   variants,	   were	   overexpressed	   in	   E.	   coli	  
TOP10	  using	  Terrific	  Broth	  (TB)	  medium	  containing	  50	  μg	  mL-­‐1	  ampicillin	  and	  0,02	  %	  (wv-­‐1)	  
L-­‐arabinose.	   CRE2−PAMO	   (and	   the	   linker	   variants),	   CRE2−PAMOM446G	   and	   CRE2−CHMO	  
were	  overexpressed	  at	  24	  °C	  during	  36	  hours.	  CRE2−CPMO,	  CRE2−HAPMO	  and	  CRE2−EtaA	  
were	  overexpressed	  at	  17	   °C	  during	  48	  hours.	   Thereafter,	   cells	  were	  harvested,	  washed	  
and	   resuspended	   in	   50	   mM	   Tris/HCl,	   pH	   7,5	   containing	   10	   μM	   FAD.	   Cells	   expressing	  
CRE2−CHMO	  were	   resuspended	   in	   50	  mM	  Tris/HCl,	   pH	   7,5	   supplemented	  with	   0,5	  mM	  
DTT	  and	  10	  %	  (wv-­‐1)	  glycerol,	  whereas	  cells	  expressing	  CRE2−EtaA	  were	  resuspended	  in	  50	  
mM	  Tris/HCl,	  pH	  7,5	  supplemented	  with	  1	  mM	  β-­‐mercaptoethanol,	  1	  mM	  NaN3,	  100	  mM	  
KCl,	  10	  %	  (wv-­‐1)	  glycerol	  and	  1	  %	  (vv-­‐1)	  Triton	  X-­‐100.	  All	  further	  steps	  were	  carried	  out	  at	  4	  
°C.	  After	  breaking	  the	  cells	  by	  ultrasonication	  and	  removing	  cell	  debris	  by	  centrifugation,	  
fusion	   enzymes	   were	   purified	   using	   2	   mL	   Ni-­‐NTA	   column.	   After	   purification,	   excess	   of	  
imidazole	  was	  removed	  using	  an	  Econo-­‐PAC	  10DG	  desalting	  column	  (BioRad).	  The	  fusion	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Determination	  of	  kinetic	  parameters	  of	  isolated	  fusion	  enzymes	  
Activities	   of	   purified	   enzymes	   were	   determined	   spectrophotometrically	   by	   monitoring	  
increase	   or	   decrease	   of	   NADPH	   in	   time	   at	   340	   nm	   (εNADPH	   =	   6,2	  mM
-­‐1	   cm-­‐1)	   or	   370	   nm	  
(εNADPH	  =	  2,7	  mM
-­‐1	  cm-­‐1).	  The	  reaction	  mixture	  (1	  mL)	  typically	  contained	  50	  mM	  Tris/HCl,	  
pH	  7,5,	  100	  µM	  coenzyme,	  2	  mM	  ketone	  or	  5	  mM	  Na2HPO3	  and	  0,05	  –	  1	  µM	  enzyme	  at	  	  	  
25	  °C.	  The	  following	  ketones	  were	  used:	  phenylacetone	  for	  CRE2−PAMO	  and	  CRE2-­‐EtaA,	  
cyclohexanone	   for	   CRE2−CHMO,	   cyclopentanone	   for	   CRE2−CPMO,	   4-­‐hydroxy-­‐
acetophenone	   for	   CRE2−HAPMO	   and	   benzaldehyde	   for	   CRE2−PAMOM446G.	   Kinetic	  
parameters	   were	   obtained	   by	   fitting	   the	   obtained	   data	   as	   described	   previously	  
(Kamerbeek	  et	  al.	  2003).	   Thermostability	  of	   the	  enzymes	  was	  determined	  by	   incubating	  
approximately	  30	  μM	  enzyme	  at	  37	  °C	  or	  50	  °C,	  after	  which	  their	  remaining	  activity	  was	  
determined	  at	  25	  °C	  using	  saturating	  substrate	  concentrations.	  	  
Thermostability	  measurements	  of	  CRE2−PAMO	  linker	  variants	  
Thermostability	   of	   the	   enzymes	  was	   determined	   by	   incubating	   approximately	   10	   μM	  of	  
enzyme	  in	  the	  presence	  of	  10	  μM	  of	  FAD	  at	  55	  °C,	  after	  which	  their	  remaining	  activity	  was	  
determined	   at	   25	   °C.	   Activity	   was	   measured	   by	   monitoring	   the	   absorbance	   at	   340	   nm	  
(NADPH	   depletion/production)	   (PAMO:	   0,1	   µM	   enzyme,	   100	   µM	   NADPH,	   2	   mM	  
phenylacetone;	  PTDH:	  0,05	  µM	  enzyme,	  100	  µM	  NADP+,	  5	  mM	  phosphite)	  
Melting	   temperature	   determination	  of	   CRE2−PAMO	   linker	   variants	   via	   ThermoFAD	  
(Forneris	  et	  al.	  2009)	  	  
50	  μM	  of	  purified	  protein,	  adjusted	  with	  buffer	  to	  a	  volume	  of	  50	  μl	  was	  placed	  in	  a	  real	  
time	  PCR	  (RT-­‐PCR)	  apparatus	  (Biorad)	  equipped	  with	  a	  470-­‐543	  nm	  excitation	  filter	  and	  a	  
SYBRGreen	   fluorescence	   emission	   filter	   (523-­‐543	   nm).	   During	   a	   temperature	   gradient	  
from	   20	   to	   90	   °C	   the	   fluorescence	   was	   measured	   every	   0,5	   °C,	   with	   10	   s	   delay	   for	  
stabilization.	   TM	   values	   are	   based	   on	   the	   peaks	   of	   the	   derivatives	   of	   the	   fluorscence	  
intensity	  data.	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General	  protocol	  for	  cleared	  cell	  extract	  (CCE)	  biotransformations	  
Fresh	  TB	  medium	  (0,2	  or	  0,5	  L)	  containing	  50	  μg	  mL-­‐1	  ampicillin	  was	  inoculated	  with	  1%	  of	  
an	   overnight	   preculture	   of	   recombinant	   E.	   coli	   TOP10	   overexpressing	   CRE2−PAMO,	  
CRE2−CHMO	   or	   CRE2−CPMO	   a	   1	   or	   2,5	   L	   baffled	   Erlenmeyer	   flask,	   respectively.	  
L-­‐arabinose	   was	   added	   to	   a	   final	   concentration	   0.02	   %	   (wv-­‐1)	   and	   the	   culture	   was	  
incubated	  at	  120	  rpm	  at	  24	  °C	  on	  an	  orbital	  shaker	  for	  24	  or	  40	  hours,	  depending	  on	  the	  
total	  volume.	  Cells	  were	  harvested	  by	  centrifugation	  (6000	  ×	  g,	  10	  min,	  4	  °C,	  Sigma	  3K30	  
centrifuge,	  rotor	  19777).	  The	  cell	  pellets	  were	  resuspended	  in	  10	  mM	  PBS	  buffer,	  pH	  7,4	  
(double	  volume	  of	  cells)	  containing	  0,1	  %	  (vv-­‐1)	  PMSF	  and	  disintegrated	  by	  ultrasonication.	  
Cell	  debris	  was	  removed	  by	  centrifugation	  (15000	  ×	  g,	  20	  min,	  4	  °C,	  Sigma	  6K15	  centrifuge,	  
rotor	   372/C).	   The	   CCE	   was	   divided	   into	   aliquots	   of	   0,5	   mL	   and	   stored	   at	   –20	   °C	   until	  
needed.	   Protein	   concentration	   of	   the	   cleared	   cell	   extract	   was	   estimated	   by	   Bradford	  
method	   using	   Protein	   Assay	   (Bio-­‐Rad).	   Biotransformations	   using	   CCE	   were	   realized	   in	  
either	  regular	  96-­‐well	  or	  12-­‐well	  plates.	  The	  total	  reaction	  volume	  in	  each	  well	  was	  150	  μL	  
or	   2	   mL,	   respectively,	   and	   contained	   approximately	   8	   mg	   mL-­‐1	   protein	   and	   100	   mM	  
Na2HPO3	   (final	   concentrations).	   Substrate	   inhibition	   studies	   were	   performed	   using	  	  	  	  	  	  	  	  	  	  	  	  
4-­‐methyl	   cyclohexanone	   (5	   −	   30	  mM).	  Other	   biotransformations	  were	   carried	   out	   using	  	  	  	  	  
5	   or	   20	   mM	   racemic	   bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	   as	   substrate.	   The	   mixture	   was	  
incubated	  at	  700	  rpm	  at	  24	  °C	  in	  a	  multi-­‐well	  plate	  incubator	  (Heidolph	  Titramax	  1000).	  All	  
biotransformations	   carried	   out	   at	   elevated	   temperatures	   (37	   °C	   and	   50	   °C)	   were	  
supplemented	   with	   10	   μM	   FAD	   (final	   concentration).	   Samples	   were	   taken	   in	   regular	  
intervals,	   extracted	   with	   ethylacetate	   including	   internal	   standard	   (1	   mM	   of	   methyl-­‐	  
benzoate)	  and	  analyzed	  by	  gas	  chromatography	  (Stewart	  et	  al.	  1996).	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  wird	  man	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  based	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  Biotechnology	  (2012),	  95,	  1479-­‐1489	  




Abstract:	   To	   expand	   the	   available	   set	   of	   Baeyer-­‐Villiger	  
monooxygenases	   (BVMOs),	   we	   have	   created	   expression	  
constructs	  for	  producing	  22	  Type	  I	  BVMOs	  that	  are	  present	  
in	   the	  genome	  of	  Rhodococcus	   jostii	  RHA1.	  Each	  BVMO	  has	  
been	   probed	   with	   a	   large	   panel	   of	   potential	   substrates.	  
Except	   for	   testing	   their	   substrate	   acceptance,	   also	   the	  
enantioselectivity	   of	   some	   selected	   BVMOs	   was	   studied.	  
The	  results	  provide	  insight	  into	  the	  biocatalytic	  potential	  of	  
this	   collection	   of	   BVMOs	   and	   expand	   the	   biocatalytic	  
repertoire	  known	  for	  BVMOs.	  This	  study	  also	  sheds	  light	  on	  
the	   catalytic	   capacity	   of	   this	   large	   set	   of	   BVMOs	   that	   is	  
present	   in	   this	   specific	   actinomycete.	   Furthermore,	   a	  
comparative	   sequence	   analysis	   revealed	   a	   new	   BVMO-­‐
typifying	  sequence	  motif.	  This	  motif	  represents	  a	  useful	  tool	  
for	  effective	  future	  genome	  mining	  efforts.	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3.1. Introduction	  
In	   the	   last	   few	   years	   the	   interest	   in	   using	   Baeyer-­‐Villiger	  monooxygenases	   (BVMOs)	   as	  
biocatalysts	  has	  increased.	  These	  flavin	  dependent	  enzymes	  are	  able	  to	  perform	  efficient	  
chemo-­‐,	   regio-­‐,	   and/or	   enantioselective	   oxygenation	   reactions	   using	   stoichiometric	  
amounts	  of	  O2	  as	  oxidant	  and	  NAD(P)H	  as	  electron	  donor.	  It	  has	  been	  shown	  that	  BVMOs	  
can	   be	   used	   as	   biocatalysts	   for	   highly	   enantioselective	   Baeyer-­‐Villiger	   oxidations	   and	  
sulfoxidations	  (de	  Gonzalo	  et	  al.	  2010).	  In	  addition,	  these	  oxidative	  biocatalysts	  have	  also	  
been	   shown	   to	   catalyze	   oxygenation	   of	   other	   heteroatoms	   like	   nitrogen,	   phosphor,	  
selenium	  and	  boron,	  as	  well	  as	  epoxidation	  reactions	  (Renz	  &	  Meunier	  1999,	  Mihovilovic	  
et	  al.	  2004).	  Such	  selective	  oxygenation	  reactions	  are	  difficult	  to	  perform	  selectively	  with	  
chemical	  catalysts,	  rendering	  BVMOs	  a	  powerful	  tool	  in	  organic	  chemistry.	  
Taking	  into	  account	  the	  urgent	  need	  for	  environmental	  friendly	  processes,	  the	  use	  of	  
biocatalysts	  is	  highly	  favorable	  due	  to	  the	  mild	  reaction	  conditions	  possible	  by	  employing	  
enzymes	   such	   as	   BVMOs.	   However,	   there	   are	   still	   some	   drawbacks	   concerning	   the	  
applicability	   of	   these	   enzymes.	   One	   of	   them	   is	   the	   fact	   that	   BVMOs	   are	   coenzyme	  
dependent	   and	   therefore	   need	   an	   NAD(P)H	   regeneration	   system.	   Several	   different	  
strategies	   have	   been	   applied	   to	   solve	   this	   problem,	   like	   the	   use	   of	   whole	   cells	   or	   of	   a	  
regeneration	  enzyme	  partner	  (Hollmann	  et	  al.	  2007,	  Torres	  Pazmiño	  et	  al.	  2009).	  Another	  
complicating	  factor	  is	  the	  limited	  availability	  of	  suitable	  BVMOs.	  With	  the	  known	  BVMOs,	  
only	  a	  limited	  set	  of	  reactions	  can	  be	  catalyzed.	  Furthermore,	  some	  of	  the	  BVMOs	  that	  are	  
of	   interest	   are	   rather	   unstable.	   This	   is	   already	   evident	   from	   the	   most	   studied	   BVMO:	  
cyclohexanone	  monooxygenase	  (CHMO).	  This	  BVMO	  from	  Acinetobacter	  has	  been	  shown	  
to	   act	   on	   a	   variety	   of	   compounds	   (Stewart	   1998,	  Mihovilovic	  et	   al.	   2002),	   but	   it	   is	   very	  
unstable	  (CHMO:	  t1/2	  =	  24	  h	  at	  25°C)	  (Zambianchi	  et	  al.	  2002).	  In	  contrast,	  phenylacetone	  
monooxygenase	   (PAMO)	   from	   Thermobifida	   fusca	   is	   a	   very	   robust	   BVMO	   (t1/2	   =24h	   at	  
52°C)	  (Fraaije	  et	  al.	  2005,	  Secundo	  et	  al.	  2010).	  Nevertheless,	  its	  substrate	  scope	  is	  rather	  
limited	  to	  small	  aromatic	  substrates.	  
The	   above-­‐mentioned	   current	   limitations	   in	   BVMO-­‐based	   biocatalysis	   has	   triggered	  
enzyme	  discovery	  and	  engineering	  studies	  to	  generate	  a	   larger	  collection	  of	  BVMOs	  that	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show	   a	   good	   operational	   stability,	   while	   covering	   a	   wide	   variety	   of	   compounds.	   One	  
approach	  to	  achieve	  this	   is	   to	  engineer	  known	  BVMOs	   in	  order	  to	  create	  supplementing	  
activities	   and	   selectivities.	   For	   this	   purpose,	   several	   enzyme	   engineering	   studies	   have	  
been	   reported	   in	   recent	   years	   (Fraaije	   et	   al.	   2005,	   Torres	   Pazmiño	   et	   al.	   2010).	   For	  
example,	  PAMO	  has	  been	  subjected	  to	  structure-­‐based	  mutagenesis	  and	  this	  has	  resulted	  
in	   several	   mutants	   that	   display	   a	   somewhat	   altered	   substrate	   range	   and/or	  
enantioselectivity	  when	  compared	  with	  the	  wild-­‐type	  enzyme	  (Bocola	  et	  al.	  2005,	  Torres	  
Pazmiño	   et	   al.	   2007,	   Wu	   et	   al.	   2010,	   Dudek	   et	   al.	   2011).	   However,	   these	   enzyme	  
engineering	  studies	  have	  also	  shown	  that	  it	   is	  difficult	  to	  introduce	  substrate	  acceptance	  
profiles	  that	  are	  significantly	  different	  from	  the	  parent	  enzyme.	  
To	  increase	  the	  number	  of	  available	  and	  distinct	  BVMOs,	  also	  the	  natural	  diversity	  can	  
be	   tapped.	   With	   the	   BVMO-­‐specific	   sequence	   motif	   it	   has	   become	   easy	   to	   survey	  
sequenced	  genomes	  for	  BVMO-­‐encoding	  genes	  (Fraaije	  et	  al.	  2002).	  Such	  identified	  genes	  
can	   subsequently	   be	   cloned	   and	   the	   corresponding	   proteins	   overexpressed	   for	  
biocatalytic	  evaluation	  studies.	  Genome	  mining	  has	  already	  delivered	  a	  number	  of	  novel	  
BVMOs	  (Torres	  Pazmiño	  et	  al.	  2010).	  Even	  though	  BVMOs	  are	  widespread	  in	  bacteria	  and	  
fungi,	   the	   average	   distribution	   is	   only	   around	   1	   BVMO-­‐encoding	   gene	   per	   microbial	  
genome	  (de	  Gonzalo	  et	  al.	  2010).	  In	  this	  respect	  the	  bacterium	  Rhodococcus	  jostii	  RHA1	  is	  
a	   peculiar	   and	   promising	   exception:	   its	   predicted	   proteome	   contains	   an	   unusually	   high	  
variety	   in	   oxidative	   enzymes,	   including	   >20	   putative	   BVMOs	   (McLeod	   et	   al.	   2006).	   The	  
Grogan	  group	  already	  performed	  an	  initial	  study	  on	  the	  BVMO	  repertoire	  of	  this	  organism	  
(Szolkowy	  et	  al.	  2009)	  and	  identified	  several	  interesting	  activities	  but	  failed	  in	  expressing	  
all	  BVMOs.	  
	  
In	   this	   chapter,	  we	   report	   on	   the	   exploration	   of	   22	   BVMOs	   derived	   from	   R.	   jostii	  
RHA1.	  By	  optimizing	  expression	  vectors	  and	  expression	  conditions	  all	  BVMOs	  were	  
obtained	   in	   a	   soluble	   form.	   Using	   a	   newly	   developed	   method	   to	   determine	   the	  
amount	  of	  expressed	  and	  active	  BVMO	  in	  a	  cell	  extract	  in	  combination	  with	  a	  novel	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generic	  activity	  screening	  assay,	  the	  substrate	  profiles	  for	  a	  large	  set	  of	  substrates	  
for	  all	  22	  BVMOs	  have	  been	  determined.	  
3.2. Results	  
3.2.1. Identification	  of	  putative	  BVMO-­‐encoding	  genes	  
By	   using	   protein	   sequences	   of	   PAMO	   and	   CHMO	   as	   baits	   for	   BLASTP	   searches	   in	   the	  
predicted	   proteome	   of	   R.	   jostii	   RHA1	   (McLeod	   et	   al.	   2006),	   and	   inspecting	   individual	  
putative	  sequences	  for	  known	  sequence	  motifs,	  23	  putative	  Type	  I	  BVMO	  genes	  could	  be	  
identified	   (Table	   3-­‐1).	   For	   consistency,	   we	   numbered	   the	   BVMOs	   according	   to	   the	  
numbering	   employed	   in	   a	   previous	   study	   by	   the	   Grogan	   group	   (Szolkowy	   et	   al.	   2009).	  
Compared	  with	  this	  study,	  our	  set	  of	  BVMOs	  contains	  one	  more	  putative	  BVMO-­‐encoding	  
gene	   that	   was	   not	   identified	   before	   (BVMO	   #24).	   Furthermore,	   it	   was	   previously	  
suggested	   that	   BVMO	   #8	   represented	   a	   BVMO	   lacking	   a	   large	   part	   of	   the	   C-­‐terminal	  
domain,	   which	   binds	   the	   NADPH	   coenzyme	   (RHA1_ro08998).	   Careful	   inspection	   of	   the	  
sequenced	   genome	   revealed	   that	   a	   large	   part	   of	   a	   C-­‐terminal	   BVMO	   sequence	   (ORF	  
RHA1_ro08999)	   resides	   upstream	   of	   RHA1_ro08998	   in	   the	   genome.	   Sequence	   analysis	  
revealed	   that	   only	   one	   nucleotide	   was	  missing	   to	   create	   a	   gene	   encoding	   a	   full	   length	  
BVMO,	   fusing	   both	   these	   open	   reading	   frames.	   The	   corrected	   BVMO	   #8	   gene	   was	  
generated	  and	   included	   in	  this	  study	  (see	  Materials	  and	  Methods).	  Except	   for	   these	  two	  
newly	  reported	  BVMOs,	  BVMO	  #8	  and	  BVMO	  #24,	  we	  also	  discarded	  one	  gene	  from	  our	  
study	  that	  was	  previously	  assigned	  as	  a	  Type	  I	  BVMO	  (BVMO	  #22	  in	  Szolkowy	  et	  al.	  2009).	  
Analysis	   of	   the	   respective	   protein	   sequence	   revealed	   that	   it	   represents	   a	   typical	   flavin-­‐
containing	   monooxygenase	   (FMO),	   which	   is	   a	   member	   of	   a	   flavoprotein	   family	   that	   is	  
distinct	   from	   BVMOs	   (Fraaije	   et	   al.	   2002).	   Furthermore,	   two	   BVMOs	   (BVMO	   #21	   and	  
BVMO	   #23)	   differed	   in	   only	   one	   amino	   acid	   out	   546	   amino	   acids.	   Based	   on	   sequence	  
alignment	  with	  phenylacetone	  monooxygenases,	  this	  residue	  (Leu	  or	  Arg	  at	  position	  480)	  
is	  predicted	  to	  be	  on	  the	  surface	  of	  the	  protein	  and	  therefore	  will	  have	  little	  effect	  on	  the	  
catalytic	  properties	  of	  these	  BVMOs.	  This	  has	  in	  fact	  been	  confirmed	  by	  the	  previous	  study	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of	   the	   Grogan	   group	   (Szolkowy	   et	   al.	   2009).	   For	   that	   reason,	   BVMO	   #23	  was	   excluded	  
from	  this	  study.	  
All	   identified	  BVMO	   sequences	   contained	   two	   conserved	  Rossmann	   fold	  motifs:	   one	  
near	  the	  N-­‐terminus	  and	  one	  in	  the	  middle	  of	  the	  sequence	  (Table	  3-­‐1).	  In	  BVMO	  #10	  and	  
BVMO	  #18,	  the	  N-­‐terminal	  GxGxxG	  motif	  is	  preceded	  by	  ~120	  amino	  acids	  instead	  of	  only	  
≈20	  amino	  acids.	  This	   indicates	   that	   these	  enzymes	  have	  acquired	  an	  additional	  domain	  
that	  is	  also	  found	  in	  a	  known	  BVMO,	  4-­‐hydroxyacetophenone	  monooxygenases	  (HAPMO),	  
and	  which	  has	  been	  suggested	  to	  play	  a	  role	  in	  dimerization	  (Kamerbeek	  et	  al.	  2005).	  As	  
described	   before,	   Type	   I	   BVMOs	   contain	   a	   typifying	   short	   sequence	   motif:	  
FxGxxxHxxxW[P/D]	  (Fraaije	  et	  al.	  2002).	  By	  allowing	  one	  or	  two	  conservative	  mutations	  in	  
this	  motif,	  all	  22	  sequences	  were	  found	  to	  contain	  such	  sequence	  motif.	  It	  shows	  that	  not	  
every	  residue	  of	  the	  previously	  described	  motif	  is	  strictly	  conserved.	  While	  the	  glycine	  and	  
tryptophan	   residues	  are	   strictly	   conserved,	   some	  mutations	   (e.g.	   F>Y	   in	  BVMO	  #4),	   also	  
occur	  which	  reflect	  the	  origin	  of	  the	  sequence	  conservation	  within	  this	  motif.	  The	  BVMO	  
motif	   is	   located	   in	   a	   loop	   region	   of	   BVMOs	   that	   allows	   protein	   dynamics	   during	   the	  
catalytic	  cycle	  while	  it	  is	  not	  directly	  involved	  in	  catalysis	  (Orru	  et	  al.	  2011).	  
For	   illustrating	   the	   sequence	   relationships	   between	   the	   identified	   R.	   jostii	   sp.	   RHA1	  
BVMOs	  and	  some	  of	  the	  best	  characterized	  BVMOs,	  all	  these	  sequences	  were	  aligned	  (see	  
Appendix).	   This	   revealed	   that	   the	   rhodococcal	   BVMOs	   are	   representatives	   of	   many	  
different	   clades	   of	   the	   Type	   I	   BVMO	   family.	   Careful	   inspection	   of	   the	   structure-­‐based	  
multiple	  sequence	  alignment	  also	  revealed	  another	  interesting	  conserved	  sequence	  motif.	  
Except	  for	  the	  two	  Rossmann	  fold	  motifs	  and	  the	  BVMO-­‐motif	  mentioned	  above,	  there	  is	  
one	   particular	   region	   of	   the	   sequences	   that	   shows	   remarkable	   conservation,	   located	  
between	   the	  N-­‐terminal	   GxGxxG	  motif	   and	   the	   known	  BVMO-­‐motif.	   This	   region	   can	   be	  
defined	  by	  [A/G]GxWxxxx[F/Y]P[G/M]xxxD.	  The	  full	  conservation	  of	  the	  aspartate	  is	  in	  full	  
agreement	  with	  the	  recent	  finding	  that	  Asp66	  in	  PAMO	  plays	  a	  crucial	  role	  in	  catalysis	  by	  
direct	   interaction	   with	   the	   NADP+	   coenzyme.	   Mutating	   this	   residue	   into	   an	   alanine	  
resulted	   in	   inactivation	  of	   the	  enzyme	  by	  decreasing	   the	   rate	  of	  NADPH-­‐mediated	   flavin	  
reduction	   (Orru	   et	   al.	   2011).	   Combined	  with	   Arg337,	   these	   two	   residues	   represent	   the	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only	  fully	  conserved	  active	  site	  residues,	  both	  crucial	  for	  catalysis.	  The	  conserved	  doublet	  
of	  glycine	   residues	   in	   this	  newly	   recognized	  motif	   is	  a	  known	  motif	   for	  a	  Rossmann	   fold	  
domain	  and	  in	  the	  BVMOs	  they	  support	  effective	  binding	  of	  the	  FAD	  cofactor.	  The	  other	  
conserved	   residues	   in	   the	   motif	   center	   around	   the	   flavin	   cofactor	   and	   appear	   to	   be	  
essential	  for	  creating	  a	  productive	  active	  site	  architecture	  (Figure	  3-­‐1).	  	  
	  
Figure	   3-­‐1:	   Structure	   of	   PAMO	  with	   conserved	   residues	   highlighted.	   The	   previously	   described	   BVMO	  motif	  
residues	  are	  in	  blue	  sticks	  while	  the	  motif	  described	  in	  this	  chapter	  is	  in	  magenta	  sticks.	  The	  FAD	  and	  NADP+	  
cofactors	  are	  shown	  in	  green	  sticks.	  
This	   newly	   recognized	   motif	   appears	   to	   be	   more	   discriminative	   for	   identifying	   BVMO	  
sequences	   as	   it	   entails	  more	   and	  more	   conserved	   residues.	   It	   also	   clearly	   differentiates	  
between	  BVMO	  and	  FMO	  sequences	  as	  the	  structure	  and	  sequence	  region	  around	  Asp66	  
(in	  PAMO)	   in	  FMOs	   is	  totally	  different	  (Fraaije	  et	  al.	  2002,	  Alfieri	  et	  al.	  2008).	  Therefore,	  




In	   order	   to	   obtain	   a	   better	   view	   on	   the	   sequence-­‐function	   relationship	   among	   the	  
tested	  set	  of	  BVMOs,	  also	  another	  sequence	  alignment	  was	  performed.	  Using	  the	  recently	  
elucidated	   crystal	   structure	   of	   PAMO,	   which	   contains	   NADP+	   and	   a	   substrate	   analogue	  
(MES),	  we	   identified	  all	   residues	   that	  are	  within	  a	  12	  Å	  radius	   from	  the	  sulphur	  atom	  of	  
the	  substrate	  analogue	  (Orru	  et	  al.	  2011).	  This	  yielded	  a	  set	  of	  59	  residues	  that	  form	  the	  
core	  of	  the	  substrate	  binding	  pocket	  and	  that	  are	  spread	  over	  the	  PAMO	  sequence.	  Upon	  
performing	  a	  structure-­‐based	  multiple	  sequence	  alignment,	  we	  filtered	  for	  all	   respective	  
59	  residues	   for	  generating	  a	  separate	  multiple	  sequence	  alignment.	  We	  anticipated	  that	  
such	   an	   approach	   of	   comparing	   partial	   sequences	   would	   have	   a	   higher	   probability	   to	  
disclose	   similarities	   in	   substrate	   specificities.	   In	   Figure	   3-­‐2,	   the	   phylogenetic	   tree	  
representation	   of	   this	   focussed	   sequence	   alignment	   of	   all	   tested	   and	   known	   BVMOs	   is	  
shown.	   The	   grouping	   differed	   slightly	   from	   the	   global	  multiple	   sequence	   alignment	   and	  
was	  used	  for	  the	  discussion	  below.	  
3.2.1. Expression	  of	  the	  putative	  BVMOs	  
All	   22	   putative	   BVMO-­‐encoding	   genes	   were	   cloned	   into	   a	   slightly	   modified	   pBAD	  
expression	   vector	   (Kamerbeek	   et	   al.	   2004)	   using	   a	   ligation	   free	   cloning	   method.	  
Subsequently,	  expression	  tests	  were	  performed	  in	  which	  the	  temperature	  and	  arabinose	  
concentration	  were	  varied.	  With	  these	  constructs,	  11	  BVMOs	  could	  be	  obtained	  in	  soluble	  
form	  with	  good	  expression	  levels,	  using	  E.	  coli	  TOP10	  as	  host	  (Table	  3-­‐1).	  A	  similar	  success	  
rate	  was	  previously	  obtained	  for	  roughly	  the	  same	  set	  of	  genes	  using	  an	  pET-­‐based	  E.	  coli	  
expression	   system	   (Szolkowy	  et	   al.	   2009)	   (Table	   3-­‐1).	   In	   the	   other	   cases,	   the	   expressed	  
protein	  was	  either	  insoluble	  or	  the	  expression	  levels	  of	  soluble	  protein	  were	  very	  low.	  To	  
increase	   the	   expression	   level	   and/or	   solubility,	   the	   11	   BVMO	   genes	   that	   could	   not	   be	  
expressed	  using	  pBAD	  were	  cloned	  into	  the	  recently	  developed	  pCRE2	  expression	  vector	  
and	  tested	  using	  various	  expression	  conditions	  (Torres	  Pazmiño	  et	  al.	  2009).	  This	  resulted	  
in	  good	  expression	  levels	  of	  soluble	  protein	  of	  most	  of	  these	  genes.	  Only	  in	  5	  cases	  poor	  
soluble	   protein	   expression	  was	   observed.	   Nonetheless,	   by	   using	   the	   NADPH-­‐dependent	  
flavin	   reduction	   method	   (vide	   infra)	   it	   was	   found	   that	   also	   these	   constructs	   led	   to	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expression	   of	   detectable	   levels	   of	   soluble	   NADPH-­‐reactive	   proteins.	   Taken	   together,	   by	  
using	  two	  expression	  vectors	  and	  careful	  tuning	  of	  expression	  conditions,	  we	  succeeded	  in	  
producing	  all	  22	  targeted	  BVMOs	  in	  a	  soluble	  form.	  
	  
Figure	  3-­‐2:	  Radial	  phylogenetic	  representation	  of	  the	  comparison	  of	  active	  site	  residues	  of	  the	  selected	  BVMO	  
protein	   sequences.	   The	   included	   sequences	   are:	   AlmA1,	  Acinetobacter	   sp.	   DSM	   17874	   (ABQ18224.1);	   EtaA,	  
Mycobacterium	  tuberculosis	  H37Rv	  (NP_218371.1);	  HAPMO,	  Pseudomonas	  fluorescens	  ACB	  (Q93TJ5.1);	  MoxY,	  
Aspergillus	  flavus	  (AAS90037.1);	  PtlE,	  Streptomyces	  avermitilis	  MA-­‐4680	  (NP_824170.1);	  CDMO,	  Rhodococcus	  
ruber	   SCI	   (AAL14233.1);	   CPDMO,	   Pseudomonas	   sp.	   strain	   HI-­‐70	   (BAE93346.1);	   CHMO,	   Acinetobacter	  
calcoaceticus	  NCIMB	   9871	   (BAA86293.1);	   PAMO,	   T.	   fusca	   (YP_289549.1);	   STMO,	   Rhodococcus	   rhodochrous	  
(BAA24454.1);	   ACMO,	   Gordania	   sp.	   strain	   TY-­‐5	   (BAF43791.1);	   MEKMO,	   Pseudomonas	   veronii	   MEK700	  
(ABI15711.1);	  CPMO,	  Comamonas	  sp.	  strain	  NCIMB	  9872	  (Q8GAW0).	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Table	  3-­‐1:	  All	  identified	  BVMOs	  and	  their	  sequence	  characteristics	  from	  the	  predicted	  R.	  jostii	  RHA1	  proteome.	  
	  
a,	   this	   gene	   has	   been	   cured,	   see	   text;	   b,	   ++	   indicates	   a	   clear	   visible	   protein	   band	   using	   SDS-­‐PAGE	   while	   +	  
indicates	   that	   no	   clear	   band	  was	   visible	   but	   flavin	   reduction	  was	   observed,	   B	   indicates	   that	   the	   respective	  
BVMO	  has	  been	  expressed	  using	  the	  pBADN-­‐vector,	  C	  indicates	  the	  use	  of	  the	  pCRE2-­‐	  expression	  vector;	  the	  
underlined	   BVMOs	   were	   previously	   expressed	   in	   soluble	   form	   in	   a	   pET	   expression	   vector	   (Szolkowy	   et	   al.	  
2009).	  n.d.:	  not	  determined.	  	  
Interestingly,	   for	   a	   number	   of	   constructs	   it	   was	   found	   that,	   using	   the	   optimal	  
expression	  conditions,	  the	  growth	  medium	  changed	  significantly	  in	  color	  (Table	  3-­‐1).	  Such	  
a	   phenomenon	   had	   been	   observed	   before	   in	   a	   BVMO	   mutagenesis	   study	   where	   the	  
M446G	  PAMO	  mutant	  was	  created	  (Torres	  Pazmiño	  et	  al.	  2007).	  This	  mutant	  BVMO	  was	  
found	   to	   form	   indigo	  blue	  by	  oxidizing	   indole,	  which	   is	   present	   in	   the	   cytosol	   of	   E.	   coli.	  
Also	  for	  some	  of	  the	  expressed	  rhodococcal	  BVMOs	  a	  blue	  color	  was	  observed	  while	  some	  
other	  constructs	  led	  to	  a	  more	  brownish	  or	  intense	  yellow	  color.	  Apparently,	  some	  of	  the	  
accession Rossman BVMO Rossman length soluble4b medium
4number motif motif Motif (aa) expression color
GxGxxG FxGxxxHxxxWP/D GxGxxG
1 ro06679 GxGxxG FxGxxxHxxxWP GxGxxG 538 +4B 6
2 ro043044 GxGxxG FxGxxxHxxxWN GxGxxA 496 ++4C 6
3 ro03247 GxGxxG FxGxxxHxxxWP GxGxxG 543 ++4C blue
4 ro030634 GxGxxG YxGxxxHxxxWR GxGxxA 549 ++4B 6
5 ro02109 GxGxxG FxGxxxHxxxWN GxGxxA 491 +4C blue
6 ro01874 GxGxxG FxGxxxHxxxWN GxGxxA 493 ++4B 6
7 ro060084 GxGxxG FxGxxxHxxxWN GxGxxA 537 ++4C blue
8a ro08998/9 GxGxxG FxGxxxHxxxWD GxGxxA 545 ++4C 6
9 ro09035 GxGxxG FxGxxxHxxxWP GxGxxG 541 ++4B 6
10 ro090394 GxGxxG FxGxxxHxxxWD GxGxxS 663 ++4B 6
11 ro06698 GxGxxG FxGxxxHxxxWP GxGxxG 545 ++4B 6
12 ro071124 GxGxxG FxGxxxHxxxWD GxGxxA 514 ++4C blue
13 ro037734 GxGxxG FxGxxxHxxxWP GxGxxA 515 +4C 6
14 ro03437 GxGxxG FxGxxxLxxxWP GxGxxG 547 ++4B 6
15 ro02492 GxGxxG FxGxxxHxxxWP GxGxxG 553 ++4B 6
16 ro02919 GxGxxG FxGxxxHxxxWP GxGxxG 498 ++4C 6
17 ro052284 GxGxxG FxGxxxHxxxWD GxGxxA 603 +4C blue
18 ro053964 GxGxxG FxGxxxHxxxWP GxGxxS 652 ++4C 6
19 ro05522 GxGxxG FxGxxxHxxxWN GxGxxA 515 +4C brown/blue
20 ro081374 GxGxxG FxGxxxHxxxWP GxGxxG 548 ++4B brown/blue
21 ro10187 GxGxxG FxGxxxHxxxWP GxGxxG 546 ++4B brown/blue
23 ro08185 GxGxxG FxGxxxHxxxWP GxGxxG 546 n.d n.d.
24 ro05323 GxGxxG FxGxxxSxxxWN GxGxxG 564 ++4B yellow
BVMO
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expressed	  BVMOs	  act	  on	  endogenous	  compounds	  present	  in	  the	  culture	  medium	  or	  in	  the	  
cells,	  which	  confirms	  functional	  expression	  of	  these	  monooxygenases.	  
3.2.2. Substrate	  profiling	  
To	  establish	  the	  biocatalytic	  potential	  of	  this	  large	  set	  of	  BVMO,	  we	  aimed	  at	  testing	  each	  
of	   these	  BVMOs	   for	  activity	  on	  a	   large	  panel	  of	  potential	   substrates.	   For	   such	   substrate	  
profiling	  study,	  we	  first	  set	  out	  to	  quantify	  the	  amount	  of	  active	  enzyme	  in	  cell	  extracts.	  
Based	  on	  the	  fact	  that	  all	  Type	  I	  BVMOs	  contain	  a	  FAD	  cofactor	  that	  is	  specifically	  reduced	  
by	   NADPH,	   we	   developed	   a	   simple	   method	   for	   accurate	   BVMO	   concentration	  
determination.	   This	   approach	   is	   somewhat	   analogous	   to	   the	   well-­‐known	   method	   to	  
quantify	   the	   amount	   of	   P450	   monooxygenases	   by	   using	   the	   specific	   heme	   absorption	  
features	   of	   reduced	   P450	   monooxygenases	   with	   carbon	   monooxide.	   In	   E.	   coli	   only	   a	  
minority	   of	   the	   native	   proteins	   contain	   a	   flavin	   cofactor	   and	  most	   of	   them	  will	   not	   be	  
reactive	   with	   NADPH.	   In	   contrast,	   the	   overexpressed	   BVMOs	   will	   be	   dominant	   in	   the	  
respective	  extracts,	  outnumbering	  the	  endogenous	  flavoproteins	  of	  E.	  coli.	  By	  measuring	  
the	  absorbance	  spectrum	  of	  the	  CCE	  before	  and	  after	  the	  addition	  of	  NADPH,	  the	  amount	  
of	  NADPH-­‐reactive	  flavin	  cofactor	  in	  the	  expressed	  BVMO	  can	  be	  determined	  (Figure	  3-­‐3).	  	  
	  
Figure	  3-­‐3:	  Absorbance	  spectra	  of	  a	  cleared	  cell	  extract	  containing	  overexpressed	  BVMO.	  The	  spectra	  of	   the	  
oxidised	   flavin	  cofactor	   in	  BVMO	  #14	  (▬)	  and	  after	   reduction	  by	  NADPH	  (▪▪▪▪)	  are	  shown.	  The	  difference	   in	  
absorbance	  at	  440nm	  that	  can	  be	  used	  to	  determine	  the	  BVMO	  concentration	  is	  indicated.	  
For	   the	   calculation	   an	   extinction	   coefficient	   is	   needed	   which	   reflects	   the	   absorbance	  
difference	   between	   an	   oxidized	   and	   reduced	   BVMO.	   For	   this,	   we	   used	   the	   extinction	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coefficients	  for	  oxidized	  PAMO	  (ε441nm	  ox	  =	  12,3	  mM-­‐1cm-­‐1)	  and	  reduced	  PAMO	  (ε441nm	  red	  =	  
3,6	   mM-­‐1cm-­‐1)	   to	   calculate	   an	   estimate	   of	   the	   difference	   extinction	   coefficient	   for	   FAD	  
containing	   BVMOs	   at	   440	   nm	   (ε440nm,	   BVMO	  diff.	   =	   8,8	   mM-­‐1cm-­‐1).	  We	   decided	   to	   use	   the	  
absorption	   at	   440	   nm	   and	   to	   neglect	   the	   small	   differences	   caused	   by	   different	   flavin	  
microenvironments	   in	   individual	   BVMOs.	   This	   corroborates	   with	   flavin	   absorbance	  
spectral	   data	   of	   known	  BVMOs	   from	   literature,	  which	   display	   highly	   similar	   absorbance	  
maxima	  and	  extinction	  coefficients	  (Table	  3-­‐2).	  	  
Table	  3-­‐2:	  Collection	  of	  literature	  values	  for	  λmax	  and	  εox	  of	  known	  BVMOs.	  
a	  these	  BVMOs	  were	  purified	  as	  PTDH	  fusion	  enzymes	  and	  analyzed	  spectrophotometrically	  in	  this	  study.	  
Validation	  of	   the	  method	  by	  using	  purified	  enzyme	  with	  a	  known	  concentration	  showed	  
that	  the	  method	  is	  accurate.	  Furthermore,	  using	  extracts	  of	  E.	  coli	  devoid	  of	  any	  expressed	  
BVMO	  did	  not	  show	  any	  significant	  A440	  change	  after	   incubation	  with	  NADPH,	   indicating	  
that	   there	   is	  no	   interfering	  absorbance.	  Using	  this	  method,	   it	  was	  possible	  to	  determine	  
the	  concentration	  of	  soluble	  BVMO	  in	  all	  22	  samples,	   independent	  of	  the	  level	  of	  BVMO	  
overexpression.	   In	   this	  way,	  we	   could	  normalize	   the	   amount	  of	   recombinant	   enzyme	   in	  
the	  substrate	  profiling	  experiments	  while	  using	  cleared	  cell	  extracts.	  
For	   substrate	  profiling	  we	  used	  39	   substrates,	   representing	  different	   compound	  classes:	  
linear	  aliphatic	  ketones,	  cyclic	  aliphatic	  ketones,	  aromatic	  ketones,	  aromatic	  amines,	  and	  
aromatic	   sulfides	   (Table	   3-­‐3).	   All	   substrates	   were	   used	   at	   two	   different	   concentrations	  	  	  	  	  
(5	  and	  1	  mM)	  and	  a	  fixed	  amount	  of	  cosolvent	  was	  used.	  For	  determining	  activity	  for	  each	  
tested	  compound,	  we	   initially	  used	  the	  NADPH	  depletion	  assay.	  Consumption	  of	  NADPH	  
by	  BVMO	  can	  be	  monitored	  by	  measuring	  the	  absorbance	  of	  NADPH	  at	  340	  nm.	  However,	  
this	  assay	  could	  not	  be	  used	  for	  compounds	  that	  absorbed	  in	  the	  same	  wavelength	  regime	  
BVMO PAMO' HAPMO' CHMO' STMO' CPMO'a CPDMO'a
Fraaije Kamerbeek+ Donoghue+ Miyamoto Griffin+ Iwaki+
et+al.+2005 et+al.+2001 et+al.+1976 et+al.+1995 et+al.+1976 et+al.+2006
λmax'(nm) 441 439 440 438 444 442
εox+(mM
/1cm/1) 12,3 12,4 13,8 11,3 14,5 12,8
literature
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of	  NADPH	   (300-­‐390	  nm)	  and	  only	  allowed	   to	  measure	   the	  conversion	  of	   relatively	   small	  
concentrations	   of	   NADPH	   and	   substrate.	   Therefore,	  we	   decided	   to	   use	   an	   assay	   that	   is	  
coupled	   to	   the	   activity	   of	   the	   employed	   regeneration	   enzyme,	  which	   allows	   to	  monitor	  
conversion	  over	  a	  longer	  time	  period.	  For	  this,	  phosphite	  dehydrogenase	  was	  used	  which	  
generates	  one	  molecule	  of	  phosphate	  for	  the	  regeneration	  of	  each	  NADPH	  molecule.	  The	  
formed	   phosphate	   could	   be	   quantified	   by	   using	   a	   chromogenic	   reaction,	   allowing	  
spectrophotometric	   detection	   of	   the	   degree	   of	   conversion.	   The	   conversions	   were	  
incubated	  for	  two	  hours	  before	  measuring	  the	  phosphate	  concentrations.	  As	  BVMOs	  also	  
can	  act	  as	  NADPH	  oxidases	  in	  the	  absence	  of	  a	  suitable	  substrate,	  formation	  of	  phosphate	  
was	  only	  regarded	  as	  significant	  when	  it	  was	  significantly	  more	  when	  compared	  with	  the	  
incubation	   without	   a	   test	   compound.	   By	   using	   this	   approach,	   poor	   substrates	   will	   be	  
overlooked	   while	   establishing	   profiles	   of	   efficient	   substrates	   for	   all	   tested	   BVMOs.	   The	  
observed	  substrate	  profiles	  for	  all	  tested	  BVMOs	  are	  summarized	  in	  Table	  3-­‐3.	  
The	   results	   disclose	   a	   broad	   substrate	   scope	   for	   the	   produced	   set	   of	   22	   BVMOs.	   To	  
verify	  the	  results,	  we	  checked	  a	  selection	  of	  substrates	  for	  conversion	  with	  several	  BVMOs	  
by	  GC	  analysis,	  which	  confirmed	  the	  majority	  of	  the	  identified	  substrates.	  For	  most	  of	  the	  
tested	  compounds,	  we	  could	  find	  at	  least	  one	  active	  enzyme,	  even	  though	  the	  intensity	  of	  
the	  activity	  varies	  a	  lot	  between	  the	  tested	  BVMOs.	  Nonetheless,	  for	  8	  BVMOs	  (BVMO	  #1,	  
#3,	  #6,	  #7,	  #8,	  #13,	  #16,	  and	  #17)	  no	  significant	  activity	  was	  observed	  for	  any	  of	  the	  tested	  
compounds.	  However,	  it	  is	  worth	  noting	  that	  of	  these	  8	  BVMOs,	  BVMO	  #3,	  BVMO	  #7,	  and	  
BVMO	  #17	  appear	  to	  produce	  some	  indigo	  blue	  when	  expressed	  in	  E.	  coli	  (Table	  3-­‐1).	  This	  
suggests	   that	   these	   BVMOs	   are	   indeed	   active	   while	   not	   very	   efficient	   on	   any	   of	   the	  
compounds	   in	   our	   test	   panel.	   Another	   relevant	   observation	   is	   the	   fact	   that	   conversions	  
using	  BVMO	  #3,	  BVMO	  #8,	  BVMO	  #13	  and	  BVMO	  #19	  in	  the	  absence	  of	  substrate	  results	  
in	   a	   4-­‐5	   fold	   higher	   background	   reaction	  when	   compared	  with	   all	   other	   tested	   BVMOs	  	  	  	  
(≈9	  mM	  phosphate	  formed	  instead	  of	  ≈2	  mM).	  For	  BVMO	  #13	  and	  BVMO	  #19	  this	  can	  be	  
explained	  by	  the	  fact	  that	  their	  expression	  was	  poor,	  which	  dictated	  the	  use	  of	  relatively	  
high	  amounts	  of	  extract,	  which	  leads	  to	  a	  relatively	  high	  background	  NADPH	  consumption.	  
Contrarily,	  BVMO	  #3	  and	  BVMO	  #8	  are	  well	  expressed.	  This	   suggests	   that	   these	  BVMOs	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display	  an	  exceptionally	  high	  uncoupling	  rate	  and	  therefore	  substrates	  may	  be	  unnoticed	  
by	  monitoring	  NADPH	  consumption	  or	  phosphate	   formation.	   It	  also	  agrees	  with	  the	  fact	  
that	   Szolkowy	  et	   al.	   (2009)	   have	   found	   that	   BVMO	   #3	   is	   indeed	   active	   on	   a	   number	   of	  
ketones.	  For	  the	  BVMOs	  that	  did	  not	  display	  significant	  background	  NADPH	  consumption	  
or	   uncoupling	   rates,	   the	   substrate	   acceptance	   profiles	   varied	   considerably.	   Among	   the	  
tested	   BVMOs,	   only	   a	   small	   set	   of	   5	   BVMOs	   were	   shown	   to	   be	   active	   on	   ≥10	   tested	  
compounds,	   leaving	   only	   5	   potent	   BVMOs	   respectively.	   This	   contrasts	   the	   catalytic	  
potential	  of	  well	  characterized	  BVMOs.	  	  
As	   known	   from	   literature,	   CHMO,	   CPMO,	   PAMO	   and	  HAPMO	  were	   indeed	   found	   to	  
accept	  a	  broad	  range	  of	  compounds.	  Only	  STMO,	  for	  which	  a	  substrate	  profile	  had	  not	  yet	  
been	   established,	   appeared	   rather	   selective	   by	   converting	   only	   9	   of	   the	   tested	  
compounds.	  Similar	  to	  the	  known	  prototype	  BVMOs,	  two	  rhodococcal	  BVMOs,	  BVMO	  #4	  
and	   BVMO	   #24,	   appeared	   to	   be	   very	   substrate	   tolerant	   as	   they	   both	   accepted	   the	  
majority	  of	  the	  tested	  compounds.	  Their	  substrate	  profiles	  resemble	  to	  a	  large	  extend	  that	  
of	  CPMO,	  with	  BVMO	  #24	  exhibiting	  greater	  efficiency	  when	  compared	  with	  BVMO	  #4.	  It	  
is	  worth	  noting	  that	  BVMO	  #24	  had	  escaped	  the	  previous	  rhodococcal	  BVMO	  exploration	  
study	   by	   the	   Grogan	   group.	   Of	   the	   other	   BVMOs,	   BVMO	   #2	   and	   BVMO	   #20	   also	   were	  
found	  to	  be	  active	  on	  a	  number	  of	  cycloalkanones.	  BVMO	  #9	  and	  BVMO	  #15	  showed	  high	  
activity	   with	   a	   number	   of	   aromatic	   ketones,	   resembling	   to	   some	   extend	   the	   substrate	  
scope	  of	  HAPMO.	  Other	  BVMOs	  appeared	  to	  be	  rather	  restricted	  in	  substrate	  scope.	  For	  
example,	  BVMO	  #10	  appears	   to	  be	   very	   selective	   in	   acting	  on	  bulky	   ketones	   converting	  
bicycloheptenone	   and	   phenendione.	   Still,	   these	   BVMOs	   may	   be	   valuable	   biocatalysts	  
exhibiting	  new	  substrate	  specificities	  and	  chemo-­‐,	  regio-­‐,	  or	  enantioselectivitiesthat	  were	  
also	  tested	  with	  the	  panel	  of	  test	  compounds	  (Table	  3-­‐3).	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Table	   3-­‐3:	   Substrate	   profiling.	   Activities	   as	   measured	   by	   phosphate	   formation	   are	   indicated	   for	   the	  
rhodococcal	  BVMOs	  and	  prototype	  BVMOs.	  BVMOs	  that	  did	  not	  show	  any	  activity	  on	  the	  tested	  compounds	  
were	  excluded.	  The	  rhodococcal	  BVMOs	  are	  indicated	  by	  their	  respective	  numbers.	  The	  observed	  activities	  are	  
indicated	  as	  +,	  ++	  or	  +++	  and	  reflect	  1,2,	  2	  or	  5	  fold	  the	  phosphate	  formation	  (cq.	  conversion)	  when	  compared	  
with	  incubations	  lacking	  the	  tested	  compound.	  	  
a,	   The	   abbreviations	   used	   are	   PA:	   PAMO,	   CP:	   CPMO,	   CH:	   CHMO,	   ST:	   STMO,	   HAP:	   HAPMO;	   b	   The	   structural	  
formulas	  and	  other	  details	  can	  be	  found	  in	  Appendix	  A-­‐2.	  The	  shading	  indicates	  different	  substrate	  classes.	  
.	  
2 4 5 9 10 11 12 14 15 18 19 20 21 24 PA CP CH ST HAP
1 Acetone + + ++ + +
2 2-Butanone + ++ + +
3 2-Octanone + + + + + ++ ++ + +++
4 2-Dodecanone ++ + + +++ +++ +++
5 3-Octanone + ++ ++ +++
6 4-Octanone + + + ++ ++ + +
7 Methylvinylketone + + + + + ++ + ++ + +++
8 3-Methyl-2,4-pentanedione + + + + ++ ++ +++
9 Cyclobutanone + + + ++ ++ +++
10 Cyclopentanone + + + + ++ ++ ++ +
11 Cyclohexanone + + + ++ +++ ++ +
12 Cyclopentadecanone + ++ + +
13 Oxocyclohexanecarbonitrile + + ++ ++ +++
14 4-Methylcyclohexanone + +++ ++ +
15 2-Propylcyclohexanone + + + +++ ++ + +
16 Dihydrocarvone + + + ++ ++ +++
17 Cyclopropylmethylketone + + + + ++ +++
18 Norcamphor + + + ++ +++ ++ +
19 Bicycloheptenone +++ + + + ++ +++ ++ +++
20 Thioanisole + + ++ ++ +++
21 Benzylethyl sulfide + + + ++ ++ ++ +++
22 Benzylphenyl sulfide + + ++ ++ + +++
23 Ethionamide + ++ + ++ +++ + +++ +++
24 Modafinil precursor + + +++ +
25 Thiacetazone + + ++ + + +
26 Nicotin + + ++ +
27 Indole + +
28 3-Acetylindole ++ + + + +++
29 Acetophenone + + ++ ++ +++ +++
30 4-Hydroxyacetophenone + + + +++ + + ++ +++
31 2,6-Dihydroacetophenone + + ++ +++
32 3-Phenylpentane-2,4-dione + + +++ ++ + +
33 Phenylacetone + + +++ + + +++ ++ + +++
34 Raspberry ketone + ++ + + + +++ + + +++
35 2-Phenylcyclohexanone + ++ ++ +
36 Benzoin + +++
37 Phenendione +++ + +
38 2-Indanone + + ++ +++ +
39 1-Indanone + + ++ +





To	   have	   a	   better	   insight	   into	   the	   biocatalytic	   potential	   of	   some	   of	   the	   BVMOs,	   a	  
selected	   set	  was	   studied	   for	   the	   conversion	  of	   some	   typical	  BVMO	  substrates,	   including	  
prochiral	   sulfides.	   Table	   3-­‐4	   shows	   that	   all	   these	   BVMOs	   convert	   the	   typical	   BVMO	  
substrates	  phenylacetone	  and	  bicycloheptenone.	  	  
Table	  3-­‐4:	  GC	  analysis	  of	  substrate	  conversions	  by	  selected	  BVMOs.	  
	  
BVMO	  #8	  gives	  poor	  conversion	  of	  phenylacetone	  while	  none	  of	  the	  other	  compounds	  are	  
converted.	  This	  confirms	  the	  outcome	  of	  the	  activity	  screening,	  which	  did	  not	  reveal	  any	  
substrate	  for	  this	  enzyme.	  That	  the	  conversion	  of	  phenylacetone	  can	  be	  observed	  is	  due	  
to	  the	  fact	  that	  the	  reactions	  have	  been	  performed	  over	  a	  relatively	  long	  time	  period.	  For	  
2-­‐indanone,	   only	   BVMO	   #24	   was	   found	   to	   be	   reactive	   which	   is	   also	   in	   line	   with	   the	  
substrate	  profiling	  study	  (Table	  3-­‐3).	  Except	  for	  BVMO	  #15,	  BVMO	  #20	  and	  BVMO	  #8,	  the	  
two	   aromatic	   sulfides	   were	   efficiently	   converted	   with	   good	   to	   excellent	   enantio-­‐	  
selectivities.	   Strikingly,	   most	   of	   the	   BVMOs	   show	   the	   same	   enantioselectivity	   forming	  
predominantly	   one	   specific	   sulfoxide	   enantiomer	   of	   each	   of	   the	   two	   aromatic	   sulfides.	  
Only	  BVMO	  #24	  is	  again	  an	  exception	  and	  shows	  opposite	  enantioselectivity.	  
3.3. Discussion	  
By	  employing	  two	  expression	  vectors	  and	  screening	  for	  proper	  expression	  conditions,	  we	  
have	  been	  able	  to	  express	  22	  Type	  1	  BVMOs	  from	  R.	  jostii	  RHA1.	  This	  is	  the	  largest	  set	  of	  
recombinant	  BVMOs	  produced	   from	  one	  microbial	  origin	   reported	  so	   far.	  The	  collection	  
supplements	   the	   previous	   set	   of	   13	   BVMOs	   produced	   by	   the	   Grogan	   group.	   Except	   for	  
establishing	  expression	  conditions	  for	  BVMOs	  that	  could	  not	  be	  expressed	  before,	  we	  also	  
BVMO 3 8 9 14 15 20 21 24
phenylacetone 99 27 99 99 92 45 99 38
22indanone <3 <3 <3 <3 <3 <3 <3 62
bicycloheptenone 97 <3 36 97 90 97 97 93
thioanisole:::::::: 87 <3 21 99 76 24 55 80
:::enantioselectivity 90:(S) n.d. 61:(S) n.d. 45:(S) 5:(S) 63:(S) 82:(R)
benzylethyl:sulfide8 60 <3 <3 72 14 4 92 91
:::enantioselectivity 75:(R) n.d. n.d. 90:(R) 20:(R) n.d. 93:(R) >99:(S)
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identified	  two	  new	  BVMO	  genes	  (BVMO	  #8	  and	  BVMO	  #24).	  The	  biocatalytic	  exploration	  
of	   this	   new	   collection	   of	   BVMOs	  was	   aided	   by	   the	   development	   of	   two	   new	  methods:	  	  	  	  	  	  
(i)	  by	  exploiting	  the	  distinct	  absorbance	  features	  of	  oxidized	  and	  reduced	  protein-­‐bound	  
FAD,	   the	   BVMO	   content	   in	   extract	   could	   be	   determined;	   and	   (ii)	   by	   performing	   the	  
conversions	   coupled	   to	   NADPH	   regeneration	   by	   phosphite	   dehydrogenase,	   conversion	  
could	  be	  quantified	  by	  colorimetric	  phosphate	  detection.	  Sequence	  analysis	  also	  revealed	  
a	   novel	   BVMO-­‐typifying	   motif:	   [A/G]GxWxxxx[F/Y]P[G/M]xxxD.	   This	   motif	   includes	  
residues	   that	   are	   part	   of	   the	   active	   site	   and	   therefore	   represents	   a	   useful	   tool	   for	  
annotating	  BVMO-­‐encoding	  genes.	  The	  motif	   is	  absent	   in	  FMO	  sequences	  and	  therefore	  
allows	   discrimination	   between	   members	   of	   the	   two	   sequence-­‐related	   flavoprotein	  
subfamilies,	  BVMOs	  and	  FMOs.	  
The	   unraveled	   substrate	   profiles	   of	   the	   studied	   BVMOs	   differed	   significantly	   among	  
the	  produced	  BVMOs.	  For	  some	  BVMOs	  no	  substrate	  could	  be	  identified	  using	  a	  test	  set	  of	  
39	   compounds.	   This	   could	   indicate	   that	   the	   natural	   substrates	   for	   these	   enzymes	   differ	  
too	  much	   from	  the	   tested	  compounds.	  However,	   it	  may	  also	  be	   that	   these	  BVMOs	  only	  
display	   very	   low	   oxygenation	   activities	   that	   could	   not	   be	   detected	   with	   the	   employed	  
assay.	  Such	  low	  activity	  has	  also	  been	  observed	  for	  EtaA	  from	  Mycobacterium	  tuberculosis	  
(Fraaije	   2003).	   This	   drug-­‐resistance	   related	   enzyme	   was	   shown	   to	   act	   on	   a	   variety	   of	  
typical	   BVMO	   substrates	   but	   with	   very	   low	   activity.	   A	   small	   number	   of	   the	   produced	  
BVMOs	  were	   active	   on	   ≥10	   compounds:	   BVMO	  #4,	   BVMO	  #15,	   BVMO	  #20,	   BVMO	  #21,	  
BVMO	  #24.	  BVMO	  #24	  appeared	  to	  be	  a	  very	  potent	  biocatalyst	  as	   it	  showed	  very	  good	  
activities	  on	  26	  compounds.	  BVMO	  #3	  may	  also	  belong	  to	  this	  group	  of	  potent	  BVMOs	  but	  
appears	  to	  act	  as	  NADPH	  oxidase	  which	  prevented	  establishing	  its	  true	  substrate	  profile.	  
To	   correlate	   sequence	   to	   substrate	   profiles,	   we	   generated	   a	   phylogenetic	   tree	   that	   is	  
based	   on	   the	   comparison	   of	   residues	   that	   make	   up	   the	   core	   of	   the	   active	   site.	   This	  
revealed	   that	   all	   BVMOs	   that	   displayed	   a	   relaxed	   substrate	   acceptance	   profile	   were	  
closely	   related	   to	   the	   clades	   that	   include	   the	   well-­‐known	   prototype	   BVMOs	   (CHMO,	  
CPMO,	   PAMO	   and	   STMO).	   The	   above-­‐mentioned	   potent	   rhodococcal	   BVMOs,	   including	  
BVMO	  #3,	  are	  all	  closely	  related	  to	  these	  prototype	  BVMOs	  (Figure	  3-­‐2).	  The	  rhodococcal	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BVMOs	   that	   are	   part	   of	   sequence	   related	   groups	   that	   include	   other	   known	   but	   less	  
explored	  BVMOs	   (HAPMO,	  MoxY,	   EtaA,	  AlmA)	   appear	   to	   be	   less	   promising	   biocatalysts.	  
This	   observation	   is	   valuable	   for	   future	   BVMO	   discovery	   efforts:	   it	   appears	   more	  
productive	   to	   search	   for	   homologs	   of	   the	   typical	   prototype	   BVMOs	   when	   looking	   for	  
potent	  biocatalysts.	  
Two	   BVMOs	   display	   a	   peculiar	   behavior:	   BVMO	   #3	   and	   BVMO	   #8	   act	   as	   NADPH	  
oxidases	  when	  no	  potential	  substrate	  is	  present.	  For	  the	  other	  BVMOs	  and	  all	  previously	  
characterized	  Type	  1	  BVMOs,	  this	  futile	  oxidation	  of	  NADPH	  was	  typically	  very	  slow.	  The	  
relatively	  high	  NADPH	  oxidase	  activity	  may	  reflect	   the	   fact	   that	   these	  respective	  BVMOs	  
do	   not	   function	   properly	  when	   taken	   out	   of	   their	   natural	   context.	   Alternatively,	   it	  may	  
indicate	  that	  these	  enzymes	  have	  acquired	  NADPH	  oxidase	  activity	  for	  a	  certain	  purpose,	  
e.g.	  to	  regenerate	  NADP+	  in	  the	  cell	  or	  to	  produce	  H2O2.	  Production	  of	  H2O2	  complies	  with	  
the	  recent	  discovery	  that	  actinomycetes	  are	  relatively	  rich	  in	  peroxidases	  (van	  Bloois	  et	  al.	  
2010).	   In	   line	  with	  this,	  a	  DyP-­‐type	   lignin	  peroxidase	  from	  R.	   jostii	   sp.	  RHA1	  has	  recently	  
been	   identified	   and	   characterized	   (Ahmad	   et	   al.	   2011).	   Except	   for	   displaying	   NADPH	  
oxidase	   activity,	   BVMO	   #3	   also	   was	   found	   to	   be	   acting	   as	   an	   oxygenase	   as	   the	   cells	  
expressing	   this	   enzyme	   developed	   a	   blue	   color	   indicative	   of	   indole	   oxygenation.	   This	  
would	  imply	  that	  BVMO	  #3	  and	  BVMO	  #8	  have	  a	  dual	  function	  in	  R.	  jostii	  RHA1:	  acting	  as	  
oxygenases	  or	  NADPH	  oxidases.	   In	   this	  context,	   it	   is	  worth	  noting	   that,	  due	  to	  a	  missing	  
nucleotide,	   the	   gene	   encoding	   BVMO	   #8	   is	   disrupted.	   This	  may	   reflect	   that	   due	   to	   the	  
relative	  high	  NADPH	  oxidase	  activity,	  generating	  toxic	  hydrogen	  peroxide,	  it	  was	  beneficial	  
to	   silence	   the	   gene.	   Further	   work	   on	   the	   enzymes	   reported	   in	   this	   study	   will	   disclose	  
details	  on	  their	  catalytic	  properties	  and	  biocatalytic	  potential.	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3.4. Experimental	  Section	  
Reagents	  &	  enzymes	  
Oligonucleotide	  primers	  were	  purchased	   from	  Sigma,	  dNTPs	  and	   In-­‐Fusion™	  2.0	  CF	  Dry-­‐
Down	   PCR	   Cloning	   Kit	   from	   Clontech,	   Phusion	   polymerase	   from	   Finnzymes.	   All	   other	  
chemicals	   were	   obtained	   from	   Acros	   Organics,	   ABCR,	   Sigma-­‐Aldrich,	   TCI	   Europe,	   and	  
Roche	  Diagnostics	  GmbH.	  
Bacterial	  strains	  and	  Plasmids	  
Escherichia	   coli	   TOP10	   from	   Invitrogen	   was	   used	   as	   a	   host	   for	   DNA	  manipulations	   and	  
protein	  expression.	   Two	  expression	  vectors	  have	  been	  used:	   (i)	   a	  modified	  pBAD	  vector	  
(pBADN)	   in	  which	  the	  NdeI	  site	  was	  replaced	  by	   the	  original	  NcoI	  site	   (Kamerbeek	  et	  al.	  
2004),	   and	   (ii)	   the	   recently	   engineered	   pCRE2	   vector	   which	   harbors	   a	   codon-­‐optimized	  
gene	   encoding	   a	   18x	   mutant	   of	   phosphite	   dehydrogenase	   (PTDH)	   with	   an	   N-­‐terminal	  	  	  	  	  
His-­‐tag	  (Torres	  Pazmiño	  et	  al.	  2009).	  
Sequence	  analysis	  and	  cloning	  	  
The	   NCBI	   server	   was	   used	   for	   DNA	   sequence	   retrieval	   and	   BLAST	   searches	  
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).	   The	   preliminary	   alignment	   of	   BVMOs	   was	  
prepared	   using	   ClustalW	   multiple	   alignment	   software	   (Thompson	   et	   al.	   1994).	   Next,	  
secondary	   structure	   information	   was	   extracted	   from	   the	   recently	   elucidated	   PAMO	  
structure	  containing	  NADP+	  and	  a	  bound	  substrate	  analogue	  (PDB:	  2YLT,	  chain	  A)	  (Orru	  et	  
al.	  2011)	  and	  used	  for	  adjustments	  of	  the	  alignment.	  For	  calculating	  the	  Neighbor-­‐Joining	  
trees	   and	   bootstrapping	   (1500	   iterations),	   we	   applied	   the	   MEGA5	   software	   package	  
(Tamura	  et	  al.	  2011).	  The	  phylogenetic	  trees	  were	  visualized	  by	  using	  the	  iToL	  online	  tool	  
(Letunic	  &	  Bork	  2011).	  
Target	   genes	   were	   amplified	   using	   the	   genomic	   DNA	   of	   R.	   jostii	   RHA1	   (originally	  
isolated	  by	  Seto	  et	  al	  in	  1995	  (Seto	  et	  al.	  1995))	  as	  template.	  The	  genome	  of	  R.	  jostii	  RHA1	  
has	   been	   fully	   sequenced	   (McLeod	   et	   al.	   2006)	   and	   information	   can	   be	   found	   at	  
www.rhodococcus.ca.	   The	   genes	   were	   cloned	   into	   pBAD	   or	   pCRE2	   expression	   vectors	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using	  the	  In-­‐Fusion	  PCR	  Cloning	  kit	  from	  Clontech,	  following	  the	  recommendations	  of	  the	  
manufacturer.	  Gene	  #8	  was	  cured	  by	  inserting	  a	  nucleotide	  (C)	  at	  position	  621.	  In	  that	  way	  
the	   stop	   codon	  of	   the	  ORF	  RHA1_ro08999,	   encoding	  a	  putative	  N-­‐terminal	   domain	  of	   a	  
Type	   I	   BVMO,	   was	   changed	   into	   a	   codon	   for	   leucine.	   This	   amino	   acid	   was	   found	  most	  
frequently	   in	   BVMOs	   at	   the	   respective	   position.	   By	   the	   subsequent	   frame	   shift	   ORF	  
RHA1_ro08999	  and	  RHA1_ro08998	  are	   fused	  at	  DNA	   level	   encoding	   a	   full	   length	   Type	   I	  
BVMO.	  The	   insertion	  was	  achieved	  by	  QuikChange®	   site-­‐directed	  mutagenesis	  using	   the	  
following	  primers:	  	   forward	  5'-­‐caccggtttcgggttcctgaactcccccaa-­‐3'	  
	   	   	   	   reverse	  5'-­‐ttgggggagttcaggaacccgaaaccggtg-­‐3'	  
Gene	  expression	  	  
Expression	  was	  tested	  using	  24	  deep	  square	  well	  microtiter	  plates	  in	  the	  sandwich	  cover	  
system	   from	   Enzyscreen®,	   shaking	   at	   200	   rpm.	   Cell	   cultures	   of	   2,5	   ml	   in	   Luria–Bertani	  
medium	   supplemented	   with	   50	   μg	   mL−1	   ampicillin	   were	   grown	   at	   four	   different	  
temperatures	  (17°C	  for	  48	  h,	  24°C	  for	  32	  h,	  30°C	  and	  37°C	  for	  16	  h)	  with	  three	  different	  
inducer	   (arabinose)	   concentrations	   (0,002%,	   0,02%,	   0,2%,	   0%	   as	   control)	   each.	   Cell	  
extracts	   were	   obtained	   using	   DNase/lysozyme	   in	   combination	   with	   freezing	   in	   liquid	  
nitrogen	  and	  thawing	  at	  30°C.	  Cell	  extracts	  (CE)	  as	  well	  as	  cleared	  cell	  extracts	  (CCE)	  were	  
analyzed	  via	  SDS-­‐PAGE	  for	  (soluble)	  expression	  of	  the	  respective	  BVMOs.	  	  
BVMO	  concentration	  determination	  in	  cleared	  cell	  extract	  
For	   the	   substrate	   screening	  assays,	   cell	   cultures	  of	  500	  –	  800	  mL	   Luria–Bertani	  medium	  
supplemented	   with	   50	   μg	   mL−1	   ampicillin	   and	   the	   corresponding	   amount	   of	   arabinose	  
were	   grown.	   Cell	   extract	   (CE)	   was	   prepared	   using	   sonication	   with	   subsequent	  
centrifugation	   to	   remove	   the	   cell	   debris	   and	   obtain	   a	   cleared	   cell	   extract	   (CCE).	   An	  
absorption	   spectrum	  of	   the	  CCE	  was	  measured	   from	  700	  nm	   to	  300	  nm	   (oxidized	  FAD),	  
after	  which	  500	  μM	  NADPH	  was	  added.	  The	  sample	  was	  incubated	  at	  25°C	  for	  10	  min	  for	  
full	   flavin	   reduction	   after	   which	   again	   a	   spectrum	   was	   measured.	   Subtracting	   the	   two	  
collected	  spectra	  revealed	  the	  amount	  of	  NADPH-­‐reactive	  flavin	   in	  the	  CCE.	  To	  minimize	  
interfering	   absorbance	   due	   to	   protein	   aggregates	   of	   E.	   coli	   proteins,	   the	   absorption	   at	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440	   nm	  was	   corrected	   by	   subtracting	   the	   absorption	   value	   at	   700	   nm.	   The	   amount	   of	  
flavin-­‐containing	   BVMO	   in	   the	   CCE	   was	   calculated	   using	   the	   difference	   extinction	  
coefficient	  derived	  from	  PAMO:	  εdifference=	  8,8	  mM
-­‐1cm-­‐1.	  
Substrate	  screening	  
For	  activity	  screening,	  an	  indirect	  activity	  assay	  was	  used.	  The	  substrates	  were	  dissolved	  in	  
DMSO	   or	   dioxane.	   The	   solvent	   (DMSO	   or	   dioxane)	   concentration	  was	   kept	   at	   5%	   in	   all	  
tested	   reactions.	   For	   the	   activity	   assay,	   100	   μL	   50	  mM	  Tris/HCl	   pH	   7,5,	   containing	   1	   or	  	  	  	  	  	  	  
5	  mM	  substrate,	  100	  μM	  NADPH,	  10	  μM	  PTDH,	  10	  mM	  sodium	  phosphite	  and	  1	  μM	  BVMO	  
as	   CCE	   was	   incubated	   at	   25°C	   for	   two	   hours.	   20	   μL	   of	   the	   reaction	   mixture	   was	  
subsequently	   mixed	   with	   200	   μL	   molybdate	   reagent	   (10	   mM	   (NH4)6Mo7O24	   x	   4	   H2O,	  	  	  	  	  	  	  
100	  mM	  Zn	  acetate,	  pH	  5,	  adjusted	  with	  HCl)	  and	  50	  μl	  10%	  ascorbic	  acid	  (pH	  5,	  adjusted	  
with	  40%	  NaOH).	  During	  incubation	  of	  30	  min	  at	  30°C	  a	  blue	  colored	  complex	  formed	  due	  
to	   the	   phosphate	   generated	   during	   the	   oxidation	   reaction	   (Saheki	   et	   al.	   1985).	   By	  
measuring	  the	  absorption	  at	  600	  nm,	  the	  concentration	  of	  produced	  phosphate	  could	  be	  
quantitatively	  determined	  using	  a	  calibration	  curve.	  By	  being	  able	  to	  quantify	  the	  amount	  
of	  applied	  BVMO	  each	  conversion	  could	  be	  performed	  with	  a	  standard	  amount	  of	  BVMO	  
which	  allows	  a	  direct	  comparison.	  
GC	  analysis	  
For	  GC	  analysis,	  500	  μL	  incubations	  of	  50	  mM	  Tris/HCl	  pH	  7,5,	  containing	  5	  mM	  substrate,	  
5%	  cosolvent	   (DMSO	  or	  dioxane),	  100	  μM	  NADPH,	  3,1	  μM	  PTDH,	  10	  mM	  phosphite	  and	  	  	  	  
5	  μM	  BVMO	   (CCE)	  was	   incubated	   shaking	   at	   24°C	   for	   2	  hours.	   The	   reactions	  were	   then	  
stopped	   by	   extracting	   with	   ethyl	   acetate	   (2	   x	   0,5	   mL	   including	   0,1%	   mesitylene	   as	   an	  
internal	   standard),	   dried	   with	   magnesium	   sulfate	   and	   analyzed	   directly	   by	   GC	   to	  
determine	  the	  degree	  of	  conversion.	  The	  details	  concerning	  the	  (chiral)	  GC	  analysis	  can	  be	  
found	  in	  the	  Appendix	  A-­‐1.	  For	  every	  tested	  reaction,	  control	  experiments	  in	  the	  absence	  
of	  enzyme	  resulted	  in	  no	  conversion.	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Selbst	  das	  Staubkorn	  sollte	  uns	  nicht	  ärgern,	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  on:	   Journal	   of	  Molecular	   Catalysis	  B:	   Enzymatic	   (2013),	   88,	   20-­‐25	  	  	  




Abstract:	   With	   the	   aim	   to	   enlarge	   the	   set	   of	   available	  
flavoprotein	   monooxygenases,	   we	   have	   cloned	   eight	  
unexplored	   genes	   from	  Rhodococcus	   jostii	   RHA1	   that	  were	  
predicted	  to	  encode	  class	  B	  flavoprotein	  monooxygenases.	  
Each	  monooxygenase	   can	   be	   expressed	   as	   soluble	   protein	  
and	  has	  been	  tested	  for	  conversion	  of	  sulfides	  and	  ketones.	  
Not	   only	   enantioselective	   sulfoxidations,	   but	   also	  
enantioselective	   Baeyer-­‐Villiger	   oxidations	   could	   be	  
performed	  with	   this	   set	  of	  monooxygenases.	   Interestingly,	  
in	  contrast	  to	  known	  class	  B	  flavoprotein	  monooxygenases,	  
all	   studied	  biocatalysts	   showed	  no	  nicotinamide	   coenzyme	  
preference.	   This	   feature	   coincides	   with	   the	   fact	   that	   the	  
respective	   sequences	   appear	   to	   form	   a	   discrete	   group	   of	  
sequence	  related	  proteins,	  distinct	   from	  the	  known	  class	  B	  
flavoprotein	   monooxygenases	   subclasses:	   the	   so-­‐called	  
flavin-­‐containing	  monooxygenases	  (FMOs),	  N-­‐hydroxylating	  
monooxygenases	   (NMOs)	   and	   Type	   I	   Baeyer-­‐Villiger	  
monooxygenases	   (BVMOs).	   Taken	   together,	   these	   data	  
reveal	   the	   existence	   of	   a	   new	   subclass	   of	   class	   B	  
flavoprotein	  monooxygenases,	  which	  we	   coined	   as	   Type	   II	  
FMOs	   that	   can	   perform	   Baeyer-­‐Villiger	   oxidations	   and	  
accepts	   both	   NADPH	   and	   NADH	   as	   coenzyme.	   The	  
uncovered	   biocatalytic	   properties	   of	   the	   studied	   Type	   II	  
FMOs	   makes	   this	   newly	   recognized	   subclass	   of	   mono-­‐
oxygenases	   of	   potential	   interest	   for	   biocatalytic	  
applications.	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4.1. Introduction	  
Flavoprotein	   monooxygenases	   are	   attracting	   attention	   as	   selective	   and	   oxidative	  
biocatalysts	  that	  can	  be	  used	  for	  the	  production	  of	  high-­‐value	  chemical	  building	  blocks	  or	  
pharmaceuticals	   (van	  Berkel	  et	   al.	  2006).	   These	  biocatalysts	   efficiently	   catalyze	   chemo-­‐,	  
regio-­‐,	   and/or	  enantioselective	  oxygenations	  using	  dioxygen	  as	  mild	  oxidant	  while	  using	  
NAD(P)H	   as	   reductant.	   Flavoprotein	   monooxygenases	   can	   be	   divided	   into	   6	   distinct	  
classes,	  with	  each	  class	  containing	  sequence-­‐	  and	  structure-­‐related	  monooxygenases.	  Two	  
of	   these	   classes	   (class	   A	   and	   B)	   are	   especially	   appealing	   when	   considering	   biocatalysis.	  
These	  two	  classes	  are	  typified	  by	  being	  single	  component	  enzymes	  that	  contain	  a	  tightly	  
bound	   flavin	   cofactor,	  while	   the	  other	  monooxygenases	   rely	  on	  multiple	  protomers	  and	  
often	  employ	  a	  loosely	  bound	  flavin	  cofactor.	  The	  class	  A	  of	  flavoprotein	  monooxygenases	  
seems	  to	  have	  evolved	  to	  catalyse	  aromatic	  hydroxylations,	  as	  most	  of	  the	  characterized	  
monooxygenases	  of	  this	  class	  represent	  hydroxylases,	  typically	  acting	  on	  a	  very	  restricted	  
number	  of	  substrates	  (Montersino	  et	  al.	  2011).	  Class	  B	  flavoprotein	  monooxygenases	  do	  
not	  catalyse	  hydroxylations	  but	  perform	  Baeyer-­‐Villiger	  oxidations	  and/or	  oxygenations	  of	  
heteroatom-­‐containing	   compounds.	   In	   fact,	   three	   class	   B	   flavoprotein	   monooxygenase	  
subclasses	  have	  been	  identified	  based	  on	  specific	  sequence	  motifs,	  which	  coincide	  with	  a	  
preference	  for	  specific	  oxygenation	  types	  for	  each	  subclass	  (Fraaije	  et	  al.	  2002):	  
i)	   Baeyer-­‐Villiger	   monooxygenases	   (BVMOs)	   contain	   the	   sequence	   motif	  
(FxGxxxHxxxWP/D)	   and	   primarily	   catalyse	   Baeyer-­‐Villiger	   oxidations,	  while	   they	   are	   also	  
able	   to	   oxygenate	   heteroatom-­‐containing	   compounds	   (N,	   S,	   B	   or	   Se	   containing	  
compounds);	  
ii)	   the	   so-­‐called	   Flavin-­‐containing	   monooxygenases	   (FMOs)	   contain	   a	   slightly	  
different	  sequence	  motif	   (FxGxxxHxxxYK/R),	  and	  are	  specialized	   in	  oxidizing	  heteroatom-­‐
containing	   compounds	  while	   they	   are	   inefficient	   in	   catalyzing	  Baeyer-­‐Villiger	   oxidations.	  
The	   FMOs	   have	   mainly	   been	   studied	   as	   xenobiotic	   degrading	   enzymes	   that	   help	   the	  
human	  body	  to	  dispose	  toxic	  compounds	  (Ziegler	  1990,	  Dolphin	  et	  al.	  1997).	  The	  human	  
proteome	  encompasses	  six	  FMO	  isoforms	  (Hines	  et	  al.	  2002),	  which	  are	  able	  to	  activate	  or	  
degrade	   many	   drugs.	   Only	   very	   recently	   FMOs	   have	   been	   considered	   for	   their	   use	   as	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biocatalysts,	   due	   to	   the	   identification	   and	   production	   of	   a	   microbial	   FMO	   which,	   in	  
contrast	   to	   the	   human	   homologs,	   can	   be	   easily	   expressed	   as	   a	   soluble	   protein	   (Rioz-­‐
Martínez	  et	  al.	  2011).	  
iii)	  N-­‐hydroxylating	  monooxygenases	  (NMOs)	  share	  sequence	  homology	  with	  the	  
above-­‐mentioned	   class	   B	   flavoprotein	   monooxygenases	   but	   lack	   a	   typifying	   sequence	  
motif.	   Only	   a	   conserved	   histidine	   can	   be	   identified	   in	   the	   region	   of	   the	   BVMO/FMO	  
sequence	  motif.	   So	   far	   only	   a	   few	   NMOs	   from	   bacteria	   and	   fungi	   have	   been	   reported.	  
They	  typically	  convert	  long-­‐chain	  primary	  amines	  by	  N-­‐hydroxylation	  (Stehr	  et	  al.	  1998).	  
The	   overall	   sequence	   homology	   among	   all	   class	   B	   flavoprotein	   monooxygenases	  
reflects	   the	   fact	   that	   they	   are	   all	   single-­‐component	   FAD-­‐containing	   monooxygenases	  
composed	   of	   two	   dinucleotide	   binding	   domains	   (Rossman	   folds	   to	   bind	   both	   FAD	   and	  
NADPH),	   that	   allow	   them	   to	   combine	   flavin	   reduction	   and	   monooxygenation	   in	   one	  
polypeptide	   chain.	   They	   often	   prefer	   the	   use	   of	  NADPH	   as	   electron	   donor,	   keeping	   the	  
NADP+	   tightly	   bound	   throughout	   the	   catalytic	   cycle	   (van	   den	  Heuvel	  et	   al.	   2005,	   Torres	  
Pazmiño	  et	  al.	  2008).	  From	  the	  three	  subclasses,	  mainly	  the	  BVMOs	  have	  been	  extensively	  
studied	  as	  biocatalysts.	  
To	   tap	   the	   natural	   diversity	   for	   the	   discovery	   of	   novel	   oxygenating	   enzymes	  
Rhodococcus	  jostii	  RHA1	  is	  a	  very	  promising	  candidate.	  The	  proteome	  of	  this	  bacterium	  is	  
predicted	  to	  contain	  an	  unusually	  high	  variety	  of	  oxidative	  enzymes	  (McLeod	  et	  al.	  2006,	  
Montersino	  &	  van	  Berkel	  2012).	   Inspired	  by	   this	  observation,	  we	  and	   the	  Grogan	  group	  
have	  recently	  cloned	  22	  putative	  BVMO-­‐encoding	  genes,	  and	  succeeded	  in	  producing	  and	  
exploring	  the	  biocatalytic	  properties	  of	  these	  enzymes	  (Szolkowy	  et	  al.	  2009,	  Riebel	  et	  al.	  
2012).	   This	   research	  has	   confirmed	   that	   all	   these	  enzymes	   indeed	  act	   as	  BVMOs,	  which	  
can	  be	  used	  for	  a	  large	  number	  of	  oxygenations.	  When	  screening	  the	  predicted	  proteome	  
of	  R.	  jostii	  RHA1	  for	  monooxygenases,	  we	  also	  identified	  a	  relatively	  large	  number	  of	  other	  
putative	   class	   B	   monooxygenases	   that	   seem	   to	   be	   more	   closely	   related	   to	   NMOs	   and	  
FMOs.	  While	  BVMOs	  are	  relatively	  rare	  enzymes	  that	  are	  only	  found	  in	  bacteria	  and	  fungi	  
with	   an	   average	   distribution	   of	   only	   one	   or	   two	   BVMO-­‐encoding	   genes	   per	   microbial	  
genome	   (de	   Gonzalo	   et	   al.	   2010),	   FMOs	   and	  NMOs	   are	   even	  more	   scarce	   in	  microbes.	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FMOs	  are	  quite	  abundantly	  present	  in	  higher	  eukaryotes	  (e.g.	  the	  6	  isoforms	  in	  the	  human	  
genome	  and	  often	  more	  than	  10	  in	  plant	  genomes	   (Schlaich	  2007)),	  but	  these	  FMOs	  are	  
often	  difficult	  to	  produce	  due	  to	  their	  membrane	  association.	  
	  
In	   this	   chapter,	   we	   report	   on	   the	   exploration	   of	   8	   novel	   class	   B	   flavoprotein	  
monooxygenases	  obtained	  from	  a	  single	  microorganism,	  R.	  jostii	  RHA1,	  that	  share	  
sequence	   homology	  with	   FMOs	   and	  NMOs.	   By	   optimizing	   expression	   vectors	   and	  
expression	  conditions,	  all	  enzymes	  were	  obtained	  in	  soluble	  and	  holo	  form.	  A	  set	  of	  
ketones	   and	   aromatic	   sulfides	   was	   tested	   for	   all	   enzymes	   to	   explore	   their	  
biocatalytic	   potential.	   Also	   their	   coenzyme	   specificity	   and	   enantioselective	  
properties	  were	  analysed.	  
	  
4.2. Results	  
4.2.1. Identification	  of	  putative	  FMO/NMO-­‐encoding	  genes	  
By	  a	  PBLAST	  search	  of	   the	  proteome	  of	  R.	   jostii	  RHA1	  (McLeod	  et	  al.	  2006),	  not	  only	  23	  
Type	  I	  BVMO-­‐encoding	  genes	  could	  be	  found	  (Riebel	  et	  al.	  2012),	  but	  also	  another	  eight	  
genes	   putatively	   encoding	   class	   B	   flavoprotein	  monooxygenases	   could	   be	   identified.	   All	  
corresponding	   proteins	   contain	   two	   typical	   Rossman	   fold	   motifs	   (GxGxxG),	   clearly	  
distinguishing	   them	   from	   other	   flavoprotein	   monooxygenase	   classes.	   As	   for	   all	   class	   B	  
flavoprotein	  monooxygenases,	   one	  Rossman	   fold	  motif	   is	   close	   to	   the	  N-­‐terminus	  while	  
the	  other	  is	  in	  the	  middle	  of	  the	  sequences.	  In	  the	  previous	  chapter,	  we	  proposed	  a	  new	  
conserved	   sequence	   motif	   typical	   for	   the	   Type	   I	   BVMO	   family:	  
[A/G]GxWxxxx[F/Y]P[G/M]xxxD,	  located	  between	  the	  two	  Rossman	  fold	  motifs.	  This	  motif	  
entails	  the	  conserved	  active	  site	  aspartate	  and	  therefore	  appears	  a	  better	  fingerprint	  for	  
Type	   I	   BVMO	   sequences.	   The	   motif	   is	   absent	   in	   all	   sequences	   used	   in	   this	   study	   and	  
confirms	  that	  they	  do	  not	  represent	  classical	  BVMOs.	  The	  sequences	  do	  also	  not	  contain	  
the	  previously	  described	  BVMO-­‐typifying	  motif	  (Fraaije	  et	  al.	  2002).	  In	  fact,	  most	  of	  them	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(all	   except	   for	   monooxygenase	   H)	   appear	   more	   closely	   related	   to	   FMOs	   as	   the	   FMO-­‐
typifying	  sequence	  motif	  can	  be	  recognized	  with	  only	  one	  or	  two	  amino	  acid	  substitutions	  
(Table	   4-­‐1).	   This	   is	   also	   reflected	   by	   the	   fact	   that	   most	   of	   the	   sequences	   have	   been	  
annotated	  in	  the	  sequence	  database	  as	  putative	  flavin-­‐containing	  monooxygenases.	  When	  
performing	   a	   multiple	   sequence	   alignment,	   the	   clustering	   becomes	   apparent.	  
Monooxygenase	  H	  is	  most	  related	  to	  known	  NMOs,	  while	  the	  other	  proteins	  form	  another	  
distinct	   group	   of	   sequence-­‐related	   proteins	   (Figure	   4-­‐1).	   It	   also	   shows	   that	   all	   studied	  
sequences	   are	   quite	   distant	   from	   Type	   I	   BVMOs.	   Based	   on	   these	   observations,	   we	  
annotate	   monooxygenase	   H	   as	   an	   NMO	   (NMO-­‐H).	   The	   other	   proteins	   seem	   to	   form	  
another	   isolated	   cluster	   of	   sequence-­‐related	   class	   B	   flavoprotein	   monooxygenases	   and	  
therefore	  we	  classify	   them	  as	  Type	   II	  FMOs	   (while	   the	  known	  and	  well-­‐established	  FMO	  
class	   can	   be	   considered	   as	   	   	   	   Type	   I	   FMOs).	   Recently	   another	   class	   B	   flavoprotein	  
monooxygenase	   has	   been	   described	   that	   shows	   relatively	   high	   sequence	   similarity	  with	  
these	  Type	  II	  FMOs	  	  (FMO-­‐X	  in	  Figure	  4-­‐1).	  The	  Grogan	  group	  has	  discovered	  this	  bacterial	  
monooxygenase	   that	   can	   perform	   sulfoxidations	   and	   can	   act	   as	   BVMO	   (Jensen	   et	   al.	  
2012).	  However,	  conversion	  rates	  described	  for	  this	  monooxygenase	  seem	  rather	  modest	  
(100-­‐1000	  fold	  lower	  when	  compared	  with	  conversion	  rates	  of	  Type	  I	  BVMO).	  
This	   sequence	   analysis	   hints	   to	   a	   new	   subclass	   of	   class	   B	   flavoprotein	  
monooxygenases,	   Type	   II	   FMOs	   that	   can	   be	   employed	   as	   biocatalysts.	   By	   cloning,	  
expressing,	   and	   testing	   biocatalytic	   oxidations,	   we	   set	   out	   to	   explore	   the	   above-­‐
mentioned	  8	  putative	  class	  B	  flavoprotein	  monooxygenases.	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Figure	   4-­‐1:	   An	   unrooted	   phylogenetic	   tree	   of	   the	   studied	  monooxygenases	   and	   known	   class	   B	   flavoprotein	  
monooxygenases.	   The	   included	   sequences	   are:	   Type	   I	   BVMOs	   [EtaA,	   Mycobacterium	   tuberculosis	   H37Rv	  
(NP_218371.1);	   HAPMO,	   Pseudomonas	   fluorescens	   ACB	   (Q93TJ5.1);	   CDMO,	   Rhodococcus	   ruber	   SCI	  
(AAL14233.1);	   CPDMO,	   Pseudomonas	   sp.	   strain	   HI-­‐70	   (BAE93346.1);	   CHMO1,	   Acinetobacter	   calcoaceticus	  
NCIMB	   9871	   (BAA86293.1);	   PAMO,	   Thermobifida	   fusca	   (YP_289549.1);	   STMO,	   Rhodococcus	   rhodochrous	  
(BAA24454.1);	   ACMO,	   Gordania	   sp.	   strain	   TY-­‐5	   (BAF43791.1);	   MEKMO,	   Pseudomonas	   veronii	   MEK700	  
(ABI15711.1);	  CPMO,	  Comamonas	   sp.	   strain	  NCIMB	  9872	   (Q8GAW0)],	   [BVMOs	  1-­‐23	   from	  Rhodococcus	   jostii	  
RHA1	  (see	  [13]	  for	  numbering)],	  Type	  I	  FMOs	  [Arabidopsis	  thaliana:	  FMO1Ara(Q9LMA1);	  FMO2Ara	  (Q9FKE7);	  
Homo	   sapiens:	   FMO1hum(Q01740);	   FMO2hum	   (Q99518);	   FMO3hum	   (P31513);	   FMO4hum	   (P31512);	  
FMO5hum	   (P49326);	  Drosophila	   melanogaster:	   FMO1Dro	   (Q9W1E9);	   FMO2Dro	   (Q7K3U4);	   FMO1dog,	   Canis	  
familiaris	   (Q95LA2);	   FMOMeth,	  Methylophaga	   sp.	   strain	   SK1	   (JC7986);	   FMOTyr,	   Tyria	   jacobaeae	   (D6CHF7);	  
FMOFish,	   Oncorhynchus	   mykiss	   (B2LGF9)],	   NMOs	   [NRho_Orn,	   Rhodococcus	   jostii	   RHA1	   (YP_704660.1);	  
PVDA_Orn,	   Pseudomonas	   aeruginosa	   (NP_251076);	   IucD_Lys,	   Escherichia	   coli	   (YP_444061.1);	   SidA_Orn,	  
Aspergillus	   fumigatus	   (XP_755103.1)],	   Type	   II	   FMOs	   [FMO_X,	   Stenotrophomonas	   maltophilia	   (B2FLR2);	   the	  































































4.2.2. Expression	  of	  the	  putative	  class	  B	  flavoprotein	  monooxygenases	  
The	   targeted	   genes	   were	   cloned	   in	   a	   pBAD-­‐based	   expression	   vector	   (pBADN	   by	  
Kamerbeek	  et	  al.	  2004)	  by	  ligation	  free	  cloning.	  By	  varying	  the	  temperature	  and	  arabinose	  
concentration,	   optimal	   expression	   conditions	   were	   determined.	   By	   this	   approach,	   six	  
proteins	  could	  be	  obtained	   in	  soluble	  form	  with	  good	  expression	   levels	  (Table	  4-­‐1).	  Only	  
for	  two	  genes,	  expression	  did	  not	  yield	  satisfying	  amounts	  of	  soluble	  protein.	  We	  solved	  
this	   expression	   problem	   by	   cloning	   the	   respective	   genes	   into	   the	   recently	   developed	  
pCRE2	  expression	  vector	  (Torres	  Pazmiño	  et	  al.	  2009).	  With	  these	  constructs	  we	  were	  able	  
to	   achieve	   soluble	   expression	   of	   all	   targeted	   proteins	   that	  were	   predicted	   to	   represent	  	  	  	  	  
class	  B	  flavoprotein	  monooxygenases.	  
Interestingly,	  in	  two	  cases,	  FMO-­‐E	  and	  FMO-­‐G,	  it	  was	  found	  that	  during	  expression	  the	  
growth	  medium	   developed	   a	   bluish	   colour,	   as	   shown	   in	   Table	   4-­‐1.	  We	   have	   previously	  
observed	   this	   phenomenon	   when	   expressing	   a	   phenylacetone	   monooxygenase	   mutant	  
capable	   of	   converting	   indole	   into	   indigo	   blue	   (Torres	   Pazmiño	   et	   al.	   2007).	   Also	   the	  
expression	   of	   several	   Type	   I	   BVMOs	   from	  R.	   jostii	   RHA1	   led	   to	   blue	   pigment	   formation	  
(Riebel	   et	   al.	   2012).	   The	   same	   phenomenon	   has	   been	   observed	   when	   expressing	   a	  
bacterial	  FMO	  in	  E.	  coli	  (Choi	  et	  al.	  2003).	  Apparently,	  the	  respective	  monooxygenases	  are	  
able	   to	   form	   indigo	   blue	   by	   oxidizing	   the	   endogenous	   indole.	   The	   fact	   that	   indigo	   blue	  
formation	   is	  only	  observed	  upon	  expression	  of	  distinct	  enzymes,	  confirms	  the	  functional	  
expression	  of	  these	  monooxygenases,	  in	  our	  case	  of	  FMO-­‐E	  and	  FMO-­‐G.	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Table	   4-­‐1:	   All	   identified	   class	   B	   monooxygenases	   with	   their	   sequence	   characteristics	   and	   expression	  
performance	  in	  E.	  coli.	  
	  
a	   	   +	   indicates	   a	   clear	   visible	   protein	   band	   using	   SDS-­‐PAGE,	   while	   +++	   indicates	   a	   great	   overexpression	  was	  
observed;	  b	  indicates	  that	  the	  medium	  changed	  its	  color	  to	  blue	  during	  expression	  of	  this	  gene;	  c	  indicates	  that	  
the	  respective	  monooxygenase	  has	  been	  expressed	  using	  the	  pCRE2	  expression	  vector	  while	  all	  others	  have	  
been	  expressed	  using	  the	  pBADN-­‐vector	  (Kamerbeek	  et	  al.	  2004).	  
4.2.3. Substrate	  profile	  of	  the	  overexpressed	  monooxygenases	  
Even	   though	   using	   CCE	   for	   the	   reactivity	   tests,	   we	   used	   the	   same	   concentration	   of	  
recombinant	  enzyme	  in	  all	  assays	  to	  allow	  a	  direct	  comparison	  of	  the	  results.	  For	  this,	  the	  
amount	  of	  active	  enzyme	  in	  the	  CCEs	  was	  first	  quantified	  with	  the	  NADPH-­‐mediated	  flavin	  
reduction	  method	  established	  and	  described	  before	  (Riebel	  et	  al.	  2012).	  This	  revealed	  that	  
all	  extracts	  contained	  significant	  amounts	  of	  NADPH-­‐dependent	  flavoproteins,	  which	  is	  in	  
agreement	  with	  the	  SDS-­‐PAGE	  analysis	  of	  CCEs,	  and	  confirms	  that	  all	  enzymes	  contain	  a	  
flavin	  cofactor	  upon	  expression	  and	  accept	  NADPH	  as	  coenzyme.	  
To	   determine	   the	   biocatalytic	   potential	   of	   the	   studied	   monooxygenases,	   each	  
monooxygenase	   was	   tested	   for	   activity	   on	   several	   ketones	   and	   aromatic	   sulfides:	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2-­‐indanone,	   cyclopentadecanone,	   phenylacetone,	   bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one,	  
thioanisole,	  4-­‐methylthioanisole,	  ethyl	  benzyl	  sulfide,	  and	  benzyl	  phenyl	  sulfide.	  
None	   of	   the	   monooxygenases	   was	   found	   to	   convert	   2-­‐indanone	   or	   cyclopenta-­‐
decanone.	  In	  contrast,	   intriguingly,	  FMO-­‐E,	  FMO-­‐F,	  and	  FMO-­‐G	  were	  found	  to	  be	  able	  to	  






FMO+A RHA1_ro007404 GxGxxG WxGxxxHxxxYR GxGxxG 375 4++c
FMO+B RHA1_ro033344 GxGxxG AxIxxxHxxxYR GxGxxG 418 4++
FMO+C RHA1_ro044944 GxGxxG PxIxxxHxxxYR GxSxxG 365 4++
FMO+D RHA1_ro050324 GxGxxG FxGxxxHxxxYS GxGxxA 369 4++c
FMO+E4b RHA1_ro00824 GxGxxG FxGxxxHxxxYD GxGxxA 580 4++
FMO+F RHA1_ro042444 GxGxxG FxGxxxHxxxHP GxNxxA 602 4+++
FMO+G4b RHA1_ro056964 GxGxxG FxGxxxHxxxFV GxCxxG 595 4+++










Figure	   4-­‐2:	   Oxidations	   of	   thioanisole,	   phenylacetone	   and	   bicycloheptenone	   catalyzed	   by	   the	   novel	  
flavoprotein	  monooxygenases	  using	  NADH	  or	  NADPH	  as	  coenzymes.	  
	  
Product	   analysis	   by	   GC	   revealed	   that	   phenylacetone	   was	   converted	   into	   the	  
corresponding	   ester,	   benzylacetate	   (Table	   4-­‐2).	   Enantiodivergent	   oxidation	   of	  
bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	   was	   analyzed	   by	   chiral	   GC.	   This	   revealed	   that	   the	  
monooxygenases	  have	  a	  preference	  for	  the	  formation	  of	  the	  normal	  lactone,	  while	  still	  a	  
significant	  amount	  of	  the	  abnormal	   lactone	   is	   formed	  (Table	  4-­‐2).	  While	  the	  biocatalysts	  
are	  not	  very	  enantioselective	  in	  formation	  of	  the	  normal	  lactone,	  the	  FMO-­‐F	  and	  FMO-­‐G	  
yield	  >65%	  ee	  for	  the	  abnormal	  (1S,5R)	  enantiomer.	  Taken	  together,	  these	  data	  show	  that	  
FMO-­‐E,	  FMO-­‐F	  and	  FMO-­‐G	  act	  as	  bona	  vide	  BVMOs.	  
Table	  4-­‐2:	  Baeyer-­‐Villiger	  oxidation	  of	  phenylacetone	  and	  (±)-­‐bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one.	  
	  
Next,	   four	   prochiral	   aromatic	   sulfides	   with	   varying	   substituents	   (thioanisole,	   4-­‐methyl-­‐
thioanisole,	  ethyl	  benzyl	  sulfide,	  and	  benzyl	  phenyl	  sulfide)	  were	  tested	  as	  substrates.	  The	  
relatively	  small	  substrate	  thioanisole	  was	  the	  only	  sulfide	  that	  was	  converted	  by	  most	  of	  
the	  monooxygenases	   in	  detectable	  amounts,	  as	   indicated	   in	  Table	  4-­‐3.	  Only	  NMO-­‐H	  did	  
phenylacetone
conv.&(%) conv.&(%) ratio&normal:abnormal ee&normal&(%) ee&abnormal&(%)
FMO6E 20 100 79:21 9&(1S,5R) 7&(1R,5S)
FMO6F 19 88 78:22 <&1&(1S,5R) 70&(1S,5R)
FMO6G 5 100 78:22 7&(1R,5S) 66&(1S,5R)
(±)0bicyclo[3.2.0]hept020en060one
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not	  convert	  significant	  amounts	  of	  thioanisole	  or	  any	  other	  tested	  sulfide,	  strengthening	  
the	  classification	  of	  this	  particular	  enzyme	  as	  an	  NMO.	  	  
Table	  4-­‐3:	  Sulfoxidation	  of	  thioanisole.	  
	  
For	   the	   majority	   of	   the	   biocatalysts,	   mainly	   the	   (R)-­‐methyl	   phenyl	   was	   preferentially	  
formed,	   with	   the	   exception	   of	   FMO-­‐G,	   which	   led	   to	   the	   (S)-­‐enantiomer.	   The	  
enantioselectivity	  of	  the	  thioanisole	  sulfoxidation	  varied	  from	  low	  to	  moderate,	  achieving	  
the	   highest	   optical	   purity	   (ee	   =	   57%),	   when	   employing	   FMO-­‐G.	   The	   conversion	   of	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4-­‐methylthioanisole	  could	  only	  be	  detected	  in	  very	  low	  conversions.	  This	  is	  in	  line	  with	  the	  
observation	  of	  Grogan	  that	  FMO-­‐X	  only	  showed	  a	  poor	  conversion	  rate	  with	  this	  aromatic	  
sulfide	  (Jensen	  et	  al.	  2012).	  The	  enantioselective	  outcome	  with	  this	  substrate	  when	  using	  
the	  Type	   II	   FMOs	   from	  R.	   jostii	   RHA1	  was	   similar	   to	   that	   achieved	  with	   thioanisole.	   The	  
more	   bulky	   substrate	   benzyl	   ethyl	   sulfide	   was	   only	   converted	   by	   FMO-­‐E,	   FMO-­‐F	   and	  	  	  	  	  
FMO-­‐G,	   but	   with	   poor	   conversion.	   Only	   the	   corresponding	   methyl	   phenyl	   sulfone	   was	  
detected	  as	  product,	   indicating	  that	  these	  biocatalysts	  are	  able	  to	  oxygenate	  the	  initially	  
formed	   sulfoxide	   to	   the	   overoxidized	   product.	   The	   bulky	   benzyl	   phenyl	   sulfide	  was	   not	  
converted	  by	  any	  of	  the	  tested	  monooxygenases.	  
FMO-­‐X	  was	  found	  to	  be	  indifferent	  towards	  NADPH	  or	  NADH	  (Jensen	  et	  al.	  2012).	  This	  
is	   in	   sharp	   contrast	   with	   the	   known	   Type	   I	   BVMOs,	   which	   only	   accept	   NADPH	   as	  
coenzyme.	   It	   also	   is	   different	   from	   the	   Type	   I	   FMOs	   that	   typically	   prefer	   NADPH	   as	   a	  
coenzyme.	   Conversion	   of	   several	   of	   the	   previously	   identified	   substrates	   was	   therefore	  
conv.&(%) ee&(%) configuration
FMO5A 5 11 R
FMO5B 4 7 R
FMO5C 4 33 R
FMO5D 16 25 R
FMO5E 56 8 R
FMO5F 9 ≤&5 "




tested	   via	   GC	   with	   both	   nicotinamide	   cofactors.	   When	   we	   replaced	   NADPH	   by	   NADH,	  
almost	   identical	   degrees	   of	   conversion	   and	   enantioselectivities	   were	   found	   for	   the	  
conversions	  for	  all	  tested	  Type	  II	  FMOs.	  This	  is	  a	  highly	  interesting	  and	  relevant	  finding	  as	  
it	   suggests	   that	   the	   Type	   II	   FMOs	   have	   as	   general	   characteristic	   a	   relaxed	   coenzyme	  
specificity.	  This	  is	  attractive	  for	  biocatalytic	  applications,	  as	  NADH	  is	  a	  cheaper	  source	  than	  
its	   phosphorylated	   analogue	   (when	   considering	   use	   as	   isolated	   enzyme)	   while	   NADH	   is	  
also	  present	  at	  higher	  level	  in	  cells	  (when	  considering	  use	  of	  whole	  cells).	  This	  shows	  that	  
the	  Type	  II	  FMOs	  described	  in	  this	  chapter,	  together	  with	  the	  previously	  described	  FMO-­‐X	  
(Jensen	   et	   al.	   2012),	   represent	   a	   newly	   discovered	   subclass	   of	   class	   B	   flavoprotein	  
monooxygenases	  that	  can	  accept	  both	  NADPH	  and	  NADH.	  	  
4.3. Discussion	  	  
Eight	   class	   B	   flavoprotein	  monooxygenases	   from	  R.	   jostii	   RHA1	   have	   been	   expressed	   in	  
soluble	   form	   and	   studied	   for	   their	   biocatalytic	   potential.	   From	   the	   sequence	   alignment	  
study,	  one	  of	  the	  targeted	  monooxygenases	  (NMO-­‐H)	  was	  found	  to	  belong	  to	  the	  group	  of	  
NMOs.	   The	   prototype	   enzymes	   for	   the	   subclass	   of	   N-­‐hydroxylating	   flavoprotein	  
monooxygenases	   (NMOs)	   are	   L-­‐ornithine	   N5-­‐hydroxylase	   and	   L-­‐lysine	   N6-­‐hydroxylase	  
(Olucha	   &	   Lamb	   2011).	   An	   L-­‐ornithine	   hydroxylase	   had	   already	   been	   identified	   in	   the	  	  	  	  	  	  	  
R.	   jostii	   RHA1	  proteome	   (Rmo_Orn	   in	   Figure	   4-­‐1,	   Bosello	  et	   al.	   2012).	  When	   comparing	  
NMO-­‐H	  with	  known	  NMO	  sequences	  it	  shows	  highest	  sequence	  similarity	  with	  the	  lysine	  
hydroxylase	  IucD	  from	  E.	  coli	  (Figure	  4-­‐1).	  This	  suggests	  that	  the	  NMO-­‐H	  described	  in	  this	  
study	   probably	   represents	   a	   lysine	   hydroxylase	   present	   in	  R.	   jostii	   RHA1.	   The	   restricted	  
substrate	  scope	  of	   lysine	  hydroxylases	  also	   is	   in	   line	  with	  the	  observation	  that	  NMO-­‐H	  is	  
not	  converting	  any	  aromatic	  compound	  tested	  in	  this	  study	  (Franceschini	  et	  al.	  2012).	  This	  
confirms	   that,	   in	  contrast	   to	  BVMOs	  and	  FMOs,	  NMOs	  are	   rather	   restricted	   in	  substrate	  
acceptance	  and	  appear	  to	  be	  of	  little	  value	  as	  biocatalysts.	  
The	   FMOs	   described	   in	   this	   chapter	   do	   not	   seem	   to	   belong	   to	   the	   typical	   FMO	  
subclass,	  as	  (i)	  they	  do	  not	  contain	  a	  fully	  conserved	  FMO-­‐typifying	  motif	  (Table	  4-­‐1),	  and	  
(ii)	   they	   form	  another	  cluster	  of	  sequence-­‐related	  proteins	  distinct	   from	  the	  three	  other	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subclasses,	  FMOs,	  NMOs,	  and	  BVMOs	  (Figure	  4-­‐1).	  Also	  their	  catalytic	  properties	  deviate	  
from	  the	  other	  subclasses	  by	  accepting	  both	  nicotinamide	  coenzymes,	  NADH	  and	  NADPH,	  
without	   significant	   difference.	   Furthermore,	   several	   of	   these	   FMOs	   were	   shown	   to	  
perform	  Baeyer-­‐Villiger	  oxidations,	   a	   reaction	   for	  which	   typical	   FMOs	  display	  hardly	  any	  
activity.	   We	   coined	   this	   newly	   recognized	   subclass	   of	   class	   B	   flavoprotein	  
monooxygenases	  Type	  II	  FMOs.	  
This	   study	   reveals	   that	   of	   the	   tested	   Type	   II	   FMOs,	   FMO-­‐E,	   FMO-­‐F,	   and	   FMO-­‐G	  may	  
represent	   valuable	   new	   oxidative	   biocatalysts.	   These	   three	   enzymes	   were	   found	   to	   be	  
active	   in	   both	   sulfoxidations	   and	  Baeyer-­‐Villiger	   reactions.	  Multiple	   sequence	   alignment	  
revealed	  that	  they	  form	  a	  separate	  cluster	  of	  sequences	  (Figure	  4-­‐1).	  Except	  for	  showing	  a	  
relative	   high	   sequence	   homology	   with	   each	   other,	   these	   three	   monooxygenases	   also	  
share	  an	  N-­‐terminal	  extension	  of	  about	  160	  residues	  (see	  multiple	  sequence	  alignement	  in	  
Appendix).	   This	  may	   suggest	   that	   this	   newly	   identified	   subclass	   of	  monooxygenases	  has	  
evolved	   as	   separate	   subclass	   of	   class	   B	   flavoprotein	  monooxygenases,	   distinct	   from	   the	  
Type	   I	   BVMOs,	   towards	   a	   new	   subclass	   of	   potent	   Baeyer-­‐Villiger	   monooxygenases.	  
Therefore,	   these	   three	   FMOs	   or	   close	   homologs	   thereof	   may	   represent	   interesting	  
alternative	  biocatalysts	  (for	  instance,	  due	  to	  their	  NADH	  acceptance)	  when	  compared	  with	  
the	  known	  Type	   I	  BVMOs.	  By	  merely	  using	  the	  N-­‐terminal	  sequence	  of	  one	  of	   the	  three	  
Type	  II	  FMOs,	  it	  is	  possible	  to	  identify	  hundreds	  of	  homologous	  putative	  Type	  II	  FMOs.	  It	  
will	   be	   exciting	   to	   see	   whether	   these	   homologs	   indeed	   display	   similar	   biocatalytic	  
properties.	   Future	   research	   will	   reveal	   whether	   monooxygenases	   from	   this	   newly	  
identified	   subclass	   of	   class	   B	   flavoprotein	   monooxygenases	   (Type	   II	   FMOs)	   are	   indeed	  
valuable	  as	  biocatalysts;	  e.g.	  their	  operational	  stability	  and	  substrate	  scope	  has	  still	  to	  be	  
explored.	  
	  
In	   the	   present	   chapter,	   a	   set	   of	   eight	   new	   flavoprotein	   monooxygenases	   from	  	  	  	  	  	  	  	  	  
R.	   jostii	  RHA1	  has	  been	  expressed	  and	  obtained	   in	  soluble	  form	  by	  employing	  two	  
expression	   vectors	   and	   optimizing	   expression	   conditions.	   Sequence	   analysis	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established	  that	  one	  of	  these	  enzymes	  represents	  an	  NMO,	  while	  the	  other	  cluster	  
as	   a	   separate	   class	   B	   flavoprotein	   monooxygenase	   subclass:	   Type	   II	   FMOs.	   The	  
monooxygenases	   have	   been	   tested	   for	   their	   ability	   to	   perform	   sulfoxidations	   and	  
Baeyer-­‐Villiger	   oxidations.	   Interestingly,	   three	   of	   the	   Type	   II	   FMOs	   are	   able	   to	  
catalyze	   both	   reaction	   types	   and	   accept	   both	   NADPH	   or	   NADH	   as	   coenzyme,	  
presenting	  a	  different	  behavior	  with	  respect	  to	  classical	  FMOs	  and	  BVMOs.	  Type	  II	  
FMOs	  might	   develop	   as	   an	   interesting	   alternative	   to	   BVMOs,	   as	   they	   are	   able	   to	  
catalyze	  the	  similar	  reaction	  with	  a	  relaxed	  nicotinamide	  cofactor	  acceptance.	  	  
4.4. Experimental	  Section	  
General	  materials	  and	  methods	  
Oligonucleotide	  primers	  were	  purchased	   from	  Sigma,	  dNTPs	  and	   In-­‐Fusion™	  2.0	  CF	  Dry-­‐
Down	   PCR	   Cloning	   Kit	   from	   Clontech,	   Phusion	   polymerase	   from	   Finnzymes.	   All	   other	  
chemicals	   were	   obtained	   from	   Acros	   Organics,	   ABCR,	   Sigma-­‐Aldrich,	   TCI	   Europe,	   and	  
Roche	  Diagnostics	  GmbH.	  The	  nicotinamide	  coenzymes	  were	  purchased	  from	  Codexis.	  
The	   NCBI	   server	  was	   used	   for	   DNA	   sequence	   retrieval	   and	   BLAST	   searches.	   The	   EBI	  
server	  was	  used	  for	  multiple	  sequence	  alignment	  by	  CLUSTALW	  (Thompson	  et	  al.	  1994).	  
Treeview	  software	  was	  used	  for	  visualization	  of	  the	  sequence	  relationships.	  
NCBI	  server:	  http://blast.ncbi.nlm.nih.gov/Blast.cgi	  	  
EBI	  server:	  http://www.ebi.ac.uk/Tools/msa/clustalw2/	  
Treeview	  software:	  http://taxonomy.zoology.gla.ac.uk/rod/treeview.html	  
Cloning	  and	  expression	  
Escherichia	   coli	   TOP10	   from	   Invitrogen	   was	   used	   as	   a	   host	   for	   DNA	  manipulations	   and	  
protein	  expression.	   Two	  expression	  vectors	  have	  been	  used:	   (i)	   a	  modified	  pBAD	  vector	  
(pBADN)	   in	  which	  the	  NdeI	  site	  was	  replaced	  by	   the	  original	  NcoI	  site	   (Kamerbeek	  et	  al.	  
2004),	  and	  (ii)	  the	  recently	  engineered	  pBAD-­‐based	  pCRE2	  vector	  which	  harbors	  a	  codon-­‐
optimized	   gene	   encoding	   a	   thermostable	   mutant	   of	   phosphite	   dehydrogenase	   (PTDH)	  
with	  an	  N-­‐terminal	  His-­‐tag	  (Torres	  Pazmiño	  et	  al.	  2009).	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The	   target	   genes	   were	   amplified	   by	   PCR	   using	   genomic	   DNA	   of	   R.	   jostii	   RHA1	   as	  
template	  and	  subsequently	   cloned	   into	  pBADN	  using	   the	   In-­‐Fusion	  PCR	  Cloning	  kit	   from	  
Clontech,	   following	   the	   recommendations	   of	   the	   manufacturer.	   Expression	   of	   all	  
generated	   expression	   constructs	   was	   tested	   using	   24-­‐multiwell	   microtiter	   plates	   in	   the	  
sandwich	   cover	   system	   from	   Enzyscreen®.	   Cell	   cultures	   of	   2,5	   ml	   in	   LB	   medium	  
supplemented	  with	  50	  μg	  mL-­‐1	  ampicillin	  were	  grown	  at	  four	  different	  temperatures	  (17°C	  
for	   48	   h;	   24°C	   for	   32	   h;	   30°C	   and	   37°C	   for	   16	   h)	   with	   four	   different	   arabinose	  
concentrations	   (0,002%,	   0,02%,	   0,2%,	   and	   none)	   each,	   with	   shaking	   at	   200	   rpm.	   Cell	  
extracts	  (CEs)	  were	  obtained	  using	  DNase/lysozyme	  in	  combination	  with	  freezing	  in	  liquid	  
nitrogen	  and	  thawing	  at	  30°C.	  CEs	  as	  well	  as	  cell	  cleared	  extracts	  (CCEs)	  were	  analyzed	  by	  
SDS-­‐PAGE	   for	   (soluble)	   expression	   of	   the	   monooxygenases.	   For	   the	   genes	   that	   did	   not	  
yield	  expressed	  soluble	  protein	  when	  cloned	  into	  pBADN,	  the	  in-­‐house	  developed	  pCRE2	  
expression	  vector	  was	  used.	  	  
General	  procedure	  for	  the	  bioconversions	  employing	  the	  novel	  FMOs	  
Conversions	  were	  performed	  essentially	  as	  described	  before	   (Riebel	  et	  al.	  2012).	  For	  GC	  
analysis,	   500	  µl	   incubations	   of	   50	  mM	  Tris/HCl	   pH	  7,5,	   10%	  glycerol,	   1	  mM	  DTT,	   1	  mM	  
EDTA,	  10	  µM	  FAD,	  5	  mM	  substrate,	  5%	  cosolvent	  (1,4-­‐dioxane),	  100	  μM	  NADPH,	  3,1	  μM	  
PTDH,	   10	  mM	   phosphite	   and	   5	   μM	   of	   the	   corresponding	  monooxygenase	   in	   CCE	   form	  
(total	  volume	  of	  0,5	  mL),	  were	  shaken	  in	  glass	  vials	  at	  24°C	  for	  24	  hours.	  For	  determining	  
the	  exact	   concentration	  of	   each	  enzyme	   in	   the	   respective	  extract,	   a	   recently	  developed	  
method	  was	  used	  which	   relies	  on	   the	  decrease	   in	   absorbance	  at	   450	  nm	  upon	  NADPH-­‐
mediated	   reduction	   of	   the	   flavin	   cofactor	   (Riebel	   et	   al.	   2012).	   Each	   conversion	   was	  
stopped	   by	   extracting	   with	   ethyl	   acetate	   (2	   x	   0,5	   mL	   containing	   0,1%	   mesitylene	   as	  
standard),	   dried	  with	  magnesium	   sulfate	   and	   analyzed	   directly	   by	   GC	   to	   determine	   the	  
degree	   of	   conversion	   and	   the	   enantioselectivity.	   The	   details	   concerning	   the	   (chiral)	   GC	  
analysis	  can	  be	  found	  in	  the	  Appendix	  A-­‐1.	  For	  every	  tested	  reaction,	  control	  experiments	  
in	  the	  absence	  of	  enzyme	  resulted	  in	  no	  conversion.	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Wunder	  stehen	  nicht	  im	  Gegensatz	  zur	  Natur,	  	  
sondern	  nur	  im	  Gegensatz	  zu	  dem,	  











CHAPTER	  5 	  TYPE	  II	  FLAVIN-­‐CONTAINING	  MONOOXYGENASES:	  A	  NEW	  CLASS	  OF	  BIOCATALYSTS	  THAT	  HARBORS	  BAEYER-­‐VILLIGER	  MONOOXYGENASES	  WITH	  RELAXED	  COENZYME	  SPECIFICITY	  
	  
This	  chapter	  is	  based	  on	  chemcatchem	  (2013),	  accepted	  by	  Anette	  Riebel,	  Michael	  J.	  Fink,	  




Abstract:	   Within	   a	   newly	   identified	   subclass	   of	   flavin-­‐
containing	   monooxygenases	   (FMOs)	   we	   have	   identified	  
three	   monooxygenases	   from	   Rhodococcus	   jostii	   RHA1	  	  
(FMO-­‐E,	  FMO-­‐F,	  and	  FMO-­‐G)	  that	  are	  effective	  in	  catalyzing	  
Baeyer-­‐Villiger	   oxidations.	   All	   three	   Type	   II	   FMOs	   display	   a	  
relaxed	  coenzyme	  specificity	  by	  accepting	  both	  NADPH	  and	  
NADH	   as	   coenzyme,	   a	   novel	   and	   attractive	   feature	   among	  
biocatalysts	   capable	   to	   conduct	   Baeyer-­‐Villiger	   oxidations.	  
We	  have	  purified	   FMO-­‐E	   and	  have	  determined	   that	   the	  KM	  
values	   for	   both	   coenzymes	   are	   in	   the	   micromolar	   range	  
while	  the	  activity	  is	  highest	  for	  NADH.	  By	  using	  the	  stopped-­‐
flow	   technique,	   formation	   of	   a	   relatively	   stable	  
peroxyflavin-­‐enzyme	   intermediate	   was	   observed	   which	  
indicates	   that	   Type	   II	   FMOs	   employ	   a	   catalytic	  mechanism	  
which	   is	   similar	   to	   other	   class	   B	   flavoprotein	  
monooxygenases.	   A	   large	   set	   of	   cyclobutanones	   and	  
cyclohexanones	   was	   used	   to	   probe	   the	   regio-­‐	   and	  
enantioselectivity	   of	   all	   three	   recombinant	  
monooxygenases.	   The	   biocatalysts	   readily	   accept	   a	   large	  
number	   of	   cyclobutanones,	   enabling	   conversion	   of	  
previously	   poorly	   accepted	   substrates	   by	   other	   mono-­‐
oxygenases	   (esp.	   norcamphor),	   and	   exhibit	   excellent	   and	  
unique	   regio-­‐	   and	   enantioselectivities.	   Sequence	   analysis	  
revealed	   that	   Type	   II	   FMOs	   that	   act	   as	   Baeyer-­‐Villiger	  
monooxygenases	   contain	   a	   unique	   N-­‐terminal	   domain.	  
Sequence	  conservation	   in	   this	  protein	  domain	   can	  be	  used	  
to	   identify	   new	   NADH-­‐dependent	   Baeyer-­‐Villiger	   mono-­‐
oxygenases,	  facilitating	  future	  biocatalyst	  discoveries.	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5.1. Introduction	  
By	   being	   able	   to	   perform	   efficient	   chemo-­‐,	   regio-­‐,	   and/or	   enantioselective	   oxygenation	  
reactions	  by	  only	  using	  dioxygen	  and	  reducing	  equivalents	  like	  NADH	  and	  NADPH	  (Torres	  
Pazmiño	  et	   al.	   2010),	   flavoprotein	  monooxygenases	   represent	   potent	   catalytic	   tools	   for	  
the	  production	  of	  high-­‐value	  chemical	  building	  blocks	  or	  pharmaceuticals	  (van	  Berkel	  et	  al.	  
2006).	   Flavoprotein	   monooxygenases	   can	   be	   classified	   into	   six	   structurally	   and	  
mechanistically	  distinct	  classes.	  When	  taking	  into	  account	  the	  differences	  in	  structural	  and	  
mechanistic	  properties	  of	  the	  various	  flavoprotein	  monooxygenase	  classes,	  class	  A	  and	  B	  
monooxygenases	  are	  especially	   interesting	  for	  biocatalysis	  as	  they	  are	  single	  component	  
enzymes	  with	  a	  typically	  tightly	  bound	  FAD	  cofactor	  (Figure	  5-­‐1).	  	  
	  
Figure	  5-­‐1:	  Overview	  of	  the	  different	  class	  B	  flavoprotein	  monooxygenase	  classes;	  S/N-­‐oxidations:	  sulfur	  and	  
nitrogen	  oxidations;	  B-­‐V	  oxidations:	  Baeyer-­‐Villiger	  oxidations.	  
Class	  A	  flavoprotein	  monooxygenases	  have	  been	  shown	  to	  be	  specialized	  in	  hydroxylation	  
and	  epoxidation	  reactions	  (van	  Berkel	  et	  al.	  2006).	  Class	  B	  flavoprotein	  monooxygenases	  
typically	  cover	  another	  range	  of	  oxygenation	  reactions,	  such	  as	  Baeyer-­‐Villiger	  oxidations	  














































analysis	   of	   the	   sequence	   and	   enzymatic	   properties	   of	   class	   B	   flavoprotein	  
monooxygenases	  has	  revealed	  several	  distinct	  subclasses	  (Figure	  5-­‐1).	  	  
An	  extensively	  studied	  subclass	  of	  class	  B	  flavoprotein	  monooxygenases	   is	  formed	  by	  
the	   Type	   I	   Baeyer-­‐Villiger	   monooxygenases	   (BVMOs):	   they	   display	   unique	   catalytic	  
properties	  by	  catalysing	  NADPH-­‐dependent	  Baeyer-­‐Villiger	  oxidations,	  while	  they	  are	  also	  
capable	   of	   oxygenating	   heteroatom-­‐containing	   compounds	   (de	   Gonzalo	   et	   al.	   2010).	  
Three	  other	   subclasses	  of	   class	  B	   flavoprotein	  monooxygenases	  are	   known	   to	  date.	   The	  
Type	  I	  flavin-­‐containing	  monooxygenases	  (FMOs)	  have	  mainly	  been	  studied	  for	  their	  role	  
in	   human	   metabolism	   (Ziegler	   1990).	   The	   human	   proteome	   contains	   six	   Type	   I	   FMO	  
isoforms,	   all	   of	  which	   have	   been	   reported	   as	   important	   in	   the	   oxidative	   degradation	   of	  	  	  	  
N-­‐	  and	  S-­‐containing	  compounds.	  Only	  recently,	  some	  microbial	  representatives	  have	  been	  
discovered	  and	  were	  shown	  to	  represent	   interesting	  biocatalysts	   for	  oxidizing	  secondary	  
amines,	   including	   the	   conversion	   of	   indole	   into	   indigo	   blue	   (Rioz-­‐Martínez	   et	   al.	   2011).	  
Another	   class	   B	   subclass	   entails	   microbial	   monooxygenases	   that	   hydroxylate	   primary	  
amines,	   e.g.	   lysine	   N6-­‐hydroxylase	   and	   ornithine	   N5-­‐hydroxylase.	   Referring	   to	   their	  
reactivity,	   these	   have	   been	   named	   N-­‐hydroxylating	   monooxygenases	   (NMOs).	   All	  
together,	   these	   biocatalyst	   subclasses	   share	   a	   pronounced	   cofactor	   preference	   towards	  
NADPH.	  
	  
In	  the	  last	  chapter,	  we	  described	  a	  new	  group	  of	  sequence-­‐related	  monooxygenases	  
that	  belong	  to	  the	  class	  B	  flavoprotein	  monooxygenases:	  Type	  II	  FMOs	  (Figure	  5-­‐1).	  
We	  reported	  on	  seven	  Type	  II	  FMOs	  derived	  from	  the	  genome	  of	  Rhodococcus	  jostii	  
RHA1	   (Riebel	   et	   al.	   2013).	   Their	   unique	   sequence	   profiles	   as	  well	   as	   their	   relaxed	  
coenzyme	   specificity	   legitimated	   a	   classification	   separate	   from	   the	   other	   class	   B	  
flavoprotein	  monooxygenases.	  Substrate	  profiling	  of	  the	  seven	  rhodococcal	  mono-­‐
oxygenases	   revealed	   that	   three	   of	   them	   are	   able	   to	   perform	   Baeyer-­‐Villiger	  
oxidations.	  In	  this	  chapter,	  we	  report	  on	  the	  characterization	  of	  these	  three	  Type	  II	  
FMOs	  that	  can	  act	  as	  bona	  fide	  BVMOs.	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5.2. Results	  
5.2.1. Purification	  of	  FMO-­‐E	  
We	  have	  recently	  identified	  seven	  Type	  II	  FMO-­‐encoding	  genes	  in	  the	  proteome	  of	  R.	  jostii	  
RHA1.	  The	  respective	  enzymes,	  together	  with	  the	  monooxygenase	  of	  Stenophomamonas	  
maltophilia	   (Jensen	  et	   al.	   2012),	   are	  members	  of	   a	   new	   subclass	  of	   class	  B	   flavoprotein	  
monooxygenase:	   a	   class	   of	   sequence-­‐related	   FAD-­‐containing	   monooxygenases	   with	   a	  
relaxed	   coenzyme	   preference	   towards	   NADPH	   and	   NADH	   (Riebel	   et	   al.	   2013).	   Within	  
these	   seven	   newly	   found	   Type	   II	   FMOs,	   however,	   we	   found	   significant	   differences	  
concerning	   substrate	   acceptance.	   The	   monooxygenases	   FMO-­‐E,	   FMO-­‐F,	   and	   FMO-­‐G	  
efficiently	  catalyzed	  Baeyer-­‐Villiger	  oxidation	  of	  two	  ketones	  (phenylacetone	  (substrate	  3)	  
and	  bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	  (substrate	  1));	  a	  catalytic	  feature	  that	  was	  only	  known	  
for	  Type	  I	  BVMOs.	  However,	  different	  from	  Type	  I	  BVMOs,	  all	  Type	  II	  FMOs	  were	  shown	  to	  
be	   able	   to	   use	  NADPH	  or	  NADH	  without	   any	   preference.	   This	   aspect	   seems	  particularly	  
interesting	   for	   combining	   such	   enyzmes	   with	   other	   redox	   biocatalysts	   in	   multi-­‐step	  
biotransformations	  cascades.	  These	   features	  encouraged	  us	   to	  perform	  a	  more	   in-­‐depth	  
study	  of	  the	  newly	  identified	  Type	  II	  FMOs	  exhibiting	  BVMO	  activity.	  
To	   allow	   efficient	   one-­‐step	   purification,	   we	   produced	   the	   monooxygenases	   FMO-­‐E,	  
FMO-­‐F,	   and	   FMO-­‐G	  with	   an	   N-­‐terminal	   Strep-­‐tag	   (in	   pBADNS).	   The	   strep-­‐tag	   proved	   to	  
have	  no	  influence	  on	  the	  expression	  level.	  However,	  purification	  trials	  revealed	  that	  only	  
FMO-­‐E	  could	  be	  isolated	  in	  good	  yields.	  The	  other	  monooxygenases	  were	  found	  to	  suffer	  
from	   FAD	   loss	   during	   the	   purification	   procedure.	   As	   all	   three	   monooxygenases	   are	  
sequence	   related,	   we	   decided	   to	   use	   FMO-­‐E	   as	   prototype	   for	   a	   biochemical	  
characterization.	  From	  a	  1	  L	  culture,	  25	  mg	  pure	  FMO-­‐E	  could	  be	  obtained	  (see	  Appendix).	  
The	   purified	   enzyme	   displays	   a	   typical	   flavin	   absorbance	   spectrum,	   with	   characteristic	  
absorbance	  maxima	   at	   451	   nm	   and	   381	   nm	   (Figure	   5-­‐2).	   The	   extinction	   coefficient	  was	  
determined	  as	  11,9	  mM-­‐1cm-­‐1	  (ε451nm).	  Furthermore,	  from	  the	  measured	  A280/A451	  ratio	  




Figure	  5-­‐2:	  Absorption	  spectra	  of	  purified	  native	  FMO-­‐E	  (line)	  and	  after	  SDS	  treatment	  (dotted	  line).	  
5.2.2. Kinetic	  characterization	  of	  FMO-­‐E	  
Using	   purified	   FMO-­‐E,	   the	   steady-­‐state	   kinetic	   parameters	   were	   determined	   for	  
bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	  (1),	  NADH	  and	  NADPH.	  For	  both	  coenzymes	  and	  the	  ketone	  
substrate	  typical	  Michaelis-­‐Menten	  behavior	  was	  observed,	  yielding	  the	  catalytic	  (kcat)	  and	  
Michaelis	  constants	  (KM)	  for	  all	  three	  substrates	  (Table	  5-­‐1).	  	  
Table	  5-­‐1:	  Steady-­‐state	  kinetic	  parameters	  of	  FMO-­‐E	  for	  NADPH,	  NADH	  and	  bicycloheptenone.	  
	  
Even	  though	  FMO-­‐E	  accepts	  both	  nicotinamide	  coenzymes,	  the	  enzyme	  appears	  to	  have	  a	  
higher	  affinity	  (KM)	  for	  NADPH.	  Yet,	  the	  KM	  for	  NADH	  is	  also	  in	  the	  low	  µM	  range	  and	  the	  
kcat	  is	  higher	  when	  compared	  with	  NADPH	  (4,3	  s
-­‐1	  vs.	  2,7	  s-­‐1).	  This	  indicates	  that	  FMO-­‐E	  is	  
an	  efficient	  enzyme	  with	  NADH	  as	  coenzyme,	  which	   is	   in	   contrast	   to	  most	  other	  class	  B	  
flavoprotein	   monooxygenases.	   Also	   all	   other	   Type	   II	   FMOs	   have	   shown	   coenzyme	  
indifference	   (Riebel	   et	   al.	   2013).	   The	   determined	   kcat	   values	   also	   confirm	   FMO-­‐E	   as	   a	  
potent	  biocatalyst	   as	   the	   rate	  of	   catalysis	   is	   in	   the	   same	   range	  as	   it	   has	  been	   found	   for	  
other	   class	   B	   flavoprotein	  monooxygenases.	   For	   example,	   the	  kcat	   values	   for	   the	   typical	  
Type	   I	   BVMOs	   phenylacetone	   monooxygenase	   (Fraaije	   et	   al.	   2005)	   and	   cyclohexanone	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extremely	   low	   kcat	   values	   determined	   for	   the	   Type	   II	   FMO	   from	   Stenophomamonas	  
maltophilia	   (Jensen	  et	  al.	   2012)	  differ	  by	  2	  orders	  of	  magnitude	   relative	   to	   FMO-­‐E.	   This	  
makes	  FMO-­‐E	  a	  more	  likely	  candidate	  for	  biocatalytic	  processes.	  	  
To	   establish	   whether	   FMO-­‐E	   utilizes	   a	   similar	   catalytic	   mechanism	   when	   compared	  
with	   Type	   I	   FMOs	   and	   Type	   I	   BVMOs,	   stopped-­‐flow	   experiments	   were	   performed.	   The	  
kinetic	   mechanism	   of	   flavoprotein	   monooxygenases	   can	   be	   subdivided	   into	   two	   half-­‐
reactions:	  a	  reductive	  and	  an	  oxidative	  half-­‐reaction.	  The	  reduction	  of	  the	  FAD	  cofactor	  by	  
the	   nicotinamide	   coenzyme	   is	   considered	   as	   the	   reductive	   half-­‐reaction.	   The	   anaerobic	  
reduction	  of	  FMO-­‐E	  by	  NADPH	  was	  monitored	  over	  time	  using	  a	  stopped-­‐flow	  instrument,	  
revealing	  a	  relatively	  high	  rate	  of	  reduction	  (17,5	  s-­‐1)	  at	  a	  saturating	  NADPH	  concentration.	  
In	   the	   next	   step,	   the	   reduced	   flavin	   of	   class	   B	   flavoprotein	  monooxygenases	   is	   able	   to	  
swiftly	   react	   with	   molecular	   oxygen,	   typically	   yielding	   a	   relatively	   stable	   peroxyflavin	  
intermediate.	  The	  ability	  to	  stabilize	  such	  a	  reactive	  enzyme	  intermediate	  in	  the	  absence	  
of	  a	  substrate	  has	  been	  the	  typical	  hallmark	  of	  class	  B	  flavoprotein	  monooxygenases.	  For	  
monitoring	   the	  above-­‐described	  oxidative	  half	   reaction,	   the	  NADPH-­‐reduced	  FMO-­‐E	  was	  
rapidly	  mixed	  with	  aerated	  buffer.	  Analysis	  of	  the	  obtained	  spectral	  scans	  revealed,	  that	  
the	   data	   could	   be	   fitted	   best	   with	   an	   irreversible	   three-­‐step	   model	   (A	  à	   B	  à	   C	  à	   D)	  
(Figure	  5-­‐3).	  	  
	  
Figure	  5-­‐3:	  Deconvoluted	  flavin	  absorbance	  spectra	  upon	  mixing	  FMO-­‐E	  with	  air-­‐saturated	  buffer.	  The	  spectra	  
were	  reconstructed	  from	  a	  model	  A	  to	  B	  to	  C	  to	  D	  and	  with	  rates	  of	  respectively	  7,2,	  1,2	  and	  0,5	  s-­‐1.	  Spectra:	  A:	  
reduced	  state,	  B:	  first	  peroxyflavin	  intermediate,	  C:	  second	  peroxyflavin	  intermediate,	  D:	  oxidized	  state.	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Directly	  after	  mixing	  with	  oxygen,	  species	  B	  is	  rapidly	  formed	  with	  a	  rate	  of	  7,2	  s-­‐1	  as	  
evidenced	  by	  an	  absorbance	  peak	  at	  around	  365	  nm.	  This	  spectrum	  perfectly	  matches	  the	  
spectral	   features	  of	  a	  peroxyflavin	   intermediate	  and	  confirms	  that	  FMO-­‐E	  operates	  via	  a	  
catalytic	   mechanism	   that	   is	   similar	   to	   other	   class	   B	   flavoprotein	   monooxygenases.	   The	  
peroxyflavin	   intermediate	   (spectrum	   B)	   undergoes	   a	   slow	   and	   modest	   spectral	   change	  	  	  
(1,2	   s-­‐1)	   to	   form	   a	   less	   intense	   absorbance	   peak	   (spectrum	   C).	   This	   transition	   may	  
represent	   a	   change	   in	   the	   protonation	   state	   of	   the	   peroxyflavin	   or	   a	   conformational	  
change,	   and	   has	   also	   been	   observed	   for	   Type	   I	   BVMOs	   (Mirza	   et	   al.	   2009,	   Orru	   et	   al.	  
2011).	   In	  a	  subsequent	  slow	  process	  (0,5	  s-­‐1),	  the	  oxidized	  flavin	   is	  formed	  (spectrum	  D),	  
accompanied	   by	   formation	   of	   hydrogen	   peroxide.	   These	   kinetic	   and	   spectral	   properties	  
closely	  resemble	  the	  kinetic	  behavior	  of	  other	  class	  B	  flavoprotein	  monooxygenases.	  
5.2.3. Structural	  analysis	  of	  FMO-­‐E	  
To	  obtain	  a	  better	  view	  on	  how	  FMO-­‐E	   is	  able	   to	  catalyze	  Baeyer-­‐Villiger	  oxidations,	  we	  
compared	  a	  structural	  model	  of	  FMO-­‐E	  with	  the	  crystal	  structures	  of	  a	  Type	  I	  BVMO	  (PDB	  
1W4X)	  (Malito	  et	  al.	  2004)	  and	  a	  Type	  I	  FMO	  (PDB	  2VQ7)	  (Alfieri	  et	  al.	  2008).	  Comparison	  
of	   the	   active	   sites	   clearly	   showed	   that	   all	   three	   enzymes	   employ	   different	   strategies	   to	  
catalyse	  oxygenations	  (Figure	  5-­‐4).	  	  
	  
Figure	  5-­‐4:	  Comparison	  of	  the	  active	  side	  architectures	  of	   (A)	  a	  Type	   I	  BVMO	  (PDB:1W4X),	   (B)	  a	  Type	   I	  FMO	  
(2VQ7)	  and	  (C)	  FMO-­‐E.	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In	  Type	  I	  BVMO	  a	  strictly	  conserved	  arginine	   is	  crucial	   for	  catalysis,	   in	  Type	  I	  FMO	  an	  
asparagine	  residue	  serves	  such	  a	  role,	  while	  in	  the	  model	  of	  FMO-­‐E	  no	  such	  active	  residue	  
can	  be	   identified	   in	  the	  homologous	  structural	  positions.	  Yet,	  a	  histidine	  and	  an	  arginine	  
residue	  were	  found	  to	  be	  positioned	  close	  to	  the	  isoalloxazine	  moiety	  of	  the	  FAD	  cofactor,	  
possibly	  assisting	  in	  catalysis.	  Both	  residues	  are	  conserved	  among	  Type	  II	  FMO	  sequences.	  
To	  verify	  whether	  His222	  and	  Arg563	  serve	  a	  role	  in	  catalysis,	  the	  corresponding	  alanine	  
mutants	  were	  prepared.	  The	  first	  evidence	  of	  changed	  catalytic	  capacities	  of	  the	  mutants	  
could	   directly	   be	   seen	  when	   growing	   cultures	   under	   optimal	   expression	   conditions.	   For	  
the	  wild	   type	   FMO-­‐E	   it	   was	   observed	   that	   the	   growth	  medium	   changed	   significantly	   in	  
color.	   This	   is	   due	   to	   blue	   pigment	   formation	   which	   is	   formed	   upon	   conversion	   of	  
indigenous	   indole	   into	   indigo	   blue	   by	   FMO-­‐E	   (Riebel	   et	   al.	   2013).	   Expression	   of	   the	  
mutants	  did	  not	   result	   in	  any	   color	   change	  of	   the	  medium.	  Furthermore,	  purification	  of	  
the	   mutant	   proteins	   only	   resulted	   in	   inactive	   apo	   protein.	   Addition	   of	   FAD	   to	   the	   apo	  
protein	  samples	  did	  not	  restore	  any	  activity.	  Tests	  with	  cleared	  cell	  extracts	  containing	  the	  
different	   mutant	   enzymes	   showed	   that	   the	   activity	   was	   affected	   dramatically.	   The	  
conversion	  of	  thioanisole	  (substrate	  2)	  dropped	  from	  56%	  (Riebel	  et	  al.	  2013)	  to	  only	  6%,	  
while	  phenylacetone	   (3)	  and	  bicyclo[3.2.0]hept-­‐2-­‐en-­‐6-­‐one	   (1)	  were	  not	  converted	  at	  all	  
under	  standard	  assay	  conditions.	  
These	   results	   show	   that	   the	   targeted	   residues	   are	   important	   for	   proper	   FAD	  
binding	  while	  they	  do	  not	  provide	  conclusive	  evidence	  on	  whether	  they	  are	  important	  for	  
catalysis.	  
5.2.4. Biocatalytic	  exploration	  
As	  Type	  II	  FMOs	  are	  fundamentally	  different	  when	  compared	  to	  Type	  I	  BVMOs,	  we	  set	  out	  
to	   explore	   the	   substrate	   acceptance	   range	   and	   stereoselective	   properties	   of	   all	   three	  
studied	  FMOs	  by	  using	  whole	  cells.	  For	  this,	  14	  ketones	  (six	  prochiral	  cyclobutanones	  4-­‐9,	  
four	  prochiral	   cyclohexanones	  10-­‐13,	   three	   racemic	   fused	   cyclobutanones	  1,	   14,	   15	   and	  




Desymmetrization	   of	   prochiral	   cyclobutanones	   and	   cyclohexanones	   revealed	   a	   clear	  
preference	   (Table	   5-­‐3).	   All	   three	   monooxygenases	   efficiently	   convert	   most	  
cyclobutanones	  while	   the	  cyclohexanones	  are	  poorly	  or	  not	  accepted	  as	   substrates.	  The	  
corresponding	   lactones	   are	   formed	  with	  modest	   to	   good	   enantioselectivity	   (e.e.	   ranges	  
from	  5	  –	  79	  %,	  median	  45	  %).	  Interestingly,	  Type	  II	  FMOs	  display	  complementary	  enantio-­‐
preference	   in	   all	   cases,	   hence,	   enabling	   the	   synthesis	   of	   both	   optical	   antipodes	   in	  
enantioenriched	  form.	  	  
As	   further	   exploration	   of	   the	   biocatalytic	   potential	   of	   these	   newly	   found	  
monooxygenases,	   we	   decided	   to	   test	   conversion	   of	   racemic	   fused	   cycloketones.	  
Gratifyingly,	   the	   monooxygenases	   were	   found	   to	   be	   able	   to	   convert	   all	   tested	   fused	  
cyclobutanones	   and	   norcamphor	   (Table	   5-­‐2).	   Regiodivergent	   oxidations	   of	   fused	  
cycloketones	   resulted	   in	  preferential	   formation	  of	   the	  normal	   lactones	   (in	   this	   case,	   the	  
rearrangement	  is	  governed	  by	  higher	  nucleophilicity,	   i.e.	  higher	  degree	  of	  substitution	  of	  
the	  migrating	  carbon).	  	  
Table	  5-­‐2:	  Regiodivergent	  oxidation	  of	  fused	  cyclobutanones	  and	  norcamphor	  by	  FMO-­‐E,	  FMO-­‐F,	  and	  FMO-­‐G	  
using	  whole	  cells.	  	  
a	   Product	   regioisomers	   are	   not	   separable	   by	   preparative	   low-­‐pressure	   chromatography;	   for	   assignment	   of	  
regio-­‐	  and	  stereoisomers	  see	  Mihovilovic	  et	  al.	  2008.	  Relative	  conversion	  (Rel.	  Conv.)	  and	  enantiomeric	  excess	  
(ee)	  of	   lactone	  products	  as	  determined	  by	  chiral	  phase	  GC-­‐FID	  after	  24	  h	  biotransformation	  time.	  Selectivity	  
values	  E	  in	  kinetic	  resolution-­‐type	  reactions	  were	  calculated	  according	  to	  Sih’s	  equation	  E	  =	  [	  ln(1	  –	  eeS)	  –	  ln(1	  
+	  eeS/eeP)	  ]	  /	  [	  ln(1	  +	  eeS)	  –	  ln(1	  +	  eeS/eeP)	  ]	  from	  ee	  of	  substrate	  (eeS)	  and	  ee	  of	  product	  (eeP)	  values.	  Values	  
for	  normal	  lactones	  (N)	  in	  plain	  font,	  values	  for	  abnormal	  lactones	  (ABN)	  in	  italics.	  Absolute	  configuration	  or	  
sign	   of	   optical	   rotation	   of	   lactone	   products	   was	   assigned	   on	   the	   basis	   of	   published	   reference	  
biotransformations	  (Mihovilovic	  et	  al.	  2008).	  n.a.:	  not	  applicable,	  n.d.:	  not	  determined,	  rac.:	  racemic.	  
	  
%"Rel."Conv. %"ee"N EN %"Rel."Conv. %"ee"N EN %"Rel."Conv. %"ee"N EN
Ratio"N:ABN %%ee%ABN EABN Ratio"N:ABN %%ee%ABN EABN Ratio"N:ABN %%ee%ABN EABN
97 46"(3aR,6aS) n.d. 92 19"(3aS,6aR) n.d. 81 21"(3aS,6aR) n.d.
14":"86 3%(3aR,6aS) n.d. 12":"88 6%(3aR,6aS) n.d. 20":"80 rac. n.d.
81 39"(3aS,7aS) n.d. 77 44"(3aS,7aS) 137 91 18"(3aS,7aS) n.d.
95":"5 98%(3aR,7aS) n.d. 92":"8 71%(3aR,7aS) 59 92":"8 75%(3aR,7aS) n.d.
>99 rac. n.d. 77 91a 99 99 rac. n.d.
>99:1 n.a. n.a. >99:1 n.d. n.d. >99:1 n.a. n.a.
14 94"(1S,5R) 36 22 >99"(1S,5R) >200 47 99"(1S,5R) >200
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Table	   5-­‐3:	   Desymmetrization	   of	   cyclobutanones	   and	   cyclohexanones	   by	   FMO-­‐E,	   FMO-­‐F,	   and	   FMO-­‐G	   using	  
whole	  cells.	  
	  
a	  absolute	  configuration	  of	  product	  not	  known;	  sign	  of	  optical	   rotation	   is	  given	   instead.	  Relative	  conversion	  
(rel.	  conv.)	  and	  enantiomeric	  excess	  (ee)	  of	  lactone	  products	  as	  determined	  by	  chiral	  phase	  GC-­‐FID	  after	  24	  h	  
biotransformation	  time.	  Absolute	  configuration	  or	  sign	  of	  optical	  rotation	  of	  lactone	  products	  was	  assigned	  on	  
the	  basis	  of	  published	  reference	  biotransformations	  (Rudroff	  et	  al.	  207).	  n.a.:	  not	  applicable.	  
	  




































This	   kind	   of	   regioselectivity	   is	   known	   from	   Type	   I	   BVMOs	   of	   the	   CPMO	   cluster	  
(Mihovilovic	  et	  al.	  2008).	  Yet,	   interestingly,	   these	  FMOs	  are	   the	  only	  known	  biocatalysts	  
able	  to	  perform	  the	  kinetic	  resolution	  of	  norcamphor	  (16)	  to	  the	  normal	  lactone	  with	  both	  
excellent	  stereoselectivity	  and	  yield.	  The	  best	  reported	  biocatalyst	  for	  this	  transformation,	  
CDMO	   from	  Rhodococcus	   ruber	   SC1	   (Fink	   et	   al.	   2012),	   catalyzes	   the	   formation	   of	   both	  
regioisomers	   of	   norcamphor	   with	   excellent	   enantioselectivity	   (>98%),	   but	   in	   almost	  
equimolar	  ratio	  (57:43	  normal/abnormal)	  and	  at	  a	  rather	  low	  rate.	  Specifically,	  FMO-­‐F	  and	  
FMO-­‐G	   display	   excellent	   enantioselectivities	   (E	   >200)	   and	   regioselectivities	   (>99:1	   for	  
normal:abnormal	  lactone)	  for	  the	  oxygenation	  of	  this	  natural	  compound.	  
Clearly,	  the	  studied	  Type	  II	  FMOs	  display	  biocatalytic	  features	  that	  set	  them	  apart	  from	  
Type	  I	  BVMOs.	  As	  a	  consequence,	  they	  represent	  a	  new	  and	  promising	  group	  of	  oxidative	  
biocatalysts.	  
5.3. Discussion	  
Within	  the	  newly	  described	  class	  of	  Type	  II	  FMOs	  we	  have	  identified	  three	  FMOs	  that	  can	  
efficiently	   catalyze	   Baeyer-­‐Villiger	   oxidations.	   The	   kinetic	   analysis	   of	   one	   of	   these	  
monooxygenases,	  FMO-­‐E,	  has	  revealed	  that	  it	  is	  catalytically	  competent	  by	  displaying	  high	  
affinities	   towards	   both	   nicotinamide	   coenzymes	   and	   high	   kcat	   values.	   The	   KM	   values	   for	  
NADPH	  and	  NADH	  are	  in	  the	  low	  µM	  range	  while	  the	  highest	  rate	  of	  catalysis	  is	  observed	  
with	   NADH	   (4,3	   vs.	   2,7	   s-­‐1).	   These	   rates	   are	   significantly	   higher	  when	   compared	  with	   a	  
recently	   reported	  Type	   II	   FMO	   from	  S.	  maltophilia	   that	   can	  also	  perform	  Baeyer-­‐Villiger	  
oxidations	   (0,029	   s-­‐1).	   Interestingly,	   for	   both	   bacterial	   monooxygenases	   the	   rate	   of	  
catalysis	  is	  highest	  when	  using	  NADH.	  This	  may	  hint	  to	  a	  role	  of	  the	  coenzyme	  in	  the	  rate-­‐
limiting	   step	   of	   the	   kinetic	   mechanism	   of	   this	   monooxygenase.	   For	   the	   Type	   I	   BVMO	  
cyclohexanone	  monooxygenase	   it	  has	   indeed	  been	   shown	   that	  NADP+	   release	   limits	   the	  
rate	  of	  catalysis	  (Sheng	  et	  al.	  2001).	  	  
The	   pre-­‐steady	   state	   kinetic	   analysis	   of	   FMO-­‐E	   has	   revealed	   similar	   features	  
concerning	   the	   catalytic	  mechanism	   as	  with	   other	   class	   B	  monooxygenases:	   (i)	   oxidized	  
FMO-­‐E	  is	  rapidly	  reduced	  by	  a	  reduced	  coenzyme	  without	  the	  need	  of	  substrate	  binding,	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(ii)	   the	   reduced	   FMO-­‐E	   rapidly	   reacts	  with	  molecular	   oxygen,	   and	   (iii)	   FMO-­‐E	   is	   able	   to	  
form	  a	  stable	  peroxyflavin	  intermediate.	  For	  all	  other	  studied	  class	  B	  monooxygenases,	  it	  
has	   been	   shown	   that	   the	   oxidized	   nicotinamide	   coenzyme	   remains	   bound	   to	   the	   active	  
site	  until	  the	  peroxyflavin	  has	  oxygenated	  the	  substrate.	  Only	  then	  it	  is	  released,	  often	  in	  a	  
relatively	   slow	   kinetic	   event.	   Such	   a	   scenario	   fits	  with	   the	   steady-­‐state	   and	   pre-­‐steady-­‐
state	  kinetic	  data	  of	  FMO-­‐E	  in	  which	  NADP+/NAD+	  is	  released	  in	  a	  relatively	  slow	  process.	  
More	  detailed	  kinetic	  and	  structural	  studies	  will	  settle	  this	  issue	  in	  the	  future.	  
As	  the	  studied	  monooxygenases	  FMO-­‐E,	  FMO-­‐F,	  and	  FMO-­‐G	  can	  act	  as	  BVMOs	  and	  can	  
use	   NADH	   as	   coenzyme,	   they	   represent	   highly	   sought-­‐after	   biocatalysts.	   A	   major	  
disadvantage	  of	  the	  well-­‐studied	  Type	  I	  BVMOs	  is	  that	  they	  are	  highly	  specific	  for	  NADPH,	  
which	  is	  a	  relatively	  expensive	  cofactor	  when	  compared	  with	  NADH.	  Attempts	  to	  engineer	  
a	  Type	  I	  BVMO	  that	  accepts	  NADH	  as	  cofactor	  have	  failed	  so	  far	  (Kamerbeek	  et	  al.	  2004,	  
Dudek	  et	  al.	  2010).	  A	  relaxed	  nicotinamide	  cofactor	  acceptance	  is	  also	  a	  highly	  appealing	  
feature	   for	  designing	  enzyme	  cascade	  reactions	   that	   involve	  multiple	   redox	  biocatalysts.	  
These	  monooxygenases	  will	  be	  able	   to	   tap	   from	  both	  nicotinamide	  coenzyme	  pools	   in	  a	  
cell.	  When	  employing	  whole-­‐cell	  processes,	  a	  significantly	  better	  balanced	  exploitation	  of	  
the	   available	   reduction	   equivalents	   within	   a	   metabolically	   active	   cell	   may	   be	   achieved,	  
alleviating	   the	  metabolic	   burden	  of	   such	   systems.	  Additionally,	   higher	   compatibility	   and	  
flexibility	  may	  be	  achieved	  when	  designing	  redox	  cascades	  in	  a	  cell-­‐fee	  environment.	  	  
This	   study	   shows	   that	   the	   tested	   Type	   II	   FMOs	   can	   indeed	   be	   used	   as	   efficient	  
biocatalysts.	   By	   testing	   a	   set	   of	   cyclobutanone	   derivatives	   we	   have	   unveiled	   new	   and	  
excellent	   stereoselectivities.	   For	   example,	   the	   conversion	  of	   norcamphor	   (16)	   by	   FMO-­‐F	  
proceeds	  with	  >99%	  regioselectivity	  and	  >99%	  enantioselectvity.	  Such	  selectivity	  has	  not	  
been	   observed	   before	  with	   previously	   identified	   BVMOs.	   This	  may	   be	   explained	   by	   the	  
fact	  that	  Type	  II	  FMOs	  are	  only	  distantly	  related	  to	  Type	  I	  BVMOs.	  As	  a	  consequence	  they	  
will	  exhibit	  totally	  different	  active	  site	  architectures.	  In	  fact,	  Type	  II	  FMOs	  seem	  to	  lack	  the	  
typical	   active	   residues	   that	   are	   employed	   in	   Type	   I	   BVMOs	   (a	   conserved	   arginine)	   and	  
Type	  I	  FMOs	  (a	  conserved	  asparagine)	  for	  catalysis.	  By	  site-­‐directed	  mutagenesis	  we	  have	  
determined	   that	   His222	   and	   Arg563	   are	   crucial	   for	   corect	   functioning	   of	   FMO-­‐E.	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Unfortunately	   the	  protein	  sequences	  of	  FMO-­‐E	  and	  the	  Type	   II	  FMO	  from	  S.	  maltophilia	  
(Jensen	  et	  al.	  2012)	  are	  too	  dissimilar	  to	   locate	  the	  mutated	  residues	   in	  the	  structure	  of	  
the	  latter	  monooxygenase.	  Elucidation	  of	  the	  structure	  of	  FMO-­‐E	  would	  shed	  light	  on	  the	  
structural	   and	   catalytic	   properties	   of	   this	   NAD(P)H-­‐dependent	   monooxygenase.	  
Intriguingly,	  on	  protein	  sequence,	  the	  three	  special	  Type	  II	  FMOs	  described	  in	  this	  chapter	  
share	  an	  extra	  N-­‐terminal	  extension	  of	  about	  160	  residues	  when	  compared	  with	  the	  other	  
four	   rhodococcal	   Type	   II	   FMOs	   and	   the	   Type	   II	   FMO	   from	   S.	  maltophilia.	   This	   aberrant	  
sequence	   feature	   coincides	   with	   the	   potency	   to	   efficiently	   catalyze	   Baeyer-­‐Villiger	  
oxidations.	   The	   molecular	   basis	   for	   this	   correlation	   is	   unclear.	   Yet,	   it	   may	   be	   used	   to	  
identify	  new	  Type	  II	  FMOs	  that	  can	  be	  exploited	  as	  NADH-­‐driven	  biocatalysts	  for	  Baeyer-­‐
Villiger	  oxidations.	  A	  BLASTP	  search	  in	  the	  genome	  sequence	  database	  search	  reveals	  that	  
there	   is	   a	   large	   number	   of	   Type	   II	   FMOs	   that	   contain	   this	   typical	   N-­‐terminal	   extension.	  
Intriguingly,	  the	  respective	  genes	  are	  mainly	  found	  in	  fungal	  genomes.	  
This	   study	   has	   shown	   that	   Type	   II	   FMOs	   represent	   valuable	   oxidative	   biocatalysts.	  
Especially	  the	  ability	  to	  use	  NADH	  as	  cofactor	  opens	  up	  new	  possibilities	  for	  cost-­‐effective	  
biocatalytic	   Baeyer-­‐Villiger	   oxidations.	   Many	   more	   Type	   II	   FMOs	   await	   biocatalytic	  
exploration	  and	  future	  research	  will	  reveal	  how	  they	  operate	  at	  molecular	  level.	  
5.4. Experimental	  Section	  
Reagents	  &	  enzymes	  
Oligonucleotide	  primers	  were	  purchased	   from	  Sigma,	  dNTPs	  and	   In-­‐Fusion™	  2.0	  CF	  Dry-­‐
Down	   PCR	   Cloning	   Kit	   from	   Clontech,	   Phusion	   polymerase	   from	   Finnzymes.	   All	   other	  
chemicals	   were	   obtained	   from	   Acros	   Organics,	   ABCR,	   Sigma-­‐Aldrich,	   TCI	   Europe,	   and	  
Roche	  Diagnostics	  GmbH.	  
Bacterial	  strains	  and	  Plasmids	  
Escherichia	   coli	   TOP10	   from	   Invitrogen	   was	   used	   as	   a	   host	   for	   DNA	  manipulations	   and	  
protein	  expression.	  The	  used	  expression	  vector	  was	  a	  modified	  pBAD	  vector	   (pBADN)	   in	  
which	  the	  NdeI	  site	  was	  replaced	  by	  the	  original	  NcoI	  site	  (Kamerbeek	  et	  al.	  2004).	  For	  this	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study	  we	  have	  introduced	  a	  strep-­‐tag	  binding	  site	  (tggagccacccgcagtttgaaaaa)	  followed	  by	  
a	  TEV	  protease	  cleavage	  site	  (gagaatttatattttcaaggt)	  between	  promotor	  and	  start	  codon	  of	  
the	  gene	  to	  be	  cloned,	  yielding	  the	  pBADNS	  vector.	  
Sequence	  analysis,	  cloning,	  expression	  and	  protein	  purification	  
The	   NCBI	   server	   (blast.ncbi.nlm.nih.gov/Blast.cgi)	   was	   used	   for	   DNA	   sequence	   retrieval	  
and	  BLAST	   searches.	   The	  EBI	   server	   (www.ebi.ac.uk/Tools/msa/clustalw2/)	  was	  used	   for	  
multiple	  sequence	  alignment	  by	  CLUSTALW	  (Thompson	  et	  al.	  1994).	  The	  FMO-­‐E	  sequence	  
was	   used	   as	   input	   to	   prepare	   a	   structural	   model	   by	   using	   the	   CPH	   modeling	   server	  
(www.cbs.dtu.dk/services/CPHmodels/)	  (Nielsen	  et	  al.	  2010).	  The	  model	  was	  made	  based	  
on	  the	  phenylacetone	  MO	  structure	  (PDB	  1W4X).	  
The	   target	   genes	   were	   amplified	   by	   PCR	   using	   genomic	   DNA	   of	   R.	   jostii	   RHA1	   as	  
template	  and	  subsequently	  cloned	  into	  pBADNS,	  using	  the	  In-­‐Fusion	  PCR	  Cloning	  kit	  from	  
Clontech,	   following	   the	   recommendations	   of	   the	   manufacturer.	   The	   mutations	   were	  
introduced	  via	  the	  QuikChange®	  Site-­‐Directed	  Mutagenesis	  Kit	  from	  Stratagene,	  following	  
the	  recommendations	  of	  the	  manufacturer.	  
For	   expression,	   cells	   were	   grown	   in	   baffled	   flasks	   with	   800	   mL	   LB	   medium	  
supplemented	  with	  50	  μg	  mL−1	  ampicillin	  and	  arabinose	  concentrations	  of	  0,002%	  (FMO-­‐E	  
and	  FMO-­‐G)	  or	  0,2%	  (FMO-­‐F),	  shaking	  at	  200	  rpm	  at	  24°C	  for	  32	  h,	  based	  on	  the	  optimal	  
expression	  conditions	  determined	  before	  (Riebel	  et	  al.	  2013).	  Cell	  extracts	  were	  prepared	  
by	   sonication	   with	   subsequent	   centrifugation	   to	   obtain	   the	   cleared	   cell	   extracts.	  
Purification	   of	   the	   enzymes	   from	   the	   cleared	   cell	   extracts	   was	   done	  with	   Strep-­‐Tactin®	  
Sepharose	   from	   IBA	   GmbH,	   following	   the	   recommendations	   of	   the	   manufacturer.	   As	  
minor	  modification,	  10	  µM	  FAD,	  1,0	  mM	  DTT	  and	  10%	  glycerol	  were	  added	  to	  the	  buffer.	  
Determination	  of	  kinetic	  parameters	  of	  FMO-­‐E	  	  
Activities	   of	   purified	   FMO-­‐E	   were	   determined	   spectrophotometrically	   by	   monitoring	  
increase	   or	   decrease	   of	   NADPH	   or	   NADH	   respectively	   in	   time	   at	   340	   nm.	   The	   reaction	  
mixture	   (1,0	   mL)	   typically	   contained	   50	   mM	   Tris/Cl,	   pH	   7,5	   (10%	   glycerol,	   1	   mM	   DTT,	  	  	  	  	  	  	  	  	  
1	  mM	  EDTA,	  10	  µM	  FAD),	  150	  µM	  coenzyme	  NADPH	  or	  NADH,	  50	  µM	  ketone	  substrate,	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5,0	  %	  dioxane	  and	  0,1	  µM	  enzyme	  at	  25	  °C.	  Kinetic	  parameters	  were	  obtained	  by	  fitting	  
the	  data	  as	  described	  previously	  (Torres	  Pazmiño	  et	  al.	  2008).	  
Stopped-­‐flow	  experiments	  
Both,	   the	   reductive	   and	   oxidative	   half-­‐reactions	   of	   FMO-­‐E	   were	   analyzed	   using	   the	  
Applied	   Photophysics	   SX17MV	   stopped-­‐flow	   instrument	   equipped	   with	   a	   photodiode	  
array	  detector.	  All	  experiments	  described	  were	  performed	  at	  25	  °C	  in	  50	  mM	  Tris/Cl	  (10%	  
glycerol,	  1,0	  mM	  DTT,	  1,0	  mM	  EDTA),	  pH	  7,5.	  All	   concentrations	  stated	  are	   those	   in	   the	  
reaction	   chamber	   after	   mixing.	   Anaerobic	   conditions	   were	   achieved	   by	   flushing	   the	  
system	   and	   solutions	  with	  N2	   and	   removing	   traces	   of	   oxygen	   upon	   addition	   of	   1,0	  mM	  
putrescine	  and	  a	  catalytic	  amount	  of	  putrescine	  oxidase.	  The	  rate	  of	  reduction	  of	  FMO-­‐E	  
by	   NADPH	   was	   assessed	   under	   anaerobic	   conditions	   by	   adding	   equimolar	   amounts	   of	  
NADPH.	   The	   reoxidation	   of	   the	   reduced	   flavin	  was	   achieved	   by	  mixing	   NADPH-­‐reduced	  
FMO-­‐E	  with	   aerated	   buffer	   and	   following	   the	   spectral	   changes	   of	   the	   flavin	   cofactor	   in	  
time.	   The	   obtained	   spectra	   were	   analyzed	   by	  means	   of	   numerical	   integration	  methods	  
using	  Pro-­‐K	  (Applied	  Photophysics	  Ltd.),	  yielding	  the	  observed	  rate	  constants.	  
Bioconversions	  with	  cleared	  cell	  extracts	  
Conversions	  were	  performed	  as	  described	  before	  (Riebel	  et	  al.	  2013).	  For	  determining	  the	  
exact	   concentration	   of	   each	   enzyme	   in	   the	   respective	   extract,	   a	   recently	   developed	  
method	  was	  used	  which	   relies	  on	   the	  decrease	   in	   absorbance	  at	   450	  nm	  upon	  NADPH-­‐
mediated	  reduction	  of	  the	  flavin	  cofactor	  (Riebel	  et	  al.	  2012).	  
Whole-­‐cell	  conversions	  
Bioconversion	  of	  a	   set	  of	  14	   target	  compounds	  was	  performed	  by	  using	  cells	  expressing	  
FMO-­‐E,	  FMO-­‐F	  and	  FMO-­‐G	  employing	   the	  above-­‐mentioned	  expression	  conditions.	  Cells	  
were	  grown	  up	  to	  OD590	  =	  0,2–0,6	  at	  37	  °C.	  The	  cultures	  were	  then	  cooled	  to	  24	  °C	  and	  	  	  	  	  
L-­‐arabinose	   was	   added	   as	   10%	   w/v	   solution	   in	   water	   to	   the	   appropriate	   final	  
concentration.	   Cyclodextrin	   (4,0	   mM)	   was	   supplemented	   as	   cell	   membrane	   transfer	  
agent.	  This	  mixture	  was	  thoroughly	  shaken	  and	  then	  divided	  into	  aliquots	  (1,0	  mL)	  in	  24-­‐
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well	   plates.	   Substrates	   were	   added	   as	   solution	   in	   1,4-­‐dioxane	   (5,0	   mM	   final	  
concentration),	  the	  plates	  were	  sealed	  with	  adhesive	  film	  (EasySEAL,	  Greiner	  Bio	  One)	  and	  
incubated	  in	  an	  orbital	  shaker	  (Infors	  HT	  Multitron	  2	  Standard)	  at	  24	  °C	  for	  24	  h.	  Analytical	  
samples	  were	  prepared	  by	  extraction	  of	  0,5	  mL	  of	  biotransformation	  culture	  with	  1,0	  mL	  
Ethylacetate	   (supplemented	   with	   1,0	   mM	   methyl	   benzoate	   as	   internal	   standard)	   after	  
centrifugal	   separation	   of	   the	   cell	  mass	   (approx.	   15	  kRCF,	   1	  min,	   rt).	   All	   transformations	  
were	   carried	   out	   as	   technical	   triplicates;	   conversion	   and	   selectivity	   are	   reported	   as	  
arithmetic	   mean	   values.	   Absolute	   configuration	   or	   optical	   rotation	   values	   of	   lactone	  
products	   were	   assigned	   on	   the	   basis	   of	   published	   reference	   biotransformations	   for	  
substrates	  4-­‐9	  (Rudroff	  et	  al.	  2007),	  for	  substrate	  11	  (Fink	  et	  al.	  2012),	  and	  for	  substrates	  1	  
&	  14-­‐16	  (Mihovilovic	  et	  al.	  2008).	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In	  summary	  there	  are	  no	  small	  problems.	  
Problems	  that	  appear	  small	  are	  large	  problems	  that	  are	  not	  understood.	  



















Figure	  6-­‐1:	  graphical	  outline	  of	  the	  thesis	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6.1. Introduction	  and	  general	  overview	  
Flavoenzymes	   have	   mastered	   a	   huge	   range	   of	   reactions.	   Therefore,	   many	   flavin-­‐
dependent	   enzymes	   show	   great	   promise	   as	   biocatalysts	   for	   industrial	   applications.	   This	  
increases	   the	   need	   to	  make	   these	   enzymes	   applicable	   and	   easy	   to	   handle.	   Besides	   the	  
limited	   availability	   of	   flavoenzymes,	   their	   application	   is	   often	   difficult	   due	   to	   cofactor	  
dependency,	   especially	   when	   a	   flavoenzyme	   is	   strictly	   dependent	   on	   the	   expensive	  
NADPH	  coenzyme.	  
In	   this	   thesis	   the	   above-­‐mentioned	   topics	   have	   been	   addressed	   (Figure	   6-­‐1).	   To	  
increase	  the	  amount	  of	  available	  applicable	  flavoenzymes,	  a	  large	  number	  of	  flavoprotein	  
monooxygenases	   from	   the	   soil	   organism	   Rhodococcus	   jostii	   RHA1	   have	   been	   produced	  
and	   studied	   (chapter	   3,	   4,	   5).	   Chapter	   2	   offers	   a	   general	   solution	   to	   the	   nicotinamide	  
coenzyme	  dependency	  of	  flavoprotein	  monooxygenases	  by	  a	  systematic	  optimization	  of	  a	  
coenzyme	  regeneration	  system	  (CRE2).	  	  
Chapter	  4	  and	  5	  deal	  with	  the	  two	  issues	  mentioned	  above	  in	  a	  special	  way.	  With	  the	  
discovery	   of	   Type	   II	   FMOs,	   a	   new	   subclass	   of	   class	   B	   flavoprotein	  monooxygenases	   has	  
been	   found	   that	   is	   able	   to	   utilize	   both	   nicotinamide	   coenzymes,	   NADPH	   and	   NADH.	  
Members	   of	   this	   subclass	   of	   monooxygenases	   were	   found	   to	   catalyze	   Baeyer-­‐Villiger	  
oxidations.	  Therefore,	  these	  newly	  discovered	  biocatalysts	  make	  it	  possible	  to	  use	  NADH	  
instead	  of	  NADPH	  for	  enzyme-­‐catalyzed	  Baeyer-­‐Villiger	  oxidations.	  
	  
6.2. Cofactor	  regeneration	  by	  fusion	  (chapter	  2)	  
Flavoprotein	   monooxygenases	   usually	   utilize	   nicotinamide	   coenzymes.	   The	   supply	   of	  
these	   expensive	   cofactors	   is	   often	   a	   major	   bottleneck	   for	   the	   industrial	   use	   of	   these	  
biocatalysts.	   By	   fusing	   a	   Baeyer-­‐Villiger	   monooxygenase	   (BVMO)	   with	   an	   NAD(P)H-­‐
regenerating	   enzyme,	   a	   self-­‐sufficient	   and	   easy-­‐to-­‐handle	   system	   (CRE	   =	   coenzyme	  
regenerating	   enzyme)	   was	   developed	   earlier	   in	   our	   laboratory	   (Torres	   Pazmiño	   et	   al.	  
2008).	   For	   this	   approach	   phosphite	   dehydrogenase	   from	   Pseudomonas	   stutzeri	   (PTDH)	  
had	  been	  chosen	  as	  fusion	  partner	  as	  it	  has	  been	  engineered	  by	  Woodyer	  et	  al.	  towards	  a	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relaxed	   nicotinamide	   cofactor	   specificity	   (Woodyer	   et	   al.	   2003).	   In	   addition,	   no	  
interference	   of	   the	   substrates	   and	   products	   of	   both	   enzymes,	   the	  monooxygenase	   and	  
PTDH,	   have	   been	   detected.	   Furthermore,	   due	   to	   the	   favorable	   thermodynamic	  
equilibrium	   constant,	   the	   oxidation	   of	   the	   extremely	   cheap	   sacrificial	   cosubstrate	  
phosphite	  is	  an	  almost	  irreversible	  process	  (Woodyer	  et	  al.	  2003).	  Experiments	  confirmed	  
that	   the	   covalently	   fused	   PTDH-­‐BVMOs	   efficiently	   work	   well	   in	   crude-­‐cell	   extracts	   or	  
purified	   form.	   As	   the	   fusion	   of	   the	   two	   biocatalysts	   had	   no	   significant	   influence	   on	   the	  
performance	  of	  each	  entity	  it	  proves	  to	  be	  an	  efficient	  approach.	  
Fusing	  PTDH	  at	  the	  N-­‐terminus	  of	  the	  targeted	  BVMO	  was	  found	  to	  be	  beneficial	   for	  
boosting	  overexpression	  of	  the	  bifunctional	  biocatalyst	   (Torres	  Pazmiño	  et	  al.	  2008).	  For	  
the	  development	  of	  an	  improved	  second-­‐generation	  expression	  vector	  for	  the	  production	  
of	  PTDH-­‐BVMOs	   (pCRE2),	   a	  PTDH-­‐encoding	  gene	  optimized	   for	  expression	   in	  E.	   coli	  was	  
used.	  Moreover,	  PTDH	  was	  equipped	  with	  an	  N-­‐terminal	  polyhistidine-­‐tag.	  In	  this	  way	  the	  
PTDH	   can	   be	   employed	   as	   NAD(P)H	   regeneration	   system,	   while	   it	   also	   facilitates	  
expression	  and	  purification	  of	   such	  self-­‐sufficient	  bifunctional	  biocatalysts.	  Furthermore,	  
the	   optimized	   gene	   encoding	   for	   PTDH	   contains	   18	   mutations	   that	   were	   known	   to	  
improve	  its	  stability	  (Woodyer	  et	  al.	  2005,	  Johannes	  et	  al.	  2006,	  Woodyer	  et	  al.	  2006).	  This	  
18-­‐fold	   PTDH	   mutant	   shows	   much	   higher	   thermostability	   and	   solvent	   resistance	  
compared	  to	  the	  wild-­‐type	  PTDH.	  With	  the	  original	  pCRE	  construct,	   the	  fused	  PTDH	  was	  
found	  to	  be	  relatively	  labile.	  By	  using	  the	  18-­‐fold	  PTDH	  mutant,	  the	  PTDH	  fusion	  enzyme	  
was	  shown	  to	  be	  superior	  to	  all	  studied	  monooxygenase	  fusion	  partners.	  
We	  also	  tried	  to	  further	   improve	  the	  pCRE2	  expression	  vector	  by	  changing	  the	   linker	  
length	   and	   composition	   between	   PTDH	   and	   the	   targeted	   enzyme.	   In	   the	   original	   PTDH-­‐
BVMO	  fusion	  proteins,	  we	  observed	  a	   slightly	  negative	  effect	  upon	   flavin	  binding	  of	   the	  
BVMOs.	  However,	  we	  could	  not	   identify	  a	  better-­‐suited	   linker	  concerning	  the	  binding	  of	  
the	   FAD	   cofactor.	   The	   effects	   of	   various	   linker	   versions	   were	   only	   marginal.	   Based	   on	  
these	   findings,	   we	   continued	   the	   research	   using	   the	   pCRE2	   expression	   vector	   with	   the	  
original	  linker	  for	  fusing	  PTDH	  to	  target	  proteins.	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In	   chapter	   2,	   we	   also	   describe	   the	   evaluation	   of	   the	   pCRE2	   expression	   system	   by	  
producing	  six	  PTDH-­‐BVMOs	  (Torres	  Pazmiño	  et	  al.	  2009).	  Besides	  BVMOs,	  we	  could	  also	  
show	   the	   applicability	   of	   the	   pCRE2	   system	   for	   other	   NADPH-­‐dependent	   enzymes.	  
Recently	  a	  bacterial	  flavin-­‐containing	  monooxygenase	  (FMO),	  mFMO	  from	  Methylophaga	  
sp.	   strain	   SK1,	  was	   shown	   to	  be	   successfully	  produced	  by	  using	   the	  pCRE2	  vector	   (Rioz-­‐
Martínez	   et	   al.	   2011).	   Additionally,	   the	   gene	   encoding	   for	   the	   P450	   monooxygenase	  
P450BM3	  from	  Bacillus	  megaterium	  was	  cloned	  into	  pCRE2	  and	  the	  PTDH-­‐P450BM3	  could	  
efficiently	   be	   expressed	   and	   purified	   (data	   not	   published).	   The	   PTDH-­‐P450BM3	   fusion	  
protein	   was	   shown	   to	   be	   active	   as	   self-­‐sufficient	   monooxygenase.	   This	   shows	   that	   the	  
pCRE2	   system	   also	   works	   for	   large,	   multidomain	   enzymes.	   For	   the	   expression	   of	   the	  
enzymes	  discussed	  in	  this	  thesis	  (chapter	  3	  &	  4),	  the	  pCRE2	  expression	  vector	  also	  played	  
an	   important	   role.	   By	   using	   this	   fusion-­‐expression	   system	   it	  was	   possible	   to	   express	   all	  
targeted	  proteins	   in	   significant	   amounts	   to	   test	   their	   substrate	   acceptance.	  When	  using	  
the	   pBADN	   expression	   vector	   only	   around	   half	   of	   them	  would	   have	   been	   available	   for	  
further	  characterization.	  
The	   approach	   of	   producing	   recombinant	   redox	   biocatalysts	   fused	   to	   PTDH	   will	  
facilitate	  future	  studies	  of	  NAD(P)H	  dependent	  biocatalysts.	  By	  equipping	  target	  enzymes	  
with	  PTDH,	  the	  resulting	  fusion	  enzyme	  is	  not	  only	  able	  to	  regenerate	  NAD(P)H,	  but	  it	  also	  
allows	  the	  use	  of	  a	  colorimetric	  assay	  for	  quantifying	  the	  enzyme	  activity	   (chapter	  3).	   In	  
addition,	  in	  all	  cases	  tested	  so	  far,	  pCRE2	  improved	  the	  expression	  levels	  when	  compared	  
with	  expressing	  the	  native	  protein	  without	  a	  fusion	  partner.	  
As	   neither	   the	   composition	   nor	   the	   length	   of	   the	   linker	   has	   a	   drastic	   effect	   on	   the	  
performance	  of	  the	  fused	  PTDH-­‐BVMOs,	  the	  design	  of	  a	  linker	  with	  a	  protease	  recognition	  
site	  may	  be	  considered	  in	  future	  studies.	  This	  will	  allow	  the	  removal	  of	  the	  PTDH	  moiety	  
for	  studies	  on	  the	  native	  target	  enzyme.	  A	  suited	  protease	  seems	  to	  be	  the	  TEV-­‐protease	  
from	   tobacco	  etch	   virus	   as	   it	   leaves	  only	   an	   additional	   glycine	   at	   the	  N-­‐terminus	  of	   the	  
cleaved	   protein.	   Therefore	   it	   allows	   production	   of	   a	   nearly	   native	   form	   of	   the	   target	  
enzyme.	   A	   potential	   problem	   of	   this	   protease	   is	   that	   it	   recognizes	   a	   protein	   sequence	  
mainly	   consisting	   of	   amino	   acid	   residues	   strongly	   avoided	   in	   natural	   occurring	   linker	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sequences:	  ENLYFQG	   (the	   un-­‐preferred	   residues	   according	   to	   Argos	   are	  marked	   in	   bold	  
(Argos	  1990)).	  Yet,	  as	  we	  could	  show	  that	  the	  linker	  sequence	  does	  not	  have	  a	  huge	  effect	  
on	  the	  catalytic	  performance	  of	   the	   fusion	  protein,	   it	  might	  be	  of	   interest	   to	   implement	  
this	  sequence	  in	  the	  linker	  of	  the	  next	  generation	  pCRE:	  pCRE3.	  
	  
6.3. The	  oxidative	  treasures	  of	  Rhodococcus	  jostii	  RHA1	  
In	  silico	  screening	  of	  the	  genome	  of	  Rhodococcus	  jostii	  RHA1	  revealed	  that	  this	  organism	  
harbors	   a	   huge	   collection	   of	   putative	   oxidative	   enzymes.	   By	   using	   sequence	  motifs	   and	  
sequence	   homology	   searches,	   we	   could	   identify	   40	   (putative)	   flavoprotein	  
monooxygenase-­‐encoding	   genes.	   When	   compared	   with	   other	   bacterial	   genome	  
sequences,	  this	  is	  an	  exceptionally	  large	  number	  of	  flavoprotein	  monooxygenases	  for	  one	  
organism.	   Except	   for	   these	   monooxygenases,	   R.	   jostii	   RHA1	   also	   harbors	   many	   other	  
oxidative	  enzymes	  (McLeod	  et	  al.	  2006).	  
To	  explore	  the	  biocatalytic	  potential	  of	  the	  rhodococcal	  monooxygenases,	  all	  putative	  
BVMO-­‐	   and	   FMO/NMO-­‐encoding	   genes	  were	   efficiently	   cloned	   and	   expressed	   in	   E.	   coli	  
using	   the	   pBADN	   and	   the	   pCRE2	   expression	   vector.	   The	   biocatalytic	   scope	   of	   these	  
enzymes	   is	   described	   in	   chapter	   3,	   4	   and	   5.	   Except	   for	   these	   class	   B	   flavoprotein	  
monooxygenases,	   also	   Type	   II	   BVMO-­‐	   and	   LadA-­‐encoding	   genes	   have	   been	   cloned.	  
Unfortunately,	   characterization	   attempts	   of	   these	   putative	   monooxygenases	   failed,	  
mainly	  due	  to	  expression	  problems.	  This	  shows	  that	  the	  pCRE2	  is	  not	  always	  of	  help.	  For	  
these	  problematic	  cases,	  homologous	  overexpression	  in	  R.	  jostii	  RHA1	  could	  be	  a	  solution	  
(Montersino	  2012).	  
6.3.1. Type	  I	  BVMOs	  from	  Rhodococcus	  jostii	  RHA1	  (chapter	  3)	  
The	  work	  described	  in	  chapter	  3	  confirms	  that	  Rhodococcus	  jostii	  RHA1	  harbors	  23	  genes	  
that	  encode	  for	  Type	  I	  BVMOs.	  Two	  of	  them	  were	  found	  to	  differ	  in	  only	  one	  amino	  acid	  
upon	  which	  it	  was	  decided	  to	  exclude	  one	  from	  our	  studies.	  On	  the	  other	  hand	  we	  cured	  
one	   gene	   that	   suffered	   from	   a	   one-­‐nucleotide-­‐deletion	   in	   the	   genomic	   sequence	   and	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made	   it	   available	   again.	   By	   expressing	   and	   subsequent	   substrate	   screening	  of	   22	   Type	   I	  
BVMOs	   we	   increased	   the	   number	   of	   characterized	   BVMOs	   drastically.	   Sequence	  
alignment	  of	  the	  BVMOs	  together	  with	  some	  of	  the	  best	  characterized	  BVMOs	  (Figure	  3-­‐2)	  
revealed	   that	   the	   rhodococcal	   BVMOs	   represent	   many	   different	   clades	   of	   the	   Type	   I	  
BVMO	  family.	  
New	  BVMO	  identifying	  motif	  
By	   a	   multiple	   sequence	   alignment	   of	   Type	   I	   BVMO	   sequences	   we	   could	   see	   that	   the	  
previously	  described	  Type	  I	  BVMO	  typifying	  sequence	  motif	  FxGxxxHxxxW[P/D]	  (Fraaije	  et	  
al.	  2002)	  is	  not	  always	  strictly	  conserved.	  In	  a	  number	  of	  sequences	  one	  or	  two	  variations	  
were	  observed.	  As	  this	  BVMO	  motif	  is	  located	  in	  a	  loop	  region	  that	  allows	  spatial	  domain-­‐
domain	   rearrangements	   during	   the	   catalytic	   cycle,	   it	   consists	   of	   residues	   that	   are	   not	  
directly	   involved	   in	   catalysis	   (Orru	   et	   al.	   2011).	   Using	   sequences	   from	   already	  
characterized	  Type	   I	  BVMOs	   together	  with	   the	  23	   rhodococcal	   sequences,	  we	   identified	  
another	  conserved	  motif,	   located	  between	  the	  N-­‐terminal	  GxGxxG	  motif	  and	  the	  known	  
BVMO	  motif:	  [A/G]GxWxxxx[F/Y]P[G/M]xxxD.	  
The	  conservation	  of	  several	  residues	  in	  this	  motif	  is	  in	  full	  agreement	  with	  the	  fact	  that	  
they	   interact	  with	  the	  flavin	  cofactor	  and/or	  play	  a	  crucial	  role	   in	  catalysis,	  e.g.	  Asp66	  in	  
PAMO	   is	   involved	   in	   the	   direct	   interaction	  with	   the	  NADP+	  coenzyme	   and	  mutating	   this	  
residue	  resulted	  in	  inactivation	  of	  the	  enzyme	  (Orru	  et	  al.	  2011).	  As	  this	  motif	  entails	  more	  
conserved	   residues	   when	   compared	   with	   the	   other	   BVMO-­‐typifying	   motif,	   this	   newly	  
recognized	  motif	  appears	  to	  be	  more	  discriminative	  for	  identifying	  Type	  I	  BVMOs.	  	  
Unraveling	  the	  substrate	  profile	  
We	  have	  determined	   the	   substrate	  profiles	   of	   all	   studied	   rhodococcal	   BVMOs.	   For	   such	  
large	   scale	   substrate	   profiling,	   several	   technical	   procedures	   have	   been	   developed.	   To	  
allow	   a	   fast	   and	   easy	   high	   throughput	   assay	   for	   BVMO	   activities	   in	   cell	   extracts	   we	  
developed	  two	  new	  methods.	  One	  method	  allows	  determination	  of	  the	  concentration	  of	  
recombinant	  BVMO	  in	  cell	  extract.	  The	  second	  method	  involves	  a	  novel	  approach	  to	  assay	  
for	  BVMO	  activity	  in	  microtiterplates.	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Concentration	  determination	  via	  flavin	  reduction	  with	  NADPH	  
As	  all	   Type	   I	  BVMOs	  contain	  an	  FAD	  cofactor	   that	   is	   specifically	   reduced	  by	  NADPH,	  we	  
developed	   a	   simple	   method	   for	   accurate	   BVMO	   concentration	   determination.	   For	   this	  
method	   we	   were	   inspired	   by	   the	   well-­‐known	  method	   to	   quantify	   the	   amount	   of	   P450	  
monooxygenases,	   which	   uses	   the	   specific	   heme	   absorption	   features	   of	   reduced	   P450	  
monooxygenases	   in	   complex	   with	   carbon	  monooxide.	   In	   our	   method,	   we	  measure	   the	  
absorbance	   spectrum	   of	   the	   cell	   extract	   at	   440	   nm	   before	   and	   after	   the	   addition	   of	  
NADPH	  (Figure	  3-­‐3).	  With	  an	  extinction	  coefficient	  that	  reflects	  the	  absorbance	  difference	  
between	  oxidized	  and	   reduced	  BVMO,	   the	   amount	  of	  NADPH-­‐reactive	   flavin	   cofactor	   in	  
the	  expressed	  BVMO	  can	  be	  determined.	  As	  only	  one	  flavin	  is	  bound	  per	  BVMO,	  the	  flavin	  
concentration	   is	   a	   good	  measure	   for	   the	   concentration	   of	   active	   BVMO.	   The	  method	   is	  
very	   selective	   for	   the	   recombinantly	   (over)expressed	   BVMO	   as	   only	   a	   minority	   of	   the	  
native	  proteins	   in	  E.	   coli	   contains	   a	   flavin	   cofactor	   and	  most	   of	   them	  do	  not	   react	  with	  
NADPH.	   Validation	   of	   the	   method	   revealed	   that	   it	   can	   be	   applied	   to	   cell	   extracts	   and	  
purified	   enzymes.	   The	   method	   should	   also	   be	   applicable	   to	   purified	   NADH	   dependent	  
flavoenzymes.	  	  
Substrate	  screening:	  phosphate	  assay	  
The	   original	   idea	   for	   the	   substrate	   profiling	   studies	   was	   to	   apply	   the	   often-­‐used	  
photometric	   method	   which	   monitors	   the	   NADPH	   consumption	   at	   340	   nm	   during	   the	  
reaction.	  Using	  the	  initial	  depletion	  rates	  in	  combination	  with	  the	  enzyme	  concentration,	  
the	   observed	   rates	   can	   be	   determined.	   However,	   this	   method	   turned	   out	   not	   to	   be	   a	  
suitable	   one.	   The	   following	   factors	   prevented	   the	   use	   of	   this	   widely	   applied	   assay	  
procedure:	  	  
-­‐ In	  order	  to	  normalize	  the	  amount	  of	  each	  BVMO	  in	  each	  assay	  different	  amounts	  of	  
cell	   extract	   had	   to	   be	   used,	   depending	   on	   the	   expression	   level	   of	   the	   respective	  
BVMO.	   Hence	   the	   background	   absorption	   shifted	   in	   every	   measurement,	   which	  
made	  it	  difficult	  to	  compare	  the	  results	  with	  each	  other.	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-­‐ In	   order	   not	   to	   exceed	   the	   capacity	   of	   the	   instrument,	   only	   relatively	   low	  
concentrations	  of	  NADPH	  could	  be	  used.	  	  
-­‐ Many	  targeted	  compounds	  absorb	  light	  in	  the	  same	  wavelength	  regime	  as	  NADPH	  
(300–390	  nm).	  
-­‐ The	   initial	   rate	   of	   NADPH	   consumption	   does	   not	   reflect	   the	   real	   potential	   of	   a	  
biocatalyst	   in	   terms	   of	   efficiency,	   as	   this	   depends	   on	   factors	   like	   stability	   and	  
inhibitory	  effects.	  Only	  a	  longer	  reaction	  period	  allows	  probing	  these	  factors.	  
To	  overcome	   these	  problems	  we	  developed	   an	   indirect	   assay	  by	   coupling	   the	  oxidation	  
reaction	   of	   the	   BVMO	   with	   the	   NADPH	   regeneration	   of	   the	   phosphite	   dehydrogenase	  
(PTDH).	  The	  assay	  is	  based	  on	  the	  colorimetric	  detection	  of	  phosphate	  which	  is	  formed	  by	  
PTDH	   while	   regenerating	   NADPH.	   As	   it	   is	   an	   indirect	   measurement,	   all	   the	   above-­‐
mentioned	   issues	   do	   not	   play	   a	   role.	   For	   example,	   this	   set-­‐up	   allows	   monitoring	  
conversions	  over	  long	  periods	  of	  incubation.	  	  
Using	  the	  developed	  assay	  we	  were	  not	  only	  able	  to	  give	  a	  substrate	  profile	  overview	  
of	   the	   newly	   found	   rhodococcal	   BVMOs,	   but	   also	   to	   verify	   and	   supplement	   the	   list	   of	  
confirmed	  substrates	  for	  a	  number	  of	  known	  BVMOs:	  PAMO,	  STMO,	  CPMO,	  CPDMO	  (not	  
published),	   HAPMO	   and	   CHMO.	   The	   generic	   assay	   proved	   to	   be	   reliable	   and	   robust,	  
thereby	   representing	   a	   new	   tool	   for	   substrate	   profiling	   of	   nicotinamide	   coenzyme	  
dependent	   enzymes.	   With	   the	   relaxed	   specificity	   of	   PTDH	   towards	   the	   nicotinamide	  
coenzyme,	  it	  can	  be	  used	  for	  any	  enzyme	  that	  requires	  NAD(P)H.	  	  
Substrate	  scope	  
The	  results	  in	  chapter	  3	  disclose	  a	  broad	  substrate	  scope	  for	  the	  studied	  set	  of	  22	  BVMOs.	  
Upon	  screening	  39	  potential	   substrates	   (Table	  3-­‐3),	  at	   least	  one	  active	  enzyme	  could	  be	  
found	  for	  each	  substrate.	  However,	  most	  of	  the	  Rhodococcus	  BVMOs	  are	  not	  so	  efficient	  
biocatalysts:	   eight	   BVMOs	   (BVMO	   #1,	   #3,	   #6,	   #7,	   #8,	   #13,	   #16,	   and	   #17)	   did	   not	   show	  
significant	  activity	  for	  any	  of	  the	  tested	  compounds.	  Nevertheless,	  BVMO	  #3,	  #7,	  and	  #17	  
produced	   indigo	   blue	   when	   expressed	   in	   E.	   coli	   (Table	   3-­‐1),	   suggesting	   that	   they	   are	  
active,	  even	  though	  not	  very	  efficient	  on	  any	  of	  our	   test	  panel	  compounds.	  Most	  of	   the	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BVMOs	  active	  on	   the	   tested	   substrates	  displayed	  a	   rather	   limited	   substrate	   scope.	  Only	  
five	   BVMOs	   (BVMO	   #4,	   #15,	   #20,	   2#1,	   2#4)	   were	   shown	   to	   be	   active	   on	   ≥10	   tested	  
compounds.	  BVMO	  #4	  and	  BVMO	  #24	  displayed	  the	  broadest	  substrate	  scope	  of	  all	  tested	  
BVMOs.	   In	   a	   phylogenetic	   tree	   based	   on	   the	   core	   active	   site	   residues	   (Figure	   3-­‐2),	   the	  
BVMOs	  with	   a	   relaxed	   substrate	   acceptance	  profile	  were	   found	   to	  be	   closely	   related	   to	  
the	  clades	  that	   include	  the	  known	  prototype	  BVMOs	  (CHMO,	  CPMO,	  PAMO	  and	  STMO).	  
The	  less	  active	  rhodococcal	  BVMOs	  cluster	  with	  groups	  that	  include	  other	  known	  BVMOs	  
(HAPMO,	   MoxY,	   EtaA,	   AlmA)	   which	   are	   known	   for	   their	   limited	   substrate	   scope.	   This	  
indicates	   that	   it	  may	  be	  more	  productive	   to	   focus	  on	  homologs	  of	   the	   typical	  prototype	  
BVMOs	  when	  looking	  for	  novel	  and	  biocatalytically	  relevant	  BVMOs.	  
To	   verify	   the	   results	   of	   the	   indirect	   assay	   and	   to	   gain	   more	   information	   on	   the	  
biocatalytic	   potential,	   we	   evaluated	   a	   selected	   number	   of	   BVMOs	   as	   biocatalysts	   with	  
typical	  BVMO	  substrates	  and	  prochiral	  sulfides.	  The	  results	  confirmed	  the	  outcomes	  of	  the	  
substrate	   screening	  assay	  and	   revealed	   that	   the	  sulfides	  were	  efficiently	  converted	  with	  
excellent	  enantioselectivities.	  Again,	  unique	  capabilities	  of	  BVMO	  #24	  were	  observed,	  as	  it	  
displays	  opposite	  enantioselectivities	  when	  compared	  with	  the	  other	  tested	  BVMOs.	  For	  
further	  studies,	  the	  most	  exciting	  candidates	  are	  BVMO	  #4	  and	  BVMO	  #24.	  They	  show	  the	  
most	   interesting	   activities	   with	   a	   broad	   substrate	   scope	   and,	   in	   case	   of	   BVMO	   #24,	  
atypical	  enantioselective	  behavior.	  	  
6.3.2. FMOs	  and	  NMOs	  from	  Rhodococcus	  jostii	  RHA1	  (chapter	  4	  &	  5)	  
Except	   for	   the	   genes	   encoding	   for	   Type	   I	   BVMOs,	   the	  Rhodococcus	   jostii	   RHA1	   genome	  
contains	   ten	   additional	   genes	   that	   encode	   for	   proteins	  with	   two	   Rossmann-­‐fold	  motifs,	  
indicative	  for	  class	  B	  flavoprotein	  monooxygenases.	  Most	  of	  these	  predicted	  flavoproteins	  
resembled	  FMOs	  as	  they	  contain	  the	  FMO	  motif.	  Already	  the	  finding	  of	  23	  Type	  II	  BVMOs	  
in	   the	   genome	   of	   one	   organism	   was	   spectacular	   (the	   average	   is	   one	   or	   two	   BVMO-­‐
encoding	   genes	   per	   microbial	   genome).	   Finding	   even	   more	   class	   B	   flavoprotein	  
monooxygenases	   is	   quite	   remarkable,	   as	   FMOs	   are	   even	   more	   rare	   in	   bacteria	   when	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compared	   with	   BVMOs	   (de	   Gonzalo	   et	   al.	   2010).	   All	   ten	   genes	   have	   been	   cloned,	  
expressed	  and	  tested	  for	  activity	  as	  previously	  described	  for	  the	  BVMOs.	  
Three	  of	   the	   studied	   enzymes	  were	   found	  not	   to	   belong	   to	   the	   FMO	   family.	  One	  of	  
them	   is	   an	   NMO	   (NMO-­‐H,	   chapter	   4),	   while	   another	   gene	   appears	   to	   encode	   for	   a	  
tryptophan	   monooxygenases.	   The	   third	   enzyme	   is	   a	   putrescine	   oxidase	   homolog	  
(unpublished	   results).	   The	   remaining	   seven	   protein	   sequences	   share	   the	   FMO-­‐typifying	  
sequence	  motif,	  with	  only	  one	  or	   two	  amino	  acid	   substitutions	   (Table	  4-­‐1).	  They	  cluster	  
together	   in	   one	   branch	   of	   a	   phylogenetic	   tree	   of	   class	   B	   flavoprotein	  monooxygenases.	  
They	   form	   a	   distinct	   group	   of	   sequences	   different	   from	   known	   FMOs	   (Figure	   4-­‐1).	   As	   a	  
consequence,	   we	   classified	   them	   as	   Type	   II	   FMOs,	   while	   naming	   the	   known	   and	   well-­‐
established	  FMOs	  Type	  I	  FMOs.	  
One	   interesting	   fact	   and	   clear	   justification	   for	   the	   introduction	   of	   a	   new	   class	   of	  
subclass	  B	  flavoprotein	  monooxygenases	  was	  the	  discovery	  that	  the	  Type	  II	  FMOs	  show	  no	  
coenzyme	   preference	   –	   they	   accept	   both,	   NADH	   and	   NADPH	   with	   similar	   affinity	   as	  
reduction	   equivalents.	   This	   is	   a	   unique	   and	   new	   feature	   of	   class	   B	   flavoprotein	  
monooxygenases.	  According	   to	   the	  expected	  substrate	  scope	   for	  FMOs,	   the	  new	  Type	   II	  
FMOs	   were	   first	   tested	   for	   activity	   towards	   reactions	   typically	   catalyzed	   by	   FMOs:	   the	  
oxidation	   of	   sulfides	   and	   amines.	  We	   successfully	   adapted	   a	   colorimetric	   assay	   for	   the	  
conversion	  of	   indole	  and	   indole-­‐derivatives	  described	  in	  the	  work	  of	  Rioz-­‐Martinez	  et	  al.	  
(Rioz-­‐Martínez	  et	  al.	  2011)	  for	  the	  use	  with	  cell	  extracts	  (data	  not	  published).	  Surprisingly,	  
none	  of	   the	   tested	   indoles	   (in	   total	  20	  derivatives)	  and	  amines	  was	  converted	  by	  any	  of	  
the	  new	  Type	  II	  FMOs.	  This	  indicates	  that	  the	  natural	  substrates	  for	  these	  enzymes	  might	  
be	   completely	   different	   when	   compared	   with	   the	   substrate	   scope	   of	   Type	  I	   FMOs.	  
Sulfoxidation	   reactions	   were	   only	   catalyzed	   with	   low	   rates.	   Three	   of	   the	   Type	   II	   FMOs	  
(FMO-­‐E,	  -­‐F,	  and	  -­‐G)	  showed	  higher	  conversions	  in	  the	  sulfoxidation	  of	  thioanisole	  then	  the	  
other	  four.	  These	  three	  enzymes	  were,	  in	  contrast	  to	  the	  other	  Type	  II	  FMOs,	  also	  able	  to	  
convert	   larger	  and	  bulkier	   sulfoxides,	  albeit	  with	  very	   low	  activity.	  The	  most	   remarkable	  
feature	  of	  these	  three	  enzymes	  was	  the	  fact	  that	  they	  were	  also	  able	  to	  convert	  ketones,	  
yielding	   the	   products	   of	   a	   Baeyer-­‐Villiger	   oxidation.	   This	   reaction	   is	   rarely	   catalyzed	   by	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FMOs	  and	   suggests	   that	   this	   subgroup	  of	  Type	   II	   FMOs	   (FMO-­‐E,	   -­‐F,	   and	   -­‐G)	  has	  evolved	  
towards	   bona	   fide	   Baeyer-­‐Villiger	   monooxygenases.	   Especially	   in	   combination	   with	   the	  
relaxed	   coenzyme	   preference,	   they	   represent	   a	   very	   interesting	   group	   of	   enzymes	   for	  
biocatalysis.	  FMO-­‐E,	   -­‐F,	  and	   -­‐G,	  are	  closely	   related	   in	   sequence	  and	  share	  an	  N-­‐terminal	  
extension	   of	   about	   160	   residues.	   Using	   such	   N-­‐terminal	   sequence,	   hundreds	   of	  
homologous	  putative	  Type	   II	  FMOs	  can	  be	   identified	   in	   the	  databases,	  which	  are	  mainly	  
from	   fungi.	   It	   will	   be	   interesting	   to	   see	   whether	   the	   Baeyer-­‐Villiger	   monooxygenase	  
activity	  and	  the	  relaxed	  coenzyme	  specificity	  can	  also	  be	   found	   in	  all	   these	  homologs.	   If	  
so,	  they	  might	  represent	  interesting	  alternative	  biocatalysts	  compared	  to	  known	  BVMOs.	  
Additionally,	   it	  might	  well	  be	  that	  the	  observed	  BVMO	  activity	  is	   just	  a	  promiscuous	  side	  
activity	  and	  the	  original	  function	  for	  these	  Type	  II	  FMOs	  still	  has	  to	  be	  explored.	  
In	  chapter	  5	  we	  set	  out	  to	  investigate	  the	  three	  special	  Type	  II	  FMOs,	  FMO-­‐E,	  -­‐F,	  and	  	  	  	  	  
-­‐G	   in	   more	   detail.	   Besides	   analyzing	   the	   enantioselectivity	   towards	   thioanisole	   and	  
bicycloheptenone	  (Table	  4-­‐3	  and	  Table	  4-­‐2),	  the	  three	  enzymes	  were	  used	  to	  convert	  a	  set	  
of	   cyclohexanone	   and	   cyclobutanone	   derivatives.	  While	   the	   cyclohexanones	   where	   not	  
converted,	   the	   cyclobutanones	   were	   oxidized	   into	   the	   corresponding	   lactones	   with	  
modest	  to	  good	  enantioselectivity	  (Table	  5-­‐3	  and	  Table	  5-­‐2).	  In	  the	  conversion	  of	  racemic	  
fused	   cyclobutanones	   (Table	   5-­‐2)	   they	   disclosed	   new	   and	   excellent	   stereoselectivities,	  
better	  than	  ever	  observed	  for	  any	  known	  BVMO	  in	  the	  case	  of	  norcamphor.	  	  
For	  a	  more	  detailed	  characterization	  we	  purified	  FMO-­‐E	  using	  a	  strep-­‐tag.	  The	  enzyme	  
displays	   a	   typical	   flavin	   absorbance	   spectrum	   (Figure	   5-­‐2).	   In	   steady-­‐state	   kinetic	  
experiments	  FMO-­‐E	  showed	  typical	  Michaelis-­‐Menten	  behavior	  with	  the	  two	  coenzymes	  
NADH	   and	   NADPH	   and	   the	   Baeyer-­‐Villiger	   substrate	   bicycloheptenone.	   High	   kcat	   values	  
confirm	   that	   it	   is	  a	   competent	  enzyme:	   the	   rate	  of	   catalysis	   is	   in	   the	  same	  range	  as	  has	  
been	   found	   for	   other	   class	   B	   flavoprotein	   monooxygenases.	   FMO-­‐E	   also	   shows	   high	  
affinities	  towards	  both	  nicotinamide	  coenzymes	  with	  both	  KM	  values	  in	  the	  low	  µM	  range.	  
To	   establish	   the	   reaction	  mechanism,	   FMO-­‐E	  was	   studied	  by	  using	   the	   stopped-­‐flow	  
technique	   (Figure	   5-­‐3).	   Pre-­‐steady	   state	   kinetic	   analysis	   revealed	   features	   known	   for	  	  	  	  
class	  B	  flavoprotein	  monooxygenases:	  (i)	  oxidized	  FMO-­‐E	  is	  rapidly	  reduced	  by	  a	  reduced	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coenzyme	  without	   the	   need	   of	   substrate	   binding,	   (ii)	   the	   reduced	   FMO-­‐E	   rapidly	   reacts	  
with	  molecular	  oxygen,	  and	  (3)	  FMO-­‐E	  is	  able	  to	  form	  a	  stable	  peroxyflavin	  intermediate.	  
With	   the	   identification	   of	   the	   peroxyflavin	   intermediate,	   which	   is	   considered	   to	   be	   the	  
crucial	  oxygenating	  species,	  we	  could	  show	  that	  these	  enzymes	  operate	  similar	  to	  Type	  I	  
BVMOs.	  
The	  next	  step	  was	  a	  careful	  inspection	  of	  the	  predicted	  active	  site	  residues	  to	  find	  out	  
the	  differences	  between	  the	  Type	  II	  FMOs	  when	  compared	  with	  “real”	  Type	  I	  BVMOs	  and	  
Type	   I	  FMOs.	  For	  BVMOs	  and	  FMOs	   it	   is	  quite	  well	  known	  which	  residues	  are	   important	  
for	   catalysis.	   As	   no	   structural	   data	   is	   available	   for	   the	   Type	  II	   FMOs,	   the	   analysis	   was	  
performed	   on	   a	   homology	   model.	   It	   became	   obvious	   that	   all	   three	   enzymes	   employ	  
different	  strategies	  to	  catalyse	  oxygenation	  reactions:	  even	  though	  the	  Type	  II	  FMOs	  have	  
conserved	   residues	   (His222	   &	   Arg563	   in	   FMO-­‐E)	   on	   similar	   positions	   close	   to	   the	  
isoalloxazine	   ring	   as	   the	   other	   two	   class	   B	   enzymes,	   they	   form	   a	   different	   active	   site	  
architecture	   (Figure	   5-­‐4).	   We	   have	   targeted	   these	   two	   residues	   in	   a	   site-­‐directed	  
mutagenesis	  strategy	  by	  alanine	  replacements.	  We	  observed	  that	  mutating	  these	  residues	  
has	  an	  effect	  on	  cofactor	  binding.	  Purification	  experiments	  only	  yielded	  the	   inactive	  apo	  
form	  without	  bound	  FAD	  and	  it	  was	  impossible	  to	  restore	  the	  activity	  by	  adding	  the	  flavin	  
cofactor	  afterwards.	  Biocatalysis	  performed	  with	  the	  mutants	  as	  cell	  extracts	  showed	  that	  
the	  mutant	  enzymes	  show	  no	  BVMO	  activity.	  These	  results	  imply	  that	  these	  two	  residues	  
obviously	  play	  an	  important	  role	  in	  binding	  of	  the	  flavin	  cofactor.	  	  
All	   these	   data	   confirm	   that	   the	   newly	   discovered	   subclass	   of	   Type	   II	   FMOs	   has	   very	  
interesting	  catalytic	  capabilities,	  especially	  in	  combination	  with	  the	  preference	  for	  NADH.	  
This	  not	  only	   sets	   them	  apart	   from	  Type	   I	  BVMOs	  and	  FMOs,	  but	  makes	   them	  valuable	  
biocatalysts	  on	   their	  own.	  Further	  structural,	  kinetic	  and	  mutagenesis	  studies	  will	   reveal	  
the	   details	   on	   their	   functioning.	   It	   will	   also	   be	   interesting	   to	   find	   out	   what	   the	   native	  
substrates	  for	  these	  biocatalysts	  are.	  With	  many	  homologs	  in	  fungal	  genomes,	  this	  class	  of	  
enzymes	  represents	  a	  promising	  and	  exciting	  new	  player	  in	  the	  world	  of	  flavoenzymology.	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I	  believe	  in	  intuition	  and	  inspiration.	  
Imagination	  is	  more	  important	  than	  knowledge.	  
For	  knowledge	  is	  limited,	  whereas	  imagination	  embraces	  the	  entire	  world,	  
stimulating	  progress,	  giving	  birth	  to	  evolution.	  
It	  is,	  strictly	  speaking,	  a	  real	  factor	  in	  scientific	  research.	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GC	  conditions	  	  
The	  following	  columns	  were	  used	  for	  the	  determination	  of	  conversions	  and	  enantiomeric	  
excesses	  of	  the	  sulfoxides	  by	  GC:	  	  
	   A:	  Alltech	  GT-­‐A	  (30	  m	  x	  0,25	  mm	  x	  0,25	  µm),	  	  
	   B:	  Hewlett	  Packard	  HP-­‐1	  (30m	  x	  0,32	  mm	  x	  0,25µm,	  12,2	  psi	  N2),	  	  
	   C:	  Chirasil	  Dex	  CB	  (30	  m	  x	  0,25	  mm	  x	  0,25	  µm,	  12	  psi	  N2).	  
Table	  A-­‐1:	  GC-­‐conditions	  for	  the	  determination	  of	  the	  conversions	  and	  enantioselectivities.	  
	  
a	  Program:	  initial	  T	  (°C)/	  time	  (min)/	  slope	  (°C/min)/T	  (°C)/	  time	  (min).	   	  





thioanisole 40/0/10/160/8 A 7,5 14.3%(R);%16.7%(S)
15.1(sulfoxide)
15.9%(sulfone)





benzyl%phenyl%sulfide 100/5/5/200/5 B 21,7 27.3%(sulfoxide)
2Bindanone 70/10/3/180/5 B 22,3 32,7









bicycloheptB2BenB6Bone 130ϒC%isotherrm C 9.7%and%9.9
phenylacetone 70/7/5/120/2 B 13,5
bicycloheptB2BenB6Bone 70/5/5/150/0 B 6,6
benzyl%ethyl%sulfide 70/5/10/200/2 B 12,5
benzyl%ethyl%sulfide 40/0/10/160/8 A 8,8
thioanisole 70/5/10/200/2 B 11,4
pBtolyl%methyl%sulfide 70/5/10/200/2 B 11,5
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Tested	  compounds	  in	  the	  phosphite	  screening	  assay	  
Table	  A-­‐2:	  Name,	  CAS	  number	  and	  structural	  formular	  of	  the	  used	  assay	  substrates.	  
Compound	  name	   	  	  	  CAS	  number	   	  	  	  	  	  	  	  	  	  	  	  	  	  structure	  
Acetone	   67-­‐64-­‐1	  
O
	  
2-­‐Butanone	   78-­‐93-­‐3	  
O
	  
2-­‐Octanone	   111-­‐13-­‐7	  
O
	  
2-­‐Dodecanone	   6175-­‐49-­‐1	  
O
	  
3-­‐Octanone	   106-­‐68-­‐3	   O
	  
4-­‐Octanone	   589-­‐63-­‐9	  
O
	  
Methylvinylketone	   78-­‐94-­‐4	  
O
	  




Cyclobutanone	   1191-­‐95-­‐3	  
O
	  
Cyclopentanone	   120-­‐92-­‐3	   O
	  
Cyclohexanone	   108-­‐94-­‐1	  
O
	  
Cyclopentadecanone	   502-­‐72-­‐7	   O
	  
Oxocyclohexanecarbonitrile	   4513-­‐77-­‐3	   O
CN
	  





2-­‐Propylcyclohexanone	   94-­‐65-­‐5	  
O
	  
Dihydrocarvone	   7764	  50	  3	   O
	  
Cyclopropylmethylketone	   765-­‐43-­‐5	  
O
	  
Norcamphor	   497-­‐38-­‐1	  
O
	  
Bicycloheptenone	   13173-­‐09-­‐6	  
O
	  
Thioanisole	   100-­‐68-­‐5	   S
	  
Benzylethyl	  sulfide	   6263-­‐62-­‐3	   S
	  
Benzylphenyl	  sulfide	   831-­‐91-­‐4	   S
	  
Ethionamide	   536-­‐33-­‐4	   N S
NH2
	  












Nicotin	   54-­‐11-­‐5	   N N
	  





















3-­‐Phenylpentane-­‐2,4-­‐dione	   5910-­‐25-­‐8	  
O
O 	  
Phenylacetone	   103-­‐79-­‐7	  
O
	  
Raspberry	  ketone	   5471-­‐51-­‐2	   OH O
	  
2-­‐Phenylcyclohexanone	   1444-­‐65-­‐1	  
O
	  
Benzoin	   119-­‐53-­‐9	  
O
OH 	  
Phenendione	   83-­‐12-­‐5	  
O
O 	  
2-­‐Indanone	   615-­‐13-­‐4	   O
	  
1-­‐Indanone	   83-­‐33-­‐0	  
O
	  
The	  shading	  indicates	  different	  substrate	  classes.	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Multiple	  sequence	  alignment	  of	  BVMO	  protein	  sequences	  	  
PAMO         1 -------------------------------------------------------------------------------------------------------------- 
CPMO         1 ---------------------------------------------------MTTMT------------------------------------------------------ 
BVMO1        1 ---------------------------------------------------MSTAA------------------------------------------------------ 
BVMO3        1 ---------------------------------------------------MNTTL------------------------------------------------------ 
BVMO4        1 ---------------------------------------------------MTAIH------------------------------------------------------ 
BVMO9        1 -------------------------------------------------------------------------------------------------------------- 
BVMO11       1 ---------------------------------------------------MTTAS------------------------------------------------------ 
BVMO14       1 -------------------------------------------------------------------------------------------------------------- 
BVMO15       1 ------------------------------------------------------MS------------------------------------------------------ 
BVMO20       1 ---------------------------------------------------MTASQ------------------------------------------------------ 
BVMO21       1 ---------------------------------------------------MSTTA------------------------------------------------------ 
BVMO23       1 ---------------------------------------------------MSTTA------------------------------------------------------ 
BVMO24       1 --------------------------------------------------MTTSMK------------------------------------------------------ 
STMO         1 ---------------------------------------------------MNGQH------------------------------------------------------ 
ACMO         1 ---------------------------------------------------MSTTT------------------------------------------------------ 
CHMO         1 ---------------------------------------------------MSQKM------------------------------------------------------ 
MEKMO        1 ---------------------------------------------------MSAQS------------------------------------------------------ 
CDMO         1 ---------------MTTSIDREALRRKYAEERDKRIRPDGNDQYIRLD-HVDGWS------------------------------------------------------ 
CPDMO        1 MSQLIQEPAEAGVTSQKVSFDHVALREKYRQERDKRLRQDGQEQYLEVAVTCDEYL------------------------------------------------------ 
PtlE         1 ------------------MVDIEAVRAKYREERDKRVQADGGRQYLSAQGEFAHYA------------------------------------------------------ 
BVMO8        1 --------------------------------------------------------------------------------------MITEIRKRAREVLTNDLTAVLGVP 
BVMO10       1 --MTETIAAGLAVPSD-------RDAQLYNAIAESDPAPLLMALVHATGDTGLLDEFGARLTIEEPGNHYRTGIRPTAPPGIYPEDVAEDIRIRAREILTPDVVAELGVP 
HAPMO        1 ----------MSAFNTTLPSLDYDDDTLREHLQGADIPTLLLTVAHLTGDLQILKPNWKPSIAMGVAR---------SGMDLETEAQVREFCLQRLIDFRDSGQPAPGRP 
BVMO18       1 MKAAQQVQEAGAATDDRINPDRLTESEIRTAVARANVPSLLMVVFQTTGDEKWLAAPYRPTRGKGLGDHDSGGLEEP------IQDEIREAAVKAILDLQNGALPAVETP 
MoxY         1 -------------------------------------------------------------------------------------------------------------- 
BVMO19       1 -------------------------------------------------------------------------------------------------------------- 
BVMO2        1 -------------------------------------------------------------------------------------------------------------- 
EtaA         1 -------------------------------------------------------------------------------------------------------------- 
BVMO5        1 -------------------------------------------------------------------------------------------------------------- 
BVMO6        1 -------------------------------------------------------------------------------------------------------------- 
BVMO7        1 -------------------------------------------------------------------------------------------------------------- 
AlmA1        1 -------------------------------------------------------------------------------------------------------------- 
BVMO12       1 -------------------------------------------------------------------------------------------------------------- 
BVMO13       1 -------------------------------------------------------------------------------------------------------------- 
BVMO16       1 -------------------------------------------------------------------------------------------------------------- 
BVMO17       1 -------------------------------------------------------------------------------------------------------------- 
 
PAMO         1 ----------------------------------MAGQTTVDSRRQPPEEVDVLVVGAGFSGLYALYRLRELG--RSVHVIETAGDVGGVWYWNRYPGARCDIESIEYCY 
CPMO         6 ----------------------------------TMTTEQLGMNNSVNDKLDVLLIGAGFTGLYQLYHLRKLG--YKVHLVDAGADIGGIWHWNCYPGARVDTHCQIYQY 
BVMO1        6 ----------------------------------P----------AVTEVLDVLVVGAGFAGLYQLENLRSRG--YSVKVVEAGEGLGGIWHWNRYPGARVDSEGPIYQF 
BVMO3        6 ----------------------------------L-------------EELDVLVIGGGFSGVYQLDRLRTLG--YNVKIYEAGTGLGGVWHWNSYPGARVDTWAPVYQF 
BVMO4        6 ----------------------------------APKNDLAQS--AETPTYDVIVVGGGFGGIYQLRHLRDRG--FSVILLEASGGFGGAWSLNRYPGARVDSHAPVYQF 
BVMO9        1 --------------------------------------MTVQDN-----DFDAVVVGAGISGLYAVYKLRQRG--MRVHGFESAEGVGGTWYHNRYPGARCDVESIDYSY 
BVMO11       6 ----------------------------------IDTRELD----EANGVLDVLVVGGGFAGLYQLDQLRSRG--FSVKVVEAGDSLGGIWYWNCYPGARTDSTGQIYQY 
BVMO14       1 ----------------------------------MSKTISAD--------VDVVVVGAGFAGLYALRKLRDTMK-LSTRVFEAGSEVGGTWFWNRYPGARCDIESVHYSY 
BVMO15       3 ----------------------------------ARTEVDARANRIG--DVDAVVVGAGFAGLYAVHKLRSLG--LTVQGVEAAGGVGGTWFWNRYPGARCDVESVDYSY 
BVMO20       6 ----------------------------------ADTATRTGKH-SNNDVLDVLIIGGGFSGLYALDRIRDLG--FTAKVWDAAGGLGGIWWWNCYPGARTDSTGQIYQF 
BVMO21       6 ----------------------------------SAPTETSAT---ESLELDALIIGAGVAGLYQLHQLREQG--LRVRAYDTAGDVGGTWYWNRYPGARFDSEAYIYQY 
BVMO23       6 ----------------------------------SAPTETSAT---ESLELDALIIGAGVAGLYQLHQLREQG--LRVRAYDTAGDVGGTWYWNRYPGARFDSEAYIYQY 
BVMO24       7 ----------------------------------AANPMNFPSTSDTG-IVDVLGVGAGFSGLYLSHRLTTAG--WTFAGFEAGPSVGGTWFWNTYPGARCDVESIYYSY 
STMO         6 ----------------------------------PRSVVTAPDATTGTTSYDVVVVGAGIAGLYAIHRFRSQG--LTVRAFEAASGVGGVWYWNRYPGARCDVESIDYSY 
ACMO         6 --------------------------------------------------LDAAVIGTGVAGLYELHMLREQG--LEVRAYDKASGVGGTWYWNRYPGARFDSEAYIYQY 
CHMO         6 ----------------------------------D---------------FDAIVIGGGFGGLYAVKKLRDELE-LKVQAFDKATDVAGTWYWNRYPGALTDTETHLYCY 
MEKMO        6 ----------------------------------KLAAGSCAYG--NVTSLDAMVIGAGVAGLYQLYRLREMG--LTVRAYDTASGVGGTWYWNRYPGARFDSQAEIYQY 
CDMO        41 ----------------------------------HDPYMPITPREPKLDHVTFAFIGGGFSGLVTAARLRESGV-ESVRIIDKAGDFGGVWYWNRYPGAMCDTAAMVYMP 
CPDMO       57 ----------------------------------KDPYADPIVRDPVVRETDVFIIGGGFGGLLAAVRLQQAGVSDYV-MVERAGDYGGTWYWNRYPGAQCDIESYVYMP 
PtlE        39 ----------------------------------DDPHAKPIERAPVSDEVDVTIIGAGIGGLLLGARLREACAFDTIRLVDKAGDVGGTWYWNRFPGLRCDVESYVYMP 
BVMO8       25 DPELFRRMASLRTAGTVAEEFVPILLEQAGFQIGQRRVPVTKKP---PADLGVIVIGAGMIGLNAAIKLGEAG--FGYRVFESRDDIGGTWSRNVYPGAAVDTPSHYYSY 
BVMO10     102 DDELFVRMATVCTSQRVDAEFAPILLEQAGFTKNRRHVPVTVAP---PADFDVIVIGAGIVGINAGIKLGEAG--FRYTIIEEREDVGGTWYRNTYPGAAVDTPSHYYSY 
HAPMO       92 TSDQLHILGTWLMGPVIEPYLPLIAEEAVTAEEDLRAPRWHKDHVASGRDFKVVIIGAGESGMIAALRFKQAG--VPFVIYEKGNDVGGTWRENTYPGCRVDINSFWYSF 
BVMO18     105 SPELTVRMISVCTGEEVGEEYGPMLSLELARRAAPDAPSLALEPVDAPEGYSVVVIGTGVAGIAAAQQLEDMG--IDYVILEKQPEAGGNWWQNTYPGAGVDTPSHLYSF 
MoxY         1 -------------------------------------------MDPANRPLRVVTIGTGISGILMAYQIQKQCPNVEHVLYEKNADVGGTWLENRYPMAGCDVPSHAYTY 
BVMO19       1 ------------------------------MTATTTQHAAAPDGGGDERHLRVVVVGAGLSGIAAAVKLERAG-ITDFVVLEKSDRVGGVWRENTYPGCGVDIPAPVYSF 
BVMO2        1 ---------------------------------MNLP-----------QHVHTLIVGAGFAGMGLAARILQTQPQADVLIIERGDDVGGTWRDNTYPGCACDVPTSLYSY 
EtaA         1 ----------------------------------------------MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMYTLGF 
BVMO5        1 -------------------------------------------MGGEVHRCRVLVIGTGFSGLGTAIQLRRRG-RDDFILLEKAREVGGTWRENTYPGCACDVPSHLYSF 
BVMO6        1 -----------------------------------------------MTHYDILIVGAGISGIGAAIRLKQSG-IDNFAILEKGDALGGTWRDNTYPGCACDVPSALYSY 
BVMO7        1 -----------------------------MVSYMSLPVTDTSAPPAGVRHIDTLIIGSGFAGLGAAIKLTQAG-KTDFLVLERGSDVGGTWRDNTYPGAACDVPSHLYSY 
AlmA1        1 ----------------------------------------------MEKQVDVLIIGAGISGIGLAVHLSKNCPQRKFEILERRESFGGTWDLFRYPGIRSDSDMSTFGF 
BVMO12       1 -----------------------------MVRSAIPVELPVDSVDHPPEVVDVLVVGAGFGGLGTAIRLKQAG-IDDFVVLDRAEDIGGTWRVNTYPGAQCDIPSILYSF 
BVMO13       1 ----------------------MKHITTSHDSDQETPVTITTIPEVETMDFDVLIIGAGISGIGAAYHLKTRRPDTTFAILEGKDAIGGTWTQFRYPGIRSDSDMPTFGF 
BVMO16       1 ----------------------MSHTETAAETTG---------AKTPVEHVDVLIIGAGLSGIGAAYHLQDNFPRRTYAILESRESIGGTWDLFRYPGIRSDSDMYTLGY 
BVMO17       1 -------------------------------------------MTTGTTEPDVLVVGTGFAGLCMAIKLKEAG-EENVVVLEKADRVGGTWRENTYPGCGCDVMSLMYSF 
 
PAMO        75 SFSEEVLQEWNWTERYASQPEILRYINFVADKFDLRSGITFHTTVTAAAFDEATNTWTVDTNHGDR--------IRARYLIMASGQLSVPQ--LPNFPGLKD-FAGNLYH 
CPMO        80 SI-PELWQEFNWKELFPNWAQMREYFHFADKKLDLSKDISFNTRVQSAVFDEGTREWTVRSIGHQP--------IQARFVIANLGFGASPS--TPNVDGIET-FKGQWYH 
BVMO1       70 TR-PDLWDEFAFSELYPGGDELRRYFKYVDAKLDLSKDIYYNTRIISAEFDDTANTWTVTAENGSS--------FVCKYFVLCTGFAAKPI--FPKLPGMDS-FTGINHH 
BVMO3       67 SR-EELWRDWNWSEMYPGRDELVRYFEYVDEKLDLSKDVRYETRVLAGRFDEETHRWTLVSRNERTGEEFT---TQAQFVIMCLGAGSKPL--FPNIPGLEK-FGGDCFH 
BVMO4       78 TD-EYLWKDWDFSQMYPDHEEMRSYFNYVDSKLDLSKDSRFNTKVVGATFDEEQRMWSLETQDGAT--------FRARFVVFATGSTTEPY--TPSIPDMDA-YQGELVH 
BVMO9       66 SFDEELQQEWTWTERFATQDEILRYLEHVADRHDLRSAYDFLTRVTSATYDEETTRWSITTDTGQN--------VTARFCVLATGVLSATN--KPDIPGRDT-FGGATYH 
BVMO11      76 SR-EDLWKDWSYDELYPSWSGVRDYFAYVDRKLDLSRDIIFSTRVTSADFDGERNQWTVRTDTGRM--------LRARSVVICTGFGAKPH--IPSINGLNS-FAGESHH 
BVMO14      68 SFDEDLQQEWQWSERFAGQPEILRYLEHVADRFDLRKDITFDTRVVGVHWDDENSVWTVRTDDGAV--------VRSRYFISGAGNLSVPK--TPEFGGIDN-FRGEVLL 
BVMO15      75 SFSRELEQEWDWSEKYATQPEILAYINHVADRFDLRDRFLFGTRVTSAELDEESLRWEVRTDRGDV--------LSARYCIFATGALSTAN--MPNIAGRES-FTGDTHH 
BVMO20      79 SH-KDLWKKYDFAELYPGHDGVRNYFEYVDSQLDLTRDVVFDTFAESCTWDEETRQWTARSADGKV--------QNARQVIVATGFGAKPL--YPNLEGLDL-FAGDCYH 
BVMO21      77 LFSEELYKNWSWSQRFPGQPEIERWMHYVADTLDLRRDIQLSTMITSAHYDERADKWIVRTDRGET--------ITTRFLVTCSGMLSAPM--SYVFEGQEE-FSGPIFH 
BVMO23      77 LFSEELYKNWSWSQRFPGQPEIERWMHYVADTLDLRRDIQLSTMITSAHYDERADKWIVRTDRGET--------ITTRFLVTCSGMLSAPM--SYVFEGQEE-FSGPIFH 
BVMO24      80 SFDEALQQEWTWSQRFAPQAEILSYINHVADRFDLRKHFTFNTRVVGATWNAAERLWEVQLDNGET--------RRGRYLISGAGGLSTPK--DFDVPGLGN-FTGLQVS 
STMO        80 SFSPELEQEWNWSEKYATQPEILAYLEHVADRFDLRRDIRFDTRVTSAVLDEEGLRWTVRTDRGDE--------VSARFLVVAAGPLSNAN--TPAFDGLDR-FTGDIVH 
ACMO        64 LFDEDLYKGWSWSQRFPGQEEIERWLNYVADSLDLRRDISLETEITSAVFDEDRNRWTLTTADGDT--------IDAQFLITCCGMLSAPM--KDLFPGQSD-FGGQLVH 
CHMO        66 SWDKELLQSLEIKKKYVQGPDVRKYLQQVAEKHDLKKSYQFNTAVQSAHYNEADALWEVTTEYGDK--------YTARFLITALGLLSAPN--LPNIKGINQ-FKGELHH 
MEKMO       78 WFSEELYKSWQPTERFPAQPETEEWLNFVANRLNLKKDIQFNTRIASAHFCEDSGRWVVTTAAGET--------INTQYLISCCGMLSAPL--SDRFPGQAD-FQGQIYH 
CDMO       116 LLEETGYMPT---EKYAHGPEILEHCQRIGKHYDLYDDALFHTEVTDLVWQEHDQRWRISTNRGDH--------FTAQFVGMGTGPLHVAQ--LPGIPGIES-FRGKSFH 
CPDMO      132 LLEEMGYIPT---EKYAFGTEILEYSRSIGRKFGLYERTYFQTEVKDLSWDDEAARWRITTDRGDK--------FSARFVCMSTGPLQRPK--LPGIPGITS-FKGHSFH 
PtlE       115 LLEELGRLPS---EKYATGAEIFEHCQAIARTYDLYDEALLQTSVTELSWDEDSSRWLVRTDRGDL--------VRSRFVAMAIGSLHRPK--LPSIPGTEA-FQGHSFH 
BVMO8      130 SFELNPDWSR----YYPTGPEYLDYMHAVAEKYDLYKNIELSTAVVTAEWDEAAQKWTVVTRRTDG----STPRHRASAAITGFGFLNSPN--KTDIPGLDT-FEGTVVH 
BVMO10     207 SFELNPNWSK----YYPTGPEYQNYLLDVVEKYRLREHIRFRTRVLSARWLDDEHRWEVVTEDGEG----SVVRHRARAVITAMGMLNAAN--IPEVDGLDS-FAGRVVH 
HAPMO      200 SFARG-IWDD----CFAPAPQVFAYMQAVAREHGLYEHIRFNTEVSDAHWDESTQRWQLLYRDSEG----Q-TQVDSNVVVFAVGQLNRPM--IPAIPGIET-FKGPMFH 
BVMO18     213 SFAKN-DWTT----HFELRNELQAYFGAVLKDLGAGERVRYGTEVRSTRYDEAAAQWSVDMINPDG----SSSTLRADVVISAVGVLNRPK--TPNVPGMDS-FTGTSFH 
MoxY        68 PFAPNPDWPR----YFSYAPDIWNYLDRVCKVFDLRRYMVFHTEVVGCYWNEDRGEWTVRLRQHASGSEPREFEDHCHVLVHASGVFNNPQ--WPQIPGLHDRFQGRVLH 
BVMO19      80 SFHPNPRWRS----NFALQPELLSYIEDTVDTFGLQSRISMQTDVREAAWSDERRRWILDTSRG---------TIVAQHVIFAAGPITEPS--TPAVPGIDR-FDGDVFH 
BVMO2       67 SFAPSADWSH----TFARQPEIHRYLKKVAADTGVRSRVVTDCELQEAHWDADEAVWTVRTSRG---------TVTADVVVAATGALSTPS--VPDMPGLET-FGGTTFH 
APPENDIX	  
 121 
EtaA        65 RFRPWTGRQA-----IADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGT-----LSALTCEFLFLCSGYYNYDEGYSPRFAGSED-FVGPIIH 
BVMO5       67 SFEPNPDWTR----MWSGQEEIFDYLRGLADKYDLRRNIHFGRTMTGGHWDAERRRWHVHTESGD--------EYVAQFVVSGIGALHIPN--VPDLPGADT-FDGTEFH 
BVMO6       63 SFAPNREWSR----LFAGQDEIRRYIERTAAEHGVPAHVKFGTEMQRAQWSEQSRRWTVDTSAG---------TFTANAVIAAAGPWNEPL--VPTVPGLDT-FTGEVFH 
BVMO7       81 SFALNPEWTR----SFSTQPEIQKYIQSVADKYKVRNKHLFGCDVQSAHWNESTTRWEVTTTKG---------NFVAKVLVSAVGALCEPS--LPDIKGIEG-FEGEIFH 
AlmA1       65 NFKPWAKDKV-----LASGAEIKGYLSDVISENQLKDKIHFGHRVLSANYDSTKKKWLVEIEDNNK----KKQTWSANFVMGCTGYYNYDQGYAPKFPKQED-FKGQFIH 
BVMO12      81 SFAPNPNWTR----LYPLQQEIHDYLRSCAENFGIVPHLRMGHDVQDAAWDDDSQVWHVTTSRG---------TWEARILVGAMGPFSEPA--VPNLPALES-FRGAVFH 
BVMO13      89 GFKPWTHKKA-----IADAHIILDYLQETVTENHIDEHIRFGYRVSSAEFSSSAGRWTVTAQRSGSD---ETVQITARFLFSGTGYYNHEAGFTPEFDGIED-FTGQVVH 
BVMO16      80 RFKPWSGEKS-----IADGPSILEYVKDTAAEHGIDRNIRFRHKVVRAEWSTADSHWTVDAERTDTG---ETVRLTADFLMSCSGYYRYDEGYTPEFPGLDR-FGGRVVH 
BVMO17      67 SFAPNRKWTR----MYARQPEILDYIERVVRDYDLAPHIRFGAEVISYEFDETTDRWRVETRSGS--------VYHPRIVVAGPGPLHKPS--VPDLPGRKS-FSGVAFH 
 
PAMO       174 TGNWPHEPVDFS----------GQRVGVIGTGSSGIQVSPQIAKQ-AAELFVFQRTPHFAVPARNAP--LDPEFLADLKKRYAEFREESRNTPGGTHRYQGPK------S 
CPMO       178 TALWPQEGVNMA----------GKRVAIIGTGSSGVQVAQEAALD-AKQVTVYQRTPNLALPMHQKQ--LSAEDNLRMKPELPAAFERRGKCFAGFDFDFIAK------N 
BVMO1      168 TGLWPEGGIEFA----------GKRIAIIGTGASGVQVAQEASKK-AAQLTVFQRTPVQALPMRQRQ--LTDEDNAKIKFDLADRFSRRSASFSGFDFDFIPK------S 
BVMO3      170 TARWPLEGYDLA----------GKRVAVIGTGASGVQVIQEASKV-ADHLTVFQRTPNTALPMNQRA--LGEADNAEMKKTYPERFANRKNTWAGFDYDFLKE------N 
BVMO4      176 TARWR-SDLDMT----------GKRVAIIGTGASAVQVVQEAGPV-VENLTVFQRTPNISLPMQQKY--LDDEEQAALKNKMPDVAAKCRETHAAIDYDFDPR------S 
BVMO9      165 TGEWPHEPVDFA----------GKRVGVIGTGSSGIQSIPVIAEE-AAEVFVFQRSPNYSIPAGNRP--LTGEYIAEVKANYAERRRLSRMSGGGTPNSAYPK------G 
BVMO11     174 TALWPQEGLDMA----------GKRVGIIGTGSSGVQVTQEAAAD-AEQITIFQRTPNLALPMRQQQ--LTGQLKEKLKENLPERFAQRRRSFAGFDMDFIPK------S 
BVMO14     167 TGNWPREGADFT----------GKRVAVIGTGASGIQAIPFIAED-AAELVVFQRTPNFATPLGNGP--MDPNELADIKSNYADVRTAARNHFLGVPFNQVQP------S 
BVMO15     174 TGQWPHEGVDFT----------GRRVGIIGTGSSGIQSIPLIAEQ-AEHLYVFQRSANYSVPAGNQA--WDDEMRRAIKAGYEERRRLSRESGGGSPYNAHPK------S 
BVMO20     177 TARWPQEGVDMT----------GRKVVVMGTGSSGVQVVQEAGHV-AEHVTVFQRTPNLAIPMQQRA--LTHDDNEQFRKGLPERFEARYKAFAGFDFDFLPQ------N 
BVMO21     176 TSRWPKEGADLD----------GKRVAVIGVGATGIQVIQTVADK-VEHLKVFIRTPQYALPMKNPT--FDESDVAAYKSRFAELKETLPNTFSGFEYDFEH-------V 
BVMO23     176 TSRWPKEGADLD----------GKRVAVIGVGATGIQVIQTVADK-VEHLKVFIRTPQYALPMKNPT--FDESDVAAYKSRFAELKETLPNTFSGFEYDFEH-------V 
BVMO24     179 TSRWNISLDDLA----------GKRVAVIGTGSSGVQAIPLIAEV-AEHVTVFQRTPNYVMPARNAE--LPLERVDSIKDDYPAIREECRHSPGGIPDRPVTD------K 
STMO       179 TARWPHDGVDFT----------GKRVGVIGTGSSGIQSIPIIAEQ-AEQLFVFQRSANYSIPAGNVP--LDDATRAEQKANYAERRRLSRESGGGSPHRPHPK------S 
ACMO       163 TARWPKEGIDFA----------GKRVGVIGNGATGIQVIQSIAAD-VDELKVFIRTPQYALPMKNPS--YGPDEVAWYKSRFGELKDTLPHTFTGFEYDFTD-------A 
CHMO       165 TSRWP-DDVSFE----------GKRVGVIGTGSTGVQVITAVAPL-AKHLTVFQRSAQYSVPIGNDP--LSEEDVKKIKDNYDKIWDGVWNSALAFGLNESTV------P 
MEKMO      177 TGLWPKDPVDFN----------GKRVAVVGTGATGIQVIQTIAPT-VGSMTVFVRTPQYVIPMRNPK--YSKADWEKWGTQFHQLKKRVRETFAGFDYDFDAG------P 
CDMO       212 TSRWDYDYTGGDALGAPMDKLADKRVAVIGTGATAVQCVPELAKY-CRELYVVQRTPSAVDERGNHP--IDEKWFAQIAT--PGWQKRWLDSFTAIWDGVLTDPSELAIE 
CPDMO      228 TSRWDYSYTGGDQTGN-LEGLKDKRVAIIGTGATSIQAVPHLAAY-AQELYVIQRTPISVGFRGNKP--TDPEWAKSLQ---PGWQQARMDNFNAITHGMPVD------- 
PtlE       211 TSRWDFAYTGGDISGG-LEKLGDKRVGIVGTGATAVQCIPHLAES-AAHLYVFQRTPSTVSVRNNRP--TDPGWAAGLE---PGWQQRRMDNFHALTSGVDQD------- 
BVMO8      229 TAEWDPS-LDLT----------GKRVVVVGTGCTAVQIVASIVDD-VATVDAIVRSPHWIVPEKLWS----TRYRPGRSGQCGTCRTSRIGSGSEPTGLPQNN------- 
BVMO10     306 TAEWDSD-LDLS----------GKRVVVLGTGCTSVQVVANIVDQ-VEALDVVVRSPHWLVPEKAVS----GDVTEGEKWALANLPFYDRWFRLRSYWFASDN------- 
HAPMO      297 SAQWDHD-VDWS----------GKRVGVIGTGASATQFIPQLAQT-AAELKVFARTTNWLLPTPDLH----EKISDSCKWLLAHVPHYSLWYRVAMAMPQSVG------- 
BVMO18     311 SAAWPDD-LDLD----------GKRVAIVGTGASSMQIAPAIADR-VAHLSIYQRSPQWVAPFEKFR----APIPMELRRLMQTCPIYHSWYWIRLFWQFGDK------- 
MoxY       172 TARWPDD-YQESQWK-------SDRVAVIGSGASSIQTVPGMQPT-VKHLDVFARTGVWFGVLAGNTGSQTKEYSPTERDEFRRNPAALVAHAKAIEDQVN--------- 
BVMO19     174 SARWNHD-VDLT----------GKRVAVVGTGASAVQFIPEIQPD-VEELYVFQRTPAWVVPRLDF------PFPRIAQWAFARVPAVQRALRRLLDVIL---------- 
BVMO2      161 SATWNHD-HDLT----------GERVAVIGTGASAVQFVPEIAPV-AEHLTVFQRTPAWVIPRLDR------ELSGSEKRLYRRLPLVQKAVRGTVYGFR---------- 
EtaA       164 PQHWPED-LDYD----------AKNIVVIGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDR-----DGIAEKLNRWLPETMAYTAVRWKNVLRQA---------- 
BVMO5      162 SARWNHD-YDLR----------GKKVAVIGTGASAVQFVPEIVGD-VAELHLYQRTPPWVIPGLNF------GIPPEARRLFGRVPLARRMVRAAVYWTY---------- 
BVMO6      157 SSRWNHT-YDLT----------GKRVAVVGTGASAVQFVPAIQPT-VESLHLYQRTAQWVLPKPDH------TLPGVERAILRRVPGAIRALRRVEYAIM---------- 
BVMO7      175 SARWNHD-ADLT----------GKRVAVIGTGASAIQIVPAIGKK-VSHLDVYQRTAPWILPRADR------EYTKLEHTAFKYLPGFQKLCRTGIYWMR---------- 
AlmA1      165 PQHWPEN-LDYT----------GKKVVIIGSGATAITLVPSMVKGGAGHVTMLQRSPTYIATIPSI-----DFIYEKTRKFMSEETAYKFTRARNIGMQR---------- 
BVMO12     175 SAAWDHE-HDLA----------GERVAVIGTGASAVQIIPRIQPI-VGSMTVFQRTPTWILPHPDQ------PMTGWPRKLFARVPVAQRLARSGLDLVQ---------- 
BVMO13     190 PQHWPEE-LDYS----------GKKVVVIGSGATAATLIPAMAGT-AAHITMLQRSPSYVLSLPAE-----DAIANTLNKLIGPKRAYPIIRRKNIMMHR---------- 
BVMO16     181 PQQWPED-LDYE----------GKRVVIIGSGATAVTLAPSMAAD-AAHVTMLQRSPTYIISMPAK-----DKLANKLRRHLPAKLAYGLTRLKNASVAT---------- 
BVMO17     162 SAEWDHS-VDLT----------GKRVAVVGTGASAVQFVPEVAKT-AAHVDVFQRTPHWILPKLDR------PITAGEKAVFKAVPGVQKAYRGAIYWSH---------- 
 
PAMO       265 ALEVSDEELVETLERYWQEGG-P-DILAAYRDILRDRDANE-RVAEFIRNKIRNTVRD-PEVAERLVPKG--YPFGTKRLILEI--DYYEMFNRDNVHLVDTLSAPIETI 
CPMO       269 ATELSAAERTEILEELWNAGG-FRYWLANFQDYLFDDKAND-YVYEFWRDKVRARIKD-PKVAEKLAPMKKPHPYGAKRPSLEQ--WYYEIFNQNNVTLVDVNETPVLRI 
BVMO1      259 ALGVSDEERITTYERLWECG--FEFWLGTYQDVFVDDDAND-TAYEFWRDRTRARIKD-PVIAEKLAPTKKAYPFGVKRPSLEQ--TYYDIFNQDNVRVVDLHEDPIETI 
BVMO3      261 IQDLTEERRNEILEELWTNGG-LQPWLGGFLNVLFDKDDND-ILYAFWRDKTRQRITR-PELVELLAPTEPIHPWGVKRVSLEQ--NYFESLCRDNVELVDTSANPIREV 
BVMO4      266 GFETPEDERNAVFERLWNQGG-FAFWLGNFSDYLFNDKTNA-LTYEFWKNKIKPQIKD-PVKAELLVPEIAPHPFGAKRPALHQ--NYYEVMNQTNVSLVSTKETPIVGF 
BVMO9      256 ALEVDAEERRRVYDEWWQRGG-Y-LFAKAFPDQTISQAAND-TAREYVEAKIREMVTD-PDIADQLVPTD--HPIGTKRIVTDN--GYFKTFNRGNVTLVNLRRTPITEI 
BVMO11     265 VFEVSDEERADTYERMWATGG-FELWLANYQDILLDERANR-IMYDFWRDKVRQRVTD-PVKAEKLAPMDPPHPFGTKRPSLEQ--NFYDVVNQENVDIVDVNEDPIERI 
BVMO14     258 ALAVDAEERRRTFDERWNAGG-FRLFIDSYQDILFDKKAND-TIADYIRDRIHERVQD-PAKAATLAPTG--YAYGTKRPPLET--NYYEAFNRDSVSVVDVKSTPIDEI 
BVMO15     265 ALDVSDEERREAYETRWKLGG-V-LFAKTFPDQTKTEAANA-TAREFAEEKIRLLVDD-PAVADKLIPND--HPIGTKRIVTDT--HYFETYNRPNVTLVDLKAAPIESI 
BVMO20     268 AADLSMEERDAIYEKMWAEGG-FEMWLGNFQDILVDEDANR-TFYDFWRNKVLERVTD-PKKAAIVAPETPPHPYGVKRPSLEQ--DYFDVINQSNVEVIDSNLTPIRRV 
BVMO21     266 WADLTPEQRNDVLEEIYENGS-LKLWLASFGEMFYDEEISE-EISEFVRRKMRARLQD-PHLCDLLIPTD--YGFGTHRVPLET--NYLETYHRPNVEAIGVRDNPITRI 
BVMO23     266 WADLTPEQRNDVLEEIYENGS-LKLWLASFGEMFYDEEISE-EISEFVRRKMRARLQD-PHLCDLLIPTD--YGFGTHRVPLET--NYLETYHRPNVEAIGVRDNPITRI 
BVMO24     270 AFDVSAEERQRRYEAAYERSG-FNGVGGEFADLLTDVEANR-TASEFIHDKIREIVED-PATAELLVPRY--HPLGAKRSVFGT--DYYETYNRPNVSLVSLRDEPIETM 
STMO       270 ALEVSEEERRAVYEERWKLGG-V-LFSKAFPDQLTDPAAND-TARAFWEEKIRAVVDD-PAVAELLTPKD--HAIGAKRIVTDS--GYYETYNRDNVELVDLRSTPIVGM 
ACMO       253 WEDLTPEQRRARLEDDYENGS-LKLWLASFAEIFSDEQVSE-EVSEFVREKMRARLVD-PELCDLLIPSD--YGFGTHRVPLET--NYLEVYHRDNVTAVLVRDNPITRI 
CHMO       255 AMSVSAEERKAVFEKAWQTGGGFRFMFETFGDIATNMEANI-EAQNFIKGKIAEIVKD-PAIAQKLMPQD----LYAKRPLCDS--GYYNTFNRDNVRLEDVKANPIVEI 
MEKMO      268 WAEKTPDERQAVLEQLWKDGS-LAMWLASFPEMFFDEQVNE-VVSQFVRIKMRERLRSRPDLCDLLIPTD--YGFGTHRVPLEN--NYLEVYLQSNVKAVDCKQSPIERI 
CDMO       317 HEDLVQDGWTALGQRMRAAVGSVPIEQYSPENVQRALEEADDEQMERIRARVDEIVTD-PATAAQLKAWFR---QMCKRPCFHD--DYLPAFNRPNTHLVDTGGKGVERI 
CPDMO      324 -VDLVQDSWTKIFGEIGVFLGSD----------GSRAQMVDFQLMEQIRARVDQEVKD-PATAESLKPYYN---IMCKRPGFHD--SYLPSFNKPNVTLVDTQGAGVERI 
PtlE       307 -VDLVQDGWTEITSKLAAILPKSAADAD-PKDIGTAVELADFHKMEELRKRVDAIVHD-KDTADALKPYYR---LFCKRPCFHD--GYLDTYNRPNVTLVDTQGRGVERL 
BVMO8      316 ---------------LYMMPR-I-DPEWAATHLSVSPVNDL-VMQTSLQYLEQTLPDR-PDLREKLTPS---IRPYAKRIVKDP--GFLEALERDHVSLHR---ASPKHV 
BVMO10     393 ---------------LYPLPR-I-DKEWAATHLSASPANDM-VLRTAQEYLQTSFTDR-PDLIAKLTPD---FRPYAKRIVKDP--GFFAALNREHVSLHR---ASFEKV 
HAPMO      384 ---------------FLEDVM-V-DVGYPPTELAVSARNDR-LRQDISAWMEPQFADR-PDLREVLIPD---SPVGGKRIVRDNG-TWISTLKRDNVSMIR---QPIEVI 
BVMO18     398 ---------------VIESLR-V-DPEWEHPERSVNARNDA-HREYFTRYITSQVGDR-TDLLDKVMPD---YPPFGKRILLDN--GWYSTLRKDNVDLVD---RSVTAV 
MoxY       264 ---------------------------GMWGAFYTGSKGQA-MGSAFFRQRTANLIKD-ERLREGLDPP---FAFGCRRITPGD--PYMEAIQKENVHVHF---TPVVSC 
BVMO19     256 --------------------------RTLTWVMR-CERTAR-LLNPIGTRWLARQVPD-PALRAALTPN---FTLGCKRLLLSN--TYLPALTKSNVELIP---HALAEV 
BVMO2      243 --------------------------EALGGVLAHATGLLP-VFEMVAKAHLRRQVRD-PELRRKLTPN---FTIGCKRMLLSN--DWLRTLDRPDVTLVD---AGLAGV 
EtaA       248 -----------------------------AVYSACQKWPRR-MRKMFLSLIQRQLPEG-YDVRKHFGPH---YNPWDQRLCLVPNGDLFRAIRHGKVEVVT---DTIERF 
BVMO5      244 --------------------------ESLALGFNGHSRLMR-PIESMARKNLNRTVAD-PELRRKLTPS---YRIGCKRILGSD--VYYPALISPKTVVIT---EGIAEV 
BVMO6      239 --------------------------ESLGLGFR-HPWILR-VIQQVGKAQLRAQVRD-PKLRKALTPD---YTLGCKRLLLSN--TYYPALTRPNVEVHA---NAVESV 
BVMO7      257 --------------------------ESQVVGLAKAPVFMK-PLQFAAERHLRRQIKD-KALRKKVTPN---FQIGCKRMLISN--NYYPTLAQDNVDLVT---DGIAEV 
AlmA1      249 -----------------------------GIYALAQKYPKT-VRRLLLKGIELQLKGK-VDMK-HFTPS---YNPWDQRLCVVPDGDLFKALREGQASVET---DQIEKF 
BVMO12     257 --------------------------EAMVPGFVYKPALLK-GLAALGRAHLRRQVHD-PELRTKLTPT---YAFGCKRPTFSN--SFYPALAQPNVDVIT---DGIREV 
BVMO13     273 -----------------------------GIFKACRRSPKL-MRKLLIANARRQLPKN-FDVDTHFTPR---YNPWDQRLCMVPNGDLFKAISTGHASVVT---DRIERF 
BVMO16     264 -----------------------------AIYQLCQRYPEF-MKGRIRQLQEKWLPKG-YDIDTHFTPR---YNPWDQRLCLVPNGDLFRAIRNDEVSIVT---DHIDTF 
BVMO17     244 --------------------------ESLIAGFL-HPRLMT-VLESAARGLLRRQVRD-PELRATLTPD---YIIGCKRILVSS--NFYPALQRGNVDLVT---SGISEV 
 
PAMO       367 TPRGVRTSE-R--EYELDSLVLATGFDALT----GALFKIDIRGVGNVALKEKWAA--GPRTYLGLSTAGFPNLFFIAGPGSP-SALSNMLVSIEQ-HVEWVTDHIAYMF 
CPMO       374 TEKGIVTAE-G--EAEFDLIVFATGFDAVT----GGLTSIDFRNNQGQSFKDVWSD--GIRTQLGVATAGFPNLLFGYGPQSP-AGFCNGPSSAEY-QGDLLIQLMNYLR 
BVMO1      363 TPTGLKTTS-E--QHEFDIIVYATGFDAVT----GGLTAMDIRGTDGTLLRDKWSN--GVRANLGVATAGFPNLLFLYGPLSP-SGFCNGPSCAEI-QGDLIVNTIDYMR 
BVMO3      366 ASDAIITAD-GT-RHEVDVIVLATGFDSVT----GGLTAIDIRGTGNETFEEVFRG--GSRTALGKATVGFPNLLYVYGPQSP-NAFCNGPTCAEL-EGEHLIQIVEHMR 
BVMO4      371 TETGIRTAD-GVEHGEFDIIVLATGFNNNT----GALTSIDVQNANGVTLRDKWSQ--GVDAYLGAVTAGFPNAIFVYGPQSP-AAFANGSTNAEL-QGEVMVDFFEFLR 
BVMO9      358 TEAGVLTTN-S--FYGLDMLVFATGFDAMT----GSLSRIDIRGRAGRNLRDEWSA--GPRTYLGLSVAGFPNMFILAGAGSP-SVLANMVLMAEQ-HVDWISNCLDYLD 
BVMO11     370 TPAGVQTKS-G--LHEFDILVFATGFDANR----GGITSIDIRGTNDQLLSHKWSE--RLDTFMGLTTAGFPNLMFVYGPQSP-AGFCNGPTCAEV-QGEIVVDFLTHVR 
BVMO14     361 TPTGVRVGD-R--VYEVDTIVLATGFDAMT----GPLMAMDIRGRGGLPLAEKWEH--GPRTYLGIMVNEFPNLFLITGPQSP-SVLYNMPLAIED-HVDFATDAIDYLD 
BVMO15     367 TPSGITTAD-A--DYALDTLVFATGFDAMT----GALDRMRIVGRGGVPLSEYWSE--GPKTYLGLGVPGFPNLFVVTGPGSP-SVLANMVLGAEQ-HVDWIADCIEHLW 
BVMO20     373 LPHGIETDD-G--VIECDLLVLATGFDNNS----GGIMAIDITGVDGLSIQDKWKS--GVDTCMGLSTRGFPNMMFLYGPQSP-SGFCNGPTSAEY-QGEIVVEFLQHLR 
BVMO21     369 VPQGLVLAD-G-TLHEVDVIVMATGFDAGT----GSLTRIDIRGRGGRALKDDWNR--DIRTTMGLMVHGYPNMLTTGAPLAPSAALCNMTTCLQQ-QTEWIAECIRYMR 
BVMO23     369 VPQGLVLAD-G-TLHEVDVIVMATGFDAGT----GSLTRIDIRGRGGRALKDDWNR--DIRTTMGLMVHGYPNMLTTGAPLAPSAALCNMTTCLQQ-QTEWIAECIRYMR 
BVMO24     373 TANAIVTSK-G--TYEADAVVLAIGFDAFT----GPLYGLGLTGASGRKLQETWQD--GIRTYLGMMTTDFPNFFMVAGPQSP-ALASNVVMTIEQ-AVDWIADLIEHAR 
STMO       372 DETGIVTTG-A--HYDLDMIVLATGFDAMT----GSLDKLEIVGRGGRTLKETWAA--GPRTYLGLGIDGFPNFFNLTGPGSP-SVLANMVLHSEL-HVDWVADAIAYLD 
ACMO       356 RENGIELAD-G-TVHELDVIIMATGFDAGT----GALTRIDIRGRDGRTLADDWSR--DIRTTMGLMVHGYPNMLTTAVPLAPSAALCNMTTCLQQ-QTEWISEAIRHLR 
CHMO       357 TENGVKLEN-G-DFVELDMLICATGFDAVD----GNYVRMDIQGKNGLAMKDYWKE--GPSSYMGVTVNNYPNMFMVLGPNGP---FTNLPPSIES-QVEWISDTIQYTV 
MEKMO      372 VPQGIQTAD-G-KIHEVDIIVLAVGFDAGS----GALSRIDIRGRDSRSLKEQWQQ--EIRTAMGLQIHGYPNLFTTGAPLAPSAALCNMTTCLQQ-QVDWITGCIEFAA 
CDMO       421 TENGVVVAG-V--EYEVDCIVYASGFEFLG-TGYTDRAGFDPTGRDGVKLSEHWAQ--GTRTLHGMHTYGFPNLFVLQ-LMQGAALGSNIPHNFVE-AARVVAAIVDHVL 
CPDMO      417 TEKGLVVNG-R--EYEVDCLIYATGFEYQT--KLSRRNGYEIHGRNGQPLSDKWKD--GLSTLWGYHIRDFPNCFILG-NGQ-SAVTPNFTHMLNE-AGKHVAYVVKHCL 
PtlE       409 TPTSVVAGG-R--EYPVDCLIFASGYESEFGVPYTNRTGFSIVGRDGIRLSEKWAE--GARTFHGLQVNGFPNCFILS-KAQ-SGLHVNVPYMLNE-QSKHVAYILKAVQ 
BVMO8      399 HPGGVSLSSGE--FVEADVIVLATGFKVE------YASFIDITGRNGKKLADKWDHGQDPRAYLGIQVSGFPNLFVTAGPNAA-PNHGAGHNITSEERVHYIVECLQYLV 
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BVMO10     476 TPEGVYTTEGA--FIPADVIILATGFKLQ------FTTSIEIEGRDGRTLSEVWNGGDDPRAYLGVQVAGFPNLFITAGPNSA-PNHGAGHNILSEEHVHYIVECLQYLL 
HAPMO      468 TPKGICCVDGT--EHEFDLIVYGTGFHASK-----FLMPINVTGRDGVALHDVWKG-DDARAYLGMTVPQFPNMFCMYGPNTG-LVVYSTVIQFSEMTASYIVDAVRLLL 
BVMO18     481 RPEGLVDDQGA--ENDVDVIVWATGFEAAR-----FVSSMDVVGMDGRTLREVWND-DDPKAYLGVSVPGFPNFFMLGGPNSF-PGSGS-FMFFMEVQMRYIRGLLTEMF 
MoxY       337 TEKGVVGGDGV--ERQVDTVVCATGFDASY-----RPRFP-IVGRDGVDLREKWKE--CPNSYLGLAVPEMPNFFTFIGPTWP-IQNGSVIGPLQA-VSKYVVQWIKKAQ 
BVMO19     329 DGRVVVGADGT--RREVDVIIFGTGFDVSH-----PPIASRIRGRDGTLLSEKWSK--SPEAYLATTTPGAPNAYIMLGPNIL-V-YNSFLGLAET-QLDYVIDGLTTAE 
BVMO2      317 TPDGVVDALGN--EHKVDTIIFATGFTPTE-----PPVAHALRGANGRTLAEHWD--GSPSAYKGTTVAGFPNLFLMYGPNTN-LGHSSIVYMLES-QSAYIADALNVMH 
EtaA       321 TATGIRLNSGR--ELPADIIITATGLNLQL-----FGGATATIDGQQVDIT-------TTMAYKGMMLSGIPNMAYTVGYTN------ASWTLKADLVSEFVCRLLNYMD 
BVMO5      318 RPHSIVAGDGA--ERVVDAIIYATGFHVTD-----GFDNVELTGVGGRRLADEWEE-HGIRTHLGITVAGYPNAFFLFGPNTG-LGHNSVVFMIES-QIRYALELMDLVD 
BVMO6      312 RGNVVVGSDGA--EREVDAIIFGTGFHILD-----MPIGSKVFDGDGRSLDDHWKG--SPQAYLGTTVAGFPNAFVLLGPALG-TGHTSAFMILEA-QLDYLIQAVTAAR 
BVMO7      331 TADSVVSKDGT--VREVDAIVVATGFHVTD-----SPTFEGIFGKDGRSLADVFDE-GGQQGYKGAAIANFPNMFFLVGPNTG-LGHTSMVFMIES-QLNYLVDALQTLD 
AlmA1      321 TANGIQLKSGK--HLEADIVISATGLEIQI-----LGGVQGSIDGKPMNTS-------QHMLYQGVMVSDVPNMAMIIGYIN------ASWTLKVDIAADYICRLINHMD 
BVMO12     331 RSNGIVTEDGV--LHEVDTIVMGTGFRLTD-----NPAFDVVRGRDGRTLAEAWNG--NARAYLGTTISGFPNFFMLLGPNS--VVYTSQVVTIEA-QIAYILSCLQEMN 
BVMO13     346 TATGIRLESGQ--ELEADIVVTATGLNMLA-----FGAIQLSVDGEPVNPP-------DTTVYKSMMLSGLPNFVFALGYTN------ISWTLKVDLISEHFCRLLDHMD 
BVMO16     337 TETGITLKSGE--ELHADVVVTATGLNLLA-----FGGMTLAVDGHDIDLT-------ETMAYKGMMLSGVPNFAFVIGYTN------ASWTLKADLVCEYVCRLLAHMD 
BVMO17     317 TERGIRTDDGT--MHEADVIVYGTGFAAGD-----RFENEHIVGRRGLTIQRAWRD--GMEAYLGVAVAGFPNFFLMMGPNSG-GGNQSIVFVIEA-QAHYITRCLALMK 
 
PAMO       466 KNGLTRSEAVLEKEDEWVEHVNEIADETLYPMTASWYTGANVPGKPR-----VFMLYVGGFHRYRQICDEVAAKGYEG-FVLT--------------------------- 
CPMO       473 DNNISRIEAQSEAQEEWSKLIADFWDSSLFPRAKSWYQGSNIPGKKV-----ESLNFPLGLPTYISKFNESAEKGYAG-FSLAS-------------------------- 
BVMO1      462 DNGLNRIESEADADAAWSDHVAELTAEALYDKADSWYMGANVPGKPR-----QLLNYPGGLPLYLAKWDETVCAGYKG-FTLS--------------------------- 
BVMO3      466 NNGYTRIEAKPEAQQYWGAHIAELTSATLFPLAKSWYMGANVPGKTV-----EMLMYPGGLSVYLEILEKAAAGGYQEQFELV--------------------------- 
BVMO4      472 SNGLTRFESTVEADKAWTAHINETDDTALFNRAKSWYNGGNIPGKKM-----QMLQYLNGVPTYLQFWQKEKESGYTDGLTVS--------------------------- 
BVMO9      457 EHNIETIEATDESVDEWVAECNEKAAGTLFPTADSWYMGANIPGKPR-----VFMPYIGGFGNYNTICAEVAAAGYKG-FELG-ERRVDVDAAAAAAAAAAAAQ------ 
BVMO11     469 DGGYQRFETSEDAEQSWTAHVEEVFHMSLFPRAKSWYHGANIPGKPS-----QMLNYSGGLPSYFDHWEENVAAGYKA-FTLS--------------------------- 
BVMO14     460 RRDLDVIEPTAQAESDWGALTNEIADQTLLPETNSWYMGANIPGKPR-----ACMVYLGGAPTYRATCDEVVAGGYSG-FALT-RAEARAASTVS--------------- 
BVMO15     466 EKDYDAIEASVPATEQWVEHCRDLAAQTLFPLANSWYMGANIPGKPR-----VFMPYLGGFGAYGRICADVAEEGFRG-FEFS-RSRTRLADPVG--------------- 
BVMO20     472 DNGITRFENTEESEKQWRAHVDELFVNSMFTKARSWYWGANVPGKPA-----QMLNYSGGVPQYFARWDKIKANGYAA-FETN--------------------------- 
BVMO21     470 AHDHTVIEPTLAGEDEWVAHHDETANATLVSKTDSWYNGANVPGKPR-----RVLSYIGGVGTYREKTLAAAAAGYKG-FQLS--------------------------- 
BVMO23     470 AHDHTVIEPTRAGEDEWVAHHDETANATLVSKTDSWYNGANVPGKPR-----RVLSYIGGVGTYREKTLAAAAAGYKG-FQLS--------------------------- 
BVMO24     472 DSGATLVEATPEGQNDWVDITEETVAQTLYATTDSWYRGSNVEGKPN-----TFMGYVGGVGKYRRMCTEIAKRGYPG-VRIDGETESPHLGPIHREIS----------- 
STMO       471 ARGAAGIEGTPEAVADWVEECRNRAEASLLNSANSWYLGANIPGRPR-----VFMPFLGGFGVYREIITEVAESGYKG-FAIL-EG------------------------ 
ACMO       457 ATGKTVIEPTAEGEEAWVAHHDELADANLISKTNSWYVGSNVPGKPR-----RVLSYVGGVGAYRDATLEAAAAGYKG-FALS--------------------------- 
CHMO       455 ENNVESIEATKEAEEQWTQTCANIAEMTLFPKAQSWIFGANIPGKKN-----TVYFYLGGLKEYRSALANCKNHAYEG-FDIQLQRSDIKQPANA--------------- 
MEKMO      473 EHGKHVVEASKALEDNWVQHHDETAAKTLVVKTDSWYMGSNVDGKPR-----RLLSYIGGAGDYHRRCAEIAAQGYPG-FEMA--------------------------- 
CDMO       523 STGTSSVETTKEAEQAWVQLLLDHG--RPLGNPECTPGYYNNEGKPAELKDRLNVGYPAGSAAFFRMMDHWLAAGSFDGLTFR--------------------------- 
CPDMO      517 DERVDVFEPTAEAEQAWVDHVMSFAGIKQQYDRECTPSYYNNEGQVNDVALTRNNFYPGGAVAFINILREWREKGDFAQFQQRKR------------------------- 
PtlE       511 QRGRQVVEASATGEKEWVETILRLANRNLDFTESCTPGLFNNEGNPRNVAILN-SSYGGGSVGFVNILKRWREADDLADLELREG------------------------- 
BVMO8      500 ENDFSAMDVKPEALTVYNEKVDEALDQTVWAHPGEGVTGYYRNQQG---------------------------------------------------------------- 
BVMO10     577 ENGHDAMDVRQDVLDTYNRKVDAALDDTVWVHPGAEVNGYYRNSSGR-----AIVPCPWRLVDYWTMLREPNPDDLTF-IG------------RRAEGRREASAR----- 
HAPMO      569 EGGHQSMEVKTPVFESYNQRVDEGNALRAWGFSK--VNSWYKNSKGR-----VTQNFPFTAVEFWQRTHSVEPTDYQL-G------------------------------ 
BVMO18     581 KKGIKAIDARPEANEEYNELVDSTHARTVWTHRG--MSTYYRNSHGR-----VVFVMPFLNVEYWQMTRRPDLENYTA-R------------------------------ 
MoxY       435 NENLRSFVPRQDRTDQFNDHVQEWVKHTVWKDNCRSCTFLLSPRSQL-----NLLRTI---------------------------------------------------- 
BVMO19     427 RQGIEVLEVRDQPFRRFNDAVQKGLEPTVFNNGG--CSSYYLDADGR-----NFAAWPWSTGSLRRRLARFDLENYAI-RP---------------------YRTEQSPA 
BVMO2      416 HSEITAFEVTEEAQRRYNTRIQSELQTTVWNKGG--CSSWYYDSEGR-----NSVQWPTFTWKFRSQLQRFDQENYVS-R--------------------------RRAA 
EtaA       411 DNGFDTVVVERPGSDVEERPFM-EFTPGYVLRSLDELPKQGSRTPWR-----LNQNYLRDIRLIRRGKIDDEGLRFAK-RP------------------APVGV------ 
BVMO5      418 RRGADSAAVRPAVQSGFNADIQRKLARGVWSTGG--CVSWYLDSHGV-----NRTIWPGSTVRYWQRTRSVEPADFEF-T-----------------------PG----- 
BVMO6      411 SNGWTRMEPRREVQDAFNAQVQEALATTVYNAGG--CQSYFLDVNGR-----NSFNWPWSTDRMRQRLGRFDEAAYDV-S-----------------------REPAS-- 
BVMO7      431 KYDIGKIEVRQDAQDRYNAELQEKLSHSVWNNGG--CASWYLDKHGN-----NTTLWPGFTFQFRNETKRFDLTAYDS-V-------------ATADLPAPVHVNGKTPG 
AlmA1      411 KNGFDEVIAHADPSQRENDTIMGKMSSGYIARAADVMPKQGKQAPWK-----ITNNYLADRKELKDAKFNDGVLEFHK-RG------------EQTANRKPKLVS----- 
BVMO12     429 AQGAASIDVRPEIQQAFVDEVDERLQTSVWNTGG--CNSYYLSGEGR-----NFTFYPGFNRRFRARTRRVDLHHYII-S----------------------GAGASAKS 
BVMO13     436 ERGYTTVEPVLTDPGMERVPLL-DLTSGYVQRAVAAFPRAGTSGPWT-----AAMAYEKDVERLREGPIEDADLRFTA-NQ------------------PALLAS----- 
BVMO16     427 ANGFTQCAPER-DSSVEEEPFL-DFAAGYVLRSVESFPKQGSKAPWR-----LRMNYFRDLVALRHGKILDDAMTFSR-P------------------------------ 
BVMO17     416 KRDATRIEVRAGAQREFNRVVHRKLAGSVWNSGG--CDSWYLDSTGH-----NRAAWPGSSASYWRRMRTPDDRHFEL-SSLA----------EREDDTEYRGPGVLTSG 
 
PAMO           ------------------------------------------------------------------------------------------------ 
CPMO           ------------------------------------------------------------------------------------------------ 
BVMO1          ------------------------------------------------------------------------------------------------ 
BVMO3          ------------------------------------------------------------------------------------------------ 
BVMO4          ------------------------------------------------------------------------------------------------ 
BVMO9          ------------------------------------------------------------------------------------------------ 
BVMO11         ------------------------------------------------------------------------------------------------ 
BVMO14         ------------------------------------------------------------------------------------------------ 
BVMO15         ------------------------------------------------------------------------------------------------ 
BVMO20         ------------------------------------------------------------------------------------------------ 
BVMO21         ------------------------------------------------------------------------------------------------ 
BVMO23         ------------------------------------------------------------------------------------------------ 
BVMO24         ------------------------------------------------------------------------------------------------ 
STMO           ------------------------------------------------------------------------------------------------ 
ACMO           ------------------------------------------------------------------------------------------------ 
CHMO           ------------------------------------------------------------------------------------------------ 
MEKMO          ------------------------------------------------------------------------------------------------ 
CDMO           ------------------------------------------------------------------------------------------------ 
CPDMO          ------------------------------------------------------------------------------------------------ 
PtlE           ------------------------------------------------------------------------------------------------ 
BVMO8          ------------------------------------------------------------------------------------------------ 
BVMO10         ------------------------------------------------------------------------------------------------ 
HAPMO          ------------------------------------------------------------------------------------------------ 
BVMO18         ------------------------------------------------------------------------------------------------ 
MoxY           ------------------------------------------------------------------------------------------------ 
BVMO19     508 LHPSGKSR---------------------------------------------------------------------------------------- 
BVMO2      492 KETVA------------------------------------------------------------------------------------------- 
EtaA           ------------------------------------------------------------------------------------------------ 
BVMO5          ------------------------------------------------------------------------------------------------ 
BVMO6      488 --ATATSR---------------------------------------------------------------------------------------- 
BVMO7      520 PAAIPAQIDLDDDKVTAQ------------------------------------------------------------------------------ 
AlmA1          ------------------------------------------------------------------------------------------------ 
BVMO12     509 IVRTAG------------------------------------------------------------------------------------------ 
BVMO13         ------------------------------------------------------------------------------------------------ 
BVMO16         ------------------------------------------------------------------------------------------------ 
BVMO17     508 DLTVAVEVFLNGHIEPLDGLYHWYGRVVGDGVDAAKGRNRTPLFLTIGDGPEVPAALAERDPWGHFRIAGVGTPPFPLAPVEVEVPISRAKLASAE 
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Sequence	  alignment	  of	  FMO	  #E,	  #F,	  #G	  
	  
f               MTQTVQPAAVQTSLTPQERVDLWLASFESALAARDVDRAAGMFAVDSFWRDLVAFTWNLK 60 
g               MTATLDAPVDTNIPQPGDIARRWLAGFGATLERGDARGAAQHFLVDGWWRDLLSFTWDLH 60 
e               MTTTFSDTDLRTD------AQAWLDGFSRFLAAELAP--TAVFAPQAYWRDVLAFTGDLR 52 
                ** *.. .   .       .  ** .*   *    .   :  *  :.:***:::** :*: 
 
f               TVEGRDAVAAMLHARLDDTDPVNFRTT-----ETPDEADG--VTSAWIEFETATGRGKGH 113 
g               TTHGRADIESRLADSVPVHEPRHLVLSPAHPAEAVADPEGD-WIQAFFTFETTLARSRGF 119 
e               TFS--DEIPAELLRRQELTKATNIRIAEDRTPPRLVERAGIPCLEVIFEFDTLAGSAVGV 110 
                *      : : *       .. ::  :         :  *    .. : *:*  . . *  
 
 
f               LRLKGDE-----AWTFLTTMQELKGHEERRGRNRVKGAVHGSGGDTLSWAEKREIEEREL 168 
g               VRLRRDDDGEWRAWTLISAMEEIKGHEEKKGHRRVQGTNHGAHRGKINWLDRR-TAKGEF 178 
e               ARLVDVPERGLLVRSLFTTLDQLADHPERTGEHRPVGQADSSKFGGPNWLDRR-IAAQAY 169 
                 **         . ::::::::: .* *: *..*  *  ..:  .  .* ::*        
 
f               GYTRQPYVLVIGGGQGGIALGARLRQLGVPAIVVDKNERPGDQWRNRYKSLCLHDPVWYD 228 
g               -ETEQPAVVIVGAGQGGLALAARLGQLGVDTLLVERNDRIGDSWRKRYHSLVLHDPVWYD 237 
e               -ENRDPDVLIVGGGQSGLTLAARLGQLDVDALVVDTHARPGDNWRTRYHALTLHNAVWLN 228 
                  ..:* *:::*.**.*::*.*** **.* :::*: : * **.**.**::* **:.** : 
 
f               HLPYMPFPDNWPVFAPKDKIGDWLEMYTKVMEIPYWSSTTCTSATFDDETKEWTVVLDRD 288 
g               HLPYLNFPDHWPVFTPKDKLANWFEFYADAMELNVWTGTEFTGGSYDDATGEWTVTVARD 297 
e               DLPYMPFPATWPQFVPKDKLAGWFEAYVEAMEINFWGTTAFIGGDYDEQSQSWVARVRRG 288 
                .***: **  ** *.****:..*:* *...**:  *  *   .. :*: : .*.. : *. 
 
f               -GEDVVLHPKQLVLATGMSGKPNVPSFPGQDVFRGEQHHSSRHPGPDAYVGKRVVVVGAN 347 
g               DGSTRTLHPRHVVLATGMSGVPNIPRIAGADTFEGTIEHSSWFVGGREMQGKKALVVGCC 357 
e               DGTVRTLRPKHVVIATGVSGIPYVPELPGLSQFAGRTLHSSEYDDANDFAGQRVVIIGTG 348 
                 *   .*:*:::*:***:** * :* :.* . * *   *** . .     *::.:::*   
 
f               NSAHDICKALFENGADVTMLQRSSTHIVKSDSLMDLGLGDLYSERAVAAGMTTEKADLTF 407 
g               NSGHDIAQELNEQGADVTILQRSSTYVMSSKHGIPGLFGGVYEE----GGPAVQDADLIF 413 
e               NSAHDVAQDLHAHGIDVTMVQRSSTTIVSVDPSAAAADASYLTA------PTLEDCDLLS 402 
                **.**:.: *  :* ***::***** ::. .       ..           : :..**   
 
f               ASLPYKIMHEFQIPIYQKIAERDRDFYDRLEKAGFKLDFGDDGSGLFMKYLRRGSGYYID 467 
g               ASLPYPLLAGIHAGATEAIAEKDAEMLDGLRKAGFKVDFGEDGSGLFMKYLRRGGGYYID 473 
e               MATVYPDLYTGSQMITATMKELDKDLVAALNRIGFRTDYGEEDTGQQMKFMRRGGGYYLN 462 
                 :  *  :          : * * ::   *.: **: *:*::.:*  **::***.***:: 
 
f               VGASELVADGSIHLVSG-QVDHLTEDAVVLTDGTELPADLVVYATGYGSMNGWAADLMGQ 526 
g               VGASELIASGEVSVKQGTEIDHFTPDGVVFADGTEMPVDVVVLATGYKNMRESARKFLGD 533 
e               VGCSDLLISGQVGLVQYADTAGFVAEGLSLTNGDVVEADAVILATGYQTQQEGVRALLGD 522 
                **.*:*: .*.: : .  :   :. :.: :::*  : .* *: **** . .  .  ::*: 
 
f               EVADKVGKCWGLGSDTTKDPGPWEGEQRNMWKPTQQEALWFHGGNLHQSRHYSLYLALQL 586 
g               AVADRCQDVWGLDA---------EGELRTVWRRSGHPGFWFMAGNLHQSRHYSKYLAFQI 584 
e               EIADAVGPIWGYDD---------EGEVRNTWRRTAQPGLWFSSGNFQLCRIYSKVLAMQI 573 
                 :**     ** .          *** *. *: : : .:** .**:: .* **  **:*: 
 
f               KARHEEIPTPVYGLQEVHHLS 607 
g               KAQEE-------GLQPIR--- 595 
e               RTELDN------G-------- 580 
                ::. :       *         
 
Legend:	  	   N-­‐term.	  extention	  	  	  	  
	   	   mutated	  residues	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All	  protein	  sequences	  of	  the	  cloned	  Rhodococcus	  jostii	  RHA1	  genes	  















































































































































































































































Other	  cloned	  Rhodococcus	  jostii	  RHA1	  flavoproteins	  	  























































E     Strep-E 
        Washfractions 
 
1        2        3        4       5 
25 mg / 1L 
                nmol 
 




              Elutionfractions 
 
1        2       3         4       5       6         7 
 combined Elution 
 
   1+4      2+3    5-7 
300 nmol 
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Ein	  Buch	  ist	  nicht	  nur	  ein	  Freund,	  es	  schafft	  Dir	  neue	  Freunde.	  	  
Wenn	  Du	  ein	  Buch	  in	  Gedanken	  und	  im	  Geist	  besessen	  hast,	  bist	  Du	  bereichert.	  
Aber	  wenn	  Du	  das	  Buch	  weitergegeben	  hast,	  bist	  Du	  dreifach	  bereichert.	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GELE	  VOORUITZICHTEN	  	  EEN	  STUDIE	  NAAR	  FLAVOPROTEIN	  MONOOXYGENASES	  	  
Enzymen,	  ook	  wel	  biokatalysatoren	  genoemd,	  zijn	  de	  werkers	  die	  in	  een	  levend	  organisme	  
alles	   op-­‐,	   af-­‐	   en	   ombouwen.	   In	   elk	   orgaan	   en	   elke	   cel	   zijn	   veel	   verschillende	   enzymen	  
aanwezig	  die	  de	  meest	  diverse	  taken	  kunnen	  uitvoeren.	  Zoals	  DNA	  het	  bouwplan	  van	  het	  
leven	  genoemd	  wordt,	  kan	  men	  enzymen	  de	  huiselfjes	  van	  het	  leven	  noemen.	  Want	  niet	  
alleen	  zijn	  ze	  onmisbaar	  in	  alle	  levende	  organismen,	  ze	  zijn	  ondertussen	  ook	  onmisbaar	  in	  
ons	   dagelijkse	   leven.	   We	   gebruiken	   enzymen	   namelijk	   voor	   vele	   taken.	   Zo	   zitten	   er	  
enzymen	  in	  wasmiddel	  en	  op	  teststrips	  waarmee	  kwaliteit	  van	  levensmiddelen	  getest	  kan	  
worden.	  Dit	  zijn	  maar	  twee	  van	  de	  vele	  diverse	  voorbeelden	  die	  genoemd	  zouden	  kunnen	  
worden.	  
Sinds	  de	  ontdekking	  van	  enzymen	  wordt	  er	  veel	  onderzoek	  naar	  gedaan.	  Niet	  alleen	  de	  
werking	   in	   levende	  organismes	  wordt	  onderzocht,	  maar	  ook	  wordt	  er	   gekeken	  naar	  het	  
gebruik	  van	  enzymen	   in	  de	  chemische/biotechnologische	   industrie.	  Zo	  worden	  enzymen	  
tegenwoordig	  vaak	  gebruikt	   in	  milieuvriendelijkere	  en/of	  goedkopere	  alternatieven	  voor	  
klassieke	  chemische	  industriële	  productie	  processen.	  
Enzymen	   zijn	   in	   staat	   om	   zeer	   complexe	   moleculen	   te	   produceren	   die	   via	   een	  
traditionele	  chemische	  route	  alleen	  zeer	  moeilijk,	  en	  daarmee	  vaak	  duur,	   te	  maken	  zijn.	  
Daarnaast	   worden	   enzymen	   ook	   steeds	   vaker	   gebruikt	   om	   alledaagse	   chemicaliën	   te	  
produceren.	   Enzymen	  kunnen	   in	   staat	   zijn	  onder	  mildere	  omstandigheden	  producten	   te	  
maken	  waarbij	  voor	  de	  klassieke	  chemische	  route	  bijvoorbeeld	  hoge	  druk	  of	  zeer	  giftige	  
oplosmiddelen	  nodig	  zijn.	  Tevens	  zorgt	  de	  hoge	  specificiteit	  van	  enzymkatalyse,	  ook	  wel	  
biokatalyse	   genoemd,	   ervoor	   dat	   producten	   vaak	   al	   zuiverder	   zijn	   waardoor	   er	   minder	  
gecompliceerde	  zuiveringsstappen	  nodig	  zijn.	  Bovendien	  zijn	  enzymen	  niet	  alleen	  zelf	  van	  
een	   biologische	   oorsprong	   (opgebouwd	   uit	   aminozuren),	   ze	   faciliteren	   ook	   het	   gebruik	  
van	   hernieuwbare	   grondstoffen	   en	   afvalproducten	   –	   en	   produceren	   daarmee	   weer	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biologisch	  afbreekbare	  producten.	  Dat	  alles	  komt	  het	  milieu	  ten	  goede	  en	  maakt	  enzymen	  
ideaal	  gereedschap	  in	  de	  industrie.	  
	  
De	  enzymen	  die	  in	  dit	  proefschrift	  worden	  behandeld	  (figuur	  NL-­‐1),	  behoren	  allemaal	  tot	  
de	   klasse	   oxidoreductases	   (EC1.x.x.x).	   Oxidoreductases	   zijn	   verantwoordelijk	   voor	   de	  
overdracht	   van	   elektronen	   in	   biochemische	   reacties.	   Enzymen	   worden	   daarnaast	   nog	  
verder	   geclassificeerd	   afhankelijk	   van	   de	   reactie	   de	   gekatalyseerd	   wordt.	   Onder	  
oxidoreductases	   vallen	   weer	   21	   enzymsoorten.	   De	   enzymen	   die	   in	   dit	   proefschrift	  
behandeld	   worden,	   behoren	   tot	   monooxygenases	   (EC	   1.13.xx	   en	   EC	   1.14.xx).	   Deze	  
subklasse	   is	   in	   staat	   om	   zuurstof	   (O2)	   te	   splitsen.	   Bij	   reacties	   van	   deze	   subklasse	  wordt	  
daarna	   één	   van	   de	   zuurstofatomen	   in	   een	   organisch	   substraat	   ingebouwd	   terwijl	   het	  
andere	  zuurstofatoom	  tot	  water	  (H2O)	  gereduceerd	  wordt.	  Dissociatie	  van	  zuurstof	  is	  niet	  
makkelijk	  en	  is	  alleen	  maar	  mogelijk	  door	  toevoeging	  van	  elektronen.	  Om	  elektronen	  toe	  
te	  voegen	  gebruikt	  het	  enzym	  een	  “hulpgereedschap”,	  namelijk	  een	  cofactor.	  In	  de	  natuur	  
bestaan	   vele	   verschillende	   “hulpgereedschappen”	   die	   op	   verschillende	   manieren	  
eenzelfde	   chemische	   overdracht	   mogelijk	   maken.	   De	   enzymen	   die	   hier	   besproken	  
worden,	  gebruiken	  als	  cofactor	  een	  flavine	  (zie	  paragraaf	  1.2).	  Een	  flavine	  cofactor	  is	  een	  
geel	   molecuul	   waardoor	   ook	   de	   enzymen	   die	   flavine	   bevatten	   geel	   zijn.	   Onder	  
monooxygenases	   zijn	   er	   zes	   subklassen	   (A-­‐F)	   die	   flavine	   als	   cofactor	   gebruiken.	   Deze	  
subklassen	   worden	   daarom	   flavoprotein	   monooxygenases	   genoemd.	   Alhoewel	   deze	  
enzymen	   dus	   allemaal	   flavine	   nodig	   hebben	   om	   zuurstof	   te	   activeren,	   katalyseren	   ze	  
vervolgens	  verschillende	   reacties.	  Het	   zuurstofatoom	  wordt	  door	  verschillende	  enzymen	  




Figuur	  NL-­‐1:	  Overzicht	  van	  de	  classificatie	  van	  de	  in	  dit	  proefschrift	  besproken	  enzymen.	  
	  
In	  dit	  proefschrift	  worden	  alleen	  klasse	  B	  monooxygenases	  behandeld.	  Dit	   zijn	  enzymen	  
die	  Baeyer-­‐Villiger	  oxidaties	  en	  oxidaties	  van	  heteroatomen	  verrichten	  (figuur	  NL-­‐2).	  
In	   figuur	   NL-­‐2	   is	   te	   zien	   dat	   er	   nog	   een	   ingrediënt	   nodig	   is	   om	   de	   reactie	   te	   laten	  
verlopen,	  namelijk	  een	  coenzym	  in	  de	  vorm	  van	  NAD(P)H	  (zie	  paragraaf	  1.3).	  Dit	  levert	  de	  
elektronen	   die	   de	   flavine	   cofactor	   gebruikt	   om	   het	   zuurstof	   te	   activeren.	   Een	  





























het	  coenzym	  NAD(P)H	  naar	  de	   flavine	   te	   transporteren.	  De	  enzymen	  uit	  andere	  enzyme	  
klassen	  (C-­‐F)	  hebben	  daarvoor	  nog	  weer	  een	  extra	  enzym	  nodig,	  een	  aparte	  reductase.	  
	  
Figuur	   NL-­‐2:	   Reacties	   die	   door	   klasse	   B	   monooxygenasen	   gekatalyseerd	   worden.	   R	   stelt	   verschillende	  
organische	  reststukken	  van	  het	  molecuul	  voor	  en	  x	  staat	  voor	  zwavel,	  stikstof,	  boor	  of	  selenium.	  
	  
Er	   bestaan	   twee	   versies	   van	   bovengenoemd	   coenzym	  met	   als	   enige	   verschil	   een	   extra	  
fosfaatgroep;	  NADH	  en	  NADPH.	  De	  fosfaatgroep	  heeft	  geen	  invloed	  op	  de	  reactiviteit	  van	  
het	   coenzym.	   Tot	   voor	   kort	   werd	   gedacht	   dat	   klasse	   B	   monooxygenases	   alleen	   met	  
NADPH	   functioneren.	  Wij	   hebben	   echter	   een	   nieuwe	   subklasse	   van	   enzymen	   gevonden	  
die	   ook	   NADH	   accepteert	   (Hoofdstuk	   5	   en	   6).	   Het	   probleem	   van	   de	   NADH	   en	   NADPH	  
coenzymen	  zijn	  echter	  de	  kosten	  ervan;	  NADH	  is	  al	  zeer	  duur,	  en	  NADPH	  is	  nog	  zo’n	  tien	  
keer	   zo	   duur.	   Dit	   maakt	   het	   gebruik	   van	   NAD(P)H-­‐afhankelijke	   enzymen	   minder	  
aantrekkelijk	   voor	   industriële	   toepassingen.	   Daarom	   wordt	   er	   veel	   gedaan	   om	   het	  
coenzym	  binnen	  de	  reactie	  te	  hergebruiken	  zodat	  er	  minder	  van	  het	  dure	  coenzym	  nodig	  
is.	  De	  meest	  aantrekkelijke	  methode	  om	  dit	  te	  doen	  lijkt	  om	  nog	  een	  extra	  enzym	  aan	  de	  
reactie	  toe	  te	  voegen.	  Dit	  extra	  enzym	  verbruikt	  een	  “offer”-­‐substraat	  en	  zet	  daarbij	  het	  
NAD(P)+	   weer	   om	   naar	   NAD(P)H.	   Door	   onze	   onderzoeksgroep	   is	   een	   expressiesysteem	  
ontwikkeld	   dat	   op	   DNA	   niveau	   een	   regeneratie-­‐enzym	   heeft	   gekoppeld	   aan	   een	  
monooxygenase.	   Dit	   expressiesysteem	   zorgt	   ervoor	   dat	   ons	   eiwit	   geproduceerd	   wordt	  
door	   de	   bacterie	   Escherichia	   coli.	   Het	   nieuwe	   expressiesysteem	   fuseert	   beide	   enzymen	  
met	  een	  linker	  en	  zorgt	  zo	  voor	  de	  productie	  van	  een	  bifunctioneel	  enzym	  (figuur	  NL-­‐3);	  
het	   CRE-­‐Systeem	   (coenzyme	   regenerating	   enzyme).	   Het	   enzym	   wat	   in	   dit	   geval	   aan	   de	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men	  dus	  alleen	  wat	  goedkoop	  substraat	  voor	  het	  PTDH	  toe	  te	  voegen	  (fosfiet)	  zodat	  het	  
systeem	  lang	  kan	  doorwerken	  met	  slechts	  een	  kleine	  hoeveelheid	  van	  het	  dure	  coenzym.	  	  
	  
Figuur	  NL-­‐3:	  Reacties	  die	  plaatsvinden	  met	  behulp	  van	  het	  bifunctionele	  CRE	  enzym.	  MO	  =	  monooxygenase,	  
PTDH	  =	  fosfiet	  dehydrogenase,	  R	  geeft	  verschillende	  organische	  reststukken	  van	  het	  molecuul	  aan.	  
	  
In	  Hoofdstuk	  2	  wordt	  de	  tweede	  generatie	  van	  het	  CRE-­‐systeem	  beschreven	  (CRE2).	  Het	  
originele	  systeem	  werd	  gelimiteerd	  door	  de	   lage	  stabiliteit	  van	  het	  PTDH	  die	  de	   looptijd	  
van	   het	   bifunctionele	   systeem	   negatief	   beïnvloedde.	   Om	   dit	   te	   verbeteren	   hebben	   we	  
gekozen	  voor	  een	  stabielere,	  genetisch	  geoptimaliseerde	  versie	  van	  het	  PTDH.	  Het	  gebruik	  
van	  het	  nieuwe	  PTDH	  voor	  het	  CRE2-­‐systeem	  heeft	  als	  bijkomend	  voordeel	  dat	  dit	  PTDH	  
tot	  hoge	  expressie	  heeft.	  Dat	  wil	  zeggen	  een	  cel	  kan	  relatief	  makkelijk	  veel	  van	  dit	  eiwit	  
produceren.	  Doordat	  het	  PTDH	  gefuseerd	  is	  aan	  een	  monooxygenase,	  verhoogt	  dit	  ook	  de	  
expressie	   van	   het	   bifunctionele	   enzym.	   Daarnaast	   hebben	  we	   ook	   de	   zuivering	   van	   het	  
bifunctionele	   enzym	   makkelijker	   gemaakt	   door	   er	   een	   zogenaamde	   His-­‐tag	   aan	   te	  
plakken.	   Dit	   nieuwe	   systeem	   is	   succesvol	   getest	   met	   andere	   NAD(P)H-­‐afhankelijke	  
enzymen	   en	   zeer	   efficiënt	   bevonden.	   Als	   laatste	   is	   ook	   nog	   onderzoek	   gedaan	   naar	   de	  
sequentie	   van	   de	   linker	   die	   de	   beide	   enzymen	   aan	   elkaar	   koppelt.	   Hier	   is	   echter	   geen	  
sequentie	  uitgekomen	  die	  het	  gehele	  systeem	  verbeterde.	  
Ondanks	  dat	  enzymen	  zeer	  veelzijdig	  zijn,	  is	  er	  nog	  niet	  voor	  elke	  reactie	  of	  substraat	  
de	  passende	  biokatalysator	  gevonden.	  Daarom	  wordt	  er	  veel	  onderzoek	  gedaan	  naar	  het	  
aanpassen	   van	   bekende	   enzymen	   om	   ze	   andere	   reacties	   te	   laten	   uitvoeren	   of	   andere	  
substraten	   te	   accepteren.	   Helaas	   zijn	   de	   methoden	   hiervoor	   erg	   onnauwkeurig	   en	  
voornamelijk	  gebaseerd	  op	  het	  trial-­‐and-­‐error	  principe.	  Deze	  methoden	  en	  experimenten	  























voor	   de	   verschillende	   flavoprotein	   monooxygenases	   speciale	   sequentie	   motieven	  
(fingerprint-­‐motief)	   waarmee	   potentiele	   kandidaten	   in	   databanken	   opgezocht	   kunnen	  
worden.	   In	  de	  verschillende	  databanken	  zijn	  alle	  bekende	  genomen,	  al	  het	  DNA	  van	  een	  
organisme,	   opgeslagen.	   In	   de	   databanken	   zijn	   ook	   vele	   bekende	   enzymsequenties	   (de	  
volgorde	  van	  de	  aminozuren	  waaruit	  ze	  bestaan)	  en	  de	  genen	  (een	  stuk	  DNA	  wat	  voor	  een	  
enzym	  codeert)	  te	  vinden.	  	  
Voor	   dit	   promotie-­‐traject	   is	   het	   genoom	   van	   de	   bodembacterie	   Rhodococcus	   jostii	  
RHA1	   met	   behulp	   van	   fingerprint-­‐motieven	   doorzocht	   en	   zijn	   interessante	   kandidaten	  
geïdentificeerd.	   R.	   jostii	   herbergt	   een	   uitzonderlijk	   groot	   aantal	   oxidatieve	   enzymen	  
waaronder	   meer	   dan	   40	   potentiele	   flavoprotein	   monooxygenases.	   De	   focus	   van	   dit	  
promotieonderzoek	   lag	   op	   twee	   subgroepen	   van	   klasse	   B	   monooxygenases;	   Type	   I	  
Baeyer-­‐Villiger	   monooxygenases	   (BVMOs)	   en	   flavine	   bevattende	   monooxygenases	  
(FMOs).	  Hoewel	  dergelijke	  enzymen	  niet	  ongewoon	  zijn	  in	  bacteriën	  en	  schimmels,	  heeft	  
elk	  micro-­‐organisme	   doorgaans	  maar	   ca.	   één	   BVMO	   gen	   en	   FMO’s	   zijn	   nog	   zeldzamer.	  
Met	   40	   potentiele	   kandidaten	   lijkt	   R.	   jostii	   dus	   een	   ongekend	   grote	   bron	   te	   zijn	   en	  
vanwege	   de	   kennis	   over	   de	   capaciteiten	   van	   dit	   organisme	   zijn	   de	   verwachtingen	   voor	  
deze	   kandidaten	   hoog.	   In	   totaal	   zijn	   er	   23	   BVMO’s,	   zeven	   FMO’s	   en	   nog	   verschillende	  
andere	  flavine	  afhankelijke	  enzymen	  geïdentificeerd,	  gekloneerd	  in	  E.	  coli	  en	  tot	  expressie	  
gebracht	   en	   geanalyseerd.	   In	   Hoofdstuk	   3	   worden	   de	   resultaten	   over	   de	   BVMOs	  
besproken	  en	  in	  Hoofdstuk	  4	  &	  5	  de	  resultaten	  over	  de	  FMOs.	  Om	  het	  analyseren	  van	  een	  
groot	   aantal	   samples	   makkelijker	   en	   efficiënter	   te	   maken	   zijn	   er	   twee	   nieuwe	  
analysemethodes	  ontwikkeld.	  Met	  de	  eerste	  methode	  is	  het	  mogelijk	  de	  concentratie	  van	  
NADPH-­‐afhankelijke	   enzymen	   te	   bepalen	   in	   het	   cellysaat,	   dit	   is	   de	   inhoud	   van	   een	   cel	  
nadat	   een	   cel	   is	   opengebroken.	   Dit	   zorgt	   ervoor	   dat	   het	   niet	   nodig	   is	   om	   complexe	   en	  
tijdrovende	  zuiveringsstappen	  uit	  te	  voeren.	  De	  tweede	  methode	  is	  een	  kwantitatieve	  test	  
voor	   het	   verbruik	   van	   NAD(P)H	   waarmee	   indirect	   enzymactiviteit	   bepaald	   wordt.	   Met	  
deze	  twee	  methoden	  kan	  een	  enzym	  snel	  voor	  zeer	  veel	  verschillende	  substraten	  getest	  
worden.	  De	  combinatie	  van	  beide	  testen	  staat	  een	  snelle,	  relatief	  goedkope	  en	  accurate	  
analyse	   van	   nieuwe	   enzymen	   toe.	   Bovendien	   hebben	   we	   op	   grond	   van	   de	   grote	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hoeveelheid	   data	   een	   nieuw	   sequentie	   motief,	   fingerprint-­‐motief,	   voor	   de	   identificatie	  
van	  BVMOs	  ontdekt.	  
Uit	  de	   resultaten	  van	  de	  FMO	  analyse	   (Hoofdstuk	  4)	  bleek	  dat	  het	  hier	   ging	  om	  een	  
nieuwe	   subgroep	   van	   klasse	   B	   monooxygenases;	   Type	   II	   FMOs.	   Alle	   zeven	   kandidaten	  
hebben	  het	  typische	  FMO	  sequentie	  motief	  maar	  katalyseren	  de	  omzetting	  van	  typische	  
substraten	  van	  Type	  I	  FMOs	  slecht.	  Ze	  zijn,	  in	  tegenstelling	  tot	  de	  andere	  subgroepen	  van	  
klasse	   B	   monooxygenases,	   in	   staat	   om	   niet	   alleen	   NADPH,	   maar	   ook	   het	   goedkopere	  
NADH	  als	   coenzym	   te	   gebruiken.	   Alleen	   al	   deze	   vaardigheid	  maakt	   ze	   zeer	   interessante	  
biokatalysatoren	   waarvan	   het	   substraatspectrum	   dringend	   onderzocht	   moet	   worden.	  
Bovendien	   waren	   drie	   enzymen	   van	   deze	   nieuwe	   subgroep	   in	   staat	   om	   Baeyer-­‐Villiger	  
oxidaties	  te	  katalyseren,	  een	  reactie	  die	  voorheen	  niet	  bij	  FMOs	  geobserveerd	  werd.	  Dit	  in	  
combinatie	   met	   de	   coenzym	   flexibiliteit	   maakt	   deze	   enzymen	   heel	   aantrekkelijk.	  
Hoofdstuk	  5	  gaat	  over	  het	  verdere	  onderzoek	  aan	  deze	  drie	  enzymen	  met	  betrekking	  tot	  
substraatbereik	  en	  kinetische	  eigenschappen.	  Aan	  de	  hand	  van	  modellen	  (zie	  Figure	  5-­‐4)	  
zijn	   de	   aminozuren,	   de	   bouwstenen	   van	   enzymen,	   van	   het	   potentiele	   actieve	   centrum	  
geïdentificeerd	  en	  hun	  invloed	  op	  de	  enzymactiviteit	  door	  mutatiestudies	  bevestigd.	  Alle	  
resultaten	  duiden	  op	  een	  zeer	   interessante	  nieuwe	  enzymklasse.	  Een	  bijzonder	  kenmerk	  
van	  deze	  enzymklasse	  lijkt	  een	  extra	  lange	  sequentie	  aan	  het	  enzymeinde	  te	  zijn.	  Hiermee	  
zijn	  meer	  potentiele	  kandidaten	  van	  deze	  enzymklasse	  in	  de	  verschillende	  databanken	  te	  
vinden.	  
	  
Naast	   de	   ontwikkeling	   van	   nieuwe	   methoden	   ter	   karakterisering	   van	   oxidatieve	  
enzymen	  heeft	  dit	  promotieonderzoek	  voor	  een	  verhoogd	  aantal	  gekarakteriseerde	  
BVMOs	  gezorgd.	  Maar	  dat	  niet	  alleen;	  door	  dit	  promotieonderzoek	  is	  er	  een	  nieuwe	  
en	   veelbelovende	   subgroep	   van	   de	   flavoprotein	   monooxygenase	   familie	   ontdekt.	  
Deze	  nieuwe	  Type	   II	  FMOs	  hebben	  de	  potentie	  de	  nieuwe	  sterren	  van	  de	  klasse	  B	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Heute	  mach	  ich	  mir	  kein	  Abendbrot.	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GELBE	  AUSSICHTEN	  	  STUDIEN	  ZU	  FLAVOPROTEIN	  MONOOXYGENASEN	  	  
Enzyme,	  auch	  Biokatalysatoren	  genannt,	  sind	  sozusagen	  die	  Handwerker,	  die	  in	  lebenden	  
Organismen	   alles	   auf-­‐,	   ab-­‐	   oder	   umbauen.	   Jedem	   Organ	   und	   jeder	   Zelle	   stehen	   die	  
unterschiedlichsten	   Enzyme	   für	   die	   verschiedensten	   Aufgaben	   zur	   Verfügung.	  Während	  
die	   DNA	   nur	   die	   Bauanleitung	   darstellt,	   sind	   die	   Enzyme	   durchaus	   als	   die	  
Heinzelmännchen	  des	  Lebens	  zu	  betrachten.	  Und	  nicht	  nur	  das,	  sie	  sind	  auch	  in	  der	  Lage,	  
ihre	   Tätigkeiten	   außerhalb	   vom	   lebenden	   Organismus	   durchzuführen,	   z.B.	   in	   der	  
Waschmaschine	  oder	  auf	  Teststreifen	  in	  der	  Lebensmittelkontrolle.	  
Seit	   ihrer	   Entdeckung	   werden	   Enzyme	   ausführlich	   studiert,	   insbesondere	   für	   den	  
Einsatz	   in	   der	   chemischen	   Industrie.	   Wurden	   sie	   zu	   Beginn	   eher	   als	   eine	   Spielerei	   der	  
Natur	   betrachtet,	   so	   hat	   sich	   daraus	  mittlerweile	   eine	   eigene	   Disziplin	   entwickelt	   –	   die	  
Biochemie	  und	  Biotechnologie	  –	  die	  sich	  derzeit	  zu	  einer	  ernstzunehmenden	  Alternative	  
zur	   klassischen	   chemischen	   Industrie	   etabliert,	   insbesondere	   im	   Hinblick	   auf	  
umweltfreundliche	  Verfahrensweisen.	  
Enzyme	  sind	  nicht	  nur	   in	  der	  Lage	  Stoffe	  herzustellen,	  die	  auf	  chemischem	  Wege	  nur	  
sehr	  kompliziert	  und	  somit	   teuer	   zu	  produzieren	  sind,	   immer	  häufiger	  ersetzen	  sie	  auch	  
Verfahren	   bei	   der	   Produktion	   von	   Alltags-­‐Chemikalien.	   Durch	   ihre	   Fähigkeit	   z.B.	   unter	  
milden	   Bedingungen	   und	   im	   Wässrigen	   zu	   arbeiten,	   machen	   sie	   Extrembedingungen	  
(hoher	  Druck	  oder	   Temperatur),	   sowie	   toxische	   Lösungsmittel	   überflüssig.	  Aufgrund	  der	  
hohen	   Spezifität	   der	   Enzymkatalyse	   ist	   oft	   auch	   die	   Reinheit	   der	   Produkte	   höher	   als	   im	  
konventionellen	  Verfahren	  und	  auf	  teure	  und	  komplizierte	  Aufreinigungsmethoden	  kann	  
verzichtet	  werden.	  Außerdem	   sind	   sie	   nicht	   nur	   selbst	   biologischer	  Herkunft	   (aufgebaut	  
aus	   Aminosäuren),	   sie	   ermöglichen	   oft	   auch	   die	   Verwertung	   von	   nachwachsenden	  
Rohstoffen	  und	  Abfallprodukten,	   und	  generieren	   ihrerseits	  wieder	  biologisch	   abbaubare	  
Produkte.	   Das	   alles	   schont	   Umwelt	   und	   Geldbeutel	   und	   macht	   Enzyme	   zu	   idealen	  
Werkzeugen	  für	  die	  Industrie.	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Die	   Enzyme,	   die	   in	   dieser	  Dissertation	   behandelt	  werden	   (Abbildung	  D-­‐1)	   gehören	   ganz	  
allgemein	  zur	  Klasse	  der	  Oxidoreduktasen	  (EC1.x.x.x)	  und	  sind	  somit	  für	  den	  Transfer	  von	  
Elektronen	   in	   biochemischen	   Reaktionen	   verantwortlich.	   Allerdings	   gibt	   es	   bei	   den	  
Enzymen,	   wie	   im	   Handwerk	   unterschiedliche	   Berufe,	   d.h.	   typische	   Reaktionen,	   die	   von	  
den	   einzelnen	   Enzymklassen	   katalysiert	   werden.	   Unter	   den	   Oxidoreduktasen	   gibt	   es	  
derzeit	   21	   verschiedene	   Spezialisierungen	   und	   die	   Enzyme,	   die	   in	   dieser	   Dissertation	  
erforscht	  werden,	   gehören	   zu	   den	  Monooxygenasen	   (EC	   1.13.xx	   und	   EC	   1.14.xx).	   Diese	  
Subklasse	  ist	  in	  der	  Lage	  Sauerstoff	  (O2)	  zu	  spalten.	  Bei	  den	  Reaktionen	  dieser	  Klasse	  wird	  
daraufhin	  eines	  der	  Sauerstoffatome	  in	  ein	  organisches	  Substrat	  eingebaut,	  während	  das	  
andere	   zu	  Wasser	   reduziert	  wird.	   Die	   Spaltung	   von	   Sauerstoff	   ist	   nicht	   einfach	   und	   nur	  
durch	  die	  Zuführung	  von	  Elektronen	  zu	  bewerkstelligen.	  Das	  Enzym	  benötigt	  dazu	  als	  eine	  
Art	  Werkzeug	  einen	  Cofaktor.	  In	  der	  Natur	  gibt	  es	  verschiedene	  solcher	  „Werkzeuge“,	  die	  
letztlich	  alle	  auf	  unterschiedliche	  Weise	  dieselbe	  chemische	  Transaktion	  ermöglichen.	  Im	  
Falle	  der	  hier	  betrachteten	  Enzyme	  ist	  der	  verwendete	  Cofaktor	  das	  Flavin	  (siehe	  Absatz	  
1.2),	  ein	  gelber	  Stoff,	  der	  auch	  den	  Enzymen	  die	  ihn	  beinhalten	  eine	  gelbe	  Farbe	  verleiht.	  
Unter	  den	  Monooxygenasen	  gibt	  es	  6	  Subklassen	  (A	  –	  F)	  die	  als	  Cofaktor	  „das	  Werkzeug“	  
Flavin	   für	   die	   Aktivierung	   des	   Sauerstoff	   verwenden,	   sie	   werden	   als	   Flavoprotein	  
Monooxygenasen	   bezeichnet.	   Allerdings	   katalysieren	   die	   Enzyme	   dieser	   Gruppe	   jedes	  
eine	   leicht	   unterschiedliche	   Reaktion,	   d.h.	   sie	   fügen	   das	   Sauerstoffatom	   in	   jeweils	  




Abbildung	  D-­‐1:	  Übersicht	  über	  die	  Klassifikation	  der	  hier	  diskutierten	  Enzyme.	  
In	  dieser	  Arbeit	  werden	  ausschließlich	  Enzyme	  der	  Subklasse	  B	  behandelt,	  Enzyme	  deren	  































Abbildung	   D-­‐2:	   Reaktionen	   katalysiert	   von	   Klasse	   B	   Monooxygenasen.	   R	   steht	   als	   Platzhalter	   für	  
unterschiedliche	   organische	   Reste	   im	   Molekül,	   x	   steht	   als	   Platzhalter	   für	   eines	   der	   folgenden	   Elemente:	  
Schwefel,	  Stickstoff,	  Bor,	  Selen.	  
Wie	   in	   Abbildung	   D-­‐2	   zu	   sehen	   ist,	   wird	   für	   die	   Reaktion	   außer	   Sauerstoff	   noch	   eine	  
weitere	   Zutat	   benötigt,	   das	   Coenzym	   NAD(P)H	   (siehe	   Absatz	   1.3).	   Dieses	   liefert	   die	  
Elektronen,	   die	   dann	   vom	   Flavin	   auf	   den	   Sauerstoff	   übertragen	   werden	   können.	   Eine	  
Besonderheit	   der	   Klasse	   B	   Monooxygenasen	   ist,	   dass	   sie	   selbst	   in	   der	   Lage	   sind,	   die	  
Elektronen	  vom	  Coenzym	  NAD(P)H	  auf	  das	  Flavin	  zu	  transportieren.	  Die	  Monooxygenasen	  
der	  anderen	  Klassen	  (C-­‐F)	  benötigen	  dafür	  ein	  extra	  Enzym,	  eine	  separate	  Reduktase.	  
Das	   Coenzym	   existiert	   in	   zwei	   Versionen,	   die	   sich	   strukturell	   nur	   durch	   eine	  
Phosphatgruppe	   unterscheiden	   (NADH	   und	  NADPH).	   Diese	   hat	   zwar	   keinen	   Einfluss	   auf	  
die	  Funktion,	  aber	  die	  Klasse	  B	  Monooxygenasen	  funktionieren	  ausschließlich	  mit	  NADPH	  
–	   das	   dachte	  man	   zumindest	   bisher:	   wir	   haben	   eine	   neue	   Subklasse	   gefunden,	   welche	  
auch	  NADH	  akzeptiert,	  mehr	  dazu	   in	  Kapitel	   5	  und	  6.	  Das	  Problem	  mit	  diesem	  Coenzym	  
sind	   die	   Kosten:	   NADH	   ist	   schon	   teuer,	   aber	   NADPH	   ist	   ca.	   zehnmal	   teurer,	   was	  
grundsätzlich	   alle	   Enzyme,	   die	   auf	   dieses	   Coenzym	   angewiesen	   sind,	   für	   die	   Industrie	  
unattraktiv	  macht.	  Es	  wird	  daher	  viel	  Aufwand	  betrieben,	  um	  dieses	  Coenzym	   innerhalb	  
eines	   Reaktionsansatzes	   zu	   recyceln.	   Als	   geeignetste	   Methode	   hat	   sich	   dabei	   die	  
Verwendung	   eines	   weiteren	   Enzyms	   im	   Reaktionsansatz	   erwiesen,	   welches	   in	   einer	  
zweiten	   Reaktion	   (unter	   Verbrauch	   eines	   billigen	   „Opfer“-­‐Substrats)	   das	   verbrauchte	  
NAD(P)+	   wieder	   zu	   NAD(P)H	   regeneriert.	   In	   unserem	   Labor	   haben	   wir	   ein	  
Expressionssystem	   entwickelt,	   das	   auf	   DNA	   Ebene	   sozusagen	   ein	   solches	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Monooxygenase	  verbindet	  und	  beide	  Enzyme	  zu	  einem	  bifunktionellen	  Enzym	  fusioniert	  
(Abbildung	  D-­‐3):	   das	   CRE-­‐System	   (Coenzyme	  Regenerating	  Enzyme).	  Mit	   diesem	   System	  
erhält	   man	   einen	   einfach	   zu	   handhabenden	   Biokatalysator,	   der	   unter	   Zugabe	   des	  
günstigen	   Opfer-­‐Substrates	   Phosphit	   mit	   einer	   sehr	   geringen	   Menge	   des	   teuren	  
Coenzymes	  auskommt.	  	  
	  
Abbildung	   D-­‐3:	   Reaktionen	   des	   bifunktionellen	   CRE	   Enzyms.	   MO	   =	   Monooxygenase,	   PTDH	   =	   Phosphit	  
Dehydrogenase,	  R	  steht	  als	  Platzhalter	  für	  unterschiedliche	  organische	  Reste	  im	  Molekül.	  
In	   Kapitel	   2	   wird	   die	   nächste	   Generation	   dieses	   Systems	   beschrieben	   (CRE2).	   Ein	  
limitierender	  Faktor	  im	  originalen	  System	  war	  die	  geringe	  Stabilität	  der	  PTDH,	  welche	  die	  
Laufzeit	   des	   Biokatalysators	   beschränkte.	   Zur	  Optimierung	  haben	  wir	   eine	   stabilere	   und	  
genetisch	   optimierte	   Version	   der	   PTDH	   verwendet.	   Da	   die	   PTDH	   ein	   leicht	   zu	  
exprimierendes	  Enyzm	  ist,	  wirkt	  sie	  bei	  der	  Expression	  des	  bifunktionalen	  Enzyms	  nun	  als	  
eine	   Art	   Zugpferd	   und	   erhöht	   somit	   zusätzlich	   die	   Expression	   der	   Monooxygenase.	   Als	  
weitere	   Neuerung	   haben	   wir	   einen	   kleinen	   Anhang	   (His-­‐tag)	   angefügt,	   der	   die	  
Aufreinigung	  des	  Biokatalysators	  erleichtert.	  Das	  neue	  System	  wurde	  erfolgreich	  auch	  mit	  
anderen	   NAD(P)H	   abhängigen	   Enzymen	   getestet	   und	   hat	   sich	   als	   äußerst	   effizient	  
erwiesen.	   Des	   Weiteren	   wurde	   die	   Sequenz,	   welche	   die	   beiden	   Enzyme	   miteinander	  
verbindet	  (linker)	  genauer	  untersucht,	  es	  konnte	  aber	  keine	  alternative	  Sequenz	  gefunden	  
werden	  welche	  die	  Eigenschaften	  des	  Gesamtkonstrukts	  verbesserte.	  	  
So	  vielseitig	  Enzyme	  auch	  sind,	   so	   ist	  doch	  noch	  nicht	   für	  alle	  Reaktionen	  und	  Substrate	  
das	   passende	  Werkzeug,	   sprich	   der	   optimale	   Biokatalysator	   gefunden.	   Derzeit	  wird	   viel	  
daran	  geforscht,	  um	  einzelne,	  bekannte	  Enzyme	  so	  zu	  verändern,	  dass	  sie	  auch	  alternative	  























noch	   sehr	   unpräzise	   und	   laufen	   meist	   nach	   dem	   Trial-­‐and-­‐Error	   Prinzip	   ab.	   Dennoch	  
ermöglichen	  solche	  Experimente	  genauere	  Informationen	  über	  die	  einzelnen	  Enzyme	  und	  
Enzymklassen.	   So	   existiert	   z.B.	   für	   die	   verschiedenen	   Untergruppen	   der	   Flavoprotein	  
Monooxygenasen	   ein	   spezielles	   Sequenzmotiv	   (fingerprint–Motiv),	   anhand	   dessen	  
potentielle	   Kandidaten	   in	   Datenbanken	   aufgespürt	   werden	   können,	   die	   sämtliche	  
analysierten	  DNA-­‐	  und	  Enzymsequenzen	  sammeln.	  	  
Für	   diese	   Dissertation	   wurde	   das	   Genom	   des	   Bodenbakteriums	   Rhodococcus	   jostii	  
RHA1	   mit	   Hilfe	   solcher	   Sequenzen	   durchmustert	   und	   die	   interessanten	   Kandidaten	  
identifiziert.	   R.	   jostii	   beherbergt	   eine	   ungewöhnlich	   große	   Anzahl	   oxidativer	   Enzyme,	  
darunter	   mehr	   als	   40	   potentielle	   Flavoprotein	   Monooxygenasen.	   Der	   Fokus	   dieser	  
Dissertation	  lag	  auf	  zwei	  Untergruppen	  der	  Klasse	  B	  Monooxygenasen:	  den	  Typ	  I	  Baeyer-­‐
Villiger	   Monooxygenasen	   (BVMOs)	   und	   den	   Flavin-­‐beinhaltenden	   Monooxygenasen	  
(FMOs).	  Zwar	  sind	  solche	  Enzyme	  bei	  Bakterien	  und	  Pilzen	  nicht	  selten,	  aber	  üblicherweise	  
findet	  sich	  nur	  ca.	  ein	  BVMO	  Gen	  pro	  Mikroorganismus,	  FMOs	  sind	  sogar	  noch	  seltener.	  	  
R.	  jostii	  stellt	  somit	  eine	  außergewöhnliche	  Quelle	  dar,	  und	  aufgrund	  der	  Kenntnisse	  über	  
die	   vielfältigen	   Fähigkeiten	   dieses	   Organismus	   sind	   die	   Erwartungen	   an	   seine	   Enzyme	  
hoch.	  Insgesamt	  wurden	  23	  BVMOs	  und	  sieben	  FMOs,	  sowie	  verschiedene	  andere	  Flavin	  
abhängige	  Enzyme	  identifiziert,	  kloniert,	  in	  E.	  coli	  exprimiert	  (=	  produziert)	  und	  analysiert.	  
In	  Kapitel	  3	  werden	  die	  Ergebnisse	  der	  BVMO	  Analyse	  beschrieben	  und	  in	  Kapitel	  4	  &	  5	  
die	   der	   FMOs.	   Um	   die	   zeit-­‐	   und	   bedingungsgleiche	   Analyse	   einer	   so	   großen	   Anzahl	   an	  
Enzymen	  bewältigen	  zu	  können,	  wurden	  zwei	  neue	  Methoden	  entwickelt.	  Eine	  Methode	  
dient	   der	   Bestimmung	  der	   Enyzmkonzentration	  NADPH	  abhängiger	   Enzyme	   im	   Zelllysat,	  
also	   dem	   Gesamtinhalt	   einer	   Zelle	   nach	   deren	   Aufbrechen,	   was	   eine	   aufwendige	   und	  
zeitraubende	  Aufreinigung	  der	  Enzyme	  überflüssig	  macht.	  Die	  zweite	  Methode	  stellt	  einen	  
quantitativen	  Test	  zum	  Nachweis	  des	  NAD(P)H	  Verbrauchs	  dar,	  wodurch	   indirekt	  auf	  die	  
Enzymaktivität	   geschlossen	   werden	   kann.	   Mit	   Hilfe	   dieses	   Tests	   kann	   ein	   Enzym	  
gleichzeitig	   und	   schnell	   für	   sehr	   viele	   verschiedene	   Substrate	   getestet	   werden.	   Die	  
Kombination	  beider	  Methoden	  erlaubt	  ohne	  großen	  Aufwand	  eine	  schnelle	  und	  dennoch	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akkurate	  Analyse	  neuer	  Enzyme.	  Zusätzlich	  konnten	  wir	  aufgrund	  der	  großen	  Datenmenge	  
ein	  neues	  Sequenz-­‐Motiv	  für	  die	  Identifikation	  von	  BVMOs	  in	  Datenbanken	  identifizieren.	  
Die	  Resultat	  der	  FMO	  Analyse	  (Kapitel	   4)	  ergab,	  dass	  es	  sich	  hierbei	  um	  eine	  eigene,	  
neue	   Untergruppe	   der	   Klasse	   B	   Monooxygenasen	   handelt:	   Typ	   II	   FMOs.	   Alle	   sieben	  
Kandidaten	   zeigen	   das	   typische	   FMO	   Sequenz-­‐Motiv,	   katalysieren	   aber	   die	   Umsetzung	  
typischer	  Substrate	  dieser	  Enzymklasse	  nur	  schlecht.	  Dafür	  sind	  sie	  –	  ganz	  im	  Gegenteil	  zu	  
allen	   anderen	   Untergruppen	   der	   Klasse	   B	   Monooxygenasen	   –	   in	   der	   Lage,	   nicht	   nur	  
NADPH,	   sondern	   auch	  das	   günstigere	  Coenzym	  NADH	   zu	   verwenden.	   Schon	  allein	  diese	  
Fähigkeit	   macht	   sie	   zu	   äußert	   interessanten	   Biokatalysatoren,	   deren	   natürliches	  
Substratspektrum	  dringend	  erforscht	  werden	  sollte.	  Drei	  Enzyme	  innerhalb	  dieser	  neuen	  
Gruppe	   waren	   zusätzlich	   noch	   in	   der	   Lage	   typische	   Baeyer-­‐Villiger	   Oxidationen	  
durchzuführen,	  eine	  Reaktion,	  die	  von	  FMOs	  üblicherweise	  nicht	  ausgeführt	  wird	  –	  aber	  
besonders	   zusammen	   mit	   der	   Coenzym	   Flexibilität	   eine	   äußerst	   attraktive	   Fähigkeit	  
darstellt.	   Aufgrund	   dessen	   haben	   wir	   diese	   drei	   Kandidaten	   in	   Kapitel	   5	   genauer	  
untersucht,	   weitere	   Substrate	   getestet	   und	   ihre	   kinetischen	   Eigenschaften	   analysiert.	  
Anhand	   eines	   Modells	   (siehe	   Figure	   5-­‐4)	   wurden	   die	   Aminosäuren	   des	   potentiellen	  
aktiven	   Zentrums	   identifiziert	   und	   ihr	   Einfluss	   auf	   die	   Enzymaktivität	   durch	  
Mutagenesestudien	  bestätigt.	  All	   diese	  Daten	  deuten	  auf	  eine	  höchst	   interessante	  neue	  
Enzymklasse	   hin.	   Ein	   besonderes	   Merkmal	   scheint	   eine	   extralange	   Sequenz	   am	  
Enzymende	   zu	   sein,	   mit	   deren	   Hilfe	   sich	   viele	   weitere	   potentielle	   Kandidaten	   in	   den	  
Datenbanken	  finden	  lassen.	  
	  
Neben	   der	   Entwicklung	   und	   Bereitstellung	   neuer	  Methoden	   zur	   Charakterisierung	  
oxidativer	   Enyzme	   hat	   diese	   Dissertation	   nicht	   nur	   die	   Anzahl	   charakterisierter	  
BVMOs	   drastisch	   erhöht,	   sondern	   stellt	   auch	   die	   Geburtsstunde	   eines	   neuen	   und	  
vielversprechenden	  Mitglieds	   der	   Flavoprotein	  Monooxygenase	   Familie	   dar.	   Diese	  
neuen	   Typ	   II	   FMOs	   haben	   das	   Potential	   die	   neuen	   Stars	   der	   Klasse	   B	  
Monooxygenasen	  zu	  werden,	  sozusagen	  mit	  glänzend	  gelben	  Aussichten...	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Bei	  Interesse	  steht	  hier	  eine	  drei-­‐minütige	  Einführung	  zum	  Thema	  Enzyme	  zur	  Verfügung,	  
live	  von	  meinem	  Auftritt	  bei	  “FameLab	  2013”	  in	  Leipzig.	  	  
	  
“Von	  Werkzeugkästen	  und	  Heinzelmännchen”	  
	  
	   158 
	   	  
	   159 
how	  to	  be	  an	  artist	  
stay	  loose.	   learn	  to	  watch	  snails.	  plant	  impossible	  gardens.	   invite	  someone	  dangerous	  to	  
tea.	  make	  little	  signs	  that	  say	  yes!	  and	  post	  them	  all	  over	  your	  house.	  make	  friends	  with	  
freedom	  and	  uncertainty.	  look	  forward	  to	  dreams.	  cry	  during	  movies.	  swing	  as	  high	  as	  you	  
can	   on	   a	   swingset	   by	  moonlight.	   cultivate	  moods.	   refuse	   to	   be	   “responsible“.	   do	   it	   for	  
love.	   take	   lots	   of	   naps.	   give	  money	   away.	   do	   it	   now.	   the	  money	  will	   follow.	   believe	   in	  
magic.	   laugh	   a	   lot.	   celebrate	   every	   gorgeous	   moment.	   take	   moonbaths.	   have	   wild	  
imaginings,	  transformative	  dreams,	  and	  perfect	  calm.	  draw	  on	  the	  walls.	  read	  every	  day.	  
imagine	  yourself	  enchanted.	  giggle	  with	  children.	  listen	  to	  old	  people.	  open	  up.	  dive	  in.	  be	  
free.	  bless	  yourself.	  drive	  away	  fear.	  play	  with	  everything.	  entertain	  your	  inner	  child.	  you	  
are	  innocent.	  build	  a	  fort	  with	  blankets.	  get	  wet.	  hug	  trees.	  write	  love	  letters...and	  dance	  
as	  much	  as	  you	  can!	  
	  








Finally	  done!	  	  
Done?	  	  
Probably	  not.	  	  
And	  even	  if	  it	  would	  be	  –	  I	  am	  sure	  I´d	  find	  something	  that	  could/should	  have	  been	  better	  
in	  this	  or	  that	  way...I	  guess	  that´s	  life	  J	  
	  
Something	   that	   could	  definitely	   not	  have	  been	  better	   are	   the	  people	   I	   have	  met	   in	   this	  
wonderful	  city	  of	  Groningen!	  	  
	  
But	   before	   I	   start	   getting	   lost	  mentioning	   all	   these	   great	   people,	   I	  want	   to	   thank	   some	  
special	  ones:	  my	  PhD	  Supervisor	  Prof.	  Marco	  Fraaije	  for	  blindsiding	  me	  with	  the	  chance	  to	  
make	  a	  PhD	  in	  the	  Netherlands.	  It	  was	  you,	  who	  inspired	  me	  to	  give	  science	  a	  new	  chance,	  
to	  try	  this	  adventure	  of	  making	  a	  PhD	  abroad	  and	  who	  gave	  me	  the	  freedom	  to	  develop	  
and	  find	  to	  myself	  within.	  You	  are	  a	  great	  supervisor	  –	  never	  stop	  being	  this	  friendly,	  easy	  
going	  and	  young	  minded!	  
Actually,	  at	  that	  point	  I	  also	  have	  to	  thank	  Prof.	  Dick	  Janssen.	  Not	  only	  for	  having	  Marco	  
around	  –	  and	  therefore	  also	  us	  “Fraaijos”	  –	  but	  especially	  for	  giving	  Sebastian	  the	  chance	  
to	   spend	   this	   time	   together	   with	   me	   in	   Groningen.	   I	   think	   we	   both	   agree	   that	   my	  
persistent	  reminders	  to	  deal	  with	  “this	  application	  from	  Germany”	  were	  a	  good	  idea…	  
	  
However,	   all	   this	   could	   not	   have	   been	   finished	   without	   the	   members	   of	   the	   reading	  
committee:	   Prof.	   Dr.	   L.	   Dijkhuizen,	   Prof.	   Dr.	   G.J.W.	   Euverink	   and	   Prof.	   Dr.	   W.J.H.	   van	  
Berkel.	  Thank	  you	  for	  taking	  the	  time	  to	  go	  through	  these	  few	  (…)	  pages	  and	  the	  helpful	  
suggestions.	   Also	   for	   taking	   part	   in	   my	   defence	   ceremony	   together	   with	   Prof.	   Dr.	   D.B.	  
Janssen,	   Prof.	   Dr.	   J.G.	   Roelfes	   and	   Jun.-­‐Prof.	   Dr.	   A.	   Schallmey.	   Here,	   I	   want	   to	   specially	  
thank	  Anett.	  Du	  hast	  mich	  fast	  mein	  ganzes	  bisheriges	  wissenschaftliches	  Leben	  begleitet	  
und	  warst	  mir	  immer	  eine	  große	  Hilfe!	  In	  Greifswald	  eher	  zufällig	  aufgrund	  der	  ähnlichen	  
Namen	   einander	   zugeordent,	   setzte	   sich	   die	   Zusammenarbeit	   sogar	   bis	   in	   das	   “ferne”	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Ausland	   fort	   –	   unabhängig	   voneinander	   geplant	   aber	   dafür	   umso	   schöner.	   Es	   fühlt	   sich	  
einfach	  richtig	  an,	  dass	  du	  heute	  hier	  mit	  dabei	  bist.	  Vielen	  Dank!	  
	  
From	   an	   organisational	   point	   of	   view,	   the	   next	   thank	   should	   probably	   go	   to	   my	  
Paranymphs	  Ana	  and	  Gosia.	  But	  I	  do	  not	  only	  want	  them	  mentioned	  here	  because	  of	  their	  
“Paranymph	  duty”:	  dear	  Ana	  and	  Gosia,	  I	  am	  very	  grateful	  for	  our	  friendship!	  	  
“Paranimfen”	  are	  a	  nice	  Dutch	  tradition	  that	  support	  and	  escort	  the	  Promovendus	  during	  
the	  defense	  ceremony.	  Nowadays	  it	  is	  a	  more	  symbolic	  and	  decorational	  function	  and	  less	  
protective	  and	  scientifically	  relevant	  than	  it	  used	  to	  be.	  However,	  you	  should	  choose	  them	  
carefully	  and	  often	  they	  represent	  your	  closest	   friends.	  Unfortunately	   the	  system	  allows	  
only	   two	   of	   them…	   I	   am	   really	   glad	   that	   choosing	   this	   couple	   was	   a	   tough	   decision,	  
meaning	   that	   I	   had	   more	   of	   such	   real	   friends	   that	   were	   beside	   me	   almost	   from	   the	  
beginning!	   Like	   Hanna	   for	   example.	   I	   will	   not	   start	   making	   a	   list	   here,	   the	   respective	  
people	  know…	  all	   I	  want	  to	  say	  to	  these	  special	  friends	  is	  THANK	  YOU	  for	  your	  company	  
and	  for	  sharing	  your	  lives	  with	  me!	  We	  will	  continue	  and	  I	  am	  looking	  forward	  to	  that!	  	  
	  
With	   finishing	   this	   book,	   a	   special	   thank	   goes	   to	  Geeske	   for	   the	   summary	   translation	   –	  
without	  her,	  the	  “nederlandse	  leek”	  might	  have	  had	  a	  hard	  time	  reading	  selfsame	  book	  J.	  
	  
Some	  other	  group	  also	  had	  a	  quite	  important	  influence	  on	  the	  outcome	  of	  this	  book	  –	  the	  
‘stuff’	  behind	  the	  scenes:	  our	  technician	  Piet	  and	  the	  secretaries	  Sandra	  and	  Karlien.	  Only	  
because	   of	   you	   everything	   can	   run	   so	   smoothly!	   We	   all	   know	   that,	   even	   though	   we	  
probably	  do	  not	  often	  enough	  tell	  you	  so.	  That´s	  why	  I	  do	  it	  here:	  THANK	  YOU!	  
	  
The	  next	  group	  I	  want	  to	  thank	  are	  my	  BIOMOX	  fellow	  ladies	  Evelien,	  Stephania,	  Harini	  –
and	   the	   first	   lady	  of	  all:	  René.	   It	  was	  nice	   to	  meet	  you	   regularly	   throughout	   the	  year	  at	  
different	  places	   in	  the	  Netherlands.	  And	   it	  was	  great	  to	  see	  all	  our	  projects	  develop	  and	  
grow	  together	  to	  one	  big	  project.	   It	   is	  a	  pity	  that	   it	  ended	  when	  finally	  all	  our	   individual	  
projects	  reached	  a	  stage	  where	  we	  eventually	  could	  work	  together,	  despite	  the	  distance	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of	  our	  labs	  –	  but	  the	  way	  scientific	  research	  is	  organized	  it	  will	  always	  be	  like	  that:	  funding	  
is	  over	  when	  the	  really	   interesting	  results	   finally	  come…	  It	  seems	   in	   this	  point	   there	   is	  a	  
correlation	  between	  life	  and	  science…	  However,	  the	  end	  of	  one	  thing	  is	  just	  the	  beginning	  
of	  something	  new	  and	  working	  with	  you	  was	  a	  nice	  experience	  to	  take	  along.	  I	  wish	  us	  all	  
a	  happy	  continuation	  on	  whatever	  and	  wherever	  we	  want	  it!	  	  
	  
Another	   few	   fellows	   that	   made	   these	   years	   special	   are	   my	   two	   and	   a	   half	   bachelor	  
students	  Willem,	  Alrik	  and	  “half”	  Michael,	  and	  our	  apprentice	  Raoul.	  It	  was	  a	  pleasure	  to	  
teach	  you	  and	  guide	  you	  through	  the	  lab	  –	  and	  to	  take	  part	  in	  your	  lives	  as	  well.	  You	  gave	  
me	   the	  opportunity	   to	  work	  on	  a	   totally	  different	  aspect	  of	   science	  –	   the	  personal	  one.	  
You	  showed	  me	  that	  I	  really	  like	  that.	  Thank	  you!	  
	  
Next	   I	  want	  to	  thank	  all	  my	  office	  mates	   in	  the	  “baby	  office”.	  You	  were	  not	  only	  a	  good	  
address	  for	  scientific	  questions	  –	  here	  I	  especially	  want	  to	  thank	  Edwin	  and	  Danny	  –	  as	  the	  
inofficial	  name	  of	  the	  office	  already	   implies,	   I	  also	   learned	  a	   lot	  about	  raising	  children	   in	  
these	   few	   years	  J.	   It	   might	   well	   be	   that	   the	   surprisingly	   productive	   bird	   and	   tomato	  
experiments	  are	  a	  result	  of	  the	  fertile	  environment	  –	  thank´s	  for	  tolerating	  my	  little	  side	  
projects,	  and	  not	  letting	  them	  die	  during	  my	  holidays.	  
	  
The	  group	  is	  of	  course	  much	  bigger	  than	  just	  one	  office	  and	  I	  really	  enjoyed	  the	  people	  we	  
had	  around.	  Thank	  you	   for	   the	  nice	  atmosphere,	   the	   insight	   into	  your	  different	  cultures	  
and	  sharing	  of	  your	  knowledge.	  Thank	  you	  for	  the	  many	  hours	  in	  the	  coffee	  corner	  or	  at	  
restaurants,	  both,	  during	  lunch	  time	  at	  the	  campus	  or	  in	  the	  evenings	  in	  the	  city	  –	  or	  the	  
best	   dinners	   of	   all,	   self	   cooked	   at	   home.	   Thank	   you	   for	   the	   borrels	   and	   private	   parties.	  
Thank	  you	  for	  the	  excursions	  you	  took	  me	  along	  or	  joined	  my	  ideas.	  Thank	  you	  for	  all	  the	  
support	   I	   received	   during	   the	   years	   and	   that	   you	   always	   agreed	   with	   my	   present	  
suggestions	   (you	   cannot	   imagine	   how	   I	   felt	  when	   I	   heard	   “Anette´s	   pret-­‐pakket”	  was	   a	  
serious	  wish	  on	  an	  official	  wish	  list).	  Thank	  you	  for	  gladly	  having	  been	  my	  “culinary	  guinea	  
pig”	  and	  always	  having	  liked	  my	  cakes	  J.	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All	  these	  “Thanks”	  include	  of	  course	  also	  the	  numerous	  guests	  from	  all	  over	  the	  world	  we	  
had	   in	   these	   years,	   as	   well	   as	   several	   members	   of	   the	   other	   groups	   in	   the	   “centre	   of	  
‘rondje	  lab’”!	  	  
Now	  substract	  the	  work	  related	  “Thanks”	  and	  apply	  the	  list	  to	  all	  the	  other	  friends	  I	  made	  
here,	  mainly	   found	   in	  dutch	   classes,	   couch	   surfing	  events	   and	   “Expats	  of	  Groningen”	  or	  
GRASP	  (the	  PhD	  student	  network,	  now	  called	  Gopher)	  activities.	  	  
I	  did	  not	  only	   spend	  my	   time	  with	   foreigners	   (even	   though	   that	   is	  often	  much	  easier	   to	  
realize	  and	  organize	  than	  really	  meeting	  and	  getting	  to	  know	  a	  real	  Dutch…)	  I	  also	  spend	  
some	  time	  with	  “natives”,	  mainly	  playing	  or	  dancing	  J.	  There	  is	  first	  to	  mention	  the	  huge	  
balfolk	  community	  in	  the	  Netherlands	  that	  is	  really	  active	  throughout	  the	  whole	  country.	  
Last	   but	   not	   least	   I	  want	   to	  mention	   the	   spellenvereiniging	   Rabenhaupt,	  where	   I	   spend	  
most	  of	  my	  Sunday	  nights.	  To	  be	  honest,	  this	  is	  where	  I	  really	  learned	  my	  Dutch...	  
	  
And	  then	  there	  is	  still	  the	  most	  important	  person	  of	  all:	  Lieber	  Sebastian,	  vielen	  Dank,	  dass	  
du	   immer	   für	   mich	   da	   warst	   und	   bist,	   und	   zwar	   ganz	   egal	   wo.	   Viele	   Beziehungen	  
überleben	  es	   nicht	  wenn	  mehrere	  Hundert	   Kilometer	   dazwischen	   liegen,	   bei	   uns	   hat	   es	  
geklappt.	   Allerdings	  will	   ich	   auch	   nicht	   bestreiten,	   dass	   es	   sehr	   schön	  war,	   dass	   du	  mir	  
letztlich	   ins	   Ausland	   gefolgt	   bist	   -­‐	   deine	   Anwesenheit	   hat	   nicht	   unerheblich	   zu	   dem	  
positiven	  Fazit	  über	  den	  Aufenthalt	   in	  den	  Niederlanden	  beigetragen	  J.	  Hier	  haben	  wir	  
auch	  endlich	  das	  Experiment	  “zusammenwohnen”	  ausprobieren	  können	  –	  und	  ich	  glaube	  
behaupten	  zu	  können,	  dass	  es	  ganz	  großartig	  funktioniert...	  Auch	  die	  Tatsache,	  dass	  dies	  
jetzt	   schon	   das	   zweite	   wissenschaftliche	   Buch	   ist,	   in	   dem	   ich	   mich	   bei	   dir	   für	   deine	  
Unterstützung	  und	  deine	  Geduld	  mit	  mir	  bedanken	  kann	  macht	  mir	  Mut	  für	  die	  Zukunft.	  
Ich	  freue	  mich	  schon	  auf	  die	  nächsten	  gemeinsamen	  “Experimente”…	  	  
	  
Auch	   meiner	   Familie	   möchte	   ich	   für	   ihre	   Unterstützung	   danken,	   sowie	   für	   die	   vielen	  




Finally	  I	  can	  just	  say,	  that	  this	  time	  in	  the	  Netherlands	  was	  great	  –	  and	  you	  all	  were	  part	  of	  
this	  greatness.	   I	  will	  miss	   the	  canals	   in	  every	  city,	  everything	  that	  can	  be	  described	  with	  
that	   unique	   dutch	   expression	   “gezellig”,	   the	   cows	   on	   every	   inch	   of	   grass,	   the	   cute	  
language,	   the	   borrels,	   the	   old-­‐fashioned	   windmills	   on	   the	   horizon,	   myriads	   of	   flowers,	  
pepernoten,	  the	  market	  culture,	  the	  healthy	  working	  attitude,	  the	  gadget	  shops,	  the	  cozy	  
villages,…	  and	  yes,	   even	  a	   kroket	  now	  and	   then.	   I	   learned	   so	  much	  besides	   science	  and	  
language!	  Here	  I	  met	  the	  whole	  world	  in	  so	  many	  different	  ways	  and	  tastes.	  	  
Thank	  you	  just	  for	  having	  been	  at	  the	  same	  place	  where	  I	  was	  at	  the	  very	  same	  moment!	  
For	  all	  the	  upcoming	  moments	  in	  your	  life	  I	  wish	  you	  all	  the	  best	  –	  and	  I	  hope	  we	  might	  
share	  a	  few	  more	  ones	  together!	  	  
(You	  probably	  don´t	  know	  this	  yet,	  but	   I	  never	  forget	  anyone	   I	   like	  –	  that’s	  a	  promise.	   If	  
you	  see	  that	  now	  as	  an	  honor	  or	  a	  challenge,	  well	  that’s	  up	  to	  you	  J.)	  
	  
In	  the	  end,	  I	  would	  like	  to	  give	  you	  a	  small	  gift	  to	  remind	  you	  of	  me	  –	  as	  often	  as	  you	  want.	  
I	  know	  how	  difficult	  the	  food	  situation	  in	  the	  Netherlands	  is,	  so	  just	  with	  you	  I	  will	  share	  a	  
piece	  of	  my	  childhood:	  my	  very	  special	   recipe	   for	  my	  world	   famous,	   traditionally	  pfälzer	  
(the	   palatinate,	   a	   special	   area	   in	   Germany),	   but	   personally	   perfectionized	   redwine	   cake	  
that	  we	  shared	  on	  so	  many	  occasions.	  And	  as	  typically	   for	  any	  of	  my	  gifts	   it	  comes	  with	  
lots	   of	   ingredients	   and	   comments	   that	   just	   together	   unfold	   its	   complete	   and	   complex	  
(tasting)	  beauty….	  
	  






Anette´s world famous, traditionally pfälzer but personally perfectionized 
redwine cake 
 
First grease a baking form and place it in the fridge (that cake loves to stick on the form, 
so this is just a try to trick it… at least I always had the impression that it works better 
this way – but maybe it’s just superstition). 
 
Mix 250g flour, 200g sugar, 2 tea spoons cinnamon (or probably more – as much as I know 
me… You can also add a hint of ground ginger, anise and ground gloves, I do that sometimes, 
depending on my mood on the baking day J), 2 table spoons cacao, 1 package baking powder 
and vanilla sugar each and 150g chocolate sprinkles (alternatively all sorts of crushed 
Nikoläuse / Sinterklaases / Santa Clauses or easter bunnys…). 
 
In a separate bowl mix the wet stuff: 3 eggs, 250ml redwine and 1/3 of a 500g margarine 
package J (you are old enough to calculate that yourself).  
Now mix wet and dry stuff together. Cover the form (remember? its still in the fridge) with 
some flour and pour in the dough. Then bake it for around 1h at 180°C. 
 
After its cooled down the original receipe now covers the cake with a layer of sugar icing 
(powdered sugar with a few spoons of redwine). For me the cake is already sweet enough, 
so I just sift a bit of powdered sugar over it to give it some homogenous colour. Another 
tasty alternative actually is a melted chocolate frosting.  
 
And NO, I will not add any reference here. True enough, it is based on a traditional recipe 
from the german area “Pfalz” (where all the good german wines grows…), but the amounts 
of the sinlge ingredients are so much modified, that I claim it to be my own invention! 
(What makes this book now not only a thesis, but also an official reference for a cake – 
does that mean that its place is as much in the kitchen as it is in the lab?  
Whatever, I think I like that idea, it’s a great one J!)	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Anette	   Riebel	   was	   born	   on	   October,	   15th	   1983	   in	   Worms	   ‘am	   Rhein’	   (at	   the	   river	  
Rhine),	  one	  of	  the	  oldest	  cities	  in	  Germany	  and	  scenery	  of	  the	  Nibelungen	  Saga.	  She	  grew	  
up	   loving	   the	  historically	   and	  mythically	   impact	   all	   around	  what	   strongly	   influenced	  her	  
predilections	   when	   choosing	   her	   myriads	   of	   hobbies.	   Since	   the	   age	   of	   four	   she	   was	  
musically	  educated	  and	  proofed	  to	  be	  a	  talented	  pianist	  and	  singer.	  However,	  against	  all	  
expectations	  she	  did	  not	  make	  music	  her	  profession	  but	  decided	  to	  study	  biochemistry.	  	  
She	  chose	  the	  Ernst-­‐Moritz-­‐Arndt	  University	  in	  Greifswald	  and	  moved	  to	  the	  other	  side	  
of	  Germany	  after	  finishing	  the	  higher	  education	  (Eleonoren	  Gymnasium,	  Abitur)	   in	  2002.	  
Greifswald	   is	  placed	  close	   to	   the	  Baltic	  Sea	  and	  part	  of	   the	   former	  East	  Germany	   (DDR);	  
now,	   fully	   restored,	   an	   absolutely	   adorable	   village.	   During	   the	   five	   years	   of	   studies	   she	  
specialized	   on	   molecular	   biology	   (Prof.	   R.	   Walther)	   and	   biotechnology	   (Prof.	   U.T.	  
Bornscheuer).	  	  
After	   receiving	   her	   diploma	   degree	   in	   2007	   she	   felt	   that	   it	   is	   time	   to	   also	   taste	   life	  
outside	  the	  German	  borders	  and	  went	  to	  the	  Netherlands	  to	  continue	  her	  scientific	  career	  
as	  a	  doctoral	  candidate.	  More	  precisely	  she	  went	  to	  Groningen,	  one	  of	  the	  most	  beautiful	  
cities	  in	  the	  Netherlands.	  Within	  the	  BIOMOX	  project	  she	  explored	  different	  flavoenzymes	  
in	   the	   Molecular	   Enzymology	   group	   of	   Prof.	   M.W.	   Fraaije	   at	   the	   Rijksuniversiteit	  
Groningen.	  As	  the	  Netherlands	  are	  full	  of	  expats,	  these	  years	  where	  quite	  an	  international	  
experience,	   leaving	  Anette	  with	  more	   impressions	   and	  worldwide	   connections	   than	   she	  
ever	  thought	  of.	  She	  is	  very	  grateful	  for	  both,	  Dutch	  and	  international	  experience	  and	  not	  
sure	  if	  she	  already	  had	  enough	  of	  it	  yet	  –	  the	  world	  is	  still	  so	  big	  and	  tempting…	  
At	  the	  moment	  she	  is	  back	  in	  Germany	  and	  working	  at	  the	  university	  of	  Leipzig	  –	  up	  to	  
now	  the	  closest	  place	  to	  home	  since	  she	  left	  Worms	  10	  years	  ago.	  In	  her	  current	  position	  
she	   is	   operating	   at	   the	   interface	   between	   research,	   industry	   and	   public	   by	   helping	  
scientists	  to	  successfully	  start	  a	  business	  with	  their	  research	  results.	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The	  great	  tragedy	  of	  Science	  –	  
the	  slaying	  of	  a	  beautiful	  hypothesis	  by	  an	  ugly	  fact.	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